0001193125-23-122355.txt : 20230427 0001193125-23-122355.hdr.sgml : 20230427 20230427163146 ACCESSION NUMBER: 0001193125-23-122355 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230427 DATE AS OF CHANGE: 20230427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHECK POINT SOFTWARE TECHNOLOGIES LTD CENTRAL INDEX KEY: 0001015922 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 943229135 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 000-28584 FILM NUMBER: 23857632 BUSINESS ADDRESS: STREET 1: 5 HA' SOLELIM STREET CITY: TEL AVIV, ISRAEL STATE: L3 ZIP: 67897 BUSINESS PHONE: 650-628-2000 MAIL ADDRESS: STREET 1: 959 SKYWAY ROAD STREET 2: SUITE 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 20-F 1 d473301d20f.htm 20-F 20-F
Table of Contents
falseFY0001015922L3Represents an amount lower than 0.1As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset. 0001015922 2021-12-31 0001015922 2022-12-31 0001015922 2022-01-01 2022-12-31 0001015922 2021-01-01 2021-12-31 0001015922 2020-01-01 2020-12-31 0001015922 2020-12-31 0001015922 2019-12-31 0001015922 us-gaap:FairValueInputsLevel1Member us-gaap:CashMember 2021-12-31 0001015922 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001015922 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001015922 us-gaap:CashMember 2021-12-31 0001015922 us-gaap:MoneyMarketFundsMember 2021-12-31 0001015922 us-gaap:BankTimeDepositsMember 2021-12-31 0001015922 us-gaap:SubscriptionArrangementMember 2021-12-31 0001015922 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2021-12-31 0001015922 chkp:OtherArrangementMember 2021-12-31 0001015922 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001015922 us-gaap:FairValueInputsLevel2Member chkp:GovernmentAndCorporateDebenturesFixedInterestRateMember 2021-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFixedInterestRateMember 2021-12-31 0001015922 chkp:GovernmentSponsoredEnterprisesDebenturesMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001015922 chkp:GovernmentSponsoredEnterprisesDebenturesMember 2021-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFloatingInterestRateMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFloatingInterestRateMember 2021-12-31 0001015922 country:IL 2021-12-31 0001015922 country:US 2021-12-31 0001015922 chkp:RestOfWorldMember 2021-12-31 0001015922 chkp:CoreTechnologyMember 2021-12-31 0001015922 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001015922 us-gaap:CustomerRelationshipsMember 2021-12-31 0001015922 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001015922 us-gaap:ComputerEquipmentMember 2021-12-31 0001015922 us-gaap:OfficeEquipmentMember 2021-12-31 0001015922 us-gaap:BuildingMember 2021-12-31 0001015922 chkp:ManufacturingPartnerAndSupplierLiabilitiesMember 2021-12-31 0001015922 chkp:SecuritySubscriptionsAndSoftwareUpdatesAndMaintenanceMember 2021-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2021-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2021-12-31 0001015922 chkp:OptionsInTheMoneyMember 2021-12-31 0001015922 chkp:OptionsOutOfMoneyMember 2021-12-31 0001015922 us-gaap:NondesignatedMember us-gaap:ForeignExchangeForwardMember 2021-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2021-12-31 0001015922 chkp:GovernmentSponsoredEnterprisesDebenturesMember 2021-12-31 0001015922 chkp:WithinOneYearMember 2021-12-31 0001015922 chkp:AfterOneYearThroughFiveYearsMember 2021-12-31 0001015922 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2021-12-31 0001015922 us-gaap:FairValueInputsLevel1Member us-gaap:CashMember 2022-12-31 0001015922 us-gaap:CashMember 2022-12-31 0001015922 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001015922 us-gaap:MoneyMarketFundsMember 2022-12-31 0001015922 us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember 2022-12-31 0001015922 us-gaap:BankTimeDepositsMember 2022-12-31 0001015922 us-gaap:SubscriptionArrangementMember 2022-12-31 0001015922 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2022-12-31 0001015922 chkp:OtherArrangementMember 2022-12-31 0001015922 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001015922 chkp:PerformanceStockUnitsPsuMember 2022-12-31 0001015922 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFixedInterestRateMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFixedInterestRateMember 2022-12-31 0001015922 us-gaap:FairValueInputsLevel2Member chkp:GovernmentSponsoredEnterprisesDebenturesMember 2022-12-31 0001015922 chkp:GovernmentSponsoredEnterprisesDebenturesMember 2022-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFloatingInterestRateMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFloatingInterestRateMember 2022-12-31 0001015922 country:IL 2022-12-31 0001015922 country:US 2022-12-31 0001015922 chkp:RestOfWorldMember 2022-12-31 0001015922 chkp:CoreTechnologyMember 2022-12-31 0001015922 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001015922 us-gaap:CustomerRelationshipsMember 2022-12-31 0001015922 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001015922 us-gaap:ComputerEquipmentMember 2022-12-31 0001015922 us-gaap:OfficeEquipmentMember 2022-12-31 0001015922 us-gaap:BuildingMember 2022-12-31 0001015922 chkp:ManufacturingPartnerAndSupplierLiabilitiesMember 2022-12-31 0001015922 chkp:SecuritySubscriptionsAndSoftwareUpdatesAndMaintenanceMember 2022-12-31 0001015922 chkp:ResearchAndDevelopmentTaxCreditMember 2022-12-31 0001015922 chkp:USFederalMember 2022-12-31 0001015922 chkp:USStateMember 2022-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2022-12-31 0001015922 chkp:EmployeeStockPurchasePlanDomesticMember 2022-12-31 0001015922 chkp:EmployeeStockPurchasePlanForeignMember 2022-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2022-12-31 0001015922 chkp:OptionsInTheMoneyMember 2022-12-31 0001015922 chkp:OptionsOutOfMoneyMember 2022-12-31 0001015922 chkp:PerformanceStockUnitsPsuMember srt:MinimumMember 2022-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2022-12-31 0001015922 chkp:GovernmentSponsoredEnterprisesDebenturesMember 2022-12-31 0001015922 chkp:WithinOneYearMember 2022-12-31 0001015922 chkp:AfterOneYearThroughFiveYearsMember 2022-12-31 0001015922 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2022-12-31 0001015922 chkp:OdoSecurityLtdMember 2020-01-01 2020-12-31 0001015922 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2020-01-01 2020-12-31 0001015922 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001015922 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001015922 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-12-31 0001015922 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001015922 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember chkp:TwoChannelPartnerMember 2020-01-01 2020-12-31 0001015922 us-gaap:CustomerConcentrationRiskMember chkp:OneChannelPartnerMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-12-31 0001015922 us-gaap:CustomerConcentrationRiskMember chkp:OtherChannelPartnerMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-12-31 0001015922 chkp:FinancialExpenseMember 2020-01-01 2020-12-31 0001015922 chkp:FinancialIncomeMember 2020-01-01 2020-12-31 0001015922 srt:AmericasMember 2020-01-01 2020-12-31 0001015922 us-gaap:EMEAMember 2020-01-01 2020-12-31 0001015922 srt:AsiaPacificMember 2020-01-01 2020-12-31 0001015922 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0001015922 chkp:NetworkSecurityGatewaysMember 2020-01-01 2020-12-31 0001015922 chkp:OtherProductMember 2020-01-01 2020-12-31 0001015922 chkp:ProductAndLicensingMember 2020-01-01 2020-12-31 0001015922 chkp:SecuritySubscriptionsMember 2020-01-01 2020-12-31 0001015922 chkp:SoftwareUpdatesAndMaintenanceMember 2020-01-01 2020-12-31 0001015922 country:US 2020-01-01 2020-12-31 0001015922 chkp:AmortizationOfTechnologyMember 2020-01-01 2020-12-31 0001015922 us-gaap:PhantomShareUnitsPSUsMember 2020-01-01 2020-12-31 0001015922 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001015922 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember chkp:FinancialIncomeMember 2020-01-01 2020-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:OperatingExpenseMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-01-01 2020-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2020-01-01 2020-12-31 0001015922 chkp:AvananMember 2021-01-01 2021-12-31 0001015922 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0001015922 us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001015922 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001015922 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-12-31 0001015922 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001015922 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember chkp:TwoChannelPartnerMember 2021-01-01 2021-12-31 0001015922 us-gaap:CustomerConcentrationRiskMember chkp:OneChannelPartnerMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-12-31 0001015922 us-gaap:CustomerConcentrationRiskMember chkp:OtherChannelPartnerMember us-gaap:SalesRevenueNetMember 2021-01-01 2021-12-31 0001015922 chkp:FinancialExpenseMember 2021-01-01 2021-12-31 0001015922 chkp:FinancialIncomeMember 2021-01-01 2021-12-31 0001015922 srt:AmericasMember 2021-01-01 2021-12-31 0001015922 us-gaap:EMEAMember 2021-01-01 2021-12-31 0001015922 srt:AsiaPacificMember 2021-01-01 2021-12-31 0001015922 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001015922 chkp:NetworkSecurityGatewaysMember 2021-01-01 2021-12-31 0001015922 chkp:OtherProductMember 2021-01-01 2021-12-31 0001015922 chkp:ProductAndLicensingMember 2021-01-01 2021-12-31 0001015922 chkp:SecuritySubscriptionsMember 2021-01-01 2021-12-31 0001015922 chkp:SoftwareUpdatesAndMaintenanceMember 2021-01-01 2021-12-31 0001015922 country:US 2021-01-01 2021-12-31 0001015922 chkp:AmortizationOfTechnologyMember 2021-01-01 2021-12-31 0001015922 us-gaap:PhantomShareUnitsPSUsMember 2021-01-01 2021-12-31 0001015922 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001015922 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember chkp:FinancialIncomeMember 2021-01-01 2021-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:OperatingExpenseMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2021-01-01 2021-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2021-01-01 2021-12-31 0001015922 chkp:MarketableSecuritesMember 2021-01-01 2021-12-31 0001015922 chkp:SpectralCyberTechnologiesLtdMember 2022-01-01 2022-12-31 0001015922 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2022-01-01 2022-12-31 0001015922 chkp:TechnologicalPreferredEnterpriseMember 2022-01-01 2022-12-31 0001015922 us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001015922 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001015922 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-12-31 0001015922 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001015922 chkp:OtherProductMember us-gaap:ProductConcentrationRiskMember chkp:ProductsAndLicensesRevenuesMember 2022-01-01 2022-12-31 0001015922 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember chkp:TwoChannelPartnerMember 2022-01-01 2022-12-31 0001015922 us-gaap:CustomerConcentrationRiskMember chkp:OneChannelPartnerMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-12-31 0001015922 us-gaap:CustomerConcentrationRiskMember chkp:OtherChannelPartnerMember us-gaap:SalesRevenueNetMember 2022-01-01 2022-12-31 0001015922 srt:MinimumMember 2022-01-01 2022-12-31 0001015922 srt:MaximumMember 2022-01-01 2022-12-31 0001015922 chkp:CoreTechnologyMember 2022-01-01 2022-12-31 0001015922 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001015922 us-gaap:TrademarksAndTradeNamesMember srt:MinimumMember 2022-01-01 2022-12-31 0001015922 us-gaap:TrademarksAndTradeNamesMember srt:MaximumMember 2022-01-01 2022-12-31 0001015922 chkp:FinancialExpenseMember 2022-01-01 2022-12-31 0001015922 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001015922 chkp:PerformanceStockUnitsPsuMember 2022-01-01 2022-12-31 0001015922 chkp:FinancialIncomeMember 2022-01-01 2022-12-31 0001015922 srt:AmericasMember 2022-01-01 2022-12-31 0001015922 us-gaap:EMEAMember 2022-01-01 2022-12-31 0001015922 srt:AsiaPacificMember 2022-01-01 2022-12-31 0001015922 us-gaap:DomesticCountryMember 2022-01-01 2022-12-31 0001015922 us-gaap:BuildingMember 2022-01-01 2022-12-31 0001015922 us-gaap:ComputerEquipmentMember srt:MinimumMember 2022-01-01 2022-12-31 0001015922 us-gaap:ComputerEquipmentMember srt:MaximumMember 2022-01-01 2022-12-31 0001015922 us-gaap:OfficeEquipmentMember srt:MinimumMember 2022-01-01 2022-12-31 0001015922 us-gaap:OfficeEquipmentMember srt:MaximumMember 2022-01-01 2022-12-31 0001015922 chkp:NetworkSecurityGatewaysMember 2022-01-01 2022-12-31 0001015922 chkp:OtherProductMember 2022-01-01 2022-12-31 0001015922 chkp:ProductAndLicensingMember 2022-01-01 2022-12-31 0001015922 chkp:SecuritySubscriptionsMember 2022-01-01 2022-12-31 0001015922 chkp:SoftwareUpdatesAndMaintenanceMember 2022-01-01 2022-12-31 0001015922 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001015922 country:US 2022-01-01 2022-12-31 0001015922 srt:MinimumMember chkp:ResearchAndDevelopmentTaxCreditMember 2022-01-01 2022-12-31 0001015922 srt:MaximumMember chkp:ResearchAndDevelopmentTaxCreditMember 2022-01-01 2022-12-31 0001015922 chkp:USFederalMember 2022-01-01 2022-12-31 0001015922 chkp:USStateMember 2022-01-01 2022-12-31 0001015922 chkp:TwoThousandFiveEquityIncentivePlansMember 2022-01-01 2022-12-31 0001015922 chkp:AmortizationOfTechnologyMember 2022-01-01 2022-12-31 0001015922 us-gaap:PhantomShareUnitsPSUsMember 2022-01-01 2022-12-31 0001015922 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001015922 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember chkp:FinancialIncomeMember 2022-01-01 2022-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:OperatingExpenseMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2022-01-01 2022-12-31 0001015922 dei:BusinessContactMember 2022-01-01 2022-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2022-01-01 2022-12-31 0001015922 chkp:MarketableSecuritesMember 2022-01-01 2022-12-31 0001015922 chkp:AvananMember 2022-01-01 2022-12-31 0001015922 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2022-01-01 2022-12-31 0001015922 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-01-01 2022-12-31 0001015922 us-gaap:SubsequentEventMember us-gaap:TaxYear2020Member us-gaap:IsraelTaxAuthorityMember 2023-01-01 2023-01-01 0001015922 us-gaap:SubsequentEventMember chkp:TaxYearTwoThousandSixteenThroughTwoThousandAndNineteenMember us-gaap:IsraelTaxAuthorityMember 2023-01-01 2023-01-01 0001015922 us-gaap:SubsequentEventMember us-gaap:TaxYear2020Member us-gaap:IsraelTaxAuthorityMember 2023-01-01 0001015922 chkp:TaxYearTwoThousandSixteenThroughTwoThousandAndNineteenMember us-gaap:SubsequentEventMember us-gaap:IsraelTaxAuthorityMember 2023-01-01 0001015922 chkp:ShareRepurchaseProgramMember 2023-02-13 0001015922 chkp:EmployeeStockPurchasePlanMember 2020-12-31 0001015922 us-gaap:RetainedEarningsMember 2019-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001015922 us-gaap:TreasuryStockMember 2019-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001015922 us-gaap:CommonStockMember 2019-12-31 0001015922 us-gaap:RetainedEarningsMember 2020-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001015922 us-gaap:TreasuryStockMember 2020-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001015922 us-gaap:CommonStockMember 2020-12-31 0001015922 us-gaap:RetainedEarningsMember 2021-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001015922 us-gaap:TreasuryStockMember 2021-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001015922 us-gaap:CommonStockMember 2021-12-31 0001015922 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001015922 chkp:PerformanceStockUnitsPsuMember 2021-12-31 0001015922 us-gaap:CommonStockMember 2022-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001015922 us-gaap:TreasuryStockMember 2022-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001015922 us-gaap:RetainedEarningsMember 2022-12-31 0001015922 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2021-12-31 0001015922 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2021-12-31 0001015922 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2022-12-31 0001015922 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-12-31 iso4217:USD xbrli:pure xbrli:shares utr:Year utr:Month iso4217:ILS iso4217:ILS xbrli:shares chkp:Segment iso4217:USD xbrli:shares chkp:Product
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM
20-F
 
 
☐
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
 
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2022
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
    
    
    
to
    
    
    
    
OR
 
☐
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
    
    
    
    
Commission file number
000-28584
 
 
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
(Exact name of Registrant as specified in its charter)
 
 
ISRAEL
(Jurisdiction of incorporation or organization)
5 Shlomo Kaplan Street Tel Aviv 6789159, Israel
(Address of principal executive offices)
Shira Yashar, Adv.
General Counsel
Check Point Software Technologies Ltd.
5 Shlomo Kaplan Street Tel Aviv 6789159, Israel
Tel: (+972)
3-753-4555
(Name, Telephone,
E-mail
and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
 
Title of each class
  
Trading symbol(s)
  
Name of each exchange on which registered
Ordinary shares, NIS 0.01 nominal value
  
CHKP
  
NASDAQ Global Select Market
Securities registered or to be registered pursuant to Section 12(g) of the Act. None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. None
 
 
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of December 31, 2022. 120,761,971 ordinary shares, nominal value NIS 0.01 per share.
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act:    Yes ☒    No ☐
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934:    Yes ☐    No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒    No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒    No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
Large Accelerated filer    ☒         Accelerated filer    ☐
        Non-accelerated
filer    ☐         Emerging growth company    ☐
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards † provided pursuant to Section 13(a) of the Exchange Act. ☐
The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to
§240.10D-1(b).
☐
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
 
U.S. GAAP ☒           
    International Financial Reporting Standards as issued
    by the International Accounting Standards Board ☐
    Other ☐
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.    Item 17 ☐     Item 18 ☐
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act):    Yes ☐    No ☒
 
Auditor Firm Id:
    1281   
Auditor Name:
    Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global        
 
 
 

Table of Contents

Currency of Presentation and Certain Defined Terms

In this Annual Report on Form 20-F, or the Annual Report, references to “U.S.” or “United States” are to the United States of America, its territories and possessions; and references to “Israel” are to the State of Israel. References to “$”, “dollar” or “U.S. dollar” are to the legal currency of the United States of America; references to “NIS” or “Israeli shekel” are to the legal currency of Israel and references to “Euro” are to the legal currency of the European Union. Our financial statements are presented in U.S. dollars and are prepared in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP.

All references to “we,” “us,” “our” or “Check Point” shall mean Check Point Software Technologies Ltd., and, unless specifically indicated otherwise or the context indicates otherwise, our consolidated subsidiaries.

Forward-Looking Statements

In addition to historical fact, this Annual Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements are subject to risks and uncertainties, and include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, plans and objectives. In some cases you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements concerning the following:

 

  •

our expectations for our business, trends related to our business and the markets in which we operate and into which we sell products;

 

  •

uncertain macro-economic and industry trends (such as inflation and fluctuations in supply chains), which may impact demand and supply of our products;

 

  •

the effects of increased competition in our market;

 

  •

our ability to timely and effectively scale and adapt our existing technology and infrastructure to meet current and future market demands;

 

  •

the effects on our business of the global COVID-19 pandemic;

 

  •

our ability to develop or acquire new and more technologically advanced products, and to successfully commercialize these products;

 

  •

our ability to protect our proprietary technology and intellectual property;

 

  •

our ability to increase adoption of our products and to maintain or increase our market share;

 

  •

our ability to maintain our growth;

 

  •

future amounts and sources of our revenue;

 

  •

our future costs and expenses;

 

  •

the adequacy of our capital resources;

 

  •

our expectations to provide security for all organizations;

 

  •

our expectations with respect to share repurchases by us and dividend payments by us;

 

  •

the effects on our business of evolving laws and regulations, including government export or import controls and U.S. tax regulations and the potential economic effects of “Brexit”;

 

  •

the impact of the significant military action against Ukraine launched by Russia and any related political or economic responses and counter-responses or otherwise by various global actors;

 

  •

our ongoing relationships with our current and future customers and channel partners, suppliers, contract manufacturers and distributors; and

 

  •

our other expectations, beliefs, intentions and strategies.

 

1

Table of Contents

These statements are subject to known and unknown risks, uncertainties and other factors, which are difficult to predict and which may cause our actual results to differ materially and adversely from those implied by the forward-looking statements. Many of these risks, uncertainties and assumptions are described in the risk factors set forth in “Item 3 – Key Information – Risk Factors” and elsewhere in this Annual Report. All forward-looking statements included in this Annual Report are based on information available to us on the date of the filing. While we may elect to update forward-looking statements in the future, we specifically disclaim any obligation to update or revise any of the forward-looking statements after the date of the filing, except as required by applicable law.

 

2

Table of Contents

TABLE OF CONTENTS

 

     PART I       

Item 1.

   

Identity of Directors, Senior Management and Advisers

      4  

Item 2.

   

Offer Statistics and Expected Timetable

      4  

Item 3.

   

Key Information

      4  

Item 4.

   

Information on Check Point

      19  

Item 4A.

   

Unresolved Staff Comments

      28  

Item 5.

   

Operating and Financial Review and Prospects

      28  

Item 6.

   

Directors, Senior Management and Employees

      36  

Item 7.

   

Major Shareholders and Related Party Transactions

      46  

Item 8.

   

Financial Information

      47  

Item 9.

   

The Offer and Listing

      48  

Item 10.

   

Additional Information

      48  

Item 11.

   

Quantitative and Qualitative Disclosures about Market Risk

      58  

Item 12.

   

Description of Securities Other than Equity Securities

      59  
     PART II       

Item 13.

   

Defaults, Dividend Arrearages and Delinquencies

      59  

Item 14.

   

Material Modifications to the Rights of Security Holders and Use of Proceeds

      59  

Item 15.

   

Controls and Procedures

      59  

Item 16A.

   

Audit Committee Financial Expert

      60  

Item 16B.

   

Code of Ethics

      60  

Item 16C.

   

Principal Accountant Fees and Services

      61  

Item 16D.

   

Exemptions from the Listing Standards for Audit Committees

      61  

Item 16E.

   

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

      61  

Item 16F.

   

Change in Registrant’s Certifying Accountant

      62  

Item 16G.

   

Corporate Governance

      62  

Item 16H.

   

Mine Safety Disclosure

      63  

Item 16I.

   

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

      63  
     PART III       

Item 17.

   

Financial Statements

      63  

Item 18.

   

Financial Statements

      63  

Item 19.

   

Exhibits

      63  

 

3

Table of Contents

PART I

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

Not applicable.

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

Not applicable.

ITEM 3. KEY INFORMATION

Risk Factors

An investment in our ordinary shares involves a high degree of risk. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, also may become important factors that affect us. If any of the following risks materialize, our business, financial condition, results of operations and prospects could be materially harmed. In that event, the market price of our ordinary shares could decline and you could lose part or all of your investment.

Risks Related to Our Business and Our Market

If the market for information and network security solutions does not continue to grow, our business will be adversely affected

The market for information and network security solutions may not continue to grow. Continued growth of this market will depend, in large part, upon:

 

  •  

the continued expansion of Internet usage and the number of organizations adopting or expanding intranets;

 

  •  

the continued adoption of “cloud” infrastructure by organizations;

 

  •  

the ability of the infrastructures implemented by organizations to support an increasing number of users and services;

 

  •  

the continued development of new and improved services for implementation across the Internet and between the Internet and intranets;

 

  •  

the adoption of data security measures as it pertains to data encryption and data loss prevention technologies;

 

  •  

continued access to mobile API’s, APPs and application stores with Apple, Google and Microsoft;

 

  •  

government regulation of the Internet and governmental and non-governmental requirements and standards with respect to data security and privacy; and

 

  •  

economic, social, or political conditions, including conditions resulting from a decline in the macroeconomic environment, rising interest rates, exchange rate fluctuations, inflation, the COVID-19 pandemic, global supply chain disruptions and conditions resulting from geopolitical uncertainty and instability or war, including the Russia-Ukraine armed conflict and the tension between China and Taiwan.

In 2021 and 2022, global and regional economies around the world and financial markets remained volatile as a result of a multitude of factors, including economic and political uncertainty, rising interest rates, inflation, the COVID-19 pandemic, the war in Ukraine, terrorism, governmental instability and other factors. During this period, many organizations limited their expenditures and a significant portion of such organizations have remained reluctant to increase expenditures. If challenging conditions continue or worsen, it may cause our customers to reduce or postpone their technology spending significantly, which could result in reductions in sales of our products, longer sales cycles, slower adoption of new technologies and increased price competition.

Further, if the necessary infrastructure or complementary products and services are not developed in a timely manner and, consequently, the enterprise security, data security, Internet or intranet markets fail to grow or grow more slowly than we currently anticipate, our business, results of operations and financial condition may be materially adversely affected. Additional details are provided in “Item 4 – Information on Check Point”.

We may not be able to successfully compete, which could adversely affect our business and results of operations

The market for information and network security solutions is intensely competitive and we expect that competition will continue to increase in the future. Our competitors include Cisco Systems, Inc., Fortinet Inc., Palo Alto Networks, Inc. and SonicWall Inc. and other companies in the network security space. We also compete with several other companies, including Zscaler, Inc., Trellix, Trend Micro Inc., NortonLifeLock Inc., Lookout, Inc., Zimperium, Inc, CrowdStrike Holdings, Inc., SentinelOne, Inc., Sophos Group plc, Proofpoint, Inc., Broadcom, Inc. Mimecast Limited, Microsoft Corp. and Wiz Ltd., with respect to specific products that we offer.

 

4

Table of Contents

In addition, there are hundreds of small and large companies that offer security products and services that we may compete with from time to time.

Some of our current and potential competitors have various advantages over us, including longer operating histories; access to larger customer bases; significantly greater financial, technical and marketing resources; a broader portfolio of products, applications and services; and larger patent and intellectual property portfolios. As a result, they may be able to adapt better than we can to new or emerging technologies and changes in customer requirements, or to devote greater resources to the promotion and sale of their products. Furthermore, some of our competitors with more diversified product portfolios and larger customer bases may be better able to withstand a reduction in spending on information and network security solutions, as well as a general slowdown or recession in economic conditions in the markets in which they operate. In addition, some of our competitors have greater financial resources than we do, and they have offered, and in the future may offer, their products at lower prices than we do, or may bundle security products with their other offerings, which may cause us to lose sales or to reduce our prices in response to competition.

In addition, consolidation in the markets in which we compete may affect our competitive position. This is particularly true in circumstances where customers are seeking to obtain a broader set of products and services than we are able to provide.

The markets in which we compete also include many niche competitors, generally smaller companies at a relatively early stage of operations, which are focused on specific Internet and data security needs. These companies’ specialized focus may enable them to adapt better than we can to new or emerging technologies and changes in customer requirements in their specific areas of focus. In addition, some of these companies can invest relatively large resources on very specific technologies or customer segments. The effect of these companies’ activities in the market may result in price reductions, reduced gross margins and loss of market share, any of which will materially adversely affect our business, results of operations and financial condition.

Further, vendors of operating system software, networking hardware or central processing units, or CPUs, may enhance their products to include functionality that is currently provided by our products. The widespread inclusion of similar functionality to that which is offered by our solutions, as standard features of operating system software and networking hardware could significantly reduce the demand for our products, particularly if the quality of such functionality were comparable to that of our products. Furthermore, even if the network or application security functionality provided as standard features by operating systems software and networking hardware is more limited than that of our solutions, a significant number of customers may elect to accept more limited functionality in lieu of purchasing additional products.

We may not be able to continue competing successfully against our current and future competitors, and increased competition within the market may result in price reductions, reduced gross margins and operating margins, reduced net income, and loss of market share, any or all of which may materially adversely affect our business, results of operations and financial condition. For additional information, see “Item 4 – Information on Check Point”.

If we fail to enhance our existing products, develop or acquire new and more technologically advanced products, or fail to successfully commercialize these products, our business and results of operations will suffer

The information and network security industry is characterized by rapid technological advances, changes in customer requirements, frequent new product introductions and enhancements, and evolving industry standards in computer hardware and software technology. In particular, the markets for data security, Internet and intranet applications are rapidly evolving. As a result, we must continually change and improve our products in response to changes in operating systems, application software, computer and communications hardware, networking software, programming tools, and computer language technology. We must also continually change our products in response to changes in network infrastructure requirements, including the expanding use of cloud computing. Further, we must continuously improve our products to protect our customers’ data and networks from evolving security threats.

Our future results of operations will depend upon our ability to enhance our current products and to develop and introduce new products on a timely basis; to address the increasingly sophisticated needs of our customers; and to keep pace with technological developments, new competitive product offerings, and emerging industry standards. Our competitors’ introduction of products embodying new technologies and the emergence of new industry standards may render our existing products obsolete or unmarketable. While we have historically been successful in developing, acquiring, and marketing new products and product enhancements that respond to technological change and evolving industry standards, we may not be able to continue to do so. In addition, we may experience difficulties that could delay or prevent the successful development, introduction, and marketing of these products, as well as the integration of acquired products. Furthermore, our new products or product enhancements may not adequately meet the requirements of the marketplace or achieve market acceptance. In some cases, a new product or product enhancements may negatively affect sales of

 

5

Table of Contents

our existing products. If we do not respond adequately to the need to develop and introduce new products or enhancements of existing products in a timely manner in response to changing market conditions or customer requirements, our business, results of operations and financial condition may be materially adversely affected.

For additional information, see “Item 4 – Information on Check Point” and under the caption “We may not be able to successfully compete, which could adversely affect our business and results of operations” in this “Item 3 – Key Information – Risk Factors”.

We may need to change our pricing models to compete successfully

The intense competition we face in the sales of our products and services and general economic and business conditions can put pressure on us to change our prices. If our competitors offer deep discounts on certain products or services or develop products that the marketplace considers more valuable, we may need to lower prices or offer other favorable terms in order to compete successfully. Any such changes may reduce margins and could adversely affect results of operations. Additionally, the increasing prevalence of cloud and SaaS delivery models offered by us and our competitors may unfavorably impact pricing in both our on-premise enterprise software business and our cloud business, as well as overall demand for our on-premise software product and service offerings, which could reduce our revenues and profitability. Our competitors may offer lower pricing on their support offerings, which could put pressure on us to further discount our product or support pricing.

Our business, results of operations and financial condition are subject to the risks of earthquakes, fire, floods, pandemics and other natural events, as well as manmade problems such as power disruptions or terrorism or war, and have been and may continue to be adversely affected by the COVID-19 pandemic.

We operate our business primarily from Israel, we sell our products and have operations worldwide. For example, our headquarters in the United States, as well as certain of our research and development operations, are located in the Silicon Valley area of Northern California, a region known for seismic activity. We also have significant operations in other regions that have experienced natural disasters. A significant natural disaster occurring at our facilities in Israel or the United States or elsewhere, or where our channel partners are located, could have a material adverse impact on our business, results of operations and financial condition. In addition, acts of terrorism or war (including the significant military action against Ukraine launched by Russia and any related political or economic responses and counter-responses or otherwise by various global actors or general effect on the global economy) could cause disruptions to our or our customers’ businesses or the economy as a whole. Further, we rely on information technology systems to communicate among our workforce located worldwide. Any disruption to our internal communications, whether caused by a natural disaster, pandemics or by manmade problems, such as power disruptions or terrorism or war, could delay our research and development efforts. To the extent any of the foregoing causes disruptions or result in delays or cancellations of customer orders, our research and development efforts or the deployment of our products, our business and results of operations would be materially and adversely affected.

In addition, following the Russia-Ukraine armed conflict, the United States and other countries imposed economic sanctions and severe export control restrictions against Russia and Belarus, and the United States and other countries could impose wider sanctions and export restrictions and take other actions should the conflict further escalate, which affect our exports or sales into Russia and Belarus and create difficulties in business planning and forecasting due to the uncertainty of the impact of the war on aspects of our business, such as on our distributors, resellers and end-customers. Our efforts to comply with such measures may be costly and time consuming. We take precautions to ensure that we and our partners comply with all relevant sanctions-related regulations, any alleged or actual failure by us or our partners to comply with such laws and regulations could have negative consequences for us, including reputational harm, government investigations and penalties. The sanctions and other macroeconomic effects of the war may also result in the devaluation of the local currency and other inflationary effects.

The COVID-19 pandemic and efforts to mitigate its impact have significantly curtailed the movement of people, goods and services worldwide in 2020 and 2021 and to a lesser extent in 2022, including in the geographic areas in which we conduct our business operations and from which we generate our revenue. It has also caused societal, economic and financial market volatility, resulting in business shutdowns and reduced business activity.

The COVID-19 pandemic has disrupted and may continue to disrupt the operations of our customers and partners, particularly our customers in industries, including travel and entertainment that have been especially impacted by the pandemic. Other disruptions or potential disruptions resulting from the COVID-19 pandemic include global supply chain disruptions which impacted the availability of raw products and resulted in prolonged shipping and delivery times across a variety of industries, restrictions on our personnel and the personnel of our partners to travel and access customers, delays in product development efforts, working in the hybrid model bringing employees to the office for part of the work week which may negatively impact employees who wish to work remotely full time, and additional government requirements or other incremental mitigation efforts that may further impact our business and results of operations. To the extent the COVID-19 pandemic continues to adversely affect our business and financial condition, it is likely to also have the effect of heightening many of the other risks described in this “Risk Factors” section.

 

6

Table of Contents

Prolonged economic uncertainties or downturns, globally or in certain regions or industries, could materially adversely affect our business.

Our business depends on our current and prospective customers’ ability and willingness to invest money in our products and security, which in turn is dependent upon their overall economic health and the strength of the broader macroeconomic environment. The negative economic conditions in the global economy or certain regions, including conditions resulting from financial and credit market fluctuations (including rising interest rates), exchange rate fluctuations, or inflation, and the potential for regional or global recessions could cause a decrease in corporate spending on cybersecurity software. Other matters that influence customer confidence and spending, such as, political unrest, public health crises, including COVID-19, terrorist attacks, armed conflicts (such as the ongoing conflict between Russia and Ukraine), rising energy costs, and natural disasters, could also negatively affect our customers’ spending on our products and services. The armed conflict involving Russia and Ukraine has resulted in sanctions which restrict the selling of goods, services, or technology in affected regions. The instability in these regions could further exacerbate the macroeconomic impacts on a global scale.

Negative economic conditions may cause existing and prospective customers to reduce their spending. Customers may delay or cancel cybersecurity projects or seek to lower their costs by renegotiating renewals or maintenance and support agreements. Further, customers or channel partners may be more likely to refrain from making payments and/or make late payments in worsening economic conditions. If the economic conditions of the general economy or industries in which we operate continue to worsen from present levels, our business, results of operation and financial condition could be adversely affected.

If our products fail to protect against attacks and our customers experience security breaches, our reputation and business could be harmed

Hackers and other malevolent actors are increasingly sophisticated, often affiliated with organized crime and operate large scale and complex attacks. In addition, their techniques change frequently and generally are not recognized until launched against a target. If we fail to identify and respond to new and increasingly complex methods of attack and to update our products to detect or prevent such threats in time to protect our customers’ high-value business data, our business and reputation will suffer.

In addition, an actual or perceived security breach or theft of the sensitive data of one of our customers, regardless of whether the breach is attributable to the failure of our products, could adversely affect the market’s perception of our security products. Despite our best efforts, there is no guarantee that our products will be free of flaws or vulnerabilities, and even if we discover these weaknesses we may not be able to correct them promptly, if at all. Our customers may also misuse our products, which could result in a breach or theft of business data.

Product defects may increase our costs and impair the market acceptance of our products and technology

Our products are complex and must meet stringent quality requirements. They may contain undetected hardware or software errors or defects, especially when new or acquired products are introduced or when new versions are released. In particular, the personal computer hardware environment is characterized by a wide variety of non-standard configurations that make pre-release testing for programming or compatibility errors very difficult and time-consuming. We may need to divert the attention of our engineering personnel from our research and development efforts to address instances of errors or defects.

Our products are used to deploy and manage Internet security and protect information, which may be critical to organizations. As a result, the sale and support of our products entails the risk of product liability and related claims. We do not know whether, in the future, we will be subject to liability claims or litigation for damages related to product errors, or will experience delays as a result of these errors. Our sales agreements and product licenses typically contain provisions designed to limit our exposure to potential product liability or related claims. In selling our products, we rely primarily on “shrink wrap” licenses that are not signed by the end user, and for this and other reasons, these licenses may be unenforceable under the laws of some jurisdictions. As a result, the limitation of liability provisions contained in these licenses may not be effective. Although we maintain product liability insurance for most of our products, the coverage limits of these policies may not provide sufficient protection against an asserted claim. If litigation were to arise, it could, regardless of its outcome, result in substantial expense to us, significantly divert the efforts of our technical and management personnel, and disrupt or otherwise severely impact our relationships with current and potential customers. In addition, if any of our products fail to meet specifications or have reliability, quality or compatibility problems, our reputation could be damaged significantly and customers might be reluctant to buy our products, which could result in a decline in revenues, a loss of existing customers, and difficulty attracting new customers.

 

7

Table of Contents

We are subject to risks relating to acquisitions

We have made acquisitions in the past, including the acquisitions of Spectral in 2022, Avanan in 2021, and Odo Security in 2020, and we may make additional acquisitions in the future. The pursuit of acquisitions may divert the attention of management and cause us to incur various expenses in identifying, investigating, and pursuing suitable acquisitions, whether or not they are consummated.

Competition within our industry for acquisitions of businesses, technologies, assets and product lines has been, and may in the future continue to be, intense. As such, even if we are able to identify an acquisition that we would like to consummate, we may not be able to complete the acquisition on commercially reasonable terms or because the target is acquired by another company. Furthermore, in the event that we are able to identify and consummate any future acquisitions, we could:

 

  •  

issue equity securities which would dilute the current shareholders’ percentage of ownership;

 

  •  

incur substantial debt;

 

  •  

assume contingent liabilities; or

 

  •  

expend significant cash.

These financing activities or expenditures could harm our business, results of operations and financial condition or the price of our ordinary shares. Alternatively, due to difficulties in the capital and credit markets, we may be unable to secure capital on acceptable terms, or at all, to complete acquisitions. In addition, we may not be able to integrate acquired personnel, operations, and technologies successfully or effectively manage the combined business following the completion of any future acquisition. We may also not achieve the anticipated benefits from the acquired businesses due to a number of factors, including:

 

  •  

unanticipated costs or liabilities associated with the acquisition;

 

  •  

incurrence of acquisition-related costs;

 

  •  

diversion of management’s attention from other business concerns;

 

  •  

harm to our existing business relationships with manufacturers, distributors and customers as a result of the acquisition;

 

  •  

the potential loss of key employees;

 

  •  

use of resources that are needed in other parts of our business;

 

  •  

use of substantial portions of our available cash to consummate the acquisition; or

 

  •  

unrealistic goals or projections for the acquisition.

Moreover, even if we do obtain benefits from acquisitions in the form of increased sales and earnings, there may be a delay between the time when the expenses associated with an acquisition are incurred and the time when we recognize such benefits.

We are dependent on a limited number of product families

Currently, we derive the majority of our revenues from sales of integrated appliances and Internet security products, as well as related revenues from security subscriptions and from software updates and maintenance. We expect that this concentration of revenues from a small number of product families will continue for the foreseeable future. Endpoint security products and associated software updates, maintenance, and security subscriptions represent an additional revenue source as well as our cloud initiatives. Our future growth depends heavily on our ability to effectively develop and sell new and acquired products as well as add new features to existing products. For more details, see “Item 4 – Information on Check Point” and “Item 5 – Operating and Financial Review and Prospects”.

Competition for highly skilled personnel is intense

We compete in a market marked by rapidly changing technologies and an evolving competitive landscape. In order for us to successfully compete and grow, we must attract, recruit, retain and develop personnel, at an appropriate cost, with requisite qualifications to provide expertise across the entire spectrum of our intellectual capital and business needs. In recent years, the industry has experienced record growth and activity and as a result, the high-tech industry in Israel has experienced significant levels of employee attrition and is currently facing a shortage of skilled human capital. Similar competition for highly skilled personnel exists in the U.S. and in other markets in which we operate. Failure to retain or attract qualified personnel, at an appropriate cost, could have a material adverse effect on our business, financial condition and results of operations.

 

8

Table of Contents

Risks Related to Our Dependence on Third-Parties

We are dependent on a small number of distributors

We derive our sales primarily through indirect channels. During 2022, 2021 and 2020, we derived approximately 60%, 58% and 57%, respectively, of our sales from our ten largest distributors. In 2022, 2021 and 2020, our two largest distributors accounted for approximately 40%, 40% and 39% of our sales, respectively. We expect that a small number of distributors will continue to generate a significant portion of our sales. Furthermore, there has been an industry trend toward consolidation among distributors, and we expect this trend to continue in the near future which could further increase our reliance on a small number of distributors for a significant portion of our sales. If these distributors reduce the amount of their purchases from us for any reason, including because they choose to focus their efforts on the sales of the products of our competitors, our business, results of operations and financial condition could be materially adversely affected.

Our future success is highly dependent upon our ability to establish and maintain successful relationships with our distributors. In addition, we rely on these entities to provide many of the training and support services for our products and equipment. Accordingly, our success depends in large part on the effective performance of these distributors. Recruiting and retaining qualified distributors and training them in our technology and products requires significant time and resources. Further, we have no minimum purchase commitments with any of our distributors, and our contracts with these distributors do not prohibit them from offering products or services that compete with ours. Our competitors may be effective in providing incentives to existing and potential distributors to favor their products or to prevent or reduce sales of our products. Our distributors may choose not to offer our products exclusively or at all. Our failure to establish and maintain successful relationships with distributors would likely materially adversely affect our business, results of operations and financial condition.

We purchase several key components and finished products from limited sources, and we are increasingly dependent on contract manufacturers for our hardware products.

Many components, subassemblies, and modules necessary for the manufacture or integration of our hardware products are obtained from a limited group of suppliers. The majority of our hardware is manufactured in Taiwan. Any increase in the tension between China and Taiwan, could adversely affect our manufacturing operations in Taiwan. Although we do not manufacture in China, some of our component parts are sourced from China. Our reliance on sole or limited suppliers, particularly foreign suppliers, and our reliance on subcontractors involves several risks, including a potential inability to obtain an adequate supply of required components, subassemblies, or modules and limited control over pricing, quality, and timely delivery of components, subassemblies or modules. Such risks could become exacerbated to the extent such suppliers and subcontractors are materially disrupted by quarantines, factory slowdowns or shutdowns and border closings, as well as travel restrictions such as those experienced in 2020 and 2021 due to the COVID-19 pandemic. For example, global supply chain disruptions in the first half of 2022 impacted the availability of raw products and resulted in prolonged shipping and delivery times. While we continue to monitor the global effects of the COVID-19 pandemic on the supply chains in which we rely, any material supply chain disruption could negatively impact our business, financial condition and results of operations. Although we have been successful in the past, replacing suppliers may be difficult and it is possible it could result in an inability or delay in producing designated hardware products. We are already seeing delays which could have a material adverse impact on our business.

Managing our supplier and contractor relationships is particularly difficult during time periods in which we introduce new products and during time periods in which demand for our products is increasing, especially if demand increases more quickly than we expect. We also have extended support contracts with these suppliers and have been dependent on their ability to perform over a period of years.

We incorporate third-party technology in our products, which may make us dependent on the providers of these technologies and expose us to potential intellectual property claims

Our products contain certain technology that we license from other companies. Third-party developers or owners of technologies may not be willing to enter into, or renew, license agreements with us regarding technologies that we may wish to incorporate in our products, either on acceptable terms or at all. If we cannot obtain licenses to these technologies, we may be at a disadvantage compared with our competitors who are able to license these technologies. In addition, when we do obtain licenses to third-party technologies that we did not develop, we may have little or no ability to determine in advance whether the technology infringes the intellectual property rights of others. In the event such third-party developers and owners are otherwise unable to provide such technology or services to us, our ability to provide our products and services could be disrupted. This includes mandated government shutdowns. Our suppliers and licensors may not be required or may not be able to indemnify us in the event that a claim of infringement is asserted against us, or they may be required to indemnify us only up to a maximum amount, above which we would be responsible for any further costs or damages. Any failure to obtain licenses to intellectual property or any exposure to liability as a result of incorporating third-party technology into our products could materially and adversely affect our business, results of operations and financial condition.

 

9

Table of Contents

Failures of the third-party servers, cloud service providers and other third-party hardware, software and infrastructure on which we rely could adversely affect our business

We rely on servers, cloud service providers and other third-party hardware, software and infrastructure to support our operations. The owners and operators of the data centers and cloud services with which we are engaged do not guarantee uninterrupted or error-free services. Problems faced by our third-party hosting providers, including technological or business-related disruptions, could adversely impact our business and results of operations.

Our servers, data centers and other facilities are also vulnerable to damage or interruption from fires, natural disasters, terrorist attacks, power loss, telecommunications failures, pandemics or similar catastrophic events. Disruptions to these servers or facilities could interrupt our ability to provide our products and services and materially adversely affect our business and results of operations.

Risks Related to Tax, Legal and Regulatory Matters

We are the defendants in various lawsuits and have been subject to tax disputes and governmental proceedings, which could adversely affect our business, results of operations and financial condition

As a global company we are subject to taxation in Israel, the United States and various other countries. We attempt to utilize an efficient operating model and accordingly to pay taxes based on the laws in the countries in which we operate. Nonetheless, various tax authorities in different parts of the world may disagree with our operating sale model. This may lead to disputes and to tax assessments, which can have a negative effect on our tax liabilities.

In addition, we are subject to the continuous examination by tax authorities around the world. It is possible that tax authorities may disagree with certain positions we have taken and any adverse outcome of such a review, investigation or audit could have a negative effect on our financial position and results of operations. We regularly assess the likelihood of adverse outcomes resulting from these examinations, and audits to determine the adequacy of our provision for income and other taxes, but the determination of our worldwide provision for income taxes and other tax liabilities requires significant judgment by management, and there are transactions where the ultimate tax determination is uncertain. Although we believe that our estimates are reasonable, the ultimate tax outcome may differ from the amounts recorded in our consolidated financial statements and may materially affect our financial results in the period or periods for which such determination is made. There can be no assurance that the outcomes from continuous examinations will not have an adverse effect on our business, financial condition and results of operations.

In particular, following audits of our 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued in January 2023 orders for the years 2016 through 2019 challenging our positions on several issues, including matters such as our position to claim a tax credit made for foreign taxes withheld on income payments that was due to the Company outside of Israel, taxation of interest earned outside of Israel by a wholly-owned Singapore subsidiary which the ITA is seeking to tax in Israel and deductibility of expenses attributed to employee stock options. The ITA orders also contest the Company’s positions on various other issues. The ITA therefore demanded the payment of additional taxes in the aggregate amount of NIS 428 million (approximately $122 million), not including an amount of NIS 418 million (approximately $119 million) related to expenses that will be deductible in future years , with respect of these four tax years (these amounts include interest through December 31, 2022). We believe we have good arguments against these orders and intend to file an appeal.

In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes in the aggregate amount of NIS 74 million (approximately $21 million), not including an amount of NIS 94 million (approximately $27 million) related to expenses that will be deductible in future years, with respect to this year (these amounts include interest through December 31, 2022). There can be no assurance that the ITA will accept the Company’s positions on the matters raised and, if it does not, the ITA may also issue an order with respect to the 2020 tax year.

We are the defendant in various other lawsuits, including employment-related litigation claims, construction claims and other legal proceedings in the normal course of our business. Litigation and governmental proceedings can be expensive, lengthy and disruptive to normal business operations, and can require extensive management attention and resources, regardless of their merit. While we currently intend to defend the aforementioned matters vigorously, we cannot predict the results of complex legal proceedings, and an unfavorable resolution of a lawsuit or proceeding could materially adversely affect our business, results of operations and financial condition. See also “Item 8 – Financial Information” under the caption “Legal Proceedings”.

Uncertainties in the interpretation and application of worldwide tax reforms, complex tax laws and regulations could materially affect our tax obligations and effective tax rate

On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Tax Act”), which, among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, limited the tax deduction for interest expense to 30% of adjusted taxable income, implemented a “base erosion anti-abuse tax”, repealed the alternative minimum tax, or AMT, for corporations, limited the deduction for net operating

 

10

Table of Contents

losses carried forward from taxable years beginning after December 31, 2017 to 80% of current year taxable income, eliminated net operating loss carrybacks, and beginning in 2022 eliminated the option to deduct research and development expenditures currently and required taxpayers to capitalize and amortize them over five or fifteen years.

The base erosion and profit shifting (“BEPS”) project undertaken by the OECD may have adverse consequences to our tax liabilities. The first pillar of BEPS’s project is focused on the allocation of taxing rights between countries for in-scope large multinational enterprises that sell goods and services into countries with minor or no local physical presence. We do not expect to be within the scope of this first Pillar.

In December 2022, the Council of the EU (i.e., the EU Member States) unanimously adopted the Directive on BEPS’s Pillar 2 ensuring a global minimum level of taxation at the rate of 15% for multinational enterprise (MNE) groups and large-scale domestic groups, with an annual global turnover exceeding €750 million, in the Union (the Directive). EU Member States are anticipating to integrate the provisions of the Directive into their national laws by December 31, 2023 and generally apply these provisions for fiscal years starting on or after December 31, 2023. It is anticipated that we would be effected from the adoption of Pillar 2’s rules, however it remains difficult to predict the magnitude of the effect of such new rules on our financial results. We are currently monitoring the new rules and awaiting further guidance and local legislation in the relevant jurisdictions.

Indirect taxes including Digital Service tax (DST) measures as adopted unilaterally in certain countries could also adversely affect our tax obligations.

Class action litigation due to stock price volatility or other factors could cause us to incur substantial costs and divert our management’s attention and resources

In the past, following periods of volatility in the market price of a public company’s securities, securities class action litigation has often been instituted against that company. Companies such as ours in the technology industry are particularly vulnerable to this kind of litigation as a result of the volatility of their stock prices. We have been named as a defendant in this type of litigation in the past. Any litigation of this sort in the future could result in substantial costs and a diversion of management’s attention and resources.

We are subject to governmental export and import controls that could subject us to liability or impair our ability to compete in international markets

Because we incorporate encryption technology into our products, certain of our products are subject to U.S. export controls and may be exported outside the U.S. only with the required export license or through an export license exception. If we were to fail to comply with U.S. export licensing requirements, U.S. customs regulations, U.S. economic sanctions, or other laws, we could be subject to substantial civil and criminal penalties, including fines, incarceration for responsible employees and managers, and the possible loss of export or import privileges. Obtaining the necessary export license for a particular sale may be time-consuming and may result in the delay or loss of sales opportunities. Furthermore, U.S. export control laws and economic sanctions prohibit the shipment of certain products to U.S. embargoed or sanctioned countries, governments, and persons. Even though we take precautions to ensure that we comply with all relevant regulations, any failure by us or any partners to comply with such regulations could have negative consequences for us, including reputational harm, government investigations, and penalties.

In addition, various countries regulate the import of certain encryption technology, including through import permit and license requirements, and have enacted laws that could limit our ability to distribute our products or could limit our end-customers’ ability to implement our products in those countries. Changes in our products or changes in export and import regulations may create delays in the introduction of our products into international markets, prevent our end-customers with international operations from deploying our products globally or, in some cases, prevent or delay the export or import of our products to certain countries, governments, or persons altogether. Any change in export or import regulations, economic sanctions or related legislation, shift in the enforcement or scope of existing regulations, or change in the countries, governments, persons, or technologies targeted by such regulations, could result in decreased use of our products by, or in our decreased ability to export or sell our products to, existing or potential end-customers with international operations. Any decreased use of our products or limitation on our ability to export to or sell our products in international markets would likely adversely affect our business, financial condition, and results of operations.

Risks Related to Our Intellectual Property

We may not be able to successfully protect our intellectual property rights, which could cause substantial harm to our business

We seek to protect our proprietary technology by relying on a combination of statutory as well as common law copyright and trademark laws, trade secrets, confidentiality procedures and contractual provisions as indicated below in the section entitled “Proprietary Rights” in “Item 4 – Information on Check Point”. We have certain patents in the United States and in several other

 

11

Table of Contents

countries, as well as pending patent applications. We cannot assure you that pending patent applications will be issued, either at all or within the scope of the patent claims that we have submitted. In addition, someone else may challenge our patents and these patents may be found invalid. Furthermore, others may develop technologies that are similar to or better than ours, or may work around any patents issued to us. Despite our efforts to protect our proprietary rights, others may copy aspects of our products or obtain and use information that we consider proprietary. In addition, the laws of some foreign countries do not protect our proprietary rights to the same extent as the laws of the United States and Israel. Our efforts to protect our proprietary rights may not be adequate and our competitors may independently develop technology that is similar to our technology.

In addition to patents, we rely on trade secret and other rights to protect our unpatented proprietary intellectual property and technology. Despite our efforts to protect our proprietary technologies and our intellectual property rights, unauthorized parties, including our employees, consultants, service providers or customers, may attempt to copy aspects of our products or obtain and use our trade secrets or other confidential information. We generally enter into confidentiality agreements with our employees, consultants, and other service providers, and generally limit access to and distribution of our proprietary information and proprietary technology through certain procedural safeguards. These agreements and arrangements may not effectively prevent unauthorized use or disclosure of our intellectual property or technology and may not provide an adequate remedy in the event of unauthorized use or disclosure of our intellectual property or technology. We cannot be certain that the steps taken by us will prevent misappropriation of our intellectual property or technology or infringement of our intellectual property rights.

If we are unable to secure, protect and enforce our intellectual property rights, such failure could harm our brand and adversely impact our business, financial condition and results of operations.

We incorporate open source technology in our products which may expose us to liability and have a material impact on our product development and sales

Some of our products utilize open source technologies. These technologies are licensed to us under varying license structures, including the General Public License. If we have improperly used, or in the future improperly use, software that is subject to such licenses with our products in such a way that our software becomes subject to the General Public License, we may be required to disclose our own source code to the public. This could enable our competitors to eliminate any technological advantage that our products may have over theirs. Any such requirement to disclose our source code or other confidential information related to our products could materially and adversely affect our competitive position and impact our business, results of operations and financial condition.

If a third-party asserts that we are infringing its intellectual property, whether successful or not, it could subject us to costly and time-consuming litigation or expensive licenses, which could harm our business

There is considerable patent and other intellectual property development activity in our industry. Our success depends, in part, upon our ability not to infringe upon the intellectual property rights of others. Our competitors, as well as a number of other entities and individuals, own or claim to own intellectual property relating to our industry. From time to time, third parties have brought, and continue to bring, claims that we are infringing upon their intellectual property rights, and we may be found to be infringing upon such rights. In addition, third-parties have in the past sent us correspondence claiming that we infringe upon their intellectual property, and in the future we may receive claims that our products infringe or violate their intellectual property rights. Furthermore, we may be unaware of the intellectual property rights of others that may cover some or all of our technology or products. Any claims or litigation could cause us to incur significant expenses and, if successfully asserted against us, could require that we pay substantial damages or royalty payments, prevent us from selling our products, or require that we comply with other unfavorable terms. In addition, we may decide to pay substantial settlement costs and/or licensing fees in connection with any claim or litigation, whether or not successfully asserted against us. Even if we were to prevail, any disputes or litigation regarding intellectual property matters could be costly and time-consuming and divert the attention of our management and key personnel from our business operations. As such, third-party claims with respect to intellectual property may increase our cost of goods sold and operating expenses, reduce the sales of our products, and may have a material and adverse effect on our business.

Due to the global nature of our business, we must comply with various anti-bribery regimes and any failure to do so could adversely affect our business

The global nature of our business creates various domestic and local regulatory challenges. The U.S. Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”), the U.K. Bribery Act 2010 (the “U.K. Bribery Act”), and similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to foreign government officials and other persons for the purpose of obtaining or retaining business. In addition, companies are required to maintain records that accurately and fairly represent their transactions and have an adequate system of internal accounting controls. Further, changes in laws could result in increased regulatory requirements and compliance costs which could adversely affect our business, financial condition and results of operations.

As a result, we are exposed to a risk of violating anti-bribery laws in the countries where we operate. Although we have internal policies and procedures, including a code of ethics and proper business conduct, reasonably designed to promote compliance with anti-bribery laws, we cannot assure that our employees or other agents will not engage in prohibited conduct and render us responsible under the FCPA, the U.K. Bribery Act or any similar anti-bribery laws in other jurisdictions. If we are found to be in violation of the FCPA, the U.K. Bribery Act or other

 

12

Table of Contents

anti-bribery laws (either due to acts or inadvertence of our employees, or due to the acts or inadvertence of others), we could suffer criminal or civil penalties or other sanctions, which could have a material adverse effect on our business, results of operations, cash flows, financial condition, reputation and ability to win future business or maintain existing contracts.

Other General Risks and Risks Related to the Ownership of Our Ordinary Shares

We are exposed to various legal, business, political, economic, health-related and other risks associated with our international operations; these risks could increase our costs, reduce future growth opportunities and affect our results of operations

We operate our business primarily from Israel, we sell our products worldwide, and we generate a significant portion of our revenue outside the United States. We intend to continue to expand our international operations, which will require significant management attention and financial resources. In order to continue to expand worldwide, we will need to establish additional operations, hire additional personnel and recruit additional channel partners internationally. To the extent that we are unable to do so effectively, our growth is likely to be limited and our business, results of operations and financial condition may be materially adversely affected.

Our international sales and operations subject us to many potential risks inherent in international business activities, including, but not limited to:

 

  •  

technology import and export license requirements;

 

  •  

costs of localizing our products for foreign countries, and the lack of acceptance of localized products in foreign countries;

 

  •  

varying economic and political instability or war, including the significant military action against Ukraine launched by Russia;

 

  •  

potential tariffs, sanctions, fines or other trade restrictions, including any political or economic responses and counter-responses or otherwise by various global actors to the significant military action against Ukraine launched by Russia;

 

  •  

imposition of or increases in tariffs or other payments on our revenues in these markets;

 

  •  

greater difficulty in protecting intellectual property;

 

  •  

difficulties in managing our overseas subsidiaries and our international operations;

 

  •  

economic, social, or political conditions, including conditions resulting from a decline in the macroeconomic environment, rising interest rates, exchange rate fluctuations and inflation;

 

  •  

political instability and civil unrest which could discourage investment and complicate our dealings with governments;

 

  •  

widespread health emergencies or pandemics, such as the COVID-19 pandemic;

 

  •  

difficulties in complying with a variety of foreign laws and legal standards and changes in regulatory requirements;

 

  •  

expropriation and confiscation of assets and facilities;

 

  •  

difficulties in collecting receivables from foreign entities or delayed revenue recognition;

 

  •  

recruiting and retaining talented and capable employees;

 

  •  

differing labor standards;

 

  •  

increased tax rates;

 

  •  

potentially adverse tax consequences, including taxation of a portion of our revenues at higher rates than the tax rate that applies to us in Israel;

 

  •  

fluctuations in currency exchange rates and the impact of such fluctuations on our results of operations and financial position; and

 

  •  

the introduction of exchange controls and other restrictions by foreign governments.

These difficulties could cause our revenues to decline, increase our costs or both. This is also specifically tied to currency exchange rates which have an impact on our financial statements based on currency rate fluctuations.

Our actual or perceived failure to adequately protect personal data could subject us to sanctions and damages and could harm our reputation and business

A variety of state, national, foreign, and international laws and regulations apply to the collection, use, retention, protection, disclosure, transfer, and other processing of personal data. These privacy and data protection related laws and regulations, as demonstrated by the examples below, continue to evolve. New or modified laws and regulations are proposed and implemented frequently and existing laws and regulations subject to new or different interpretations. Compliance with these laws and regulations can be costly and can delay or impede the development and offering of new products and services.

 

13

Table of Contents

For example, the General Data Protection Regulation (“GDPR”) (which is applicable in both the EU and the UK), imposes stringent requirements for data processors and controllers. Such requirements include amongst other things, obligations to: i) provide data subjects with fulsome disclosures about the processing of personal information; ii) adhere to reasonable data retention limits; iii) comply with deletion requirements and requests; iv) comply with mandatory notification requirements in the case of a data breach and v) adhere to elevated standards regarding valid consent in some specific cases of data processing and vi) comply with stringent data transfer obligations (which have, since 2020, become more challenging to address). The GDPR also includes potentially severe penalties for failure to comply, inter alia, a fine up to 20 million Euros or up to 4% of the annual worldwide turnover, whichever is greater, which can be imposed. Compliance with these stringent requirements on privacy user notifications and data handling (both as they apply to us but also our customers) could increase our financial risk exposure, require us to adapt our business in order to comply with the GDPR requirements and incur additional costs.

Additionally, the United States has state-level data privacy laws and their fragmented regulations increase the burden of compliance. In California, the California Consumer Privacy Act (“CCPA”) provides data privacy rights for consumers and privacy related operational requirements for companies. California voters also passed the California Privacy Rights Act (“CPRA”) into law on November 3, 2020, which became effective on January 1, 2023. The CPRA, amongst other things, added new privacy rights and increased regulation on online advertising. Additionally, the CCPA and CPRA, and other legal and regulatory changes are making it easier for certain individuals to opt-out of having their personal data processed and disclosed to third parties through various opt-out mechanisms, which could result in an increase to our operational costs to ensure compliance with such legal and regulatory changes. Additional US States have introduced or are introducing comprehensive privacy laws including Virginia which enacted the Virginia Consumer Data Protection Act (“VCDPA”) on March 2, 2021, which became effective on January 1, 2023. Following California and Virginia, Colorado enacted a comprehensive privacy law with the passage of the Colorado Privacy Act (“CoPA”) on July 8, 2021 which becomes effective on July 1, 2023. The fourth comprehensive data privacy law in the United States is the Utah Consumer Privacy Act (“UCPA”), which was enacted on March 24, 2022 and will take effect on December 31, 2023. Connecticut has also enacted a comprehensive data privacy law, the Connecticut Data Privacy Act (“CTDPA”), which was enacted on May 10, 2022, and which will be in effect from July 1, 2023.

Other jurisdictions have also enacted and strengthened data protection laws, which have increased the cost of complying with them for businesses. In Latin America, Brazil’s Lei Geral de Proteção de Dados (LGPD), one of the most impactful data protection laws in Latin America, came into force in August 2020 although the penalties provided by the law did not become enforceable until August 2021. The LGPD is largely aligned to the GDPR. In China, Personal Information Protection Law of the People’s Republic of China (“PIPL”) took effect on November 1, 2021. The PIPL has parallels with the GDPR given that is has extra-territorial effect, applying to data processing activities in China and outside of China in certain circumstances. In Australia, the Privacy Legislation Amendment (Enforcement and Other Measures) Bill 2022 was passed on November 28, 2022 and entered into force on December 13, 2022. This law enhances the sanctions and the maximum penalty is the greater of: (i) $50 million AUD; (ii) three (3) times the value of the benefit derived by the company from the breach; or (iii) 30% of the company’s adjusted turnover (if the value of the benefit cannot be derived).

Our actual or alleged failure to comply with applicable laws and regulations, relating to the protection of personal data, could result in enforcement actions, significant penalties imposed by a regulator or data subject or other legal action against us or our customers or suppliers, which could result in negative publicity, increased operating costs, and financial penalties which could have a material adverse effect on our business and results of operations.

Compliance with new and changing corporate governance and public disclosure requirements adds uncertainty to our compliance policies and increases our costs of compliance

Changing laws, regulations and standards relating to accounting, corporate governance and public disclosure, including the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (“Dodd-Frank”), new SEC regulations, amendments to the Israeli Companies Law and Nasdaq Global Select Market rules are creating increased compliance costs and uncertainty for companies like ours. These new or changed laws, regulations and standards may lack specificity and are subject to varying interpretations. The implementation of these laws and their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs of compliance as a result of ongoing revisions to such governance standards.

In addition, continuing compliance with Section 404 of the Sarbanes-Oxley Act of 2002 and the related regulations regarding our required assessment of our internal control over financial reporting requires the commitment of significant financial and managerial resources and the report of an independent registered public accounting firm on the Company’s internal control over financial reporting.

In connection with our Annual Report for fiscal 2022, our management assessed our internal control over financial reporting, and determined that our internal control over financial reporting was effective as of December 31, 2022, and our independent auditors have expressed an unqualified opinion over the effectiveness of our internal control over financial reporting as of December 31, 2022. However, we will undertake management assessments of our internal control over financial reporting in connection with each annual report, and any deficiencies uncovered by these assessments or any inability of our auditors to issue an unqualified report could harm our reputation and the price of our ordinary shares.

 

14

Table of Contents

A small number of shareholders own a substantial portion of our ordinary shares, and they may make decisions with which you or others may disagree

As of February 28, 2023, our directors and executive officers owned approximately 21% of the voting power of our outstanding ordinary shares, or 24.6% of our outstanding ordinary shares if the percentage includes options currently exercisable or exercisable within 60 days of February 28, 2023 and RSUs and PSUs vesting within 60 days of February 28, 2023. The interests of these shareholders may differ from your interests and present a conflict. If these shareholders act together, they could exercise significant influence over our operations and business strategy. For example, although these shareholders hold considerably less than a majority of our outstanding ordinary shares, they may have sufficient voting power to influence matters requiring approval by our shareholders, including the election and removal of directors and the approval or rejection of mergers or other business combination transactions. In addition, this concentration of ownership may delay, prevent or deter a change in control, or deprive a shareholder of a possible premium for its ordinary shares as part of a sale of our company.

Our cash balances and investment portfolio have been, and may continue to be, adversely affected by market conditions and interest rates

We maintain substantial balances of cash and liquid investments, for purposes of general corporate purposes, which may include acquisitions, share repurchases and other purposes. Our cash, cash equivalents, short-term bank deposits and fixed-income marketable securities totaled $3,503 million as of December 31, 2022. The performance of the debt capital markets affects the market values of funds that are held in marketable securities. These assets are subject to price fluctuations, changes in interest rates and credit spreads, market liquidity and various other factors, including, without limitation, rating agency upgrades / downgrades that may impair some or all of their value, or unexpected changes in the financial markets’ healthiness worldwide.

We expect that market conditions will continue to fluctuate and the fair value of our investments may be affected accordingly. Moreover, in case we would like to liquidate some of our investments into cash – we are dependent on market conditions and liquidity opportunities, which may be impacted by economic, social, or political conditions, including, without limitation, conditions resulting from a decline in the macroeconomic environment, rising interest rates, exchange rate fluctuations, inflation, the COVID-19 pandemic, global supply chain disruptions and conditions resulting from geopolitical uncertainty and instability or war, including the significant military action against Ukraine launched by Russia.

Financial income is an important component of our net income. The outlook for our financial income is dependent on many factors, some of which are beyond our control, and they include the future direction of interest rates, foreign exchange rates, amount of any share repurchases, acquisitions that we may execute and the amount of cash flows from operations that are available for investment. We rely on third-party money managers to manage the majority of our investment portfolio in a risk-controlled framework and subject to our investment policy. Our investment portfolio is invested primarily in fixed-income securities and short-term bank deposits, and is affected primarily by changes in interest rates and credit spreads. Interest rates are highly sensitive to many factors, including governmental monetary policies and domestic and international economic and political conditions, such as the significant military action against Ukraine launched by Russia and any related political or economic responses and counter-responses or otherwise by various global actors or general effect on the global economy. Any significant decline in our financial income or the value of our investments due to changes in interest rates, interest rate expectations, credit spreads, deterioration in the credit rating of the securities in which we have invested, or general market conditions, could have an adverse effect on our results of operations and financial condition.

We generally buy and hold our fixed income securities, while limiting credit risk by setting a maximum concentration limit per issuer as well as setting minimum credit rating requirement. Our fixed income investment portfolio consists primarily of government bonds, securities issued by government agencies and corporate debentures. Although we believe that we generally adhere to conservative investment guidelines, a turmoil in the financial markets may result in impairments of the carrying value of our investment assets. We classify our investments in fixed maturity securities as available-for-sale. Changes in the fair value of investments classified as available-for-sale are not recognized as income during the period, but rather are recognized as a separate component of equity until realized. Realized losses in our investments portfolio may adversely affect our financial position and results. Had we reported the cumulative changes in the fair value of our fixed income securities as part of our income, our reported net income for the year ended December 31, 2022, would have decreased by $95 million.

Currency fluctuations may affect the results of our operations or financial condition

Our functional and reporting currency is the U.S. dollar. We generate a majority of our revenues and expenses in U.S. dollars. In 2022, we incurred approximately 46% of our expenses in foreign currencies, primarily Israeli Shekels and Euros. As such, changes in exchange rates may have a material adverse effect on our business, results of operations and financial condition. The exchange rates between the U.S. dollar and certain foreign currencies have fluctuated substantially in recent years and may continue to fluctuate substantially in the future. We expect that a majority of our revenues will continue to be generated in U.S. dollars for the foreseeable future and that a significant portion of our expenses, including payroll related costs, as well as capital and operating expenditures, will continue to be denominated in the currencies referred to above. The results of our operations may be adversely affected in relation to foreign exchange fluctuations. During 2022, we entered into forward contracts to hedge against some of the risk of foreign currency exchange rates fluctuations resulting in changes in future cash flow from payments of payroll and related expenses denominated in Israeli Shekels and Euros. As of December 31, 2022, our total outstanding forward contracts that hedge against these fluctuations in foreign currency exchange rates were $266 million.

 

15

Table of Contents

In addition, we entered into forward contracts to hedge the impact of fluctuations in exchange rates on assets and liabilities denominated in Israeli Shekels and other currencies. As of December 31, 2022, the total amount of outstanding forward contracts that did not qualify for hedge accounting, was $208 million. We may use derivative financial instruments, such as foreign exchange forward contracts, put and call options, and others, to mitigate the risk of fluctuations changes in foreign exchange rates on assets, cash flows receivables and payables denominated in certain currencies. We may not be able to purchase derivative instruments adequate to fully protect us from foreign currency exchange risks.

Additionally, our hedging activities may also generate losses as a result of volatility in foreign currency markets. If foreign exchange markets continue to be volatile, such fluctuations in foreign exchange rates could materially and adversely affect our profit margins and results of operations in future periods. Also, the volatility in the foreign exchange markets may make it difficult to hedge our foreign currency exposures effectively.

The imposition of exchange or price controls or other restrictions on the conversion of foreign currencies could also have a material adverse effect on our business, results of operations and financial condition.

Changes in foreign exchange rates around the globe, could have an adverse impact on our business and results of operations. These changes may have an impact on some of our expenses which are paid in local currencies (non US dollar), as well as an impact on our non-US customers which have their financials in non-US dollar currencies.

On December 24, 2020, the European Union and the UK announced that they had reached a new bilateral trade and cooperation agreement governing their future relationship (the “EU-UK Trade and Cooperation Agreement”) which was formally approved by the European Council on December 29, 2020 and by the UK parliament on December 30, 2020. The EU-UK Trade and Cooperation Agreement became effective on a provisional basis from January 1, 2021. It was announced on April 28, 2021, that the EU Parliament approved the EU-UK Trade and Cooperation Agreement with a large majority meaning that the Agreement applied permanently from May 1, 2021. There is an ever-changing regulatory and legislative landscape in relation to Brexit in both the UK and the EU. Brexit could lead to legal uncertainty and potentially divergent national laws and regulations as the U.K. determines which E.U. laws to replace or replicate, and those laws and regulations may be cumbersome, difficult or costly in terms of compliance. Any of these effects of Brexit, among other factors, could adversely affect our business, financial condition, results of operations and cash flows.

Third parties might attempt to gain unauthorized access to our network or seek to compromise our products and services

We regularly face attempts by others to gain unauthorized access through the Internet or to introduce malicious software to our information technology (IT) systems. Additionally, malicious hackers may attempt to gain unauthorized access and corrupt the processes of hardware and software products that we manufacture and services we provide. There are also increased threats of attacks as retaliation for sanctions imposed against Russia as a result of the significant military action against Ukraine launched by Russia. We or our products are a frequent target of computer hackers and organizations that intend to sabotage, take control of, or otherwise corrupt our manufacturing or other processes and products. We are also a target of malicious attackers who attempt to gain access to our network or data centers or those of our customers or end users; steal proprietary information related to our business, products, employees, and customers; or interrupt our systems or those of our customers or others. We believe such attempts are increasing in number and the Russia-Ukraine armed conflict was followed by increased risk of data breach and other threats from ransomware, destructive malware, distributed denial-of-service attacks, as well as fraud, spam and fake accounts, cyber-attacks or other illegal activity. From time to time we encounter intrusions or attempts at gaining unauthorized access to our products and network. To date, none have resulted in any material adverse impact to our business or operations. While we seek to detect and investigate all unauthorized attempts and attacks against our network and products, and to prevent their recurrence where practicable through changes to our internal processes and tools and/or changes or patches to our products, we remain potentially vulnerable to additional known or unknown threats. Such incidents, whether successful or unsuccessful, could result in our incurring significant costs related to, for example, rebuilding internal systems, reduced inventory value, providing modifications to our products and services, defending against litigation, responding to regulatory inquiries or actions, paying damages, or taking other remedial steps with respect to third parties. Publicity about vulnerabilities and attempted or successful incursions could damage our reputation with customers or users and reduce demand for our products and services.

Risks Related to Our Operations in Israel

Potential political, economic and military instability in Israel, where our principal executive offices and our principal research and development facilities are located, may adversely affect our results of operations

 

16

Table of Contents

We are incorporated under the laws of the State of Israel, and our principal executive offices and principal research and development facilities are located in Israel. Accordingly, political, economic and military conditions in and surrounding Israel may directly affect our business. Since the State of Israel was established in 1948, a number of armed conflicts have occurred between Israel and its Arab neighbors. Terrorist attacks and hostilities within Israel; the hostilities between Israel and Hezbollah and between Israel and Hamas; as well as tensions between Israel and Iran, have also heightened these risks, including extensive hostilities along Israel’s border with the Gaza Strip, which included missiles being fired from the Gaza Strip into Israel. Our principal place of business is located in Tel Aviv, Israel, which is approximately 40 miles from the nearest point of the border with the Gaza Strip. There can be no assurance that attacks launched from the Gaza Strip will not reach our facilities, which could result in a significant disruption of our business. In addition, there are significant ongoing hostilities in the Middle East, particularly in Syria and Iraq, which may impact Israel in the future. Any hostilities involving Israel, a significant increase in terrorism or the interruption or curtailment of trade between Israel and its present trading partners, or a significant downturn in the economic or financial condition of Israel, could materially adversely affect our operations. Ongoing and revived hostilities or other Israeli political or economic factors could materially adversely affect our business, results of operations and financial condition. In addition, there have been increased efforts by activists to cause companies and consumers to boycott Israeli goods based on Israeli government policies. Such actions, particularly if they become more widespread, may adversely impact our ability to sell our products.

Uprisings and armed conflicts in various countries in the Middle East and North Africa are affecting the political stability of those countries. This instability may lead to deterioration of the political and trade relationships that exist between Israel and these countries. In addition, this instability may affect the global economy and marketplace, including as a result of changes in oil and gas prices.

As of beginning of 2023, there has been political tension in Israel due to the government’s intent to pursue a reform in Israel’s judicial system. This has prompted protests in Israel and triggered a considerable political debate. The proposed legislation has not become effective and its scope has not been fully determined. At this stage we cannot assess the potential business impact of these developments and their likely effect on our business, results of operation, and financial condition.

Our operations may be disrupted by the obligations of our personnel to perform military service

Many of our employees in Israel are obligated to perform annual military reserve duty in the Israel Defense Forces, in the event of a military conflict, could be called to active duty. Our operations could be disrupted by the absence of a significant number of our employees related to military service or the absence for extended periods of military service of one or more of our key employees. Military service requirements for our employees could materially adversely affect our business, results of operations and financial condition.

The tax benefits available to us require us to meet several conditions, and may be terminated or reduced in the future, which would increase our taxes

For the year ended December 31, 2022, our effective tax rate was 14%. We have benefited or currently benefit from a variety of government programs and tax benefits that generally carry conditions that we must meet in order to be eligible to obtain any benefit. Our tax expenses and the resulting effective tax rate reflected in our financial statements may increase over time as a result of changes in corporate income tax rates, other changes in the tax laws of the countries in which we operate or changes in the mix of countries where we generate profit.

If we fail to meet the conditions upon which certain favorable tax treatment is based, we would not be able to claim future tax benefits and could be required to refund tax benefits already received.

Any of the following could have a material effect on our overall effective tax rate:

 

  •  

Some programs may be discontinued,

 

  •  

We may be unable to meet the requirements for continuing to qualify for some programs,

 

  •  

These programs and tax benefits may be unavailable at their current levels, or

 

  •  

We may be required to refund previously recognized tax benefits if we are found to be in violation of the stipulated conditions.

Additional details are provided in “Item 5 – Operating and Financial Review and Products” under the caption “Taxes on income”, in “Item 10 – Additional Information” under the caption “Israeli taxation, foreign exchange regulation and investment programs” and in Note 11 to our Consolidated Financial Statements.

Your rights and responsibilities as a shareholder are, and will continue to be, governed by Israeli law which differs in some material respects from the rights and responsibilities of shareholders of U.S. companies

 

17

Table of Contents

The rights and responsibilities of the holders of our ordinary shares are governed by our articles of association and by Israeli law. These rights and responsibilities differ in some material respects from the rights and responsibilities of shareholders in U.S.- based corporations. In particular, a shareholder of an Israeli company has a duty to act in good faith and in a customary manner in exercising its rights and performing its obligations towards the company and other shareholders, and to refrain from abusing its power in the company, including, among other things, in voting at a general meeting of shareholders on matters such as amendments to a company’s articles of association, increases in a company’s authorized share capital, mergers and acquisitions and related party transactions requiring shareholder approval. In addition, a shareholder who is aware that it possesses the power to determine the outcome of a shareholder vote or to appoint or prevent the appointment of a director or executive officer in the company has a duty of fairness toward the company. There is limited case law available to assist in understanding the nature of this duty or the implications of these provisions. These provisions may be interpreted to impose additional obligations and liabilities on holders of our ordinary shares that are not typically imposed on shareholders of U.S. corporations.

Provisions of Israeli law and our articles of association may delay, prevent or make difficult an acquisition of us, prevent a change of control, and negatively impact our share price

Israeli corporate law regulates acquisitions of shares through tender offers and mergers, requires special approvals for transactions involving directors, officers or significant shareholders, and regulates other matters that may be relevant to these types of transactions. Furthermore, Israeli tax considerations may make potential acquisition transactions unappealing to us or to some of our shareholders. For example, Israeli tax law may subject a shareholder who exchanges his or her ordinary shares for shares in a foreign corporation, to taxation before disposition of the investment in the foreign corporation. These provisions of Israeli law may delay, prevent or make difficult an acquisition of our company, which could prevent a change of control and, therefore, depress the price of our shares.

In addition, our articles of association contain certain provisions that may make it more difficult to acquire us, such as the provision which provides that our board of directors may issue preferred shares. These provisions may have the effect of delaying or deterring a change in control of us, thereby limiting the opportunity for shareholders to receive a premium for their shares and possibly affecting the price that some investors are willing to pay for our securities.

Additional details are provided in “Item 10 – Additional Information” under the caption “Articles of Association and Israeli Companies Law – Anti-takeover measures”.

As a foreign private issuer we are not subject to the provisions of Regulation FD or U.S. proxy rules and are exempt from filing certain Exchange Act reports

As a foreign private issuer, we are exempt from a number of requirements under U.S. securities laws that apply to public companies that are not foreign private issuers. In particular, we are exempt from the rules and regulations under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual and current reports and financial statements with the SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the Exchange Act and we are generally exempt from filing quarterly reports with the SEC under the Exchange Act. We are also exempt from the provisions of Regulation FD, which prohibits issuers from making selective disclosure of material nonpublic information to, among others, broker-dealers and holders of a company’s securities under circumstances in which it is reasonably foreseeable that the holder will trade in the company’s securities on the basis of the information. For so long as we qualify as a foreign private issuer, we are not required to comply with the proxy rules applicable to U.S. domestic companies, although pursuant to the Companies Law, we disclose the annual compensation of our five most highly compensated office holders (as defined under the Israeli Companies Law) on an individual basis, including in this Annual Report.

As a foreign private issuer whose shares are listed on the Nasdaq Global Select Market, we may follow certain home country corporate governance practices instead of certain Nasdaq requirements

As a foreign private issuer whose shares are listed on the Nasdaq Global Select Market, we are permitted to follow certain home country corporate governance practices instead of certain requirements of the Nasdaq Stock Market Rules. For example, we follow our home country law, instead of the Nasdaq Stock Market Rules, which require that we obtain shareholder approval for the establishment or amendment of certain equity based compensation plans and arrangements. Under Israeli law and practice, in general, the approval of the board of directors is required for the establishment or amendment of equity based compensation plans and arrangements, unless the arrangement is for the benefit of a director or a controlling shareholder, in which case compensation committee or audit committee and shareholder approval are also required. A foreign private issuer that elects to follow a home country practice instead of Nasdaq requirements must submit to Nasdaq in advance a written statement from an independent counsel in such issuer’s home country certifying that the issuer’s practices are not prohibited by the home country’s laws. In addition, a foreign private issuer must disclose in its annual reports filed with the Securities and Exchange Commission each such requirement that it does not follow and describe the home country practice followed by the issuer instead of any such requirement. Accordingly, our shareholders may not be afforded the same protection as provided under Nasdaq’s corporate governance rules.

 

18

Table of Contents
ITEM 4.

INFORMATION ON CHECK POINT

Check Point History and Development

Since its inception, our sole focus has been on making the world a safer place to live and work. Over the last three decades, we worked to fulfill our vision to provide any organization with the ability to conduct its business on the internet with advanced and comprehensive levels of security.

We pioneered the first commercially available firewall, followed by a steady stream of industry-first cyber security solutions. As an example, our technology provides protection against both known and unknown cyber security threats across a wide range of environments: physical and virtual networks, cloud and mobile surroundings, critical infrastructures, and the ‘Internet of Things’ (IoT). Today, the threat landscape is more complex than ever, with organizations experiencing the 5th generation of cyber-attacks –large-scale and multi-vector mega attacks using advanced attack technologies, while the security deployed by many businesses is generationally behind and incapable of protecting against such attacks.

Protecting the World from 5th Generation of Cyber Security Attacks and a Cyber Pandemic

We identified the evolving different generations of both cyber-attacks and security products. Today, we find ourselves in an increasingly complex threat landscape with organizations experiencing the 5th generation of cyber-attacks. The security deployed by most businesses is generationally behind and incapable of protecting against such attacks. Specifically, while we are facing the 5th generation of attacks, most businesses possess only 2nd or 3rd generation security.

 

  •  

Generation 1 – Late 1980s, virus attacks on stand-alone PCs affected all businesses and drove the rise of anti-virus products.

 

  •  

Generation 2 – Mid 1990s, attacks from the internet affected all business and drove the creation of the firewall.

 

  •  

Generation 3 – Early 2000s, exploiting vulnerabilities in applications affected most businesses and drove the rise in intrusion prevention systems (IPS) products.

 

  •  

Generation 4 – Approximately 2010, rise of targeted, unknown, evasive, polymorphic attacks affected most businesses and drove the increase in behavior analysis technologies such as sandboxing products.

 

  •  

Generation 5 – Approximately 2018-2022, the large-scale and multi-vector mega attacks using advanced attack technologies. These are fast-moving attacks so detection-only is not enough. These attacks targeted traditional attack vectors and expanded to mobile and cloud. Advanced threat prevention is required.

Cyber-attacks are now a daily phenomenon with widespread news coverage, resulting often in lost data and privacy, and the complete halting of a business’ operations.    Organizations that presumed their security was good enough, are now discovering it was not.

The world is dependent on the internet, now more than ever, and as organizations rapidly digitalize their operations, we believe their cyber security needs to be recalibrated to address the security of their corporate networks, hybrid-datacenters, cloud environments and lastly, securing their employees – wherever they are located.

We are bringing this vision to life with the introduction of “The 3Cs of Best Security”. By following these principles we enable organizations to deploy a cyber security architecture that works together to prevent attacks before any damage occurs.

 

  •  

Comprehensive: A security architecture that provides prevention first prevention across all attack vectors. From code to cloud, networks, users, email and IoT. The complexity level of the cyber security threat landscape has significantly evolved and more than doubled itself in the last 3 years. Cyber criminals use today more attack vectors to launch their attacks and organizations require more security technologies to defend themselves. A comprehensive solution across all attack vectors is imperative to allow prevention first approach against any attack.

 

  •  

Consolidated: The latest generation of sophisticated cyber-attacks spread quickly across all vectors and frequently bypass conventional defenses. To combat these attacks, businesses deploy multiple point solutions, many of which focus on detecting and mitigating threats rather than preventing them before they breach enterprise networks. This reactive approach to cyber-attacks is costly and ineffective, complicating security operations, and creating gaps in the security posture of an enterprise. By embracing a consolidated architecture that enhances security coordination and effectiveness, organizations improve security and save money used to integrate multiple, siloed solutions. We believe that a consolidated architecture will reduce operational overhead and more easily allow organizations to address many of the security challenges they face today.

 

19

Table of Contents
  •  

Collaborative: To be able to deploy a prevention first approach, all solutions and products must work together and respond collaboratively to any threat. When an attack hits an Endpoint for example, all other security technologies across cloud, network, email etc., must take action and respond accordingly to prevent the attack from entering through their respective vendor. To achieve that, the consolidated and comprehensive architecture must collaborate and have every security engine easily applied to any attack vector. On top of that, real-time threat intelligence information gathered from all enforcement points, research teams and 3rd party feeds, must be shared across the environment so preventive action can be taken immediately to prevent the attack.

Check Point’s Four Strategic Pillars

 

  1.

Quantum: Enterprise network security for perimeter and datacenter

Aimed to secure and effectively manage datacenter environments. Check Point Quantum Security Gateways deliver comprehensive security beyond any Next Generation Firewall (NGFW) and are designed to manage the most complex policy requirements. Powered with over 60 security services, these gateways are aimed at preventing the 5th generation of cyber-attacks. In order to serve the different needs and demands of our customers, we offer a wide portfolio of security gateways and software platforms that support a wide range of small and medium sized business (SMB) to large enterprise data center and telco-grade environments. On each security gateway, we offer the full expanse of Check Point’s network security portfolio from industry-leading next generation firewall, IPS (Intrusion Prevention System), VPN (Virtual Private Network), WAF (Web Application Firewall), SSL (Secure Sockets Layer), and DLP (Data Loss Prevention) to a wide set of threat prevention technologies blocking known and unknown advanced 5th generation cyber-attacks. Check Point‘s security gateways are available as a cloud service, software-only products that can run on standard hardware, or dedicated security gateway hardware appliances.

Check Point’s cyber security platform (R81) introduces the industry’s first autonomous threat prevention system, which eliminates labor-intensive manual threat classification and updates. All Quantum gateways are updated automatically by AI-based threat prevention for complete protection against zero-day threats.

 

  2.

CloudGuard: Automatically secure your cloud

Check Point cloud native security, delivered through CloudGuard, provides automated security and advanced threat prevention to protect cloud assets and workloads from cyber threats including sophisticated cyber-attacks and misconfigurations. CloudGuard secures cloud workloads in multiple environments including Amazon AWS, Microsoft Azure, Google, VMWare and others providing relevant capabilities for each cloud environment.

 

  1.

Cloud Network Security: advanced threat prevention and network security through a virtual security gateway—automated and unified across all multi-cloud and on-premises environments.

 

  2.

Security and Posture Management: prevents threats and achieves high fidelity posture management.

 

  3.

Cloud Workload Protection and Web Application Protection: seamless vulnerability assessment and runtime protection of modern cloud workloads, including serverless functions and containers.

 

  4.

Powered by contextual-AI, protects web applications and APIs from the most sophisticated types of threats.

 

  •

In 2022 we introduced Security from code to cloud; Developer-centric security that monitors, classifies, and protects codes, assets, and infrastructure to protect against exposed API keys, tokens, and credentials, as well as identifies and stops misconfigurations.

 

  3.

Harmony: Securing the User Environment

Check Point Harmony protects employees, devices, and internet connectivity from malicious attacks, while ensuring secure, remote zero-trust access at any scale to any corporate application. Check Point Harmony provides endpoint and secure connectivity in various forms for easy and comprehensive remote user access.

Harmony unifies five security products to deliver complete remote users security:

 

•

Harmony Endpoint protects users’ PCs from ransomware, phishing, and malware, and minimizes breach impact with autonomous detection and response capability.

 

•

Harmony Mobile protects employees’ mobile devices against malicious apps and network or operating systems attacks.

 

20

Table of Contents
•

Harmony Email & Collaboration secures users’ email clients and gives complete protection for Microsoft Office 365, Exchange, Google G Suite and others. In 2021, we extended Harmony with cloud-email security with the acquisition of Avanan – a leading cloud-email security company.

 

•

Secure Internet Browsing: Provides secure, fast, and private web browsing by inspecting all SSL traffic directly on the endpoint.

 

•

Secure remote access to corporate applications: Harmony Connect provides Secure Access Service Edge (SASE) and provides secure and easy access to any corporate application.

 

  4.

Horizon: Prevention-First Security Operations

In 2022 we introduced a new member to the Infinity architecture: Horizon, prevention-first security operations with XDR/XPR and MDR/MPR for complete coverage of threats across networks, endpoints, cloud, email and IoT, from one pane of glass. Horizon is designed to prevent advanced threats across all vectors with fewer resources by leveraging the power of ThreatCloud and AI.

 

  •

Horizon XDR/XPR: Extended Prevention and Response

Horizon XDR/XPR is prevention-first extended detection, prevention and response platform that detects and stops known and zero-day threats across email, cloud, networks and endpoints. XDR/XPR provides comprehensive threat prevention across the entire security estate through collaborative, intelligent AI correlation.

 

  •

Horizon MDR/MPR: Managed Prevention and response

Horizon MDR/MPR is a prevention-first managed detection, prevention and response solution offering complete, powerful SOC operations as a service. Check Point’s experts monitor the entire infrastructure 24X7, including: network, endpoint, email, cloud and IoT and take informed decisions to stop attacks, and optimize defenses to prevent future attacks.

Check Point Infinity Architecture

Check Point Infinity is a consolidated cyber security architecture that protects against 5th generation of cyber-attacks. It supports comprehensive prevention across attack vectors and    assets across networks, endpoint, cloud, workloads, IoT and mobile, and secures them with over 75 threat prevention engines (over 50% of which are AI-based). Through advanced threat prevention, business-oriented policy management, and cloud-based threat intelligence, Infinity delivers a solid foundation for a sustainable, effective risk management strategy. This model allows organizations to use all of Check Point’s security technologies to protect their networks, endpoint, mobile devices, cloud, and IoT through an annual security subscription based on the number of enterprise users.

Check Point Threat Prevention Technologies & Products

ThreatCloud is a centralized cloud based “brain” that combines the latest AI technologies with big data threat intelligence to prevent the advanced attacks while reducing false positives.

 

  1.

AI technologies – Accurately block zero-day ransomware, sophisticated Trojans, and other advanced malware through a market leading malware analysis technology leveraging 40+ AI based machine and deep learning engines.

  2.

Big data threat intelligence – Aggregates and analyzes big data telemetry and millions of Indicators of Compromise (IoCs) every day.

Check Point Technology Leadership in 2022

During 2022 we were endorsed by market analysts for our leadership position. Check Point was mentioned in over 160 analyst reports in 2022. Below are some of the highlight reviews:

Gartner

 

  ●  

Leader for the 23rd time in Magic Quadrant for Network Firewalls

Forrester

 

  ●  

Quantum recognized as a Market Leader in Wave for Enterprise Firewalls

 

  ●  

CloudGuard recognized as a Strong Performer in Wave for Cloud Workload Protection

 

21

Table of Contents

Miercom - Firewall Benchmark 2023

Check Point recognized as #1 in Malware and Phishing threat prevention, in independent competitive test of top enterprise firewalls. According to the Miercom report, Check Point delivered block rate at 99.7% while competitors were as low as 43%. Check Point also delivered top phishing prevention at 99.9% with the lowest miss rate (competition had 10 times higher miss rate).

Omdia

 

  ●  

Harmony Mobile recognized as a Market Leader in Radar for Mobile Security Solution

 

  ●  

Harmony Endpoint recognized as a Market Leader in Radar for Endpoint Security Platforms

KuppingerCole

 

  ●  

Harmony Connect recognized as a Market Leader in Compass Secure Access Service Edge (SASE) Integration Suites

MITRE Evaluations

 

  ●  

Leadership in Endpoint Security with 100% Detection across All Tested Unique ATT&CK Techniques

    G2.com

 

  ●  

Recognized as leader in nine Grid Reports for Firewall, Cloud, Endpoint and Mobile Data security

Acquisitions and other Corporate Information

In September 2021, we acquired 100% of the share capital of Avanan Inc., a privately-held US-based company providing cloud email security, and the developer of a patented application-programming interface (API) solution to stop email threats before arriving to the inbox (inline), for both internal and external emails using AI based engines.

In February 2022, we acquired 100% of the share capital of Spectral Cyber Technologies Ltd., a privately held Israeli company and key innovator in developer-first security tools designed by developers for developers, to extend our cloud solution, Check Point CloudGuard.

Further details regarding the material events in the development of our business since the beginning of 2020 are provided in “Item 5 – Operating and Financial Review and Prospects” under the caption “Overview”.

We incorporated as a company under the laws of the State of Israel in 1993 under the name of “Check Point Software Technologies Ltd.” Our registered office and principal place of business is located at 5 Shlomo Kaplan Street Tel Aviv 6789159, Israel. The telephone number of our registered office is 972-3-753-4555. Our company’s website is www.checkpoint.com. The contents of our website are not incorporated by reference into this Annual Report.

This Annual Report is available on our website. If you would like to receive a printed copy via mail, please contact our Investor Relations department at 959 Skyway Road, Suite 300, San Carlos, CA 94070, U.S.A., Tel.: 650-628-2050, email: ir@us.checkpoint.com.

Our agent for service of process in the United States is CT Corporation System, 818 West Seventh Street, Los Angeles, CA 90017 U.S.A.; Tel: 213-627-8252.

 

22

Table of Contents

Revenues by Category of Activity

The following table presents our revenues for the last three fiscal years by category of activity:

 

     Year Ended December 31,  
     2022      2021      2020  
        
     (in millions)  

Category of Activity:

      

Products and licenses

    $ 554.9      $ 513.9      $ 513.6  

Security subscriptions

      858.0        755.2        671.1  

Software updates and maintenance

      917.0        897.7        880.2  
  

 

 

     

 

 

     

 

 

  

Total revenues

    $ 2,329.9      $ 2,166.8      $ 2,064.9  

Sales and Marketing

We mostly sell our products and services through a two-tier distribution model; distributors that sell to resellers and to service providers and MSSPs, who sell to end-customers. We support our channel partners with a dedicated team of experienced sales professionals including account managers, channel managers and sales engineers.

Our marketing efforts include building our brand, product marketing, partner incentives and promotions, event marketing, digital marketing, communications and public relations. In 2022, we continued to invest in sales and marketing resources.

As of December 31, 2022, we had 2,829 employees and subcontractors in our sales and marketing organization, with a majority of them dedicated to pre sales and marketing support located in various jurisdictions.

Support and Services

We operate a worldwide technical services organization which provides a wide range of services including: (i) technical customer support programs and plans; (ii) professional services in implementing, upgrading and optimizing Check Point products, such as design planning and security implementation; and (iii) certification and educational training on Check Point products.

Our technical assistance centers in the United States, Israel, Canada, Japan, India, China and Australia offer support worldwide, 24-hour service, seven days per week.

As of December 31, 2022, we had 934 employees and subcontractors in our technical services organization.

Research and Product Development

We believe that our future success will depend upon our ability to enhance our existing products, and to develop, acquire and introduce new products to address the increasingly sophisticated needs of our customers.

As of December 31, 2022, we had 1,836 employees and subcontractors dedicated to research and development activities and quality assurance.

Competition

Information concerning competition is provided in “Item 3 – Key Information” under the caption “Risk Factors – Risks Related to Our Business and Our Market – We may not be able to successfully compete, which could adversely affect our business and results of operations”.

Environmental, Social and Governance (ESG) Practices

Since Check Point’s inception, our sole focus has been on making the world a safer place to live and work. For nearly 30 years, we have worked to fulfill our vision of making the Internet secure, reliable, and available for corporations and consumers. As a global brand with material social and economic influence, we recognize that our success can only be built alongside the success of our stakeholders – including, our channel partners, customers, suppliers and employees. We aim to achieve high ESG standards while continuing to develop our business and executing on our strategy.

 

23

Table of Contents

Our Commitment. Check Point is committed to making the world a safer and more secure place. In the digital era, this commitment applies to our work both on the internet and the physical world alike.

As we aspire to achieve a more sustainable future for all, we have set out the following practices and guidelines which our employees and stakeholders are expected to adhere to:

Social Standards:

 

  I.

Community – How we value each other – We believe in creating a more sustainable future for our stakeholders and for the world. We are extremely involved in the community and we invest greatly in volunteering and donations activities in an attempt to make the world a better place.

 

  •

Corporate Responsibility Policy – Check Point strongly believes that creating a positive economic, social and environmental impact advances its mission of developing security solutions to protect business and consumer transactions, and creating a more sustainable future for its stakeholders and the for the world. As part of Check Point’s corporate responsibility guidelines, Check Point identified ESG issues that are of highest relevance to its business activity and its stakeholders. These essential issues are addressed and managed constantly to ensure that they remain up to date and optimized to address the relevant concerns.

 

  •

Social Investment and Volunteer Statement – Check Point invests in its worldwide volunteering and donations activities as it is committed to making the world a safer and a better place in order to achieve a more sustainable future for all. Check Point is extremely involved in the community and is committed to the social needs of the communities we live and operate in.

 

  •

Human Resources – How we value ourselves – The most important asset of our company is our human capital. We are committed to creating a diverse, healthy, and supportive work environment where our employees can grow and learn together.

 

  •

Human Rights and Labor Policy – Check Point strives to treat its employees, contractors and suppliers with dignity and respect. Check Point promotes a safe, healthy, and supportive work environment and condemns modern slavery and human trafficking in any form. Check Point’s commitment includes closely monitoring its compliance with international standards and local laws in all of our locations around the world to ensure that the rights of our employees are protected.

 

  •

Workforce Diversity and Equality Statement – As a leading cyber security company, we are committed to nurturing diversity and equality while breaking the bias in the workplace when hiring, training, and evaluating our employees. Our teams are committed to creating a conscious culture that promotes open communication with the goal of a more equitable outcome for all. We believe that a diverse workforce encourages a wider variety of skills, talents, and viewpoints, leading to further creativity and innovation.

 

  •

Training and Employee Development Policy – The most important asset of Check Point is its human capital. Investing in the training and development of our employees, managers and groups within the company contributes not only to them, but also to Check Point as a whole. By providing our employees and managers with learning and development activities, we enable the company to achieve its business targets, and the people to constantly grow professionally.

 

  •

Anti-Slavery Policy – Check Point has zero tolerance towards modern slavery.

 

  II.

Supply Chain – How we value the process – We assure the high standards of our supply chain conduct by ensuring that the working conditions in our operations and supply chain are safe and that business operations are conducted ethically

 

  •

Supply Chain Code of Conduct – Check Point assures the high standards of its supply chain conduct by ensuring that the working conditions in Check Point’s operations and supply chain are safe and that business operations are conducted ethically. We demand our suppliers of products and services to comply with our high standards and values.

 

  •

Supply Chain Policy – Check Point assures the high standards and values of its supply chain conduct, as it considers honesty, integrity, transparency and open communication core values of our business and operations.

 

  •

Conflicts Minerals Policy – In certain conflict areas around the world, such as the Democratic Republic of the Congo and adjoining countries, the trade of certain minerals and derivative metals can be used to support corruption, money laundering and human rights abuses. In order to eradicate such behavior, Check Point has adopted a Conflicts Minerals Policy.

Environmental Standards:

 

  III.

Environment – How we value our surroundings – We take an active part in helping to ensure the sustainability of the world’s resources and environment.

 

24

Table of Contents
  •

Environmental Policy – Check Point understands that climate change and the global warming have observable effects on the environment. We therefore take an active part in helping to ensure the sustainability of the world’s resources and environment. Check Point’s impact on the environment is generally through our products, services and facilities. We comply with the applicable environmental laws and regulations and strive to be a leader in the environmental sustainability field.

 

  •

Board oversight - Our Board of Directors has a dedicated committee for overseeing environmental, social, and governance (ESG) matters (the Nominating, Sustainability and Corporate Governance Committee), which is responsible for ensuring that our environmental policies and practices are consistent with our overall business strategy. The committee reviews our environmental performance on a periodic basis.

Governance Standards:

 

  IV.

Corporate Governance – How we value our method – We have adopted corporate governance guidelines to assist our Board in carrying out its responsibilities and serving the interests of our company and its shareholders.

 

  •

Corporate Governance Guidelines – The Board of Directors of Check Point Software Technologies Ltd. has adopted Corporate Governance Guidelines to assist the Board in carrying out its responsibilities and serving the interests of the Company and its shareholders in a manner that is consistent with the Board’s fiduciary duties.

 

  •

Committee Charters – We have adopted written charters specifying the duties and responsibilities of each of our Audit Committee, Compensation Committee and Nominating, Sustainability and Corporate Governance Committee to assist the committee members in carrying out their responsibilities.

 

  V.

Ethics – How we value what is right – Check Point promotes core values of honest and ethical conduct, integrity, open communication, equal opportunity and diversity.

 

  •

Code of Ethics and Business Conduct – Check Point is a worldwide leader in developing security solutions to protect business and consumer transactions, and communications over the internet. Our goodwill and reputation are affected by what we do every day. By putting our commitment in writing we clearly set out the business practices that we follow and set clear standards of behavior for everyone associated with our organization.

 

  •

Privacy Policy – Our Privacy Policy explains how Check Point treats personal information that Check Point collects or generates both in relation to the Check Point website (www.checkpoint.com) and our products and services.

 

  •

Whistle Blower Procedure – Check Point strives to promote its values and establish uniformity within the company. Check Point’s employees and business partners are expected to adhere to and follow the standards and principles we set. In order to support the adherence to our Code of Ethics and Business Conduct as well as other policies, we provide different channels for reporting, which include the Whistle Blower Procedure. This is crucial for our high standards and values.

 

  •

Insider Trading Policy – This policy provides guidelines to employees, consultants, contractors, officers and directors of Check Point with respect to transactions in Check Point’s securities.

 

  •

Anti-Corruption, Bribery and Money Laundering Policy – Check Point’s goodwill and reputation are affected by what we do every day. Check Point clearly sets out the business practices that we follow and set clear standards of behavior for everyone associated with our organization. Our culture and values help us build trust with our customers, business partners, investors, other organizations and governments, and trust and integrity is the core of our business and operations.

On the diversity side, a described in Item 6, four senior executive officers reporting to the CEO are female executives.

Oversight of our risks, strategies, policies, programs and practices related to ESG matters is conducted by our nominating, sustainability and corporate governance committee, and our ESG Manager leads the day-to-day management of ESG matters.

Proprietary Rights

Check Point relies on a combination of copyright and trademark laws, trade secrets, confidentiality procedures and contractual provisions to protect its proprietary rights. Check Point relies on trade secrets and copyright laws to protect its software, documentation, and other written materials. Further, Check Point generally enters into confidentiality agreements with employees, consultants, customers and potential customers, and limits access and distribution of materials and information that the company considers proprietary.

 

25

Table of Contents

Check Point and its subsidiaries have 103 issued patents in the U.S. and in other regions and 21 pending patent applications worldwide. Our efforts to protect our patent rights and other proprietary rights may not be adequate and our competitors may independently develop technology that is similar. Additional details are provided in “Item 3 – Key Information” under the caption “Risk Factors – Risks Related to Our Business and Our Market – We may not be able to successfully protect our intellectual property rights”.

Effect of Government Regulation on our Business

Information concerning regulation is provided in “Item 5 – Operating and Financial Review and Products” under the caption “Taxes on income” and in “Item 10 – Additional Information” under the caption “Israeli taxation, foreign exchange regulation and investment programs”.

Organizational Structure

We are organized under the laws of the State of Israel. We wholly own the subsidiaries listed below, directly or through other subsidiaries, unless otherwise specified in the footnotes below:

 

NAME OF SUBSIDIARY

   

COUNTRY OF INCORPORATION

Check Point Software Technologies, Inc.

    United States of America (Delaware)

Check Point Software (Canada) Technologies Inc.

    Canada

Check Point Software Technologies (Japan) Ltd.

    Japan

Check Point Software Technologies (Netherlands) B.V.

    Netherlands

Check Point Holding (Singapore) PTE Ltd.

    Singapore

Check Point Holding (Singapore) PTE Ltd. – Rep office Indonesia (1)

    Singapore

Check Point Holding (Singapore) PTE Ltd. –US, NY Branch (2)

    Singapore

Israel Check Point Software Technologies Ltd. China (3)

    China

Check Point Holding AB (4)

    Sweden

Check Point Advanced Threat Prevention Ltd.

    Israel

Check Point Mobile Security Ltd.

    Israel

Check Point Software Technologies South Africa PTY. Ltd

    South Africa

Check Point Software (Kenya) Limited

    Kenya

Check Point Software Technologies B.V Nigeria Ltd. (5)

    Nigeria

Check Point Public Cloud Security Ltd.

    Israel

Check Point Web Applications and API Protection Ltd.

    Israel

Protego Labs, Inc.

    United States of America (Delaware)

Check Point IOT Security Ltd.

    Israel

Check Point Serverless Security Ltd. (6)

    Israel

Check Point Secure Remote Access Ltd.

    Israel

Check Point Email Security Ltd. (7)

    Israel

Avanan, Inc.

    United States of America (Delaware)

Check Point Developer Security Tools Ltd.

    Israel

Check Point Software Technologies (Sweden) AB. (8)

Check Point Software Technologies (Sweden) AB. – Dubai Branch (9)

   

Sweden

Sweden

Zone Labs, L.L.C. (10)

    United States of America (California)

 

(1)

Representative office of Check Point Holding (Singapore) PTE Ltd.

(2)

Branch of Check Point Holding (Singapore) PTE Ltd.

(3)

Representative office of Check Point Software Technologies Ltd.

(4)

Subsidiary of Check Point Holding (Singapore) PTE Ltd. (former name: Protect Data AB)

(5)

Subsidiary of Check Point Holding (Singapore) PTE Ltd. and Check Point Yazilim Teknolojileri Pazarlama A.S.

(6)

Subsidiary of Protego Labs, Inc

(7)

Subsidiary of Avanan, Inc.

(8)

Subsidiary of Check Point Holding AB

(9)

Branch of Check Point Software Technologies (Sweden) AB.

(10)

Subsidiary of Check Point Software Technologies Inc.

 

26

Table of Contents

Check Point Software Technologies (Netherlands) B.V. acts as a holding company. It wholly owns all or substantially all of the share capital of the principal operating subsidiaries listed below, unless otherwise indicated in the footnotes below:

 

NAME OF SUBSIDIARY

   

COUNTRY OF INCORPORATION

Check Point Software Technologies S.A.

    Argentina

Check Point Software Technologies (Australia) PTY Limited

    Australia

Check Point Software Technologies (Austria) GmbH

    Austria

Check Point Software Technologies Belarus LLC

    Belarus

Check Point Software Technologies (Belgium)

    Belgium

Check Point Software Technologies (Brazil) LTDA

    Brazil

Check Point Software Technologies (Hong Kong) Ltd. (Guangzhou office) (1)

    China

Check Point Software Technologies (Hong Kong) Ltd. (Shanghai office) (1)

    China

Check Point Software Technologies (Czech Republic) s.r.o.

    Czech Republic

Check Point Software Technologies (Denmark) ApS

    Denmark

Check Point Software Technologies (Finland) Oy

    Finland

Check Point Software Technologies Eurl

    France

Check Point Software Technologies GmbH

    Germany

Check Point Software Technologies (Greece) SA

    Greece

Check Point Software Technologies (Hungary) Ltd.

    Hungary

Check Point Software Technologies (Hong Kong) Limited

    Hong Kong

Check Point Software Technologies India Private Limited

    India

Check Point Software Technologies (Italia) S.r.l

    Italy

Check Point Software Technologies Mexico S.A. de C.V.

    Mexico

Check Point Software Technologies (Beijing) Co., Ltd.

    China

Check Point Software Technologies (New Zealand) Limited

    New Zealand

Check Point Software Technologies Norway A.S.

    Norway

Check Point Software Technologies (Philippines) Inc.

    Philippines

Check Point Software Technologies (Poland) Sp.z.o.o.

    Poland

CPST (Portugal), Sociedade Unipessoal Lda.

    Portugal

Check Point Software Technologies (RMN) SRL

    Romania

Check Point Software Technologies (Russia) OOO

    Russia

Check Point Software Technologies (Korea) Ltd.

    South Korea

Check Point Software Technologies (Spain), S.A.

    Spain

Check Point Software Technologies (Switzerland) AG

    Switzerland

Check Point Software Technologies (Taiwan) Ltd.

    Taiwan

Check Point Yazilim Teknolojileri Pazarlama A.S.

    Turkey

Check Point Software Technologies (UK) Ltd.

    United Kingdom

 

(1)

Representative office of Check Point Software Technologies (Hong Kong) Ltd.

 

27

Table of Contents

Property and Equipment

As of December 31, 2022, we own our headquarters located in Tel Aviv, Israel and we lease offices in various locations throughout the world. The breakdown in the various geographies is as follows:

 

Location

    Space (square feet)

Israel

    362,000*)

Americas

    130,000   

Europe, Middle East and Africa

    62,500   

Asia Pacific

    42,500   

 

*)

We acquired ownership of our international headquarters located in Tel Aviv, Israel pursuant to a pre-paid 49 year long-term lease on the land with the City of Tel Aviv – Jaffa. No additional payments are due under such long-term lease. Our international headquarters building contains approximately 332,000 square feet of office space. In addition, we lease approximately 30,000 square feet of additional space substantially all in Tel Aviv, Israel.

Principal Capital Expenditures and Divestitures

For more information regarding our principal capital expenditures currently in progress, see “Item 5 – Operating and Financial Review and Prospects” under the caption “Liquidity and Capital Resources”.

ITEM 4A. UNRESOLVED STAFF COMMENTS

None.

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

For discussion related to our financial condition, changes in financial condition, and the results of operations for 2021 compared to 2020, refer to Part I, Item 5. Operating and Financial Review and Prospects, in our Annual Report on Form 20-F for the fiscal year ended December 31, 2021, which was filed with the U.S. Securities and Exchange Commission on April 14, 2022.

The following discussion and analysis is based on our consolidated financial statements including the related notes, and should be read in conjunction with them. Our consolidated financial statements are provided in “Item 18 – Financial Statements”.

Overview

We develop, market and support a wide range of products and services for IT security by offering a multilevel security architecture that defends enterprises’ cloud, network, mobile devices, Endpoints information and IOT solutions. Our solutions operate under a unified security architecture, Infinity, that enables end-to-end security with a single line of unified security gateways and allow a single agent for all endpoint security that can be managed from a single unified management console. This unified management allows for ease of deployment and centralized control and is supported by, and reinforced with, real-time threat intelligence and autonomous security updates. Our products and services are sold to enterprises, service providers, small and medium sized businesses and consumers. Our open platform framework allows customers to extend the capabilities of our products and services with third-party hardware and security software applications. Our products are sold, integrated and serviced by a network of channel partners worldwide.

Our business is subject to the effects of general global economic conditions and, in particular, market conditions in the IT, Internet security and data security industries. If general economic and industry conditions deteriorate, demand for our products could be adversely affected.

 

28

Table of Contents

We derive our sales primarily through indirect channels. During 2022, 2021 and 2020, we derived approximately 60%, 58%, and 57%, respectively, of our sales from our ten largest channel partners. In 2022, 2021 and 2020, our two largest distributors accounted for approximately 40%, 40% and 39% of our sales, respectively. The following table presents the percentage of total consolidated revenues that we derive from sales in each of the regions shown:

 

     Year Ended December 31,  
         2022             2021             2020      

Region:

       

Americas, principally U.S.

      43%       43%       45%  

Europe, Middle East and Africa

      45%       45%       43%  

Asia-Pacific

      12%       12%       12%  

For information on the impact of foreign currency fluctuations, please refer to “Item 11 – Quantitative and Qualitative Disclosures about Market Risk – Foreign Currency Risk”.

COVID-19 Pandemic

The COVID-19 pandemic is having widespread, rapidly evolving, and unpredictable impacts on global society, economies, financial markets, and business practices. Federal, state and foreign governments have implemented measures to contain the virus, including social distancing, travel restrictions, border closures, limitations on public gatherings, work from home, and closure of non-essential businesses. To protect the health and well-being of our employees, partners, and third-party service providers, we have implemented work-from-home requirements, made substantial modifications to employee travel policies, and cancelled or shifted marketing and other corporate events to virtual-only formats for the foreseeable future. Our focus remains on the safety of our employees, striving to protect the health and well-being of the communities in which we operate, and providing technology to our employees, end-customers and partners to help them do their best work while remote.

The ultimate duration and extent of the impact from the COVID-19 pandemic depends on future developments cannot be accurately forecasted at this time. These developments include the severity and transmission rate of the disease, the actions of governments, businesses and individuals in response to the pandemic, the extent and effectiveness of containment actions, the impact on economic activity and the impact of these and other factors. See Risk Factors for further discussion of the possible impact of the COVID-19 pandemic on our business.

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with U.S. GAAP. These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions that we make are reasonable based upon information available to us at the time that these estimates, judgments and assumptions were made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates, judgments or assumptions and actual results, our consolidated financial statements will be affected. The accounting policies that reflect our more significant estimates, judgments and assumptions and which we believe are the most critical to aid in fully understanding and evaluating our reported financial results, include the following:

 

  •  

Revenue recognition (including sales reserves);

 

  •  

Realizability of long-lived assets (including intangible assets);

 

  •  

Accounting for income taxes;

 

  •  

Credit loss of trade receivables;

 

  •  

Impairment of marketable securities;

 

  •  

Loss Contingencies; and

 

  •  

Manufacturing Partner and Supplier Liabilities.

 

29

Table of Contents

In many cases, the accounting treatment of a particular transaction is specifically dictated by U.S. GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting among available alternatives would not produce a materially different result. Our senior management has reviewed these critical accounting policies and related disclosures with the audit committee of our board of directors. You can see a summary of our significant accounting policies in Note 2 to our consolidated financial statements, as set forth in Item 18.

Revenue recognition

We derive our revenues mainly from sales of products and licenses, security subscriptions and software updates and maintenance. Our products are generally integrated with software that is essential to the functionality of the product. We sell our products primarily through channel partners including distributors, resellers, Original Equipment Manufacturers (“OEMs”), system integrators and Managed Security Service Providers (“MSPs”), all of whom are considered end users.

Security subscriptions provide customers with access to its suite of security solutions and is sold as a service.

Software updates and maintenance provide customers with rights to unspecified software product upgrades released during the term of the agreement and include maintenance services to end-user customers, through primarily telephone access to technical support personnel as well as hardware support services.

We recognize revenues under the core principle that transfer of control to our customers should be depicted in an amount reflecting the consideration we expect to receive in revenue. Therefore, we identify a contract with a customer, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to each performance obligation in the contract and recognize revenues when (or as) we satisfy a performance obligation.

We recognize revenues from sales of products and licenses, under Topic 606, upon shipment when control of the promised goods is transferred to the customer, or upon electronic transfer of the Certificate Key to the customer.

We recognize revenues from security subscriptions and software updates and maintenance ratably over the term of the agreement due to the continuous transfer of control to the customer over the period.

Our arrangements typically contain multiple deliverables, such as products and licenses, security subscriptions and software updates and maintenance, which are generally capable of being distinct and accounted for as separate performance obligations. We evaluated the criteria to be distinct under Topic 606, and concluded that the products and the licenses were distinct and distinct in the context of the contract from the security subscription and the software updates and maintenance, as the customer can benefit from the products and licenses without the services and the services are separately identifiable within the arrangement. We allocate the transaction price to each performance obligation based on relative standalone selling price basis, by using the prices charged for a performance obligation when sold separately.

Deferred revenues represent mainly the unrecognized revenue billed for security subscriptions and for software updates and maintenance. Such revenues are recognized ratably over the term of the related agreement.

We recognize revenues net of estimated amounts that may be refunded for sales returns, rebates, stock rotations and other rights provided to customers on product and service related sales subject to varying limitations. We estimate and record these reductions based on our historical sales returns experience, analysis of credit memo data, rebate plans, stock rotation and other known factors. In each accounting period, we use judgments and estimates to determine potential future sales credits, returns and stock rotation, related to current period revenue. These estimates affect our “revenue” line item on our consolidated statements of income and affect our “deferred revenues” and “accrued expenses and other liabilities” on our consolidated balance sheets.

Realizability of long-lived assets (including intangible assets)

We are required to assess the impairment of tangible and intangible long-lived assets subject to amortization, under ASC 360 “Property, Plant and Equipment”, on a periodic basis, when events or changes in circumstances indicate that the carrying value may not be recoverable. Impairment indicators include any significant changes in the manner of our use of the assets or the strategy of our overall business, significant negative industry or economic trends and significant decline in our share price for a sustained period.

Upon determination that the carrying value of a long-lived asset may not be recoverable based upon a comparison of aggregate undiscounted projected future cash flows from the use of the asset or asset group to the carrying amount of the asset, an impairment charge is recorded for the excess of carrying amount over the fair value. We measure fair value using discounted projected future cash flows. We base our fair value estimates on assumptions we believe to be reasonable but that are unpredictable and inherently uncertain. If these estimates or their related assumptions change in the future, we may be required to record impairment charges for our tangible and intangible long-lived assets subject to amortization. No impairment charges were recognized during 2022, 2021 and 2020.

.

 

30

Table of Contents

Accounting for income tax    

We are subject to income taxes in Israel, the United States and numerous foreign jurisdictions. Significant judgment is required in evaluating our uncertain tax positions and determining our taxes. Although we believe our reserves are reasonable, no assurance can be given that the final tax outcome of these matters will not be different from that which is reflected in our historical income tax provisions and accruals. We adjust these reserves in light of changing facts and circumstances, such as the closing of a tax audit or the refinement of an estimate, or upon lapse of statute of limitations. To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will affect the provision for income taxes in the period in which such determination is made.

Significant judgment is also required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a valuation allowance, we consider all available evidence, including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that we change our determination as to the amount of deferred tax assets that can be realized, we will adjust our valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made.

Credit loss of trade receivables

We make estimates of expected credit and collectability trends for the allowance for credit losses based upon our assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of our customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect our ability to collect from customers.

Measurement of Credit Losses on Financial Instruments, using the modified retrospective transition method. Upon adoption, we changed our impairment model to utilize a current expected credit losses (CECL) model in place of the incurred loss methodology for financial instruments measured at amortized cost, including our accounts receivables.

Impairment of marketable securities

We classify all of our debt securities as available-for-sale (“AFS”). Available-for-sale debt securities are carried at fair value, with the unrealized gains and losses, net of tax, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses on sale of investments are included in financial income, net and are derived using the specific identification method for determining the cost of securities sold.

Measurement of Credit Losses on Financial Instruments, using the modified retrospective transition method. Upon adoption, we modified our impairment model for available-for-sale (“AFS”) debt securities and discontinued using the concept of “other than temporary” impairment on AFS debt securities. Each reporting period, we evaluate whether declines in fair value below amortized cost are due to expected credit losses, as well as our ability and intent to hold the investment until a forecasted recovery occurs. Allowance for credit losses on AFS debt securities are recognized in our consolidated statements of income, and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in stockholders’ equity.

We measure our money market funds and marketable securities at fair value. Money market funds and marketable securities are classified within Level 1 or Level 2. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs.

Loss Contingencies

We are currently involved in various claims and legal proceedings. We review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, we accrue a liability for the estimated loss.

Manufacturing Partner and Supplier Liabilities

We purchase manufactured products from its original design manufacture (“ODM”). We generally do not own the manufactured products. ODM’s provide services of design, manufacture, orders fulfillment and support with a full turn-key solution to meet our detailed requirements. If the actual demand is significantly lower than forecast, we record a liability for its commitment in excess of the actual demand. As of December 31, 2022 and 2021, we have not accrued any significant liability in respect to this exposure.

 

31

Table of Contents

Results of Operations

The following table presents information concerning our results of operations in 2022 and 2021:

 

     Year Ended December 31,  
     2022      2021  
     
     (in millions)  

Revenues:

      

Products and licenses

    $ 554.9      $ 513.9  

Security subscriptions

      858.0        755.2  

Software updates and maintenance

      917.0        897.7  
  

 

 

     

 

 

  

Total revenues

      2,329.9        2,166.8  
  

 

 

     

 

 

  

Operating expenses (*):

      

Cost of products and licenses

      145.6        110.7  

Cost of security subscriptions

      41.4        35.9  

Cost of software updates and maintenance

      105.5        103.0  

Amortization of technology

      11.9        8.5  
  

 

 

     

 

 

  

Total cost of revenues

      304.4        258.1  
  

 

 

     

 

 

  

Research and development

      349.9        292.7  

Selling and marketing

      675.2        597.8  

General and administrative

      116.1        110.7  
  

 

 

     

 

 

  

Total operating expenses

      1,445.6        1,259.3  
  

 

 

     

 

 

  

Operating income

      884.3        907.5  

Financial income, net

      44.0        42.1  
  

 

 

     

 

 

  

Income before taxes on income

      928.3        949.6  

Taxes on income

      131.4        134.0  
  

 

 

     

 

 

  

Net income

    $ 796.9      $ 815.6  
  

 

 

     

 

 

  

 

(*)

Including pre-tax charges for stock-based compensation, amortization of intangible assets and acquisition related expenses in the following items:

 

     Year Ended December 31,  
     2022      2021  
     
     (in millions)  

Amortization of intangible assets and acquisition related expenses

      

Amortization of technology

    $ 11.9      $ 8.5  

Research and development

      7.1        5.6  

Selling and marketing

      4.2        7.3  
  

 

 

     

 

 

  

Total amortization of intangible assets and acquisition related expenses

    $ 23.2      $ 21.4  
  

 

 

     

 

 

  

Stock-based compensation

      

Cost of products and licenses

    $ 0.4      $ 0.4  

Cost of software updates and maintenance

      5.0        4.4  

Research and development

      42.0        31.8  

Selling and marketing

      43.2        42.8  

General and administrative

      40.8        40.9  
  

 

 

     

 

 

  

Total stock-based compensation

    $ 131.4      $ 120.3  
  

 

 

     

 

 

  

 

32

Table of Contents

The following table presents information concerning our results of operations as a percentage of revenues for the periods indicated:

 

    Year Ended December 31,  
    2022     2021  

Revenues:

    

Products and licenses

     24 %      24 % 

Security subscriptions

     37       35  

Software updates and maintenance

     39       41  
 

 

 

    

 

 

  

Total revenues

     100 %      100 % 
 

 

 

    

 

 

  

Operating expenses:

    

Cost of products and licenses

     6       5  

Cost of security subscriptions

     2       2  

Cost of software updates and maintenance

     5       5  

Amortization of technology

     — *)      — *) 
 

 

 

    

 

 

  

Total cost of revenues

     13       12  
 

 

 

    

 

 

  

Research and development

     15       13  

Selling and marketing

     29       28  

General and administrative

     5       5  
 

 

 

    

 

 

  

Total operating expenses

     62       58  
 

 

 

    

 

 

  

Operating income

     38       42  

Financial income, net

     2       2  
 

 

 

    

 

 

  

Income before taxes on income

     40       44  

Taxes on income

     6       6  
 

 

 

    

 

 

  

Net income

     34 %      38 % 
 

 

 

    

 

 

  

 

*)

Less than 1%.

Revenues

We derive our revenues mainly from the sale of products and licenses, security subscriptions and software updates and maintenance. Our revenues were $2,330 million in 2022 and $2,167 million in 2021.

Total revenues in 2022 increased by 8% compared to 2021. Product and license revenues were $555 million in 2022 and $514 million in 2021. We continued to deliver increasingly more of our latest security offerings as subscriptions resulting in increased sales of our security subscription packages, including advance threat protection, Infinity CloudGuard, and Harmony. As a result, security subscription revenues increased by $103 million, or 14%, from $755 million in 2021 to $858 million in 2022. Software updates and maintenance revenues increased by $19 million, or 2%, from $898 million in 2021 to $917 million in 2022, primarily as a result of renewals of existing and sales of new maintenance contracts.

Cost of Revenues

Total cost of revenues was $304 million in 2022 and $258 million in 2021. Cost of revenues includes cost of product and licenses, cost of security subscriptions and cost of software updates and maintenance and amortization of technology. Our cost of products and licenses includes mainly cost of software and hardware production, packaging and shipping. In 2022 as a result of the shortages we have seen an increase of costs of raw materials, resulting in an increase of the cost of products. We have succeeded during such period to expedite shipments and deliver products to our customers despite the supply chain shortages. Our cost of security subscriptions is comprised of costs paid to third parties, hosting and infrastructure costs and cost of customer support related to these services. Our cost of software updates and maintenance include mainly the cost of post-sale customer support.

Cost of products and licenses was $146 million in 2022 and $111 million in 2021.

Cost of security subscriptions was $41 million in 2022 and $36 million in 2021.

Cost of software updates and maintenance was $106 million in 2022 and $103 million in 2021.

In 2022, amortization of technology was $12 million compared to $9 million in 2021. The increase in 2022 is attributed to the acquisitions made during 2022 and 2021.

 

33

Table of Contents

Research and Development

Research and development expenses were $350 million in 2022 and $293 million in 2021, and represented 15% of revenues in 2022 and 13% in 2021. Research and development expenses consist primarily of salaries and other related expenses for personnel as well as the cost of facilities and deprecation of capital equipment.

The $57 million increase in 2022 consisted of $14 million due to U.S. dollar weakened against the Israeli Shekel, is primarily a result of an increase in compensation and related expenses for personnel and in our cloud infrastructure expenses.

The majority of our personnel engaged in research and development are located in Israel, where compensation-related expenses are paid in Israeli Shekels, while our research and development expenses are reported in U.S. dollars. Therefore, changes to the exchange rate between the Israeli Shekel and the U.S. dollar have affected and may in the future affect our research and development expenses. We have forward contracts to hedge against a certain portion of the exposure mentioned above.

Selling and Marketing

Selling and marketing expenses consist primarily of salaries, commissions, advertising, trade shows, seminars, public relations, co-op activities with partners, travel and other related expenses. Selling and marketing expenses were $675 million in 2022 and $598 million in 2021, which represented 29% of revenues in 2022 and 28% of revenues in 2021.

The $77 million increase in 2022 consisted of $23 million due to fluctuations of various currencies against the U.S. dollar, is primarily a result of an increase in compensation expenses for personnel.

Our selling and marketing expenses worldwide are paid in local currencies and are reported in U.S. dollars. Therefore, changes to the exchange rates between the local currencies and the U.S. dollar have affected, and may in the future affect, our expense level.

General and Administrative

General and administrative expenses consist primarily of salaries and other related expenses for personnel, professional fees, insurance costs, legal and other expenses. General and administrative expenses were $116 million in 2022 and $111 million in 2021, which represented 5% of revenues in each of the years 2022 and 2021.

Operating Income Margin

In 2022, our operating margin was 38% compared to 42% in 2021. The decrease in our operating margin was primarily due to an increase in our cost of goods sold, workforce related expenses and cloud expenses.

We may experience future fluctuations or declines in operating margins from historical levels due to several factors, as described above in “Item 3 – Key Information” under the caption “Risk Factors – Risks Related to Our Business and Our Market”.

Financial Income, Net

Net financial income consists primarily of interest earned on cash equivalents, Short-term deposits and marketable securities. Net financial income was $44 million in 2022 and $42 million in 2021. As we generally hold debt securities until maturity, our current portfolio’s yield is derived primarily from interest rates and the yield on securities at time of purchase. Since most of our investments are U.S. dollars denominated securities, our net financial income is heavily dependent on prevailing U.S. interest rates changes and the market expectations to such changes. The increase in net financial income in 2022 was primarily due to higher interest rates and yield on marketable securities, short-term deposits and cash equivalents. In 2022 and 2021 no impairment in our marketable securities was recorded.

For further risk related to our portfolio see also Item 3, “Risk Factors – Risks Related to Our Business and Our Market – Our cash balances and investment portfolio have been, and may continue to be, adversely affected by market conditions and interest rates”.

Taxes on Income

Total taxes on income were $131 million in 2022 and $134 million in 2021. Our effective tax rate was 14% in each of the years 2022 and 2021. See Note 11 to our consolidated financial statements for further information on our statutory rates.

Additional details are provided in “Item 10 – Additional Information” under the caption “Israeli taxation, foreign exchange regulation and investment programs” and “Item 3 – Key Information” under the caption “The tax benefits available to us require us to meet several conditions, and may be terminated or reduced in the future, which would increase our taxes”.

 

34

Table of Contents

Net Income

Net income decreased by $19 million to $797 million in 2022 compared to $816 million in 2021.

Liquidity and Capital Resources

During 2022 and 2021, we financed our operations through cash generated from operations. Our total cash and cash equivalents, short-term investments and long-term interest bearing investments, were $3,503 million as of December 31, 2022 and $3,783 million as of December 31, 2021. Our cash and cash equivalents and short-term investments were $1,638 million as of December 31, 2022 and $1,694 million as of December 31, 2021. Our long-term interest bearing investments were $1,866 million as of December 31, 2022 and $2,090 million as of December 31, 2021. Our financial assets are held and managed through the parent company in Israel and our subsidiaries in Singapore, Canada and the U.S.

We generated net cash from operations of $1,098 million in 2022 and $1,204 million in 2021. Net cash from operations for 2022 and 2021 consisted primarily of net income adjusted for non-cash activity. The decrease in our cash from operations was derived mostly from the decrease in our tax accruals and other liabilities.

We used net cash in investing activities of $6 million in 2022 compared to net cash used in investing activities of $75 million in 2021. In 2022, net cash used for investing activities was decreased compared to 2021, primarily due to decrease in marketable securities investments, net, offset by cash paid in conjunction with acquisitions. Our net cash paid for acquisitions amounted to $48 million in 2022 and $220 million in 2021. Our capital expenditures amounted to $22 million in 2022 and $16 million in 2021, and consisted primarily of computer equipment, software and leasehold improvements.

Net cash used in financing activities was $1,168 million in 2022 and $1,112 million in 2021. In 2022 and 2021, net cash used in financing activities was attributed primarily to the repurchase of ordinary shares. Under the repurchase programs, we may purchase our ordinary shares from time to time, depending on market conditions, share price, trading volume and other factors. We repurchased ordinary shares in the amount of $1,300 million in each of the years 2022 and 2021. We re-issued the repurchased shares to settle exercises of options and restricted share unit awards to our employees and directors. Proceeds from such activities were $141 million and $194 million in 2022 and 2021, respectively.

Our investments in marketable securities are classified as available-for-sale. Available-for-sale securities are carried at fair value, with the unrealized gains and losses, net of tax, recorded in other comprehensive income (loss). Amortization of premium, discount and interest is recorded in our statements of income.

Our liquidity could be negatively affected by a decrease in demand for our products and services, or increase in employment costs. Also, if the financial system or the credit markets continue to deteriorate or remain volatile, our investment portfolio may be impacted and the values and liquidity of our investments could be adversely affected.

Our principal sources of liquidity consist of our cash and cash equivalents, short-term bank deposits and marketable securities (which aggregated $3,503 million as of December 31, 2022) and our cash flow from operations. We believe that these sources of liquidity will be sufficient to satisfy our present capital expenditure requirements.

Research and Development, Patents and Licenses, etc.

Additional details are provided in this Item 5, under the caption “Results of Operations”.

Trend Information

Additional details are provided in this Item 5, under the caption “Results of Operations”.

 

35

Table of Contents

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

Directors and Senior Management

Our directors and executive officers as of April 15, 2023, were as follows:

 

Name   

            Position                
                

     

Independent

Director (1)

   

Outside

Director

(2)

   

Member

of Audit

Committee

   

Member of

Compensation

Committee

   

Member of

Nominating,
Sustainability
and
Corporate
Governance
Committee

Gil Shwed    Chief Executive Officer                 
   and Director                 
Jerry Ungerman    Chairman of the Board      ✓            

Dorit Dor

   

Chief Technology Officer

                 
Nataly Kremer    Chief Product Officer                 
Rupal Hollenbeck    President                 

Roei Golan

 

Tal Payne (3)

   

Acting Chief Financial Officer

 

Chief Financial and Operation Officer

                 
Guy Gecht (4)    Lead Independent Director      ✓    ✓    ✓    ✓   
Yoav Chelouche (4)    Director      ✓    ✓    ✓    ✓   
Tzipi Ozer-Armon    Director      ✓            
Ray Rothrock (4)    Director      ✓    ✓    ✓    ✓    ✓
Tal Shavit Shenhav    Director      ✓             ✓
Shai Weiss    Director      ✓             ✓

 

(1)

“Independent Director” under the Nasdaq Global Select Market regulations and the Israeli Companies Law (see explanation below).

(2)

“Outside Director” as required by the Israeli Companies Law (see explanation below).

(3)

Ms. Payne is on sabbatical leave since November 2022.

(4)

“Financial expert” as required by the Israeli Companies Law and Nasdaq requirements with respect to membership on the audit committee (see “Item 16A – Audit Committee Financial Expert”).

 

36

Table of Contents

Gil Shwed is the founder, Chief Executive Officer and Director. Mr. Shwed served as Chairman of our board of directors until September 2015. Mr. Shwed is considered the inventor of the modern firewall and authored several patents, such as the company’s Stateful Inspection technology. Mr. Shwed has received numerous accolades for his individual achievements and industry contributions, including an honorary Doctor of Science from the Technion – Israel Institute of Technology, an honorary Doctor of Science from Tel Aviv University, the World Economic Forum’s Global Leader for Tomorrow for his commitment to public affairs and leadership in areas beyond immediate professional interests, and the Academy of Achievement’s Golden Plate Award for his innovative contribution to business and technology. Mr. Shwed is the Chairman of the Board of Trustees of the Youth University of Tel Aviv University. Mr. Shwed is a Tel Aviv University Governor and founder of the University’s Check Point Institute for Information Security. He is also Chairman of the Board of the board of directors of Yeholot Association Founded by the Rashi Foundation whose charter is, among other things, to reduce the dropout rates in high schools. In 2018, Gil was awarded the prestigious Israel Prize for his contributions to the Israeli technology industry.

Jerry Ungerman serves as the chairman of the board of directors since August 2020, after serving as Vice Chairman of our board of directors from 2005 until August 2020. From 2001 to 2005, Mr. Ungerman served as our President and before that, from 1998 until 2000, he served as our Executive Vice President. Prior to joining us, Mr. Ungerman accumulated extensive experience in high-tech sales, marketing and management experience at Hitachi Data Systems (HDS), a data storage company and a member of the Hitachi, Ltd. group. He began his career with International Business Machines Corp. (IBM), a global technology products and services company, after earning a B.A. in Business Administration from the University of Minnesota.

Dr. Dorit Dor, Chief Technology Officer at Check Point, spearheads Check Point’s rocket initiatives. Since joining the company in 1995, Dr. Dor has served in several pivotal roles in Check Point’s R&D organization over the years, including Chief Product Officer. She has been instrumental to the organization’s growth and managed many successful product releases. Dr. Dor holds a Ph.D. and M.S degree in computer science from Tel-Aviv University, in addition to graduating cum laude for her B.S. Dr. Dor has been published in several influential scientific journals for her research on graph decomposition, median selection and geometric pattern matching in d-dimensional space. In 1993, she won the Israel National Defense Prize. In 2019 Dr. Dor was named as one of Israel’s most influential women by Forbes Israel, for her leadership role in one of the world’s leading tech industries. Dr. Dor is a board member of Redis Ltd.

Nataly Kremer, Chief Product Officer and Head of Research and Development since March 2023, oversees all product and technology units and uses her proficiency in delivering network, security, and cloud technologies for large enterprises to meet customer needs. Ms. Kremer brings extensive R&D and leadership experience to Check Point. She joined the company after 12 years with AT&T, where she led its Software and Delivery organization and AT&T’s center in Israel. She holds an MBA and BSc in Computer Sciences and Management from Tel Aviv University. Ms. Kremer is a board member of IBI Investment Bank and a board member of Israel Advanced Technology Industries (IATI), where she also holds the role of Head of the ITAI Diversity and Inclusion Group.

Rupal Hollenbeck President at Check Point since March 2023, after serving as Chief Commercial Officer from March 2022 until March 2023. Ms. Hollenbeck manages Check Point’s global commercial organization since March 2022. Ms. Hollenbeck served on our board of directors from January 2021 until March 2022. She was most recently CMO of AI hardware start-up Cerebras Systems in Silicon Valley. She also served as Senior Vice President & Chief Marketing Office at Oracle, a post which she held until January 2020. Prior to joining Oracle in 2018, Ms. Hollenbeck was with Intel Corporation for over 23 years, with her most recent role being Corporate Vice President and General Manager of Global Data Center Sales. Prior to that she was Vice President and General Manager of Intel China and throughout her time at Intel has worked in Arizona, California, Singapore, and Beijing. An advocate for professional women around the world, she started several women’s initiatives while at Intel, including serving as co-chair of the Board of Intel’s Network of Executive Women in Asia. She is currently a Founding Circle Member of Neythri, a non-profit organization dedicated to enabling the professional advancement of South Asian women. Ms. Hollenbeck is also an Adjunct Professor at California State University East Bay, teaching a Women in Leadership course in the College of Business & Economics. Ms. Hollenbeck holds a BS in Finance and International Studies from Boston College, and a Master of International Management from the Thunderbird School of Global Management in Arizona. Ms. Hollenbeck is a board member of Blackbaud Inc.

Roei Golan has been serving as VP Finance of Check Point since 2021, and as Acting Chief Financial Officer since October 2022, replacing Ms. Tal Payne, the Chief Financial and Operations Officer who is on sabbatical leave since November 2022. Mr. Golan oversees Check Point’s finance operations, including accounting, business analysis, investor relations, legal, tax and treasury. Mr. Golan has over 14 years of financial experience. Prior to joining Check Point in 2021, Mr. Golan worked at EY for 11 years, where he held the role of Managing Director in the Technology practice. Mr. Golan holds a B.A. in Economics and Accounting and a M.B.A in finance management. Mr. Golan is a certified public accountant.

Tal Payne has been serving as Chief Financial Officer of Check Point since joining in 2008 and as Chief Financial and Operations Officer since 2015. Ms. Payne is on sabbatical leave since November 2022. Ms. Payne oversees Check Point’s global operations and finance, including investor relations, legal, treasury, purchasing and facilities. Prior to joining Check Point, Ms. Payne served as Chief Financial Officer at Gilat Satellite Networks, Ltd., where she held the role of Vice President of Finance for over five years. Ms. Payne began her career as a certified public accountant at PricewaterhouseCoopers. Ms. Payne holds a B.A. in Economics and Accounting and an Executive M.B.A., both from Tel Aviv University. Ms. Payne is a certified public accountant. Ms. Payne is a board member of SolarEdge Technologies, Inc.

 

37

Table of Contents

Yoav Z. Chelouche has served on our board of directors since 2006. Mr. Chelouche has also served as one of our outside directors under the Israeli Companies Law since 2006. Mr. Chelouche has been Managing Partner of Aviv Venture Capital since August 2000. He serves on boards of directors of certain Aviv companies. Prior to joining Aviv Venture Capital, Mr. Chelouche served as a President and Chief Executive Officer of Scitex Corp., a world leader in digital imaging and printing systems, from December 1994 until July 2000. From August 1979 until December 1994, Mr. Chelouche held various managerial positions with Scitex, including VP Strategy and Business Development, VP Marketing and VP Finance for Europe. Mr. Chelouche is a member of the board of directors of a number of private companies. He was also a board member and until 2015 co-Chairman of IATI-Israel Advanced Technology Industries, an Israeli nonprofit organization that researches, develops and advocates policies that promote Israel’s high tech ecosystem through activities in training, tuition, business development, public relations and public policy advocacy. Mr. Chelouche is a board member of Tower Semiconductor Ltd., Malam Team Ltd., and an external director of the Tel Aviv Stock Exchange (TASE). Mr. Chelouche is expected to resign from the board of directors of Tower Semiconductor Ltd. upon consummation of its acquisition by Intel Corporation, as announced in February 2022. Mr. Chelouche earned B.A. in Economics and Statistics from Tel Aviv University, and an M.B.A. from INSEAD University in Fontainebleau, France.

Guy Gecht has served on our board of directors since 2006 and as our Lead Independent Director since August 2020. Mr. Gecht has also served as one of our outside directors under the Israeli Companies Law since 2006. Mr. Gecht served as the Chief Executive Officer of Electronics For Imaging, Inc. (EFI), a company that provides digital imaging and print management solutions for commercial and industrial applications and has served in this position from January 2000 until October 2018. From October 1995 until January 2000, Mr. Gecht held various positions with EFI, including President of the company. Prior to joining EFI, Mr. Gecht held various software engineering positions with technology companies. In 2019, Mr. Gecht joined the board of directors of Logitech. He holds a B.S. in Computer Science and Mathematics from Ben-Gurion University in Israel.

Tzipi Ozer-Armon has served on our board of directors since January 2023. Ms. Ozer- Armon serves as the Chief Executive Officer of Lumenis Ltd. since May 2012. Before joining Lumenis, Ms. Ozer- Armon headed the Japanese market activities of Teva Pharmaceutical Industries Ltd. and served as Senior Vice President of Sales and Marketing at SanDisk Corporation. Previously, Ms. Ozer-Armon also served as VP & General Manager of MSystems Ltd. Ms. Ozer-Armon is a director of Strauss Group Ltd., Similarweb Ltd., and ICL Group Ltd. Ms. Ozer-Armon holds a BA magna cum laude in Economics and an MBA degree majoring in Finance and Marketing from Tel Aviv University and she is an AMP graduate of the Harvard Business School.

Ray Rothrock has served on our board of directors since 1995. Mr. Rothrock has also served as one of our outside directors under the Israeli Companies Law since 2000 and as a director under Roku, Inc. Mr. Rothrock is a Partner emeritus at Venrock, a venture capital firm, where he was a member since 1988 and a general partner since 1995. He retired from Venrock in 2013. Presently, Mr. Rothrock is the Chairman of RedSeal, Inc., a cybersecurity analytics company. Mr. Rothrock served as the Chief Executive Officer of RedSeal, Inc. from February 2014 until May 2020. Mr. Rothrock is a director of Nasdaq-listed Roku, Inc, and a number of private companies. Mr. Rothrock is a member of the Massachusetts Institute of Technology Corporation, and a Trustee of the University of Texas and Texas A&M Investment Management Company. Mr. Rothrock received a B.S. in Engineering from Texas A&M University, an M.S. from the Massachusetts Institute of Technology and an M.B.A. from the Harvard Business School.

Dr. Tal Shavit Shenhav has served on our board of directors since 2000. Dr. Shavit Shenhav is an organizational consultant specializing in international collaboration between Israeli and American companies, consulting in the management of cultural differences in order to forge effective collaboration. Her work with leading management teams includes the definition of organizational culture as the engine of such company’s activities. She consults with companies undergoing structural change with emphasis on organizational growth through effective mergers and acquisitions and a redefining of management roles in order to meet market changes.

Shai Weiss has served on our board of directors since 2018. Mr. Weiss is the Chief Executive Officer of Virgin Atlantic, one of the most innovative airlines in the world. Mr. Weiss joined Virgin Atlantic as Executive Vice President and Chief Financial Officer in July 2014 from Virgin Management Ltd, where he had been an Investment Partner since 2012 and was a Founding Partner of Virgin Green Fund. Prior to joining Virgin Group, he held several senior management positions at ntl:Telewest (now Virgin Media), the UK and Europe’s largest cable operator. Mr. Weiss was part of the turn-around of ntl with roles including Managing Director of Consumer Products, Director of Operations, and Director of Financial Planning for the Consumer division. Mr. Weiss was also behind the merger between Virgin Mobile UK and ntl:Telewest and the re-brand to Virgin Media. Prior to ntl, Mr. Weiss established the European office of early-stage technology venture fund JVP and was a senior associate with Morgan Stanley. He holds an M.B.A. degree from Columbia University and a BBA degree from City University of New York, Baruch College.

 

38

Table of Contents

Of the individuals mentioned above, only Gil Shwed owned more than one percent of our outstanding shares as of December 31, 2022. Additional details are provided in this Item 6, under the caption “Share ownership” and in “Item 7 – Major Shareholders and Related Party Transactions”.

Some of our directors are board members of multiple companies, some of which may be technology companies. The board of directors has determined that there are no current conflicts of interest with respect to any of our directors.

The terms of Gil Shwed, Jerry Ungerman, Dr. Tal Shavit Shenhav, Tzipi Ozer-Armon and Shai Weiss will expire at our 2023 annual meeting of shareholders. The term of Ray Rothrock will expire at our 2023 annual meeting of shareholders and the terms of Yoav Chelouche and Guy Gecht will expire at our 2024 annual meeting of shareholders.

There are no arrangements or understandings with major shareholders, customers, suppliers or others, pursuant to which any of the directors or members of senior management are elected.

Compensation of Directors and Officers

The total direct cash compensation that we accrued for our directors and executive officers as a group, including those who left the company during 2022, was approximately $3.8 million for the year ended December 31, 2022. These amounts include $0.3 million that were set aside or accrued to provide for severance and retirement insurance policies in 2022. These amounts do not include amounts accrued for expenses related to business travel, professional and business association dues and other business expenses reimbursed to officers. We do not have any agreements with our director who is also an officer that provide for benefits upon termination of employment, except for severance payments mandated by Israeli law for all employees employed in Israel.

Following is a summary of the salary and benefits paid in 2022 (i) to our five most highly compensated executive officers (referred to as the “Covered Executives”) and (ii) to our non-executive directors.

Cash Compensation

Mr. Gil Shwed, Chief Executive Officer and Director. Cash compensation expenses recorded in 2022 consisted of $19.2 thousands in salary expenses, and $5.9 thousands in benefit costs. Mr. Shwed requested to forego his salary and bonus for 2022, as he has done for the past several years. Following consideration of Mr. Shwed’s request, our compensation committee and board of directors have determined that Mr. Shwed will not receive a bonus for 2022, and did not receive any cash compensation for 2022 except for an amount equal to the minimum wage required under Israeli law.

Dr. Dorit Dor, Chief Technology Officer. Compensation expenses recorded in 2022 included $376.4 thousands in salary expenses and $89.5 thousands in benefit costs.

Ms. Tal Payne, Chief Financial Officer & Chief Operating Officer (on sabbatical leave since November 2022). Compensation expenses recorded in 2022 included $427.3 thousands in salary expenses and $101.7 thousands in benefit costs.

Mr. Sharon Schusheim, Vice President, Information Systems Compensation expenses recorded in 2022 included $273.9 thousands in salary expenses and $68.2 thousands in benefit costs.

Ms. Rupal Hollenbeck, President. Compensation expenses recorded in 2022 included $686.7 thousands in salary expenses and $44.8 thousands in benefit costs.

The salary expenses summarized above include the gross salary paid to the Covered Executives, and the benefit costs include the social benefits paid by us on behalf of the Covered Executives, including convalescence pay, contributions made by the company to an insurance policy or a pension fund, work disability insurance, severance, educational fund and payments for social security. We do not lease vehicles for our Covered Executives.

In accordance with the company’s executive compensation policy, we also paid cash bonuses upon compliance with predetermined 2022 performance parameters set by the Compensation Committee and the Board of Directors. The 2022 cash bonus expenses for Dr. Dor, Ms. Payne, Mr. Schusheim and Ms. Hollenbeck were $459.0 thousands, $498.9 thousands, $199.5 thousands and $468.1 thousands, respectively. As noted above, Mr. Shwed did not receive a cash bonus for 2022. The cash compensation amounts paid were denominated in Israeli Shekels and converted into U.S. Dollars at the exchange rate as of year-end.

 

39

Table of Contents

We currently pay each of our non-executive directors an annual cash retainer of $40.0 thousands for the services provided to our board of directors and an annual cash retainer of $7.5 thousands for each committee membership. In addition, we pay the chairman of our board of directors and the lead independent director an annual cash retainer of $20.0 thousands, the chair of our audit committee an annual cash retainer of $7.5 thousands and the chair of each of our nominating, sustainability and corporate governance committee and compensation committee an annual cash retainer of $2.5 thousands. Only directors who are not officers receive compensation for serving as directors.

Equity-based Compensation

From time to time, we grant options and other awards under our equity incentive plans (described below) to our executive officers and directors. See Item 10 “Additional Information – Compensation of Executive Officers and Directors; Executive Compensation Policy” for a detailed description of the approval procedures we follow in compensating our directors and executive officers.

Our non-employee directors receive an automatic option grant and are also eligible for discretionary awards under the plans. Each non-employee director who is first elected or appointed to the board of directors is granted an option to purchase 25,000 ordinary shares and restricted share units (RSUs) with a value of $200.0 thousands on the date of the initial election or appointment, vesting in equal annual installments over a four-year period. On the date of each annual general meeting of shareholders, each non-employee director who is to continue to serve as a non-employee director after the annual meeting is granted an option to purchase an additional 15,000 ordinary shares and RSUs with a value of $50.0 thousands, of which 50% vest six months after the grant date, 25% vest nine months after the grant date, and another 25% vest a year after the grant date, provided that the director has served as a non-employee director for at least six months prior to the date of the annual meeting. The directors in office immediately prior to the date of initial appointment or election, or of the annual meeting, as applicable, may determine to reduce the initial or annual grant to all non-employee directors or specific non-employee directors.

On August 30, 2022, following the approval of our Compensation Committee, Board of Directors and the company’s shareholders at the 2022 Annual General Meeting, we granted Mr. Gil Shwed, our Chief Executive Officer and Director, options to purchase 0.5 million ordinary shares at an exercise price equal to 100% of the closing price of the ordinary shares on the Nasdaq Global Select Market on the date of the grant, vesting gradually over a period of four years.

During 2022, we granted our executive officers and directors options to purchase an aggregate of approximately 0.7 million shares and approximately 0.22 million RSUs and PSUs under our equity incentive plans. The exercise price of these options range between $122.12-$142.40, and their expiration dates range between April 2029 and August 2029.

All options granted to directors and executive officers in 2022 were granted with an exercise price equal to 100% of the closing price of the ordinary shares on the Nasdaq Global Select Market on the applicable date of grant.

We recorded equity-based compensation expenses in our financial statements for the year ended December 31, 2022 for Mr. Shwed, Dr. Dor, Ms. Payne, Mr. Schusheim and Ms. Hollenbeck of $22.6 million, $6.4 million, $7.1 million, $1.7 million and $1.5 million, respectively. Assumptions and key variables used in the calculation of such amounts are described in Note 2y to our audited consolidated financial statements included in Item 18 of this Annual Report. All equity-based compensation grants to our Covered Executives were made in accordance with the parameters of our company’s executive compensation policy and were approved by the company’s Compensation Committee and Board of Directors, and, in the case of the equity-based compensation granted to the Chief Executive Officer, also by the company’s shareholders in accordance with the Israeli Companies Law.

As of December 31, 2022, our executive officers and directors held options to purchase an aggregate of approximately 7.3 million shares and held 0.4 million RSUs and PSUs under our equity incentive plans. The exercise prices of these options range between $84.77 and $142.40, and their expiration dates range between June 2023 and April 2029.

Other than as specified in the share ownership table under the caption “Share ownership” below, none of our directors and executive officers holds more than 1% of our outstanding shares.

Composition of Board of Directors

Our board of directors currently consists of eight members, including three outside directors in accordance with the requirements of the Israeli Companies Law. See “Outside and Independent Directors”. Under our articles of association, the number of directors on our board is to be no less than six and no more than twelve. Each director (other than an outside director as described below) is elected to serve until the next annual general meeting of shareholders and until his or her successor has been elected. Each executive officer is elected by the board of directors and serves at the discretion of the board. All of our executive officers and directors, other than non-employee directors, devote substantially all of their working time to our business. There are no family relationships among any of our directors, officers or key employees.

 

40

Table of Contents

As permitted under the Israeli Companies Law, our articles of association provide that any director may, by written notice to us, appoint another person to serve as an alternate director or may cancel the appointment of an alternate director. Any person eligible to serve as a director, other than a person who is already a director or an alternate director, may act as an alternate director. The term of appointment of an alternate director may be for one meeting of the board, for a specified period of time, a specified meeting or action of the board or until notice is given of the cancellation of the appointment. No director has appointed, and, to our knowledge, no director currently intends to appoint, any other person as an alternate director. We do not have any service contracts with our directors providing for benefits upon termination of service.

Outside and Independent Directors

Outside directors. In accordance with the Israeli Companies Law and the relevant regulations, we must have at least two outside directors who meet the Israeli statutory requirements of independence. At least one of the outside directors is required to have “financial and accounting expertise” and the other outside director or directors are required to have “professional expertise,” all as defined under the Israeli Companies Law. Our board of directors has determined that each of Yoav Chelouche, Guy Gecht and Ray Rothrock has “financial and accounting expertise,” and each of Guy Gecht and Ray Rothrock has “professional expertise”.

An outside director serves for a term of three years, which may be extended for additional three-year terms. An outside director can be removed from office only under very limited circumstances. All of the outside directors must serve on the company’s audit committee and compensation committee (including one outside director serving as the chair of the audit committee and the compensation committee), and at least one outside director must serve on each committee of the board of directors. As of December 31, 2022, Yoav Chelouche, Guy Gecht and Ray Rothrock are our outside directors under the Israeli Companies Law. Yoav Chelouche’s and Guy Gecht’s term of office will expire in 2024, and Ray Rothrock’s term of office will expire in 2023.

In 2016, the Israeli Companies Law Regulations were amended to reduce certain duplicative regulatory burden to which Israeli companies publicly-traded on Nasdaq, such as Check Point, are subject to. Generally, pursuant to the amended regulations, an Israeli company traded on Nasdaq that does not have a “controlling shareholder” (as defined in the Israeli Companies Law) will be able to elect not to appoint Outside Directors to its Board of Directors and not to comply with the Audit Committee and Compensation Committee composition and chairman requirements of the Israeli Companies Law (as described above); provided, that the company complies with the applicable Nasdaq independent director requirements and the Nasdaq Audit Committee and Compensation Committee composition requirements. Accordingly, Check Point is eligible to adopt the relief provided by the amended Israeli regulations. To date, Check Point has not elected to adopt such relief.

Independent directors. The Sarbanes-Oxley Act of 2002, as well as related rules subsequently implemented by the Securities and Exchange Commission and the Nasdaq Global Select Market, requires issuers to comply with various corporate governance practices. Under the rules applicable to us as a foreign private issuer, we are required to have a majority of independent directors within the meaning of the applicable Nasdaq regulations. Our board of directors complies with these requirements by including a majority of members who are independent directors within the meaning of the applicable Nasdaq regulations.

Pursuant to the Israeli Companies Law, an Israeli company whose shares are publicly traded may elect to adopt a provision in its articles of association pursuant to which a majority of its board of directors (or a third of its board of directors in case the company has a controlling shareholder) will consist of individuals complying with certain independence criteria prescribed by the Israeli Companies Law, as well as certain other recommended corporate governance provisions. Although we have not included these provisions in our articles of association because our board of directors already complies with the independence requirements and the corporate governance rules of the Nasdaq Global Select Market, as described below, a majority of our board of directors and all the members of our audit committee, compensation committee and nominating, sustainability and corporate governance committee are directors who comply with the independence criteria prescribed by the Israeli Companies Law.

Our board of directors has determined that each of Yoav Chelouche, Guy Gecht, Tzipi Ozer-Armon, Ray Rothrock, Tal Shavit Shenhav, Jerry Ungerman, and Shai Weiss is an independent director under the applicable Nasdaq regulations and the Israeli Companies Law. Our independent directors have regularly held meetings at which only independent directors are present.

Committees of the Board of Directors

Our articles of association provide that the board of directors may delegate all of its powers to committees of the board as it deems appropriate, subject to the provisions of Israeli law. Our board of directors has established an audit committee, a compensation committee and a nominating, sustainability and corporate governance committee.

Audit Committee. Under the Israeli Companies Law, the board of directors of any public company must establish an audit committee. The audit committee must consist of at least three directors, must include all of the outside directors (including one outside director serving as the chair of the audit committee), and a majority of the committee members must comply with the director independence requirements prescribed by the Israeli Companies Law.

 

41

Table of Contents

The audit committee may not include the chairman of the board, or any director employed by us, by a controlling shareholder or by any entity controlled by a controlling shareholder, or any director providing services to us, to a controlling shareholder or to any entity controlled by a controlling shareholder on a regular basis, or any director whose income is primarily dependent on a controlling shareholder, and may not include a controlling shareholder or any relatives of a controlling shareholder. Individuals who are not permitted to be audit committee members may not participate in the committee’s meetings other than to present a particular issue at the request of the chair of the committee. However, an employee who is not a controlling shareholder or relative may participate in the committee’s discussions but not in any vote, and the company’s legal counsel and corporate secretary (if they are not a controlling shareholder or relative) may participate in the committee’s discussions and votes if requested by the committee.

In addition, the Nasdaq regulations also require us to maintain an audit committee consisting of at least three directors, all of whom must be independent under the Nasdaq regulations applicable to audit committee members and each of whom is financially literate and one of whom has accounting or related financial management expertise. Yoav Chelouche is the chairman of the audit committee. Guy Gecht and Ray Rothrock serve as the other members of our audit committee. The audit committee has adopted a written audit committee charter as required by the Nasdaq regulations.

The audit committee’s duties include providing assistance to the board of directors in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting, internal control and legal compliance functions. In this respect the audit committee approves the services performed by our independent accountants and reviews their reports regarding our accounting practices and systems of internal accounting controls. The audit committee also oversees the audits conducted by our independent accountants and takes those actions, as it deems necessary, to satisfy itself that the accountants are independent of management. Under the Israeli Companies Law, the audit committee is also required to monitor whether there are any deficiencies in the administration of our company, including by consulting with the internal auditor and independent accountant, to review, classify and approve related party transactions and extraordinary transactions, to review the internal auditor’s audit plan and to establish and monitor whistleblower procedures.

Under the Israeli Companies Law, a meeting of the audit committee is properly convened if a majority of the committee members attend the meeting and, in addition, a majority of the attending committee members are independent directors within the meaning of the Israeli Companies Law, and include at least one outside director.

Compensation Committee. Under the Israeli Companies Law, the board of directors of any public company must establish a compensation committee. The compensation committee must consist of at least three directors, include all of the outside directors (including one outside director serving as the chair of the compensation committee), and a majority of the committee members must comply with the director independence requirements prescribed by the Israeli Companies Law.

Similar to the rules that apply to the audit committee, the compensation committee may not include the chairman of the board, or any director employed by us, by a controlling shareholder or by any entity controlled by a controlling shareholder, or any director providing services to us, to a controlling shareholder or to any entity controlled by a controlling shareholder on a regular basis, or any director whose primary income is dependent on a controlling shareholder, and may not include a controlling shareholder or any of its relatives. Individuals who are not permitted to be compensation committee’s members may not participate in the committee’s meetings other than to present a particular issue; provided, however, that an employee that is not a controlling shareholder or its relative may participate in the committee’s discussions but not in any vote. The company’s legal counsel and corporate secretary may participate in the committee’s discussions and votes if requested by the committee.

In addition, the Nasdaq rules also require us to maintain a compensation committee consisting of at least two independent directors. Each of the members of the compensation committee is required to be independent under Nasdaq rules relating to compensation committee members, which are different from the general test for independence of board and committee members. Each of the members of our compensation committee satisfies those requirements. Ray Rothrock is the chairman of the compensation committee. Yoav Chelouche and Guy Gecht serve as the other members of our compensation committee. The compensation committee has adopted a written compensation committee charter.

The compensation committee’s duties include recommending to the board of directors a compensation policy for executives and monitor its implementation, approve compensation terms of executive officers, directors and employees affiliated with controlling shareholders, make recommendations to the board of directors regarding the issuance of equity incentive awards under our equity incentive plans, and exempt certain compensation arrangements from the requirement to obtain shareholder approval under the Israeli Companies Law.

Nominating, Sustainability and Corporate Governance Committee. The nominating, sustainability and corporate governance committee identifies prospective board candidates, recommends nominees for election to our board of directors, develops and recommends board member selection criteria, considers committee member qualification, supervises the selection and composition of

 

42

Table of Contents

committees of our board of directors, provides oversight in the evaluation of our board of directors and each committee, oversees our policies, programs and strategies related to environmental, social and governance (ESG) matters and develops and recommends to the board a set of corporate governance guidelines. Shai Weiss is the chairman of the nominating, sustainability and corporate governance committee. Ray Rothrock and Tal Shavit Shenhav serve as the other members of our nominating, sustainability and corporate governance committee. The nominating, sustainability and corporate governance committee has adopted a written nominating committee charter.

Employees

As of December 31, 2022, we had 6,026 employees as well as 194 subcontractors (163 subcontractors in 2021, 116 subcontractors in 2020) Over the past three years, the number of our employees by function was as follows:

 

     As of December 31,
         2022            2021            2020    

Function:

         

Research, development and quality assurance

      1,807        1,677        1,500  

Marketing, pre sale, sales and business development

      2,678         2,509         2,317   

Customer support

      926        905        851  

Information systems, administration, finance and operation

      615        551        530  
  

 

 

 

   

 

 

 

   

 

 

 

Total

      6,026        5,642        5,198  

Over the past three years, the number of our employees by geographic area was as follows:

 

     As of December 31,
         2022            2021            2020    

Function:

         

Israel

      2,525         2,416         2,259   

Americas

      1,813        1,660        1,580  

Rest of the World

      1,688        1,566        1,359  
  

 

 

 

   

 

 

 

   

 

 

 

Total

      6,026        5,642        5,198  

We are subject to Israeli labor laws and regulations with respect to our Israeli employees. The Israeli labor laws differ materially from U.S. labor laws and, in some cases, impose material obligations on us (such as severance pay and mandatory cost of living increases). We are also subject to the labor laws and regulations of other jurisdictions in the world where we have employees.

Share Ownership

The following table shows information regarding beneficial ownership by our directors and executive officers as of February 28, 2023. Beneficial ownership is determined in accordance with rules of the Securities and Exchange Commission.

All information with respect to the beneficial ownership of any principal shareholder has been furnished by such shareholder and, unless otherwise indicated below, we believe that persons named in the table have sole voting and sole investment power with respect to all of the shares shown as beneficially owned, subject to community property laws, where applicable. All shares shown as beneficially owned have identical rights in all respects. The shares beneficially owned by the directors include the shares owned by their family members to which such directors disclaim beneficial ownership.

 

43

Table of Contents

The share numbers and percentages listed below are based on shares outstanding as of February 28, 2023.

 

Name

    Number of
shares
beneficially
owned (1)		      % of
class of
shares
(2)		     Title of securities
covered by the
options, RSUs and
PSUs		      Number of
options, RSUs,
and PSUs (3)		      Exercise price of
options		      Date of expiration of
options		  

Gil Shwed

      29,149,766        23.6 %      Ordinary shares        4,240,000      $  114.23 - $123.05          06/06/2024-08/29/2029  

All directors and officers as a group (13 persons including Mr. Shwed)(4)

      30,654,733        24.6 %      Ordinary shares        5,605,491      $ 84.77 - $142.40          06/06/2023-12/31/2029  

 

(1)

The number of ordinary shares shown includes shares that each shareholder has the right to acquire pursuant to stock options that are exercisable and RSUs and PSUs that vest within 60 days after February 28, 2023.

(2)

If a shareholder has the right to acquire shares by exercising stock options or has RSUs and PSUs (as determined in accordance with footnote (1)), these shares are deemed outstanding for the purpose of computing the percentage owned by the specific shareholder (that is, they are included in both the numerator and the denominator), but they are disregarded for the purpose of computing the percentage owned by any other shareholder.

(3)

Number of options immediately exercisable or exercisable and RSUs and PSUs that vest within 60 days from February 28, 2023.

(4)

Other than Mr. Shwed, none of our executive officers and directors beneficially own more than 1% of our outstanding ordinary shares.

Equity Incentive Plans

The following table summarizes our equity incentive plans, which have outstanding awards as of December 31, 2022:

 

Plan    Outstanding
options,
RSUs & PSUs		      Options
outstanding
exercise price		    Date of expiration of options      Options
exercisable		  

2005 United States Equity Incentive Plan

      1,356,611      $84.77-$132.91      06/06/2023-08/29/2029        554,591  

2005 Israel Equity Incentive Plan

      8,830,117      $84.77-$142.40      06/06/2023-08/29/2029        5,111,472  

Dome9 Equity Incentive Plan

      545      $12.99-$ 21.97      12/21/2027-06/27/2028        545  

In 2005, we adopted our 2005 United States Equity Incentive Plan and our 2005 Israel Equity Incentive Plan, which were subsequently amended in January 2014, July 2018 and August 2020. We refer to the plans, as amended, as the U.S. Equity Plan and the Israel Equity Plan, and, together, as the Equity Plans.

Number of Ordinary Shares Reserved for Future Grants under the Equity Plans

Following the amendments to the Equity Plans in July 2018, commencing December 31, 2018, on December 31st of each year, the number of Reserved and Authorized Shares (as defined below) under both Equity Plans together shall be automatically reset on such date to equal 10% of the sum of (i) the number of ordinary shares issued and outstanding on such date and (ii) the number of ordinary shares reserved and authorized under the Equity Plans for outstanding awards granted under the Equity Plans as of such date (provided, however, that in no event shall the number of Reserved and Authorized Shares be less than the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding awards granted under the Equity Incentive Plans as of such date). The number of “Reserved and Authorized Shares” under the Equity Plans shall equal the sum of (i) the number of ordinary shares reserved and authorized under the Equity Plans for outstanding awards granted under the Equity Plans as of such date, and (ii) the number of ordinary shares reserved, authorized and available for issuance under the Equity Plans on such date.

Accordingly, as of December 31, 2022, the number of Reserved and Authorized Shares under both Equity Plans together was reset to equal 13,092,231.

As of December 31, 2022, options to purchase 7,778,108 ordinary shares were outstanding under the Equity Plans and the Dome9 Equity Incentive Plan combined. The option exercise prices of the outstanding options as of December 31, 2022 range between $12.99 and $142.40 per share. As of December 31, 2022, 2,408,346 RSUs and PSUs were outstanding under the Equity Plans combined.

 

44

Table of Contents

Administration

Both Equity Plans are administered by our board of directors or a committee of our board. The compensation committee of our board of directors currently operates as the administrator of the Equity Plans. The administrator has full power to determine the persons to whom awards shall be granted and the other terms of the awards granted, including (a) the number of shares subject to each award, (b) the duration of the related award agreement, (c) the time, manner and form of payment upon the exercise of an award, and (d) other terms and provisions governing the awards. The administrator also establishes the vesting schedule of awards that are granted.

2005 United States Equity Incentive Plan, as Amended

Awards. The U.S. Equity Plan provides for the following kinds of awards, which we refer to generically as awards: (i) Incentive Stock Options (ISOs), (ii) Non-statutory Stock Options (NSOs), (iii) Restricted Stock, (iv) Restricted Stock Units (RSUs), (v) Performance Shares, (vi) Performance RSUs (“PSUs”) and (vii) Deferred Stock Units. All of these awards can vest based on time or performance milestones.

Granting of options, price and duration. Our U.S. Equity Plan provides that each option will expire on the date stated in the notice of grant, which will not be more than seven years from its date of grant (or five years, in the case of an ISO granted to a person who on the date of grant owns 10% or more of our voting power). The exercise price of an option cannot be less than 100% of the fair market value per share on the date of grant (or 110% of the fair market value, in the case of an ISO granted to a person who on the date of grant owns 10% or more of our voting power). The administrator will fix the period within which the award can be exercised and the exercise price. No option award can vest until at least six months after the grant date.

Granting of awards, other than options, and price. The administrator can determine the conditions that must be satisfied, which typically will be based principally or solely on the recipient’s continuing to provide services to us, but conditions may also include a performance-based component. We can issue ordinary shares under grants of Restricted Stock, RSUs, Performance Shares and PSUs upon payment of their nominal value. No such award can vest until at least one year after the grant date. Deferred Stock Units consist of Restricted Stock, RSUs, Performance Shares, or PSUs that the administrator permits to be paid out in installments or on a deferred basis.

2005 Israel Equity Incentive Plan, as Amended

Awards. The Israel Equity Plan provides for the following kinds of awards, which we refer to generically as awards: (i) “Approved 102 Options/Shares,” which are grants to directors, employees and officers that are eligible for favorable tax treatment in Israel and which must be held by a trustee for a minimum period as prescribed by Israeli law; (ii) “Non-approved 102 Options/Shares,” which are grants of options or shares that are not eligible for favorable tax treatment in Israel and which may be held directly by the participants; (iii) Restricted Stock; (iv) RSUs; (v) Performance Shares; (vi) PSUs; and (vii) Deferred Stock Units. All of these awards can vest based on time or performance milestones.

Trustee. A trustee designated by our board of directors and approved by the Israel Tax Authority must hold any shares allocated or issued upon exercise of Approved 102 Options or other shares subsequently received following any realization of rights, including bonus shares (stock dividends), for at least the period of time specified by Section 102 of Israel’s Income Tax Ordinance.

Granting of options, price and duration. Our Israel Equity Plan provides that each option will expire on the date stated in the option agreement, which will not be more than seven years from its date of grant. The exercise price of an option cannot be less than 100% of the fair market value per share on the date of grant. The administrator will fix the period within which the award can be exercised and the exercise price. No option award can vest until at least six months after the grant date.

Granting of awards, other than options, and price. The administrator can determine the conditions that must be satisfied, which typically will be based principally or solely on the recipient’s continuing to provide services to us, but conditions may also include a performance-based component. We can issue ordinary shares under grants of Restricted Stock, RSUs, Performance Shares and PSUs upon payment of their nominal value. No such award can vest until at least one year after the grant date. Deferred Stock Units consist of Restricted Stock, RSUs, Performance Shares, or PSUs that the administrator permits to be paid out in installments or on a deferred basis.

Change of control arrangements. Upon a change of control of us, if the acquirer refuses to assume or provide substitute awards, then the administrator of the equity plans, which is currently the compensation committee of our board of directors, can either terminate all unvested awards or accelerate the vesting period of any award under our Equity Plans. The administrator also has the authority to accelerate the vesting of the ordinary shares subject to outstanding awards held by our directors, officers and employees in connection with the subsequent termination of some officers’ employment following a change of control event

 

45

Table of Contents

Dome9 Security Ltd. 2011 Share Option Plan and the 2016 Equity Incentive Subplan

In connection with our acquisition of Dome9 Security Ltd. in October 2018, we assumed certain outstanding Dome9 share options under the Dome9 Security Ltd. 2011 Share Option Plan and the 2016 Equity Incentive Subplan, or the Dome9 Equity Plan, which were converted into options to purchase 47,816 of our ordinary shares.

As of December 31, 2022, options to purchase 545 ordinary shares were outstanding under the Dome9 Equity Plan on that date. The options generally have terms of between seven and ten years. The option exercise prices range from $12.99-$21.97 per share. No further options can be granted under the Dome9 Equity Plan.

Employee Stock Purchase Plans

In 1996, we adopted an Employee Stock Purchase Plan, which was subsequently amended and restated in 2015, and further amended in June 2019 and July 2020. We refer to the Employee Stock Purchase Plan, as amended and restated, as the US ESPP, and the Employee Stock Purchase Plan (Non-U.S. Employees), as the ROW ESPP, and together with the US ESPP, as the “ESPPs”. The ESPPs permit employees to purchase ordinary shares through payroll deductions.

According to the amendments, 750,000 ordinary shares are authorized for issuance under the US ESPP (out of which 341,500 ordinary shares had been issued through December 31, 2022) and 1,096,795 ordinary shares are authorized for issuance under the rest of the world (ROW) ESPP (out of which 687,684 ordinary shares had been issued through December 31, 2022).

Each ESPP has six-month offering periods, with purchases occurring in January and July. Each of the ESPPs will terminate on the earliest of (i) the last business day in January 2036, (ii) when no more shares are available for issuance under the applicable ESPP, or (iii) when all purchase rights under the applicable ESPP are granted or exercised in connection with a “Corporate Transaction” as defined in the applicable ESPP.

An eligible employee can purchase ordinary shares at a price of 85% of the fair market value of the ordinary shares at the beginning of the six-month offering period (or 85% of the fair market value of the ordinary shares on the semi-annual purchase date, if that is lower). Each eligible employee can elect to purchase ordinary shares under the ESPP in an amount of up to 15% of the employee’s compensation, but not more than 1,250 shares per participant on any purchase date. Employees may terminate their participation in the ESPP at any time during the offering period, and participation ends automatically on termination of employment with us. Each outstanding purchase right will be exercised immediately prior to our merger or consolidation with another company. Our board of directors may amend or terminate each of the ESPPs immediately after the close of any purchase date.

Disclosure of a Registrant’s Action to Recover Erroneous Awarded Compensation

Not applicable.

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

The following table shows information as of December 31, 2022, 2021 and 2020, for each person who, to the best of our knowledge, beneficially owned more than 5% of our outstanding ordinary shares as December 31, 2022:

 

Name of Five Percent Shareholders

    No. of shares
beneficially
held (1)		      % of
class of
shares
(2)		     No. of shares
beneficially
held (1)		      % of
class of
shares
(2)		     No. of shares
beneficially
held (1)		      % of
class of
shares
(2)		  
               
     December 31, 2022     December 31, 2021     December 31, 2020  

Gil Shwed

      29,149,766        23.3 %      28,369,738        21.4 %      28,704,010        20.4 % 

Massachusetts Financial Services Company (3)

      7,335,482        6.07 %      7,470,150        5.79 %      8,084,127        5.89 % 

 

(1)

The amount includes ordinary shares owned by each of the individuals, directly or indirectly, and options immediately exercisable or that are exercisable within 60 days from December 31st, of each of the years shown in this table.

(2)

If a shareholder has the right to acquire ordinary shares by exercising stock options exercisable within 60 days from December 31st, of each of the years shown in this table, these Ordinary shares are deemed outstanding for the purpose of computing the percentage owned by the specific shareholder (that is, they are included in both the numerator and the denominator), but they are disregarded for the purpose of computing the percentage owned by any other shareholder.

 

46

Table of Contents
(3)

As of December 31, 2022, based on information contained in a Schedule 13G/A filed by Massachusetts Financial Services Company with the Securities and Exchange Commission on February 8, 2023, as of December 31, 2021, based on information contained in a Schedule 13G/A filed by Massachusetts Financial Services Company with the Securities and Exchange Commission on February 2, 2022, and as of December 31, 2020, based on information contained in a Schedule 13G/A filed by Massachusetts Financial Services Company with the Securities and Exchange Commission on February 11, 2021. The address for Massachusetts Financial Services Company is 111 Huntington Avenue, Boston, Massachusetts 02199.

Our major shareholders do not have different voting rights from other shareholders with respect to our ordinary shares.

According to our transfer agent, as of December 31, 2022, there were 113 holders of record of our ordinary shares in the United States, representing approximately 81.51% of our outstanding shares. The number of record holders in the United States is not representative of the number of beneficial holders nor is it representative of where such beneficial holders are resident since many of these ordinary shares were held by brokers or other nominees.

We are not controlled by another corporation or by any foreign government, directly or through any other entity. Each of our outstanding ordinary shares has identical rights in all respects.

ITEM 8. FINANCIAL INFORMATION

Consolidated Financial Statements

You can find our financial statements in “Item 18 – Financial Statements”.

Dividend policy

We currently do not intend to distribute any amounts as dividend in the near-term. During 2013, we entered into a settlement agreement with the Israel Tax Authority, resulting in the full release of the profits we generated under the Israeli Law for the Encouragement of Capital Investments (the “Investment Law”) through the year ended December 31, 2011 (known in Israel as “trapped profits”), provided that in accordance with the Investment Law and the regulations thereunder, during the five years commencing 2013, we were obligated to meet certain conditions which included investment in (i) production assets (as defined therein), (ii) research and development activities in Israel and (iii) employment payments for certain new employees (other than office holders) added after 2011. We believe we met those conditions. For amounts that will be distributed as dividends from the non-trapped earnings, we will be exempt from additional taxes.

Legal Proceedings

We operate our business in various countries, and accordingly attempt to utilize an efficient operating model to structure our tax payments based on the laws in the countries in which we operate. This can cause disputes between us and various tax authorities in different parts of the world.

In particular, following audits of our 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued in January 2023 orders for the years 2016 through 2019 challenging our positions on several issues, including matters such as our position to claim a tax credit made for foreign taxes withheld on income payments that was due to the Company outside of Israel, taxation of interest earned outside of Israel by a wholly-owned Singapore subsidiary which the ITA is seeking to tax in Israel and deductibility of expenses attributed to employee stock options. The ITA orders also contest the Company’s positions on various other issues. The ITA therefore demanded the payment of additional taxes in the aggregate amount of NIS 428 million (approximately $122 million), not including an amount of NIS 418 million (approximately $119 million) related to expenses that will be deductible in future years , with respect of these four tax years (these amounts include interest through December 31, 2022). We believe we have good arguments against these orders and intend to file an appeal.

In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes in the aggregate amount of NIS 74 million (approximately $21 million), not including an amount of NIS 94 million (approximately $27 million) related to expenses that will be deductible in future years, with respect to this year (these amounts include interest through December 31, 2022). There can be no assurance that the ITA will accept the Company’s positions on the matters raised and, if it does not, the ITA may also issue an order with respect to the 2020 tax year.

We are the defendant in various other lawsuits, including employment-related litigation claims, lease termination claims and other legal proceedings in the normal course of our business. Litigation and governmental proceedings can be expensive, lengthy and disruptive to normal business operations, and can require extensive management attention and resources, regardless of their merit. While we currently intend to defend the aforementioned matters vigorously, we cannot predict the results of complex legal proceedings, and an unfavorable resolution of a lawsuit or proceeding could materially adversely affect our business, results of operations and financial condition.

 

47

Table of Contents

ITEM 9. THE OFFER AND LISTING

Our ordinary shares are traded publicly on the Nasdaq Global Select Market under the symbol “CHKP” and on the Frankfurt Stock Exchange under the symbol “CPW”.

ITEM 10. ADDITIONAL INFORMATION

We were incorporated in Israel in July 1993, and we are registered with the Israeli Registrar of Companies as public company number 52-004282-1.

The objectives and purposes stated in our memorandum of association are to engage in any lawful activity. We develop, market and support a wide range of products and services for IT security, and offer our customers an extensive portfolio of network security, endpoint security, data security and management solutions. A broad range of our network security solutions operate under a unified security architecture, with central management and enforcement of security policy, and with centralized real-time security updates. Our products and services are sold to enterprises, service providers, small and medium-sized businesses and consumers.

Articles of Association and Israeli Companies Law

The following is a summary of the material provisions of our articles of association and related provisions of the Israeli Companies Law. For the complete text of our articles of association, see “Item 19 – Exhibits”.

Description of shares

Our authorized share capital consists of the following: (i) 500,000,000 ordinary shares, NIS 0.01 nominal value; (ii) 5,000,000 preferred shares, NIS 0.01 nominal value; and (iii) 10 deferred shares, NIS 1.00 nominal value.

Please refer to Exhibit 2.1 for Items 10.B.3, B.4, B.6, B.7, B.8, B.9 and B.10.

Approval of certain transactions; obligations of directors, officers and shareholders

Officers and directors. The Israeli Companies Law codifies the fiduciary duties that office holders, which under the law, includes our directors and executive officers, owe to a company.

Fiduciary duties. An office holder’s fiduciary duties consist of a duty of loyalty and a duty of care.

The duty of loyalty requires an office holder to act in good faith and for the benefit of the company, including to avoid any conflict of interest between the office holder’s position in the company and personal affairs, and proscribes any competition with the company or the exploitation of any business opportunity of the company in order to receive personal advantage for himself or herself or for others. This duty also requires an office holder to reveal to the company any information or documents relating to the company’s affairs that the office holder has received due to his or her position as an office holder. A company may approve any of the acts mentioned above; provided, however, that all the following conditions apply: the office holder acted in good faith; neither the act nor the approval of the act prejudices the good of the company; and the office holder disclosed the essence of his or her personal interest in the act, including any substantial fact or document, in a reasonable time before the date for discussion of the approval. A director is required to exercise independent discretion in fulfilling his or her duties and may not be party to a voting agreement with respect to his or her vote as a director. A violation of these requirements is deemed a breach of the director’s duty of loyalty.

The duty of care requires an office holder to act with a level of care that a reasonable office holder in the same position would employ under the same circumstances. This includes the duty to use reasonable means to obtain information regarding the advisability of a given action submitted for his or her approval or performed by virtue of his or her position and all other relevant information material to these actions.

Disclosure of personal interest. The Israeli Companies Law requires that an office holder promptly disclose to the company any personal interest that he or she may have and all related material information or documents known to him or her, in connection with any existing or proposed transaction by the company. “Personal interest,” as defined by the Israeli Companies Law, includes a personal interest of any person in an act or transaction of the company, including a personal interest of his relative or of a corporation: (i) in

 

48

Table of Contents

which that person or a relative of that person holds 5% or more of the shares, a holder of 5% or more of the voting rights, or a director or general manager, or (ii) in which he or she has the right to appoint at least one director or the general manager, and includes shares for which the person has the right to vote pursuant to a power-of-attorney. “Personal interest” does not apply to a personal interest stemming merely from holding shares of the company.

The office holder must immediately make the disclosure of his or her personal interest and no later than the first meeting of the company’s board of directors that discusses the particular transaction. This duty does not apply to the personal interest of a relative of the office holder in a transaction unless it is an “extraordinary transaction”. The Israeli Companies Law defines an “extraordinary transaction” as a transaction that is not in the ordinary course of business of a company, or that is not on market terms, or which is likely to have a material impact on the company’s profitability, assets or liabilities. The Israeli Companies Law defines a “relative” as a spouse, sibling, parent, grandparent, descendant and the descendant, sibling or parent of a spouse, as well as the spouse of any of the foregoing.

Approvals. The Israeli Companies Law provides that a transaction with an office holder or a transaction in which an office holder has a personal interest requires the board approval, unless the transaction is an extraordinary transaction or the articles of association provide otherwise. The transaction shall not be approved if it is adverse to the company’s interest. If the transaction is an extraordinary transaction, or if it concerns exculpation, indemnification, insurance or compensation of an office holder, then the approval of the company’s compensation committee and the board of directors is required, except if the compensation arrangement is an immaterial amendment to an existing compensation arrangement of an officer who is not a director (in which case the approval of the compensation committee is sufficient). Exculpation, indemnification, insurance or compensation of a director or the Chief Executive Officer also requires shareholder approval.

A person who has a personal interest in a matter that is considered at a meeting of the board of directors or the audit committee generally may not attend that meeting or vote on that matter, unless a majority of the board of directors or the audit committee also has a personal interest in the matter or if such person is invited by the chairman of the board of directors or audit committee, as applicable, to present the matter being considered. If a majority of the board of directors has a personal interest in the transaction, all directors may attend that meeting and vote, and a shareholder approval would be required as well.

Shareholders. The Israeli Companies Law imposes the same disclosure requirements described above on a controlling shareholder of a public company that it imposes on an office holder. For this purpose, a “controlling shareholder” is defined as any shareholder who has the ability to direct the company’s actions, including any shareholder holding 25% or more of the voting rights, if no other shareholder owns more than 50% of the voting rights in the company. Two or more shareholders with a personal interest in the approval of the same transaction are deemed to be one shareholder.

Under the Israeli Companies Law, a shareholder has a duty to act in good faith toward the company and the other shareholders, and to refrain from abusing his or her power in the company, which includes, among other things, voting in the general meeting of shareholders on the following matters:

 

  •

any amendment to the articles of association,

 

  •

an increase of the company’s authorized share capital,

 

  •

a merger, or

 

  •

approval of interested party transactions that require shareholder approval.

In addition, any controlling shareholder, any shareholder who can determine the outcome of a shareholder vote, and any shareholder who can appoint or prevent the appointment of an office holder under the company’s articles of association, is under a duty to act with fairness towards the company. The Israeli Companies Law provides that a breach of the duty of fairness will be governed by the laws governing breach of contract. The Israeli Companies Law does not describe the substance of this duty.

Compensation of Executive Officers and Directors; Executive Compensation Policy

In accordance with the Israeli Companies Law, we have adopted a compensation policy for our executive officers and directors. The purpose of the policy is to describe our overall compensation strategy for our executive officers and directors and to provide guidelines for setting their compensation, as prescribed by the Israeli Companies Law. In addition, according to the Israeli Companies Law, the policy must be reviewed and readopted at least once every three years.

 

49

Table of Contents

The adoption of the compensation policy requires the approval of the compensation committee, the board of directors and our shareholders, in that order. The shareholder’s approval must include the majority of shares voted at the meeting. In addition to the majority vote, the shareholder approval must satisfy either of two additional tests:

 

  •

the majority includes at least a majority of the shares voted by shareholders other than our controlling shareholders or shareholders who have a personal interest in the adoption of the compensation policies; or

 

  •

the total number of shares held by non-controlling shareholders and disinterested shareholders that voted against the adoption of the compensation policies, does not exceed 2% of the aggregate voting rights of our company.

In accordance with the Israeli Companies Law, our policy was last readopted in August 2022 by the compensation committee, the board of directors and our shareholders.

Under the Israeli Companies Law, the compensation arrangements for officers (other than the Chief Executive Officer) who are not directors require the approval of the compensation committee and the board of directors; provided, however, that if the compensation arrangement is not in compliance with our executive compensation policy, the arrangement may only be approved by the compensation committee and the board of directors for special reasons to be noted, and the compensation arrangement shall also require a special shareholder approval. If the compensation arrangement is an immaterial amendment to an existing compensation arrangement of an officer who is not a director and is in compliance with our executive compensation policy, the approval of the compensation committee is sufficient.

Arrangements regarding the compensation of the Chief Executive Officer and directors require the approval of the compensation committee, the board and the shareholders, in that order. In certain limited cases, the compensation of a new Chief Executive Officer who is not a director may be approved without approval of the shareholders.

Indemnification and insurance of directors and officers; limitations on liability

Our articles of association allow us to indemnify, exculpate and insure our office holders to the fullest extent permitted under the Israeli Companies Law.

Under the Israeli Companies Law, we may indemnify an office holder for any of the following liabilities or expenses that they may incur due to an act performed or failure to act in his or her capacity as our office holder:

 

  •

Monetary liability imposed on the office holder in favor of a third party in a judgment, including a settlement or an arbitral award confirmed by a court.

 

  •

Reasonable legal costs, including attorneys’ fees, expended by an office holder as a result of an investigation or proceeding instituted against the office holder by a competent authority, provided that such investigation or proceeding concludes without the filing of an indictment against the office holder, and either:

 

  •

no financial liability was imposed on the office holder in lieu of criminal proceedings, or

 

  •

financial liability was imposed on the office holder in lieu of criminal proceedings, but the alleged criminal offense does not require proof of criminal intent.

 

  •

Reasonable legal costs, including attorneys’ fees, expended by the office holder or for which the office holder is charged by a court:

 

  •

in an action brought against the office holder by us, on our behalf or on behalf of a third party,

 

  •

in a criminal action in which the office holder is found innocent, or

 

  •

in a criminal action in which the office holder is convicted, but in which proof of criminal intent is not required.

A company may indemnify an office holder in respect of these liabilities either in advance of an event or following an event. If a company undertakes to indemnify an office holder in advance of an event, the indemnification, excluding litigation expenses, must be limited to foreseeable events in light of the company’s actual activities when the company undertook such indemnification, and reasonable amounts or standards, as determined by the board of directors.

A company may obtain insurance for an office holder against liabilities incurred in his or her capacity as an office holder. These liabilities include: a breach of duty of care to the company or a third party including a breach arising out of negligence of the office holder; and a breach of duty of loyalty and any monetary liability imposed on the office holder in favor of a third party. A company may also exculpate an office holder from a breach of duty of care in advance of that breach. Our articles of association provide that the exculpation can be made, either in advance or retroactively, to the extent permitted under Israeli law. A company may not exculpate an office holder from a breach of duty of loyalty towards the company or from a breach of duty of care concerning dividend distribution or a purchase of the company’s shares by the company or other entities controlled by the company.

 

50

Table of Contents

Under the Israeli Companies Law, a company may indemnify or insure an office holder against a breach of duty of loyalty only to the extent that the office holder acted in good faith and had reasonable grounds to assume that the action would not prejudice the company. In addition, a company may not indemnify, insure or exculpate an office holder against a breach of duty of care if the act or omission were committed intentionally or recklessly (excluding mere negligence), or with the intent to derive an unlawful personal gain, or for a fine or forfeit levied against the office holder in connection with a criminal offense.

We have resolved to indemnify our directors and officers, to the extent permitted by law and by our articles of association, for liabilities not covered by insurance, that are of certain enumerated types of events, and subject to limitations as to amount.

We have also entered into indemnification, insurance and exculpation agreements with our directors and officers undertaking to indemnify, insure and exculpate them to the full extent permitted by the Israeli Companies Law.

Charitable Contributions

Our articles of association authorize the company to contribute reasonable amounts to worthy causes. In accordance with our charitable contribution policy, we contribute from time to time to various worthy causes.

During 2022, the list of entities to which we contributed included, among others, the Tel Aviv University and the Yeholot Association. Gil Shwed, our founder and Chief Executive Officer, is a Governor of the Board of Governors of Tel Aviv University, the Chairman of the Board of Trustees of the Youth University of Tel Aviv University, the founder of Tel-Aviv University’s Check Point Institute for Information Technology and the Chairman of the Board of Directors of Yeholot Association Founded by the Rashi Foundation whose charter is, among other things, to reduce the dropout rates in high schools.

Borrowing power

Our articles of association grant broad powers to the board of directors to have us borrow, repay borrowings, make guarantees and grant security interests in borrowings.

Availability of Annual Report on Form 20-F

In accordance with our articles of association and Nasdaq rules, we post our Annual Report on Form 20-F on our website (www.checkpoint.com), rather than mail it to shareholders.

Material Contracts

None.

Israeli Taxation, Foreign Exchange Regulation and Investment Programs

The following is a summary of the principal Israeli tax laws applicable to us, the Israeli Government programs from which we benefit, and Israeli foreign exchange regulations. This section also contains a discussion of material Israeli tax consequences to our shareholders who are not residents or citizens of Israel. This summary does not discuss all aspects of Israeli tax law that may be relevant to a particular investor in light of his or her personal investment circumstances, or to some types of investors subject to special treatment under Israeli law. Examples of investors subject to special treatment under Israeli law include residents of Israel, traders in securities, or persons who own, directly or indirectly, 10% or more of our outstanding voting capital, all of whom are subject to special tax regimes that are not covered in this discussion. Some parts of this discussion are based on new tax legislation that has not been subject to judicial or administrative interpretation. The discussion should not be construed as legal or professional tax advice and does not cover all possible tax consequences.

You are urged to consult your own tax advisor as to the Israeli and other tax consequences of the purchase, ownership and disposition of our shares, including, in particular, the effect of any non-Israeli, state or local taxes.

General corporate tax structure in Israel

Taxable income of Israeli companies is subject to tax at the rate of 23% since 2018.

However, as discussed below, the rate is effectively reduced for income derived from our Technological preferred enterprise.

 

51

Table of Contents

Law for the Encouragement of Capital Investments, 1959 (“Investment Law”)

Among other changes, the new Law includes, Amendment 73 to the Investment Law (“Amendment 73”). Amendment 73 prescribes special tax tracks for technological enterprises. One of the tracks is for Technological preferred enterprise—an enterprise for which total consolidated revenues of its parent company and all subsidiaries are less than NIS 10 billion. A technological preferred enterprise, as defined in the Law, which is located in the center of Israel will be subject to tax at a rate of 12% on profits deriving from intellectual property. The special tax tracks under Amendment 73 are subject to rules issued by the Minister of Finance. On May 1, 2017, the Israeli Finance Minister signed tax regulations implementing the Organisation for Economic Co-operation and Development’s (OECD’s) “nexus approach,” a base erosion and profit shifting (BEPS) requirement for intellectual property (IP) preferential tax regimes. The proposed regulations are subject to approval by the Parliament’s Finance Committee. On May 16, 2017 the Knesset Finance Committee approved the regulations effective as of January 1, 2017.

The benefits available to a Preferred Enterprise are conditioned upon terms stipulated in the Investment Law and the related regulations. If we do not fulfill these conditions, in whole or in part, the benefits can be cancelled, and we may be required to refund the benefits in an amount linked to the Israeli consumer price index plus interest. We believe that our Preferred Enterprise program currently operates, in compliance with all applicable conditions and criteria, but we cannot assure you that it will continue to do so.

We have derived, and expect to continue to derive, a substantial portion of our operating income from our Technological preferred enterprise. We are, therefore, eligible for reduced tax rates for an unlimited period.

To prepare our consolidated financial statements, we estimate our income taxes in each of the jurisdictions in which we operate. This process involves estimating our potential tax exposure together with assessing temporary differences resulting from the differing treatment of certain items for tax and accounting purposes.

These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheet.

Reduced income under the Investment Law including the Preferred Enterprise/Technological preferred enterprise Regime will be freely distributable as dividends, subject to a 15% or 20% withholding tax (or at lower rate, under an applicable tax treaty). However, upon the distribution of a dividend from Preferred/ Technological preferred Income to an Israeli company, no withholding tax will be remitted.

Our tax assessments through the 2015 tax year are considered final.

See also Item 3 “Key Information – Risk factors” – Risks Related to Our Business and Our Market – We are the defendants in various lawsuits and have been subject to tax disputes and governmental proceedings, which could adversely affect our business, results of operations and financial condition”.

The Inflation Reduction Act of 2022

On August 16, 2022, Congress passed the Inflation Reduction Act of 2022. The tax provisions impose the newly introduced 15% corporate alternative minimum tax on large corporations with average annual financial statement income exceeding $1 billion USD and 1% excise tax on stock repurchases, which are both effective January 1, 2023. While we do not anticipate that these changes should impact our consolidated financial position, we will continue to monitor as new information and guidance becomes available.

Foreign Exchange Regulations

Under the Foreign Exchange Regulations, an Israeli company calculates its tax liability in U.S. dollars according to certain orders. The tax liability, as calculated in U.S. dollars is translated into NIS according to the exchange rate as of December 31 of each year.

Dividends, if any, paid to the holders of our shares, and any amounts payable upon our dissolution, liquidation or winding up, as well as the proceeds of any sale in Israel of our shares to an Israeli resident, may be paid in non-Israeli currency. If these amounts are paid in Israeli currency, they may be converted into freely repatriable U.S. dollars at the rate of exchange prevailing at the time of conversion. In addition, the statutory framework for the potential imposition of exchange controls has not been eliminated, and may be restored at any time by administrative action.

Equity Based Compensation

The Israeli tax legislation enables a company to grant options/shares through one of three tax tracks:

 

52

Table of Contents

(a) the income tax track through a trustee pursuant to which the employee pays income tax rate (according to the marginal tax rate of the employee), up to 47% tax in 2020, 2021 and in 2022, plus payments to the National Insurance Institute and health tax on the profit gained upon the earlier to occur of the transfer of the options/shares or the underlying shares from the trustee to the employee or the sale of the options/shares or the underlying shares by the trustee, and the company may deduct expenses pertaining to the options/shares for tax purposes. The shares/options (or upon their exercise, the underlying shares), must be held by a trustee for a period of 12 months commencing from the date of which the options/shares were issued and deposited with the trustee. As of January 1, 2013, an additional tax was imposed in a rate of 3% (“the surtax”). Accordingly, and as of December 31, 2022 the marginal tax rate of an individual can reach 50% if the employee’s taxable income for the year exceeded NIS 663,240.

(b) the capital gains tax track through a trustee pursuant to which the employee pays capital gains tax at a rate of 25% on the capital profit portion and marginal tax rate (including payments to the National Insurance Institute and health tax) on the income portion (in general, the income portion is the profit derived from the difference between the average market value of the share 30 days before the allotment date and the exercise price of the option/share) upon the earlier to occur of the transfer of the options/shares or the underlying shares from the trustee to the employee or the sale of the options/shares or the underlying shares by the trustee. (On the capital profit, the employee is not required to make payments to the National Insurance Institute and health tax). In this track, on the capital profit, we may not deduct expenses pertaining to the options/shares for tax purposes but may do so on the income portion. The shares/options (or upon their exercise, the underlying shares), must be held by a trustee for a period of 24 months commencing from the date of which the options/shares were issued and deposited with the trustee (with respect to options/shares granted before January 1, 2006, a period of 30 months commencing from the date of which the options/shares were granted or a period of 24 months commencing from the date of which the options/shares were issued and deposited with the trustee, whichever route is selected). As of January 1, 2013, an additional tax was imposed in a rate of 3% (“the surtax”). Accordingly, and as of December 31, 2022 the marginal tax rate of an individual can reach 50% if the employee’s taxable income for the year exceeded NIS 663,240.

(c) the income tax track without a trustee pursuant to which the employee pays income tax rate (according to the marginal tax rate of the employee up to 47% in 2020, 2021 and in 2022, plus payments to the National Insurance Institute and health tax on the profit at the allotment date, and pays capital gains tax at a rate of 25% or 30% on the capital profit upon the sale of the underlying shares/shares, and we may not deduct expenses pertaining to the capital gain for tax purposes but may deduct expenses pertaining to the profit at the allotment date. As of January 1, 2013, an additional tax was imposed in a rate of 3% (“the surtax”). Accordingly, and as of December 31, 2022 the marginal tax rate of an individual can reach 50% if the employee’s taxable income for the year exceeded NIS 663,240.

In accordance with the provisions of the Israeli Tax Ordinance, if a company has selected the capital gains track, the company must continue granting options/shares under the selected capital gains track until the end of the year following the year in which the first grant of options/shares under that trustee track will be made.

We implement the capital gain track on RSUs, PSUs and stock options granted to our employees and directors and the income tax track without a trustee on our ESPP.

Notwithstanding the above, the company may at any time also grant options/shares under the provisions of the income tax track without a trustee.

The above rules apply only to employees, including officeholders but excluding controlling shareholders.

Controlling shareholders will be taxable under section 3(i) to the tax ordinance, according to which, the individual pays income tax rate (according to the marginal tax rate of the individual, up to 47% in 2020, 2021 and in 2022) on the profit upon the sale of the underlying shares/shares. As of January 1, 2013, the surtax is imposed. Accordingly, the marginal tax rate of an individual increased by 3% if the employee’s taxable income in 2020 exceeded NIS 651,600, and is increased by 3% if the employee’s annual taxable income in 2021 exceeds NIS 647,640 and is increased by 3% if the employee’s annual taxable income in 2022 exceeds NIS 663,240 (as updated from time to time). Hence, the employee’s marginal tax rate can reach 50%.

Taxation of Non-Israeli Subsidiaries

Non-Israeli subsidiaries are generally taxed based upon tax laws applicable in their countries of residence. In accordance with the provisions of Israeli-controlled foreign corporation rules, certain income of a non-Israeli subsidiary, if the subsidiary’s primary source of income is passive income (such as interest, dividends, royalties, rental income or income from capital gains), which are subject to tax at a rate which does not exceed 15% in the foreign corporation’s jurisdictions may be deemed distributed as a dividend to the Israeli parent company and consequently is subject to Israeli taxation. This tax regime will not apply where the subsidiary’s dividend income is derived from taxable profits that were subject to tax exceeding 15%. An Israeli company that is subject to Israeli taxes on such deemed dividend income of its non-Israeli subsidiaries may generally receive a credit for non-Israeli income taxes paid by the subsidiary in its country of residence.

 

53

Table of Contents

Taxation of Non-Israeli Shareholders on Receipt of Dividends

Under Israeli tax law, a distribution of dividends from income attributable to an Approved Enterprise, Privileged Enterprise, Preferred Enterprise or Technological preferred enterprise will be subject to tax in Israel at the rate of 15%/20%, which is withheld and paid by the company paying the dividend (,(apply on Approved Enterprise or Privileged Enterprise which are not considered Foreign Investors Company only if the dividend is distributed during the benefits period or within the following 12 years). However, if the dividend is attributable partly to income derived from an Approved and Privileged Enterprise, and partly to other sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two types of income. Any distribution of dividends from income that is not attributable to an Approved Enterprise, Privileged Enterprise Preferred Enterprise or Technological preferred enterprise will be subject to tax in Israel at the rate of 25% (or to a reduced tax rate if is distributing to a foreign shareholder based on an applicable tax treaty), except that dividends distributed to an individual who is deemed “a substantial shareholder” will be subject to tax at the rate of 30% ( or at a lower rate based on an applicable tax treaty).

Under the United States-Israel tax treaty, the maximum tax on dividends paid to a holder of shares of our capital stock who is a United States resident is 25%.

Dividends received by a United States company that holds at least 10% of our voting rights, will be subject to withholding tax at the rate of 12.5% or 15%, depends on the nature of the taxable income, provided that certain other conditions in the tax treaty are met. Dividends distributed to other foreign shareholders may be subject to different withholding tax rates based on the applicable tax treaty.

A non-resident of Israel who has interest or dividend income derived from or accrued in Israel, from which tax was withheld at the source, is generally exempt from the duty to file tax returns in Israel in respect of such income, provided such income was not derived from a business conducted in Israel by the taxpayer.

Capital Gains Taxes Applicable to Non-Israeli Shareholders

According to Israeli domestic tax law, capital gains from the sale of our shares by non-Israeli shareholders (including United States residents) are exempt from Israeli taxation under the Israeli domestic tax law, provided that the capital gain is not derived from a permanent establishment in Israel.

A non-resident of Israel who has interest or dividend income derived from or accrued in Israel, from which tax was withheld at the source, is generally exempt from the duty to file tax returns in Israel in respect of such income, provided such income was not derived from a business conducted in Israel by the taxpayer.

United States Federal Income Tax Considerations

The following discussion describes certain material U.S. federal income tax considerations relating to the direct or indirect ownership or disposition of our shares by a shareholder who is:

 

  •

An individual citizen or resident (as defined for U.S. federal income tax purposes) of the United States;

 

  •

A domestic partnership;

 

  •

A corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States or any of its states;

 

  •

An estate, if the estates income is subject to U.S. federal income taxation; or

A trust, if a U.S. court is able to exercise primary supervision over its administration and one or more U.S. persons (e.g., a U.S. citizen, resident, or corporation) have the authority to control all of its substantial decisions or the trust has a valid election in effect under U.S. Treasury Regulations to be treated as a “United States person”. We refer to any of the above as a “U.S. Shareholder”.

This discussion is based on the provisions of the Internal Revenue Code of 1986, as amended, referred to as the “Code”, U.S. Treasury Regulations promulgated under the Code and administrative and judicial interpretations of the Code, all as in effect as of the date of this Annual Report. This discussion generally considers only U.S. Shareholders who will hold our shares as capital assets.

This summary discussion does not address tax considerations applicable to a U.S. Shareholder that may be subject to special tax rules including, without limitation, the following:

 

  •

Aspects of U.S. federal income taxation relevant to U.S. Shareholders by reason of their particular circumstances (including potential application of the alternative minimum tax);

 

  •

U.S. Shareholders subject to special treatment under the U.S. federal income tax laws, such as banks, financial institutions, insurance companies, broker-dealers or traders in securities;

 

  •

U.S. Shareholders that are tax-exempt organizations and pension funds;

 

  •

U.S. Shareholders that are former citizens or long-term residents of the United States;

 

54

Table of Contents
  •

U.S. Shareholders that are partnerships or entities treated as partnerships or other pass-through entities and persons who own our shares through such entities, and non-U.S. individuals or entities;

 

  •

U.S. Shareholders that are real estate investment trusts or regulated investment companies;

 

  •

U.S. Shareholders who own 10% or more of our outstanding voting shares, either directly or by attribution;

 

  •

U.S. Shareholders who hold our shares as part of a hedging, straddle, integrated, or conversion transaction;

 

  •

U.S. Shareholders who acquire their shares of our capital stock in a “compensatory transaction”;

 

  •

U.S. Shareholders whose “functional currency” for U.S. federal income tax purposes is not the U.S. dollar; and

 

  •

Any aspect of U.S. estate, gift, state, or local tax law, or any non-U.S. tax law.

The following summary does not address all of the tax consequences of owning or disposing of our shares to you based on your individual tax circumstances. Accordingly, you should consult your own tax advisor as to the particular tax consequences to you of owning or disposing of our shares, including the effects of applicable state, local, or non-U.S. tax laws and possible changes in the tax laws.

Dividends Paid on the Company’s Shares

Subject to the discussion below under “Passive Foreign Investment Company Status,” a U.S. Shareholder, as defined above, may be required to include in gross income the amount of any distributions made with respect of our shares (and any Israeli taxes withheld on such distributions) to the extent that the distributions are paid out of our current or accumulated earnings and profits, as determined for U.S. federal income tax purposes. We do not calculate earnings and profits under United States federal income tax principles.

Certain non-corporate U.S. Shareholders may qualify for preferential rates of taxation with respect to dividends on our capital stock if the dividends are “qualified dividend income”. Qualified dividend income generally includes dividends paid by a U.S. corporation or a “qualified foreign corporation”. A non-U.S. corporation, such as ours, generally will be considered to be a qualified foreign corporation if (i) our shares are readily tradable on an established securities market in the United States, or (ii) we are eligible for the benefits of a comprehensive U.S. income tax treaty determined to be satisfactory to the U.S. Department of the Treasury for purposes of this provision and which includes an exchange of information provision. The U.S. Department of the Treasury and the Internal Revenue Service have determined that the United States-Israel tax treaty is satisfactory for this purpose. In addition, the U.S. Department of the Treasury and the Internal Revenue Service have determined that our shares are considered readily tradable on an established securities market if they are listed on an established securities market in the United States, such as the Nasdaq Global Select Market. The information returns, reporting the dividends paid to U.S. Shareholders, will identify the amount of dividends eligible for the reduced rates.

 

55

Table of Contents

U.S. Income Tax Treatment of Dividends

Any distributions in excess of earnings and profits will be treated first as non-taxable return of capital, reducing a U.S. Shareholder’s tax basis in our shares to the extent of the distributions, and then as capital gain from a sale or exchange of our shares. Any capital gain so realized will generally be taxable to the U.S. Shareholder as either long-term or short-term capital gain depending upon whether the U.S. Shareholder has held our shares for more than one year as of the time such distribution is received. Our dividends will generally not qualify for the dividends received deduction available to corporations. Any cash distribution paid in Israeli Shekels will equal the U.S. dollar value of the distribution, calculated based on the spot exchange rate in effect on the date of the distribution, regardless of whether the foreign currency is converted into U.S. dollars at that time. Any foreign currency gain or loss a U.S. Shareholder realizes on a subsequent conversion of foreign currency into U.S. dollars will be U.S. source ordinary income or loss. A 10% or more U.S. shareholder may have additional concerns not noted here.

Credit for Israeli Taxes

Subject to certain conditions and limitations, a U.S. Shareholder of an Israeli corporation may be eligible for a foreign tax credit to offset a portion of the U.S. tax liability assessed on Israeli sourced income when repatriated to the U.S. The U.S. Internal Revenue Code provides a foreign tax credit limitation on the amount of foreign tax credits that may be used during each taxable year. This limitation requires detailed knowledge of the mechanics of the rules proscribed in the code and support regulations. Under no circumstances, can foreign tax credits be used to offset a U.S. tax assessment on U.S. source income, and the credit may not exceed the U.S. tax assessment on foreign income.

A U.S. Shareholder may elect to claim a foreign tax credit on its U.S. federal income tax return for foreign taxes paid or accrued, alternatively, the U.S. Shareholder may elect to claim a deduction for Israeli income tax withheld or paid, but only if the shareholder elects to do so for all foreign income taxes of the same year. Special rules for determining a U.S. Shareholder ’s foreign tax credit limitation apply in the case of qualified dividend income. Rules similar to those concerning adjustments to the foreign tax credit limitation to reflect any capital gain rate differential also apply to any qualified dividend income. The rules relating to foreign tax credits are complex and each U.S. Shareholder should consult his, her, or its own tax advisor to determine whether and if the specific shareholder would be entitled to this credit.

Sale, Exchange, or Other Disposition of Our Shares

The sale or exchange of our shares may result in the recognition of capital gain or loss for the U.S. Shareholder. The amount of gain or loss is the difference between the U.S. dollar value of the amount realized on the sale or exchange and the tax basis in our shares. If a U.S. Shareholder’s holding period for our shares exceeds one year at the time of the disposition, the amount of the shareholder’s gain or loss generally will be long-term capital gain or loss. Long-term capital gains of non-corporate U.S. Shareholders realized upon a sale or exchange of shares generally will be eligible for a preferential rate of taxation. The deductibility of capital losses may be subject to limitation. Gain or loss recognized by a U.S. Shareholder on a sale or exchange of shares generally will be treated as U.S. source income or loss for U.S. foreign tax credit purposes.

Additional Tax on Investment Income

U.S. Shareholders that are individuals, estates or trusts and whose income exceeds certain thresholds may be subject to a 3.8% tax on all or a portion of their “net investment income”, including, among other things, dividends on and capital gains from the sale or other disposition of our shares, subject to certain limitations and exceptions.

Passive Foreign Investment Company Status

Based upon our income, assets and activities, we believe that we are not currently, and have not been in prior years, a passive foreign investment company (PFIC) for U.S. federal income tax purposes. We do not currently anticipate that we will be a PFIC for any subsequent year. We would be classified as a PFIC if, for any taxable year, either:

 

  •

75% or more of our gross income in the taxable year is passive income, or

 

  •

50% or more of the average percentage of our assets held during the taxable year produce or are held for the production of passive income.

For this purpose, passive income includes dividends, interest, royalties, rents, annuities and the excess of gain over losses from the disposition of assets that produce passive income.

If we were a PFIC for any taxable year during which you held shares as a U.S. Shareholder and you did not timely elect to treat us as a “qualified electing fund” under Section 1295 of the Code or elect to mark our shares to market, you would be subject to special tax rules that have a penalizing effect on the receipt of an “excess distribution” on our shares. Generally, a distribution is considered an

 

56

Table of Contents

excess distribution to the extent it exceeds 125% of the average annual distributions in the prior three years (or, if shorter, your holding period of our shares before the taxable year). You would also be subject to special tax rules that have a penalizing effect on the gain from the disposition of our shares, including the treatment if any such gain as ordinary income, not capital gain.

A U.S. Shareholder may be able to mitigate certain adverse tax consequences of holding shares in a PFIC by making a “qualified electing fund,” “deemed sale” or “mark-to-market” election. However, these elections require specific conditions to be met, for example, as a U.S. Shareholder you may make a qualified electing fund election only if we agree to furnish certain tax information annually. We do not presently prepare or provide this information, and this information may not be available to you if we are subsequently determined to be a PFIC. A number of specific rules and requirements apply to a U.S. Shareholder under any of the elections available to owners of a PFIC. You are advised to consult your tax advisor concerning these elections.

Information Reporting and Back up Withholding

Dividend payments and proceeds from the sale or disposal of shares may be subject to information reporting to the Internal Revenue Service and possible U.S. federal withholding tax. However, withholding taxes may not apply to a holder, in the event they furnish a valid taxpayer identification number or certificate of foreign status and makes any other required certification, or who is otherwise exempt from withholding (for example, a corporation). Amounts withheld as withholding taxes may be credited against a U.S. Shareholder’s federal income tax liability.

Other Reporting Requirements

Certain U.S. Shareholders who are individuals are required to report information relating to an interest in our shares, subject to certain exceptions (including an exception for shares held in accounts maintained by U.S. financial institutions) by filing IRS Form 8938 (Statement of Specified Foreign Financial Assets) with their federal income tax return. U.S. Shareholders are urged to consult their tax advisors regarding their information reporting obligations, if any, with respect to their ownership and disposition of our shares.

Documents on Display

This report and other information filed or to be filed by us with the Securities and Exchange may be accessed at the Securities and Exchange Commission’s website, www.sec.gov. We intend to post our Annual Report on our website (www.checkpoint.com) promptly following the filing of our Annual Report with the Securities and Exchange Commission.

Additionally, documents referred to in this Annual Report may be inspected at our principal executive offices located at 5 Shlomo Kaplan Street, Tel Aviv 6789159, Israel.

 

57

Table of Contents

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risks that result primarily from weak economic conditions in the markets in which we sell our products, and from changes in exchange rates or in interest rates.

Interest Rate Risk

Our exposure to market risk for changes in interest rates relates primarily to our investment in fixed maturity marketable securities, and short-term bank deposits. Our marketable securities portfolio includes mainly government and government agencies debt instruments (U.S., European and other) and corporate debt instruments, which are exposed to changes in short-term interest rates. By policy, we limit the amount of credit exposure to any single issuer.

Investments in both fixed rate and floating rate interest bearing securities carry a degree of interest rate risk. Fixed rate securities may have their fair market value adversely impacted due to a rise or fall in interest rates, while floating rate securities may produce less income than predicted if interest rates fall. Due in part to these factors, our income from investments may change in the future in the event that interest rates fluctuate.

The COVID-19 Pandemic, and its effect on financial markets, have adversely affected the yield in our investment portfolio and may continue to do so. Low, zero, or negative interest rates, reduced liquidity and a slowdown in U.S. or global economic conditions, as well as COVID-19 Pandemic-related actions, have affected the values of assets in our investment portfolio

As of December 31, 2022 securities representing 6% of our investments portfolios are rated as AAA; securities representing 50% of the portfolio are rated between AA- and AA+; securities representing 43% of the portfolio are rated between A- and A+; securities representing 1% of the portfolio are rated as BBB+ or below.

The table below provides information regarding our investments in cash, cash equivalents, short-term bank deposits and marketable securities, as of December 31, 2022:

 

     Maturity      Total
Par Value		      Fair
Value at
Dec. 31, 2022		  
     2023      2024      2025      2026      2027  
                    
     (in millions)  

Marketable securities:

                     

Government and corporate debentures -fixed interest rate

    $ 677.9      $ 713.3      $ 389.0      $ 254.5      $ 68.1      $ 2,102.8      $ 2,025.8  

Government-sponsored enterprises debentures

      332.4        257.4        162.7        36.4        -        788.9        755.0  

Government and corporate debentures -floating interest rate

      36.4        39.5        6.6        14.3        -        96.8        95.3  

Cash

      65.8                    65.8        65.8  

Short-term bank deposits

      431.1                    431.1        431.1  

Cash equivalents:

                     

Money market funds

      95.5        -        -        -        -        95.5        95.5  

Short term deposits

      34.7        -        -        -        -        34.7        34.7  
  

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

  

Total

    $ 1,673.8      $ 1,010.2      $ 558.3      $ 305.2      $ 68.1      $ 3,615.6      $ 3,503.2  

 

58

Table of Contents

Foreign Currency Risk

Most of our sales are denominated in U.S. dollars, and we incur majority of our expenses in U.S. dollar, Israeli Shekel and Euro currencies. According to the factors indicated in ASC 830, “Foreign Currency Matters,” our cash flow, sale price, sales market, expense, financing and inter-company transactions, and arrangement indicators, are predominantly denominated in U.S. dollars. In addition, the U.S. dollar is the primary currency of the economic environment in which we operate, and thus, the U.S. dollar is our functional and reporting currency.

On our balance sheet, we convert into U.S. dollars all monetary accounts (principally liabilities) that are held in other currencies. For this conversion, we use the relevant foreign currency exchange rate at the balance sheet date. Any gain or loss that results from this conversion is reflected in the statement of income as financial income or financial expense, as appropriate.

We measure and record non-monetary accounts in our balance sheet in U.S. dollars. For this measurement, we use the U.S. dollar value in effect at the date that the asset or liability was initially recorded in our balance sheet (the date of the transaction).

We entered into forward contracts to hedge the foreign currency exchange impacts on assets and liabilities denominated in various foreign currencies. As of December 31, 2022, the total amount of outstanding forward contracts that did not qualify for hedge accounting was $207.9 million. These contracts were for a period of up to twelve months. The net amount of gains and losses recognized in “financial income, net” during 2022 was a loss of $19.5 million.

During 2022, we entered into forward contracts to hedge against the risk of overall changes in foreign currency exchange rates on future cash flow from payments of payroll and related expenses denominated in Israeli Shekel, Euro and British Pound. These contracts qualified for cash flow hedge accounting and as such the net amount of gains and losses of $24.4 million in gain was recognized when the related expense were incurred, and classified in operating expenses during 2022. As of December 31 2022, the notional amount of outstanding forward contracts that qualified for cash flow hedge accounting was $266.2 million and their fair value loss amount was $3.7 million.

Our operating expenses may be affected by fluctuations in the value of the U.S dollar as it relates to foreign currencies; with Israeli Shekel and Euro having the greatest potential impact. In managing our foreign exchange risk, we periodically enter into foreign exchange hedging contracts. Our goal is to mitigate the potential exposure with these contracts. By way of example, a 10% weakening in the value of the dollar relative to the currencies in which our operating expenses are denominated in 2022 would result in an increase in operating expenses of $67 million for the year ended December 31, 2022. This calculation assumes that each exchange rate would change in the same direction relative to the U.S. dollar.

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

Not applicable.

PART II

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

There are no defaults, dividend arrearages, or delinquencies that are required to be disclosed.

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

There are no material modifications to, or qualifications of, the rights of security holders that are required to be disclosed.

ITEM 15. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As of December 31, 2022, we performed an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Acting Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, our Chief Executive Officer and Acting Chief

 

59

Table of Contents

Financial Officer concluded that our disclosure controls and procedures are effective as of December 31, 2022, to provide reasonable assurance that the information required to be disclosed in filings and submissions under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information related to us and our consolidated subsidiaries is accumulated and communicated to management, including the Chief Executive Officer and Acting Chief Financial Officer, as appropriate to allow timely decisions about required disclosure.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

 

  •

pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets,

 

  •

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and

 

  •

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Our management recognizes that there are inherent limitations in the effectiveness of any system of internal control over financial reporting, including the possibility of human error and the circumvention or override of internal control.

Accordingly, even effective internal control over financial reporting can provide only reasonable assurance with respect to financial statement preparation, and may not prevent or detect all misstatements. Further, because of changes in conditions, the effectiveness of internal control over financial reporting may vary over time.

Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2022. In conducting its assessment of internal control over financial reporting, management used the framework and criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) (the 2013 Framework) as of the end of the period covered by this report. Based on that evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2022.

Our financial statements and internal control over financial reporting have been audited by Kost, Forer, Gabbay & Kasierer (A Member of EY Global), an independent registered public accounting firm, which has issued an attestation report on our internal control over financial reporting included elsewhere in this Annual Report.

Changes in Internal Control over Financial Reporting

During the period covered by this Annual Report, no changes in our internal control over financial reporting have occurred that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

Our board of directors has determined that Mr. Yoav Chelouche is an “audit committee financial expert” and that he is independent under the applicable Securities and Exchange Commission and Nasdaq Global Select Market rules.

ITEM 16B. CODE OF ETHICS

Our board of directors adopted a Code of Ethics that applies to all of our employees, directors and officers, including the Chief Executive Officer, Acting Chief Financial Officer, principal accounting officer or controller and other individuals who perform similar functions as well as to contractors working on a regular basis with Check Point. The Code of Ethics is updated from time to time and was last updated in 2022. The Code of Ethics and Business Conduct is available on our website. You can obtain a copy of our Code of Ethics without charge, by sending a written request to our investor relations department at Check Point Software Technologies, Inc., Attn: Investor Relations, 959 Skyway Road, Suite 300, San Carlos, California 94070 U.S.A; Tel: 650-628-2000; Email: ir@us.checkpoint.com

 

60

Table of Contents

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Fees and Services

The following table sets forth the aggregate fees for the audit and other services provided by Kost, Forer, Gabbay & Kasierer, a member of EY Global and other members of EY Global during the years ended December 31, 2022 and 2021:

 

     Year Ended December 31, 2022      Year Ended December 31, 2021  
       Amount          Percentage          Amount          Percentage    
           
     (in millions, except percentages)  

Audit fees (1)

    $ 0.8        67%      $ 0.8        77%  

Audit related fees (2)

      * )       3%        * )       3%  

Tax fees (3)

      0.3        30%        0.2        20%  
  

 

 

     

 

 

     

 

 

     

 

 

  

Total

    $ 1.1        100%      $ 1.0        100%  
  

 

 

     

 

 

     

 

 

     

 

 

  

 

*)

Represents an amount lower than $0.1 million.

(1)

“Audit fees” are fees for audit services for each of the years shown in this table, including fees associated with the annual audit (including audit of our internal control over financial reporting) and reviews of our quarterly financial results submitted on Form 6-K, consultations on various accounting issues and audit services provided in connection with other statutory or regulatory filings.

(2)

“Audit-related fees” are fees for professional services related to information systems audits.

(3)

“Tax fees” are fees for professional services rendered by our auditors for tax compliance, tax planning and tax advice on actual or contemplated transactions, tax consulting associated with international transfer prices and employee benefits.

Audit committee’s pre-approval policies and procedures

Our audit committee chooses and engages our independent auditors to audit our financial statements, with the approval of our shareholders as required by Israeli law. Our audit committee adopted a policy requiring our management to obtain the audit committee’s approval before engaging our independent auditors to provide any audit or permitted non-audit services to us or our subsidiaries. This policy, which is designed to assure that such engagements do not impair the independence of our auditors, requires pre-approval from the audit committee on an annual basis for the various audit and non-audit services that may be performed by our auditors. In addition, the audit committee limited the aggregate amount of fees our auditors may have received during 2022 and 2021, and will receive during 2023 for non-audit services in certain categories.

Our Acting Chief Financial Officer reviews all management requests to engage our auditors to provide services and approves a request if the requested services are of those that have received pre-approval from our audit committee. We inform our audit committee of these approvals at least quarterly and prior to the commencement of the related services. If the services are not included in those categories that were pre-approved by our audit committee, then specific approval is needed from our audit committee before these services are commenced. Our audit committee is not permitted to approve the engagement of our auditors for any services that would be inconsistent with maintaining the auditors’ independence or that are not permitted by applicable law.

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

None.

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

As of December 31, 2022 and since we started repurchases programs, we repurchased Check Point’s ordinary shares for an aggregate amount of $13,085 million. On February 13, 2023 the Company announced the expansion of the Company’s on-going share repurchase program by an additional $2 billion. Under the current plan, the Board of Directors authorized repurchases of ordinary shares at the pace of up to $325 million a quarter. Under the repurchase programs, share purchases may be made from time to time depending on market conditions, share price, trading volume and other factors and will be funded from available working capital.

During 2022, we used $1,300 million to repurchase approximately 10.3 million ordinary shares, which were repurchased under our repurchase program. The table below provides detailed information.

 

61

Table of Contents

Period

    Total Number
of Ordinary
Shares
    Purchased (1)    		      Average Price  
per Ordinary
Share		    Approximate
  Dollar Amount  
Available for
Repurchase
under the Plans
or Programs

January 1 – January 31

    0.5    $118    $1,724

February 1 – February 28

    0.9    $129    $1,604

March 1 – March 31

    1.0    $140    $1,460

April 1 – April 30

    0.7    $136    $1,365

May 1 – May 31

    1.2    $123    $1,211

June 1 – June 30

    0.6    $124    $1,135

July 1 – July 31

    0.7    $125    $1,045

August 1 – August 31

    1.3    $122    $894

September 1 – September 30

    0.7    $119    $810

October 1 – October 31

    0.9    $113    $710

November 1 – November 30

    1.0    $129    $586

December 1 – December 31

    0.8    $131    $485
  

 

   

 

   

Total

    10.3    $126   
  

 

   

 

   

 

(1)

All the Ordinary Shares were purchased as part of publicly announced plans or programs.

ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT

Not applicable.

ITEM 16G. CORPORATE GOVERNANCE

As a foreign private issuer whose shares are listed on the Nasdaq Global Select Market, we are permitted to follow certain home country corporate governance practices instead of certain requirements of the Nasdaq Marketplace Rules.

We do not comply with the Nasdaq requirement that an issuer listed on the Nasdaq Global Select Market have a quorum requirement that in no case be less than 33 1/3% of the outstanding shares of the company’s common voting stock. Our articles of association, consistent with the Israeli Companies Law, provide that the quorum requirements for an adjourned meeting are the presence of a minimum of two shareholders present in person. As such, our quorum requirements for an adjourned meeting do not comply with the Nasdaq requirements and we instead follow our home country practice.

In addition, we follow our home country law, instead of the Nasdaq Marketplace Rules, which require that we obtain shareholder approval for the establishment or amendment of certain equity based compensation plans and arrangements. Under Israeli law and practice, in general, the approval of the board of directors is required for the establishment or amendment of equity based compensation plans and arrangements, unless the arrangement is for the benefit of a director or a controlling shareholder, in which case compensation committee or audit committee and shareholder approval are also required.

As a foreign private issuer listed on the Nasdaq Global Select Market, we may also follow home country practice with regard to, among other things, composition of the board of directors, compensation practices and compensation committee practices, director nomination process and regularly scheduled meetings at which only independent directors are present. In addition, we may follow our home country practice, instead of the Nasdaq Global Select Market rules, which require that we obtain shareholder approval for certain dilutive events, such as for an issuance that will result in a change of control of the company, certain transactions other than a public offering involving issuances of a 20% or more interest in the company and certain acquisitions of the stock or assets of another company. A foreign private issuer that elects to follow a home country practice instead of Nasdaq rules must submit to Nasdaq in advance a written statement from an independent counsel in such issuer’s home country certifying that the issuer’s practices are not prohibited by the home country’s laws. In addition, a foreign private issuer must disclose in its annual reports filed with the Securities and Exchange Commission or on its website each such requirement that it does not follow and describe the home country practice followed by the issuer instead of any such requirement. Accordingly, our shareholders may not be afforded the same protection as provided under Nasdaq’s corporate governance rules.

See Item 3.D. “Key Information – Risk factors – Risks Related to Our Operations In Israel – As a foreign private issuer whose shares are listed on the Nasdaq Global Select Market, we may follow certain home country corporate governance practices instead of certain Nasdaq requirements,” Item 6 “Directors, Senior Management and Employees – Board Practices” and Item 10 “Additional Information – Articles of Association and Israeli Companies Law” for a detailed description of the significant ways in which the registrant’s corporate governance practices differ from those followed by U.S. companies under the listing standards of the Nasdaq Global Select Market.

 

62

Table of Contents

ITEM 16H. MINE SAFETY DISCLOSURE

Not applicable.

ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not applicable

PART III

ITEM 17. FINANCIAL STATEMENTS

Check Point has responded to Item 18.

ITEM 18. FINANCIAL STATEMENTS

See beginning on page F-1 below.

 

ITEM 19. EXHIBITS

 

1

    Articles of Association of Check Point Software Technologies Ltd. (1)

2.1

    Description of the rights of each class of securities registered under Section 12 of the Securities Exchange Act of 1934 (2)

4.1

    Form of Director Insurance, Indemnification and Exculpation Agreement between Check Point Software Technologies Ltd. and its directors (3)

4.2

    Check Point Software Technologies Ltd. 2005 Israel Equity Incentive Plan, as amended (4)

4.3

    Check Point Software Technologies Ltd. 2005 United States Equity Incentive Plan, as amended (5)

4.4

    Check Point Software Technologies Ltd. Employee Stock Purchase Plan, as Amended and Restated (6)

4.5

    Check Point Software Technologies Ltd. Employee Stock Purchase Plan (Non-U.S. Employees) (7)

4.6

    A translation of an agreement between Tzlil Ad Ltd. and Check Point Software Technologies Ltd., for the purchase of the leasing rights of a building in Tel Aviv, Israel, dated as of March 19, 2006 (8)

 

63

Table of Contents

4.7

    Dome9 Security Ltd. 2011 Share Option Plan and the 2016 Equity Incentive Subplan (9)

4.8

    Check Point Software Technologies Ltd. Executive Compensation Policy (10)

8

    List of subsidiaries (11)

12.1

    Certification of the Chief Executive Officer pursuant to §302 of the Sarbanes-Oxley Act of 2002

12.2

    Certification of the Acting Chief Financial Officer pursuant to §302 of the Sarbanes-Oxley Act of 2002

13.1

    Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350

13.2

    Certification of Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350

15

    Consent of Kost, Forer, Gabbay & Kasierer, a Member of EY Global

101

    Inline XBRL (Extensible Business Reporting Language) The following materials from Check Point Software Technologies Ltd.’s Annual Report on Form 20-F for the fiscal year-ended December 31, 2020, formatted in Inline XBRL:

(i)

    Consolidated Statements of Operations, (ii) Consolidated Balance Sheets, (iii) Consolidated Statements of Shareholders’ Equity/(Deficit) and Comprehensive Income/(Loss) (iv) Consolidated Statements of Cash Flows, (v) Notes to the Consolidated Financial Statements, (vi) Schedule II — Valuation and Qualifying Accounts and Reserves, and (vii) Cover Page

104

    Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

 

(1)

Incorporated by reference to Exhibit 1 of Check Point’s Annual Report on Form 20-F for the year ended December 31, 2005.

(2)

Incorporated by reference to Exhibit 2.1 of Check Point’s Annual Report on Form 20-F for the year ended December 31, 2019.

(3)

Incorporated by reference to Exhibit 4.1 of Check Point’s Annual Report on Form 20-F for the year ended December 31, 2005.

(4)

Incorporated by reference to Exhibit 4.2 of Check Point’s Annual Report on Form 20-F for the year ended December 31, 2021.

(5)

Incorporated by reference to Exhibit 4.3 of Check Point’s Annual Report on Form 20-F for the year ended December 31, 2021.

 

(6)

Incorporated by reference to Exhibit 4.1 of Check Point’s Registration Statement on Form S-8 (No. 333-207355) filed with the Securities and Exchange Commission on October 8, 2015.

(7)

Incorporated by reference to Exhibit 4.5 of Check Point’s Annual Report on Form 20-F for the year ended December 31, 2017.

(8)

Incorporated by reference to Exhibit 4.11 of Check Point’s Annual Report on Form 20-F for the year ended December 31, 2006.

(9)

Incorporated by reference to Exhibit 4.2 of Check Point’s Registration Statement on Form S-8 (No. 333-228075) filed with the Securities and Exchange Commission on October 31, 2018.

(10)

Incorporated by reference to Annex A of Check Point’s Report on Form 6-K filed with the Securities and Exchange Commission on July 27, 2022.

(11)

Incorporated by reference to “Item 4 – Information on Check Point – Organizational Structure” in this Annual Report on Form 20-F.

 

64

Table of Contents

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

 

CHECK POINT SOFTWARE TECHNOLOGIES LTD.
By:  

/s/ Gil Shwed

  Gil Shwed
  Chief Executive Office
By:  

/s/ Roei Golan

  Roei Golan
  Acting Chief Financial Officer

Date: April 27, 2023

 

 

65

Table of Contents
http://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OperatingLeaseLiability
CHECK POINT SOFTWARE TECHNOLOGIES LTD. AND SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2022
IN U.S. DOLLARS
INDEX
 
    
Page
  
F-2 - F-6
  
F-7 - F-8
  
F-9
  
F-10
  
F-11
  
F-12 - F-13
  
F-14 - F-44
 
F-1
- - - - - - - - - -
 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of Check Point Software Technologies Ltd.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Check Point Software Technologies Ltd. and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of income, comprehensive income, changes in shareholders’ equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated April 27, 2023, expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
 
F-2

 
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Revenue from Contracts with Customers—Estimate of Standalone Selling Price
 
Description of the Matter
   
As described in Note 2 to the consolidated financial statements, the Company primarily derives revenues from sales of products and licenses, security subscriptions and software updates and maintenance. The Company’s contracts with customers often contain multiple goods and services which are accounted for as separate performance obligations when they are distinct. The Company allocates the transaction price to the distinct performance obligations on a relative standalone selling price.
 
Auditing the management’s determination of the standalone selling price required challenging and subjective auditor judgment due to the subjective assumptions used to establish the standalone selling price for each performance obligation. Standalone selling price for goods and services can evolve over time due to changes in the Company’s pricing practices that are influenced by intense competition, changes in demand for products and services, and economic factors, among others. This in turn led to significant auditor judgment, subjectivity and effort in performing procedures and evaluating audit evidence related to management’s determination of the standalone selling price.
How We Addressed the Matter in Our Audit
   
We obtained an understanding, evaluated the design and tested the operating effectiveness of the Company’s revenue process, including controls over the development and review of assumptions used to determine the standalone selling prices.
 
Our substantive audit procedures included testing management’s determination of standalone selling prices for each performance obligation, including, among others, assessing the appropriateness of the methodology applied, testing mathematical accuracy of the underlying data and evaluated the sources of the historical data and assumptions that the Company used by considering their reliability. We also performed sensitivity analyses over key assumptions to assess the impact on revenue recognition that could result from changes to the Company’s assumptions. We also evaluated the Company’s disclosures included in notes to the consolidated financial statements.
 
F-3

 
Uncertain Tax Positions
 
Description of the Matter
   
As discussed in Note 11 to the consolidated financial statements, the Company operates its business in various countries, and accordingly attempts to utilize an efficient operating model to structure its tax payments based on the laws in the countries in which the Company operates. This can cause disputes between the Company and various tax authorities in different parts of the world. The Company uses significant judgment in (1) determining whether a tax position’s technical merits are
more-likely-than-not
to be sustained and (2) measuring the amount of tax benefit that qualifies for recognition.
 
Auditing management’s analysis of the Company’s uncertain tax positions was especially subjective and complex due to the significant judgments made by management to determine the provisions for tax uncertainties. These provisions are based on interpretations of complex tax laws and determination of arm’s length pricing for certain intercompany transactions. The assumptions underlying the provisions for uncertain tax positions include the potential tax exposure resulting from management’s interpretations and the determination of the cumulative probability that the uncertain tax position will be upheld upon regulatory examination.
How We Addressed the Matter in Our Audit
   
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s process to assess and review their uncertain tax positions. For example, we tested the controls over the review of assumptions used in the estimation calculation such as the Company’s review over existing and potential tax controversies and tax audit results, and the computation of the impact to uncertain tax positions and tax reserves.
 
Our audit procedures included, among others, evaluating the assumptions the Company used to develop its uncertain tax positions and related unrecognized income tax benefit amounts by jurisdiction and testing the completeness and accuracy of the underlying data used by the Company to calculate its uncertain tax positions. Our audit procedures also included, with the assistance of our tax professionals, evaluating the technical merits of the Company’s tax positions and the amounts recorded for uncertain tax positions. This included assessing the Company’s correspondence with the relevant tax authorities and evaluating income tax opinions or other third-party advice obtained by the Company based on our knowledge of, and experience with, the application of international and local income tax laws by the relevant income tax authorities. We also evaluated the Company’s financial statement disclosures related to these tax matters.
/s/ KOST FORER GABBAY & KASIERER
A Member of EY Global
We have served as the Company’s auditor since 1994.
Tel-Aviv,
Israel
April 27, 2023
 
F-4

 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of Check Point Software Technologies Ltd.
Opinion on Internal Control Over Financial Reporting
We have audited Check Point Software Technologies Ltd. and subsidiaries’ internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Check Point Software Technologies Ltd. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related consolidated statements of income, comprehensive income, changes in shareholders’ equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes and our report dated April 27, 2023 expressed an unqualified opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
 
F-5

 
Definition and Limitation of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ KOST FORER GABBAY & KASIERER
A Member of EY Global
Tel-Aviv,
Israel
April 27, 2023
 
F-6
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
 
In millions
 
                 
    
December 31,
    
2022
  
2021
     
ASSETS
                 
     
CURRENT ASSETS:
                 
Cash and cash equivalents
    $ 196.0        $ 271.9     
Short-term bank deposits
      431.1       492.5  
Marketable securities
      1,010.5       929.3  
Trade receivables, net
      644.2       597.8  
Prepaid expenses and other assets
      50.0       46.4  
    
 
 
 
  
 
 
 
     
Total
current assets
      2,331.8       2,337.9  
    
 
 
 
  
 
 
 
     
LONG-TERM ASSETS:
                 
Marketable securities
      1,865.6       2,089.7  
Property and equipment, net
      82.8       83.4  
Deferred tax asset, net
      77.6       51.7  
Intangible assets, net
      58.8       61.0  
Goodwill
      1,236.7       1,196.2  
Other assets
      71.5       80.3  
    
 
 
 
  
 
 
 
     
Total
long-term assets
      3,393.0       3,562.3  
    
 
 
 
  
 
 
 
     
Total
assets
    $      5,724.8     $      5,900.2  
    
 
 
 
  
 
 
 
The accompanying notes are an integral part of the consolidated financial statements.
 
F-7
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (CONT’D)
 
In millions (except share and per share data)
 
    
December 31,
  
    
2022
    
2021
  
     
LIABILITIES AND SHAREHOLDERS’ EQUITY
                 
     
CURRENT LIABILITIES:
                 
Trade payables
    $ 29.6     $ 9.8  
Employees and payroll accruals
      223.7       206.3  
Deferred revenues
      1,363.4       1,257.4  
Accrued expenses and other liabilities
      222.5       238.6  
    
 
 
    
 
 
  
     
Total
current liabilities
      1,839.2       1,712.1  
    
 
 
    
 
 
  
     
LONG-TERM LIABILITIES:
                 
Deferred revenues
      514.4       449.7  
Income tax accrual
      419.7       454.9  
Other liabilities
      22.2       26.4  
    
 
 
    
 
 
  
     
Total
long-term liabilities
      956.3       931.0  
    
 
 
    
 
 
  
     
Total
liabilities
      2,795.5       2,643.1  
    
 
 
    
 
 
  
     
SHAREHOLDERS’ EQUITY:
                 
Ordinary shares, NIS 0.01 par value, 500,000,000 shares authorized at December 31, 2022 and 2021; 261,223,970 shares issued at December 31, 2022 and 2021; 120,761,971 and 129,065,690 shares outstanding at December 31, 2022 and 2021, respectively      0.8       0.8  
Additional
paid-in
capital
      2,500.7       2,276.7  
Treasury shares at cost, 140,462,677 and 132,181,781 ordinary shares at
December 31, 2022 and 2021, respectively
      (11,802.1 )      (10,550.7 ) 
Accumulated other comprehensive loss
      (97.9 )      (0.6 ) 
Retained earnings
      12,327.8       11,530.9  
    
 
 
    
 
 
  
     
Total
shareholders’ equity
      2,929.3       3,257.1  
    
 
 
    
 
 
  
     
Total
liabilities and shareholders’ equity
    $      5,724.8     $      5,900.2  
    
 
 
    
 
 
  
The accompanying notes are an integral part of the consolidated financial statements.
 
F-8
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
 
In millions (except share and per share data)
 
    
Year ended

December 31,
    
2022
  
2021
  
2020
Revenues:
                         
Products and licenses
    $ 554.9       $ 513.9       $ 513.6    
Security subscriptions
      858.0       755.2       671.1  
Software updates and maintenance
      917.0       897.7       880.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
Total
revenues
      2,329.9       2,166.8       2,064.9  
    
 
 
 
  
 
 
 
  
 
 
 
       
Operating expenses:
                         
Cost of products and licenses *)
      145.6       110.7       96.8  
Cost of security subscriptions *)
      41.4       35.9       26.4  
Cost of software updates and maintenance *)
      105.5       103.0       96.7  
Amortization of technology
      11.9       8.5       6.6  
    
 
 
 
  
 
 
 
  
 
 
 
       
Total
cost of revenues
      304.4       258.1       226.5  
       
Research and development
      349.9       292.7       252.8  
Selling and marketing
      675.2       597.8       569.9  
General and administrative
      116.1       110.7       111.5  
    
 
 
 
  
 
 
 
  
 
 
 
       
Total
operating expenses
      1,445.6       1,259.3       1,160.7  
    
 
 
 
  
 
 
 
  
 
 
 
       
Operating income
      884.3       907.5       904.2  
Financial income, net
      44.0       42.1       66.6  
    
 
 
 
  
 
 
 
  
 
 
 
       
Income before taxes on income
      928.3       949.6       970.8  
Taxes on income
      131.4       134.0       124.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
Net income
    $ 796.9     $ 815.6     $ 846.6  
    
 
 
 
  
 
 
 
  
 
 
 
       
Basic earnings per ordinary share
    $ 6.37     $ 6.13     $ 6.03  
Number of shares used in computing basic earnings per share
      125,205,504       133,121,763       140,495,886  
    
 
 
 
  
 
 
 
  
 
 
 
       
Diluted earnings per ordinary share
    $ 6.31     $ 6.08     $ 5.96  
Number of shares used in computing diluted earnings per share
      126,338,989       134,110,048       141,977,992  
    
 
 
 
  
 
 
 
  
 
 
 
 
*)
Not including amortization of technology shown separately.
The accompanying notes are an integral part of the consolidated financial statements.
 
F-9
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 
In millions (except per share data)
 
    
Year ended

December 31,
  
    
2022
     
2021
     
2020
  
       
Net income
      $  796.9        $  815.6        $  846.6  
    
 
 
     
 
 
     
 
 
  
       
Other comprehensive income (loss)
                           
       
Change in unrealized gains (losses) on marketable securities:
                           
Unrealized gains (losses) arising during the period, net of tax
      (93.4)        (38.5)        21.2  
Gains reclassified into earnings, net of tax
      *)        (1.7)        (3.4)  
    
 
 
     
 
 
     
 
 
  
       
       (93.4)        (40.2)        17.8  
    
 
 
     
 
 
     
 
 
  
       
Change in unrealized gains (losses) on cash flow hedges:
                           
Unrealized gains (losses) arising during the period, net of tax
      (25.4)        (0.1)        6.4  
Losses (gains) reclassified into earnings, net of tax
      21.5        (1.0)        (5.2)  
    
 
 
     
 
 
     
 
 
  
       
       (3.9)        (1.1)        1.2  
    
 
 
     
 
 
     
 
 
  
       
Other comprehensive income (loss), net of tax
      (97.3)        (41.3)        19.0  
    
 
 
     
 
 
     
 
 
  
       
Comprehensive income
      $      699.6        $      774.3        $      865.6  
    
 
 
     
 
 
     
 
 
  
*) Represents an amount lower than 0.1
The accompanying notes are an integral part of the consolidated financial statements.
 
F-10
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
 
In millions (except share and per share data)
 
                         
Accumulated
                
             
           
Additional
     
Treasury
     
other
            
Total
  
    
Ordinary
     
paid-in
     
shares
     
comprehensive
     
Retained
     
shareholders’
  
    
shares
     
capital
     
at cost
     
income (loss)
     
earnings
     
equity
  
Balance as of January 1, 2020
    $  0.8      $  1,770.3      $ (8,092.7)      $ 21.7      $ 9,868.7      $ 3,568.8  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
             
Issuance of treasury shares under stock purchase plans, upon exercise of options and vesting of restricted stock units (3,118,665 ordinary shares)
      -        145.4        71.4        -        -        216.8  
Treasury shares at cost (11,376,531 ordinary shares)
      -        -        (1,297.7)        -        -        (1,297.7)  
Stock-based compensation
      -        112.5        -        -        -        112.5  
Other comprehensive income, net of tax
      -        -        -        19.0        -        19.0  
Fair value of awards attributable to
pre-acquisition
services
      -        0.2        -        -        -        0.2  
Net income
      -        -        -        -        846.6        846.6  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
             
Balance as of December 31, 2020
    $ 0.8      $ 2,028.4      $ (9,319.0)      $ 40.7      $ 10,715.3      $ 3,466.2  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
             
Issuance of treasury shares under stock purchase plans, upon exercise of options and vesting of restricted stock units and performance share units (2,872,272 ordinary shares)
      -        126.2        67.8        -        -        194.0  
Treasury shares at cost (10,900,938 ordinary shares)
      -        -        (1,299.5)        -        -        (1,299.5)  
Stock-based compensation
      -        120.3        -        -        -        120.3  
Other comprehensive loss, net of tax
      -        -        -        (41.3)        -        (41.3)  
Fair value of awards attributable to
pre-acquisition
services
      -        1.8        -        -        -        1.8  
Net income
      -        -        -        -        815.6        815.6  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
             
Balance as of December 31, 2021
    $ 0.8      $ 2,276.7      $ (10,550.7)      $ (0.6)      $ 11,530.9      $ 3,257.1  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
             
Issuance of treasury shares under stock purchase plans, upon exercise of options and vesting of restricted stock units (2,094,108 ordinary shares)
      -        92.6        48.5        -        -        141.1  
Treasury shares at cost (10,324,181 ordinary shares)
      -        -        (1,299.9)        -        -        (1,299.9)  
Stock-based compensation
      -        131.4        -        -        -        131.4  
Other comprehensive loss, net of tax
      -        -        -        (97.3)        -        (97.3)  
Net income
      -        -        -        -        796.9        796.9  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
             
Balance as of December 31, 2022
    $       0.8      $     2,500.7      $   (11,802.1)      $         (97.9)      $     12,327.8      $          2,929.3  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
The accompanying notes are an integral part of the consolidated financial statements.
 
F-11
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
In millions
 
                         
    
Year ended

December 31,
    
2022
  
2021
  
2020
Cash flows from operating activities:
                         
       
Net income
    $ 796.9     $ 815.6     $ 846.6  
Adjustments required to reconcile net income to net cash provided by operating activities:
                         
Depreciation of property and equipment
      22.7       20.6       18.9  
Amortization of premium and accretion of discount on marketable securities, net
      18.5       21.0       9.4  
Realized gain on sale of marketable securities, net
      -       (1.4 )      (4.5 ) 
Amortization of intangible assets
      13.5       10.1       8.2  
Stock-based compensation
      131.4       120.3       112.5  
Deferred income tax expense (benefit)
      (0.5 )      (4.0 )      10.5  
Increase in trade receivables, net
      (46.1 )      (51.6 )      (45.0 ) 
Decrease in prepaid expenses and other assets
      0.1       1.2       20.2  
Increase (decrease) in trade payables
      19.8       (7.7 )      1.6  
Increase (decrease) in employees and payroll accruals
      26.3       (8.9 )      36.1  
Increase (decrease) in income tax accrual and accrued expenses and other liabilities
      (54.6 )      66.4       46.1  
Increase in deferred revenues
      170.3       216.8       95.2  
Other
      0.2       5.5       5.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
Net cash provided by operating activities
      1,098.5       1,203.9       1,161.0  
    
 
 
 
  
 
 
 
  
 
 
 
       
Cash flows from investing activities:
                         
       
Proceeds from short-term bank deposits
      538.4       214.5       -  
Proceeds from maturity of marketable securities
      1,056.6       1,551.7       2,299.7  
Proceeds from sale of marketable securities
      9.1       184.1       318.6  
Investment in marketable securities
      (1,063.1 )      (1,297.5 )      (2,460.2 ) 
Investment in short-term bank deposits
      (477.0 )      (492.5 )      (213.9 ) 
Cash paid in conjunction with acquisitions, net of acquired cash
      (48.3 )      (219.7 )      (23.1 ) 
Purchase of property and equipment
      (22.1 )      (15.9 )      (19.3 ) 
    
 
 
 
  
 
 
 
  
 
 
 
       
Net cash used in investing activities
    $ (6.4 )    $ (75.3 )    $ (98.2 ) 
    
 
 
 
  
 
 
 
  
 
 
 
*) Represents an amount lower than 0.1
The accompanying notes are an integral part of the consolidated financial statements.
 
F-12
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONT’D)
 
In millions
 
                         
    
Year ended

December 31,
    
2022
  
2021
  
2020
Cash flows from financing activities:
                         
       
Proceeds from issuance of treasury shares upon exercise of options
      $ 141.2       $ 194.0       $ 216.8  
Purchase of treasury shares at cost
      (1,299.9 )      (1,299.5 )      (1,297.7 ) 
Payments related to shares withheld for taxes
      (9.3 )      (6.9 )      (5.4 ) 
    
 
 
 
  
 
 
 
  
 
 
 
       
Net cash used in financing activities
      (1,168.0 )      (1,112.4 )      (1,086.3 ) 
    
 
 
 
  
 
 
 
  
 
 
 
       
Increase (decrease) in cash and cash equivalents
      (75.9 )      16.2       (23.5 ) 
Cash and cash equivalents at the beginning of the year
      271.9       255.7       279.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
Cash and cash equivalents at the end of the year
      $ 196.0       $ 271.9       $ 255.7  
    
 
 
 
  
 
 
 
  
 
 
 
       
Supplemental disclosure of cash flow information:
                         
       
Cash paid during the year for taxes on income
      $ 113.5     $ 101.0       $ 90.8  
    
 
 
 
  
 
 
 
  
 
 
 
       
Non-cash
investing activity
                         
       
Fair value of awards attributable to
pre-acquisition
services
      -       1.8       0.2  
Operating lease liabilities arising from obtaining right of use assets
      $ 8.0       $ 1.4       $ 10.3  
    
 
 
 
  
 
 
 
  
 
 
 
The accompanying notes are an integral part of the consolidated financial statements.
 
F-13
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 1:-
GENERAL
 
  a.
Check Point Software Technologies Ltd., an Israeli
corporation
(“Check Point Ltd.”), and subsidiaries (collectively, the “Company” or “Check
Point
”), develop, market and support wide range of products and services for IT security, by offering a multilevel security architecture that defends enterprises’ cloud, network and mobile device held information.
 
    
The Company operates in one operating and reportable segment and its revenues are mainly derived from the sales of its network and data security products, including licenses, related software updates, maintenance and security subscriptions. The Company sells its products worldwide primarily through multiple distribution channels (“channel partners”), including distributors, resellers, system integrators, Original Equipment Manufacturers (“OEMs”) and Managed Security Service Providers (“MSPs”).
 
  b.
During 2022, 2021 and 2020, approximately 40%, 40% and 39% of the Company’s revenues were derived from two channel partners, respectively. Revenues derived from one channel partner in 2022, 2021 and 2020 were 25%, 24% and 22%, respectively, and revenues derived from the other channel partner in 2022, 2021 and 2020 were 15%, 16%, and 17%, respectively, of the Company’s revenues in such years. Trade receivable balances from these two channel partners aggregated to $301.2 and $271.8 as of December 31, 2022 and 2021, respectively.
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES
The consolidated financial
statements
are prepared in
conformity
with United States generally accepted accounting principles (“U.S. GAAP”).
 
  a.
Use of estimates:
 
    
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
 
  b.
Financial statements in United States dollars:
 
    
Most of the Company’s revenues and costs are denominated in United States dollar (“dollar”). The Company’s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company’s functional and reporting currency.
 
    
Accordingly,
non-dollar
denominated transactions and balances have been
re-measured
into the functional currency in accordance with Accounting Standard Code (“ASC”) No. 830, “Foreign Currency M
a
tters”.
 
F-14
CHECK POINT SO
FT
WARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIA
L
STATEMENTS
 
In millions
(except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

   
All transaction gains and losses from the
re-measured
monetary balance sheet items are
reflected
in the
statements
of income as financial income or expenses, as appropriate.
 
  c.
Principles of consolidation:
 
   
The consolidated financial statements include the accounts of Check Point Ltd. and subsidiaries. Intercompany transactions and balances have been eliminated upon consolidation.
 
  d.
Cash equivalents:
 
   
Cash equivalents are short-term unrestricted highly liquid investments that are readily convertible to cash and with original maturities of three months or less at investment.
 
  e.
Short-term bank deposits:
 
   
Bank deposits with maturities of more than three months at investment but less than one year are included in short-term bank deposits. Such deposits are stated at cost which approximates fair values.
 
  f.
Trade Receivables:
 
   
Trade receivables are recorded net of credit losses allowance for any potential uncollectible amounts.
 
   
The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based upon its assessment of various factors, including historical collectability experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.
 
   
As of December 31, 2022 and 2021, the allowances for credit losses of trade receivable were insignificant.
 
   
The Company writes off receivables when they are deemed uncollectible, having exhausted all collection efforts. Actual collection experience may not meet expectations and may result in increased bad debt
expense
.
Allowance
for credit losses and total write offs expenses during 2022, 2021 and 2020 were insignificant.
 
F-1
5
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
  g.
Investments in marketable securities:
 
   
The Company accounts for investments in marketable securities in accordance with ASC No. 320, “Investments - Debt Securities”.
 
   
Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determinations at each balance sheet date. The Company classifies all of its debt securities as
available-for-sale
(“AFS”).
Available-for-sale
debt securities are carried at fair value, with the unrealized gains and losses, net of tax, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses on sale of investments are included in financial income, net and are derived using the specific identification method for determining the cost of securities sold.
 
   
The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization together with interest on securities is included in financial income, net.
 
   
At each reporting period, the Company evaluates whether declines in fair value below amortized cost are due to expected credit losses, as well as the company’s ability and intent to hold the investment until a forecasted recovery occurs in accordance with ASC 326, Financial Instrument- Credit losses. Allowance for credit losses on AFS debt securities are recognized in the Company’s consolidated statements of income, and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in stockholders’ equity.
 
   
No credit losses were recorded for the years ended December 31, 2022, 2021 and 2020.
 
  h.
Property and equipment, net:
 
   
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:
 
    
%
   
Computers and peripheral equipment
    33 – 50
Office furniture and equipment
    10 – 20
Building
    4
Leasehold improvements
    The shorter of term of the lease or the useful life of the asset
 
F-16
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
  i.
Leases:
The company’s operating leases comprised of office leases.
The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability or
right-of-use
(“ROU”) asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate
non-lease
components for its leases.
ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate on similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option. The ROU assets are included in Prepaid expenses and other assets in the consolidated balance sheet, while the short-term portion of lease liabilities are included in Accrued expenses and other liabilities, and the long-term portion of lease liabilities are included in Other liabilities.
As of December 31, 2022, the Company had total ROU assets of $20.8, with corresponding liabilities of $20.3 on the consolidated balance sheets.
Rent expenses for the years ended December 31, 2022, 2021 and 2020, were $6.3, $8.1 and $13.1 respectively.
 
  j.
Business combination:
The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill.
 
F-17
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks and tradenames from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred (see also Note 3).
 
  k.
Goodwill:
Goodwill has been recorded as a result of acquisitions. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable net tangible and intangible assets acquired. Goodwill is not amortized, but rather is subject to an impairment test.
ASC No. 350, “Intangibles - Goodwill and other” (“ASC No. 350”) requires goodwill to be tested for impairment at the reporting unit level at least annually or between annual tests in certain circumstances, and written down when impaired.
ASC No. 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the quantitative goodwill impairment test is performed. Alternatively, ASC No. 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment test. If the carrying value of a reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB Accounting Standards Update (“ASU”)
No. 2017-04,
Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment.
The Company operates in one operating segment, and this segment is the only reporting unit. The Company performs the quantitative goodwill impairment test during the fourth quarter of each fiscal year, or more frequently if impairment indicators are present and compares the fair value of the reporting unit with its carrying value.
During the years 2022, 2021 and 2020, no Goodwill impairment losses have been identified.
 
F-18
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
  l.
Intangible assets, net:
Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives, which range from 4 to 20 years. These intangible assets consist of core technology, customer relationship, trademarks and trade names which are amortized over their estimated useful lives.
 
  m.
Impairment of long-lived assets including intangible assets subject to amortization and ROU assets:
The Company’s long-lived assets are reviewed for impairment in accordance with ASC No. 360, “Property, Plant and Equipment,” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years 2022, 2021 and 2020, no impairment losses have been identified.
 
  n.
Manufacturing partner and supplier liabilities:
The Company purchases manufactured products from its original design manufacture (“ODM”). The Company generally does not own the manufactured products. ODM’s provide services of design, manufacture, orders fulfillment and support with a full
turn-key
solution to meet the Company’s detailed requirements. If the actual demand is significantly lower than forecast, the Company records a liability for its commitment in excess of the actual demand. As of December 31, 2022 and 2021, the Company has not accrued any significant liability in respect with this exposure.
 
  o.
Research and development costs:
Research and development costs are charged to the statements of income as incurred. ASC
No. 985-20,
“Software - Costs of Software to Be Sold, Leased, or Marketed”, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility.
Based on the Company’s product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release, have been insignificant. Therefore, all research and development costs are expensed as incurred.
 
F-19
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
  p.
Revenue recognition:
The Company derives its revenues mainly from sales of products and licenses, security subscriptions and software updates and maintenance. The Company’s products are generally integrated with software that is essential to the functionality of the product. The Company sells its products primarily through channel partners including distributors, resellers, OEMs (Original Equipment Manufacturers), system integrators and MSPs (Managed Service Providers), all of whom are considered
end-users.
The Company’s security subscriptions provide customers with access to its suite of security solutions and is sold as a service.
The Company’s software updates and maintenance provide customers with rights to unspecified software product upgrades released during the term of the agreement and include maintenance services to
end-user
customers, through primarily telephone access to technical support personnel as well as hardware support services.
The Company recognizes revenues in accordance with ASC No. 606, “Revenue from Contracts with Customers”. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation.
Revenues from sales of products and licenses are recognized when control of the promised goods is transferred to the customer, or upon electronic transfer of the Certificate Key to the Customer. Revenues from security subscriptions and from software updates and maintenance are recognized ratably over the term of the agreement.
The Company’s arrangements typically contain various combinations of its products and licenses, security subscriptions and software updates and maintenance, which are distinct and are accounted for as separate performance obligations. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price using the prices charged for a performance obligation when sold separately.
Deferred revenues represent mainly the unrecognized revenue billed for security subscriptions and for software updates and maintenance. Such revenues are recognized ratably over the term of the related agreement. The amount of revenues recognized in the period that was included in the opening deferred revenues balance was $1,257.4 and $1,108.6 for the year ended December 31, 2022 and December 31, 2021, respectively.
Revenues expected to be recognized from remaining performance obligations were $2,146.1 and $2,013.6 as of December 31, 2022 and December 31, 2021, respectively. Of the balance as of December 31, 2022 the Company expects to recognize approximately $1,437.3 over the next 12 months and the remainder thereafter.
 
F-20
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
The Company records a provision for estimated sales returns, rebates, stock rotations and other rights provided to customers on product and services based on historical sales returns, analysis of credit memo data, rebate plans, stock rotation arrangements and other known factors. This provision is accounted for as variable consideration that is deducted from revenue in the period in which the revenue is recognized. Such provision amounted to $9.5 and $10.4 as of December 31, 2022 and 2021, respectively, and is included in accrued expenses and other liabilities in the consolidated balance sheets.
Sales commissions earned by the Company’s sales force are considered incremental and recoverable costs of obtaining a contract with a customer. These costs are deferred and then amortized over a period of benefit which is typically over the term of the customer contracts as initial commission rates are commensurate with the renewal commission rates. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of income. If the amortization period of those costs is one year or less, the costs are expensed as incurred. As of December 31, 2022 and 2021, the amount of deferred commission was $15.3 and $17.1, respectively, and is included in other long term assets on the balance sheets. During the years ended on December 31, 2022, 2021 and 2020 the Company recorded amortization expenses in connection with deferred commissions in the amount of $10.4, $11.6 and $15.3, respectively.
For information regarding disaggregated revenues, please refer to Note 15 below.
 
  q.
Cost of revenues:
Cost of products and licenses is comprised of cost of software and hardware production, manuals, packaging and shipping.
Cost of security subscriptions is comprised of costs paid to third parties, hosting and infrastructure costs and costs of customer support related to these services.
Cost of software updates and maintenance is mainly comprised of cost of post-sale customer support.
Amortization of technology is comprised of amortization of core technology assets which are used in the Company’s operations, and is presented separately as part of cost of revenues.
 
F-21
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
  r.
Severance pay:
Effective January 1, 2007, the Company’s agreements with employees in Israel, are under Section 14 of the Severance Pay Law, 1963. The Company’s contributions for severance pay have extinguished its severance obligation. Upon contribution of the full amount based on the employee’s monthly salary for each year of service, no additional obligation exists regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheets, as the Company is legally released from the obligation to employees once the required deposit amounts have been paid.
 
  s.
Employee benefit plan:
The Company has a 401(K) defined contribution plan covering certain employees in the U.S. The Company matches 50% of employee contributions to the plan up to a limit of 6% of their eligible compensation. The Company’s matching contribution to the plan were insignificant for the years ended December 31, 2022, 2021 and 2020.
 
  t.
Income taxes:
The Company accounts for income taxes in accordance with ASC No. 740, “Income Taxes” (“ASC No. 740”). ASC No. 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined for temporary differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. The Company accrues interest and indexation related to unrecognized tax benefits on its taxes on income.
ASC No. 740 contains a
two-step
approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes.
The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
 
F-22
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
  u.
Advertising costs:
Advertising costs are expensed as incurred. Advertising expenses for the years ended December 31, 2022, 2021 and 2020, were $4.6, $4.1 and $3.7 respectively.
 
  v.
Concentrations of credit risk:
Financial instruments that could potentially expose the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, short-term bank deposits, marketable securities, trade receivables and foreign currency derivative contracts.
The majority of the Company’s cash and cash equivalents and short-term bank deposits are deposited in major banks in the U.S., Israel and Europe. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions. Marketable securities are held mainly by Check Point Ltd., the Company’s Singaporean subsidiary, Canadian subsidiary and the U.S. subsidiary, and are invested in securities denominated in US dollar.
The Company’s marketable securities consist of investments in government, corporate and government sponsored enterprises debentures. The Company’s investment policy, approved by the Board of Directors, limits the amount that the Company may invest in any one type of investment, or issuer, thereby reducing credit risk concentrations.
The Company’s trade receivables are geographically dispersed and derived from sales to channel partners mainly in the United States, Europe and Asia. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures.
 
  w.
Derivatives and hedging:
The Company accounts for derivatives and hedging based on ASC No. 815, “Derivatives and Hedging” (“ASC No. 815”). ASC No. 815 requires the Company to recognize all derivatives on the balance sheets at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, as well as the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. If the derivatives meet the definition of a hedge and are designated as such, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in accumulated other comprehensive income until the hedged item is recognized in earnings.
 
F-23
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
The Company entered into forward contracts to hedge the fair value of assets and liabilities denominated in several foreign currencies. As of December 31, 2022 and 2021, the Company had outstanding forward contracts that did not meet the requirement for hedge accounting, in the notional amount of $207.9 and $171.1, respectively. The Company measured the fair value of the contracts in accordance with ASC No. 820, “Fair Value Measurement” (“ASC No. 820”) (classified as level 2 of the fair value hierarchy). The net gains (losses) resulting from these forward contracts recognized in financial income, net during 2022, 2021 and 2020 were $(19.5), $(0.6) and $24.8, respectively. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant.
The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekel, in Euro, and in British Pound. As of December 31, 2022 and 2021, the Company had outstanding forward contracts for payroll and related expenses in the notional amount of $266.2 and $155.0, respectively. These contracts were for a period of up to twelve months.
The Company measured the fair value of the contracts in accordance with ASC No. 820 (classified as level 2 of the fair value hierarchy). These contracts met the requirement for cash flow hedge accounting and, as such, gains (losses) on the contracts are recognized initially as component of Accumulated Other Comprehensive Income in the balance sheets and reclassified to the statements of income in the period the related hedged items affect earnings.
During 2022, 2021 and 2020 gains (losses) in the amount of $(24.4), $1.1 and $5.9, respectively, were reclassified when the related expenses were incurred and recognized in operating expenses. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant.
 
  x.
Basic and diluted earnings per share:
Basic earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year. Diluted earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year, plus dilutive potential ordinary shares outstanding during the year, in accordance with ASC No. 260, “Earnings Per Share”.
The total weighted average number of shares related to the outstanding options excluded from the calculations of diluted earnings per share, since it would have an anti-dilutive effect, was 1.7, 4.9 and 6.2 for 2022, 2021 and 2020, respectively.
 
F-24
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
  y.
Accounting for stock-based compensation:
The Company accounts for stock-based compensation in accordance with ASC No. 718, “Compensation-Stock Compensation” (“ASC No. 718”). ASC No. 718 requires companies to estimate the fair value of equity-based payment awards on the grant date using an option-pricing model.
The Company recognizes compensation expenses for the value of awards granted, based on the straight line method for service based awards and based on the accelerated method for performance-based awards. Compensation expense is recognized over the requisite service period of the awards. The Company recognizes forfeitures of awards as they occur.
The Company selected the Black-Scholes-Merton option pricing model as the most appropriate model for determining the fair value for its stock options awards and Employee Stock Purchase Plan, whereas the fair value of restricted stock units is based on the closing market value of the underlying shares at the date of grant. The option-pricing model requires a number of assumptions, the most significant of which are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options.
The expected term of options granted is based upon historical experience and represents the period of time between when the options are granted and when they are expected to be exercised. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term to the expected term of the options. The Company has historically not paid dividends and has no plans to pay dividends in the foreseeable future.
The fair value of options granted and Employee Stock Purchase Plan in 2022, 2021 and 2020 is estimated at the date of grant using the following weighted average assumptions:
 
    
        Year ended December 31,        
       
    
        2022        
  
        2021        
  
        2020        
       
Employee Stock Options
             
Expected volatility
    25.56%   25.28%   23.63%
Risk-free interest rate
    3.16%   0.65%   0.32%
Dividend yield
    0.0%   0.0%   0.0%
Expected term (years)
    4.75   4.22   4.15
       
Employee Stock Purchase Plan
             
       
Expected volatility
    22.16%   22.44%   36.58%
Risk-free interest rate
    2.56%   0.24%   0.05%
Dividend yield
    0.0%   0.0%   0.0%
Expected term (years)
    0.5   0.5   0.5
 
F-25
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
  z.
Fair value of financial instruments:
The Company measures its investments in money market funds (classified as cash equivalents), short-term bank deposits, marketable securities and its foreign currency derivative contracts at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:
 
  Level 1 -
Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
 
  Level 2 -
Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
 
  Level 3 -
Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
 
  aa.
Comprehensive income:
The Company accounts for comprehensive income in accordance with ASC No. 220, “Comprehensive Income”. Comprehensive income generally represents all changes in shareholders’ equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on hedging derivative instruments and unrealized gains and losses on
available-for-sale
debt securities.
 
  ab.
Treasury shares:
The Company repurchases its ordinary shares from time to time on the open market and holds such shares as treasury shares. The Company presents the cost to repurchase treasury stock as a separate component of shareholders’ equity.
The Company reissues treasury shares under the stock purchase plan, upon exercise of options and upon vesting of restricted stock units. Reissuance of treasury shares is accounted for in accordance with ASC
No. 505-30
whereby gains are credited to additional
paid-in
capital and losses are charged to additional
paid-in
capital to the extent that previous net gains are included therein; otherwise to retained earnings.
 
F-26
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
 
  ac.
Legal contingencies:
The Company is currently involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss.
 
  ad.
Recently Adopted Accounting Pronouncements:
The Company has reviewed recent accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on the consolidated financial statements as a result of their future adoption.
 
NOTE 3:-
ACQUISITIONS
 
  a.
On September 17, 2020 the Company completed the acquisition of all outstanding shares of Odo Security Ltd., a privately-held Israeli-based company, and a developer of a cloud-based, clientless Secure Access Service Edge (SASE) technology that delivers secure remote access.
 
  b.
On September 1, 2021, the Company completed the acquisition of all outstanding shares of Avanan Inc. (“Avanan”), a privately-held
US-based
company providing cloud email security, and the developer of a patented application-programming interface (API) solution to stop email threats before arriving to the inbox (inline), for both internal and external emails using AI based engines. The Company acquired Avanan for total consideration of approximately $227.1.
 
  c.
On February 3, 2022, the Company completed the acquisition of all outstanding shares of Spectral Cyber Technologies Ltd. (“Spectral”), a privately-held Israeli-based company, is a key innovator in developer security with a thriving open-source community. Spectral’s developer-first approach to security focuses on code safety and trust, fast code scanning and simple and cool developer experience.
The Company accounted for this transaction as a business combination and allocated the purchase consideration to tangible and intangible assets acquired and liabilities assumed based on their estimated fair values.
In addition, the transactions included additional consideration related to compensation for post combination services which were recorded as prepaid expenses and other long term assets and will be recognized over the requisite service period.
 
F-27
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 4:-
CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES
 
    
December 31,
  
    
2022
     
2021
  
Cash and cash equivalents:
                  
Cash
    $ 65.8          $ 170.8      
Money market funds
      95.5            6.6      
Short term deposits
      34.7            94.5      
    
 
 
     
 
 
  
     
Total Cash and cash equivalents
      196.0            271.9      
     
Short-term bank deposits:
      431.1            492.5      
Marketable securities:
                  
Government and corporate debentures - fixed interest rate
      2,025.8            2,262.5      
Government-sponsored enterprises debentures
      755.0            641.4      
Government and corporate debentures - floating interest rate
      95.3            115.1      
    
 
 
     
 
 
  
Total Marketable securities
      2,876.1            3,019.0      
Total Cash and cash equivalents, short-term bank deposits and marketable securities
    $     3,503.2          $     3,783.4      
    
 
 
     
 
 
  
The gross unrealized gains on the Company’s marketable securities were $0.1 and $14.2 as of December 31, 2022 and 2021, respectively. The gross unrealized losses on the Company’s marketable securities were $123.4 and $15.7 as of December 31, 2022 and 2021, respectively. From the total of $123.4 unrealized losses as of December 31, 2022, $87.3 was in continuous unrealized loss for more than 12 months. The unrealized losses are mainly driven by the higher interest rate environment and the recent interest rate hikes by global central banks during 2022, which was due mainly to elevated inflation rates, therefore negatively impacted the fair value of securities in our portfolio, and increased the unrealized
The following table classifies the Company’s marketable securities by contractual maturities:
 
    
December 31,
  
    
2022
     
2021
  
    
Fair Value
     
Amortized

Cost
     
Fair Value
     
Amortized

Cost
  
Contractual maturity year:
                                    
Within one year
    $ 1,010.5       $ 1,024.9      $ 929.3       $ 925.8   
After one year through five years
      1,865.6         1,974.5        2,089.7         2,094.7   
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
    $     2,876.1       $     2,999.4      $     3,019.0       $     3,020.5   
    
 
 
     
 
 
     
 
 
     
 
 
  
As of December 31, 2022 and 2021, interest receivable amounted to $15.6 and $15.3, respectively, and is included within prepaid expenses and other assets in the balance sheets.
 
F-28
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 5:-
FAIR VALUE MEASUREMENTS
In accordance with ASC No. 820, the Company measures its money market funds, short-term bank deposits, marketable securities and foreign currency derivative contracts at fair value. Money market funds and marketable securities are classified within Level 1 or Level 2. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments.
The Company’s financial assets measured at fair value on a recurring basis, excluding accrued interest components, consisted of the following types of instruments as of the following dates:
 
    
December 31,
  
    
2022
     
2021
  
    
Fair value measurements using input type
     
Fair value measurements using input type
  
    
Level 1
     
Level 2
     
Total
     
Level 1
     
Level 2
     
Total
  
Cash
    $ 65.8      $ -        $ 65.8      $ 170.8      $ -        $ 170.8  
Cash equivalents
                                                      
Money market funds
      95.5     
-          95.5        6.6        -          6.6  
Short term deposits
      34.7        -          34.7        94.5        -          94.5  
Short-term bank deposits
      431.1        -          431.1        492.5        -          492.5  
Marketable securities:
                                                      
Government and corporate debentures-fixed interest rate
      -          2,025.8        2,025.8        -          2,262.5        2,262.5  
Government-sponsored enterprises debentures
      -          755.0        755.0        -          641.4        641.4  
Government and corporate debentures - floating interest rate
      -          95.3        95.3        -          115.1        115.1  
Foreign currency derivative contracts
      -          (3.6)        (3.6)        -          0.7        0.7  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Total financial assets
    $     627.1      $     2,872.5      $     3,499.6      $     764.4      $     3,019.7      $     3,784.1  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
 
NOTE 6:-
PROPERTY AND EQUIPMENT, NET
 
    
December 31,
    
2022
   
2021
Cost:
                  
Computers and peripheral equipment
    $ 78.1        $ 66.8    
Office furniture and equipment
      7.8          7.4    
Building
      78.7          78.5    
Leasehold improvements
      30.9          28.5    
    
 
 
 
   
 
 
 
     
       195.5              181.2    
Accumulated depreciation
          112.7          97.8    
    
 
 
 
   
 
 
 
     
Property and equipment, net
    $ 82.8        $ 83.4    
    
 
 
 
   
 
 
 
 
F-29
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 7:-
GOODWILL AND INTANGIBLE ASSETS, NET
 
  a.
Goodwill:
 
    
    2022    
     
    2021    
  
Balance as of January 1
    $ 1,196.2      $ 1,002.2  
Acquisitions
      40.5        194.0  
    
 
 
     
 
 
  
Balance as of December 31
    $     1,236.7      $     1,196.2  
    
 
 
     
 
 
  
 
  b.
Intangible assets, net:
 
    
Useful
     
December 31,
    
Life
     
2022
  
2021
Original amount:
                          
Core technology
      8      $ 93.5       $ 82.2    
Trademarks and trade names
      15 – 20        25.5       25.5  
Customer relationship
      4        5.8       5.8  
             
 
 
 
  
 
 
 
       
                124.8       113.5  
             
 
 
 
  
 
 
 
       
Accumulated amortization:
                          
Core technology
               39.6       28.0  
Trademarks and trade names
               24.5       24.0  
Customer relationship
               1.9       0.5  
             
 
 
 
  
 
 
 
       
                66.0       52.5  
             
 
 
 
  
 
 
 
       
Intangible assets, net:
                          
Core technology
               53.9       54.2  
Trademarks and trade names
               1.0       1.5  
Customer relationship
               3.9       5.3  
             
 
 
 
  
 
 
 
       
              $         58.8     $         61.0  
             
 
 
 
  
 
 
 
Intangible assets which were fully amortized as of the prior year, are disposed from the original amount and the accumulated amortization balances.
The estimated future amortization expense of Intangible assets as of December 31, 2022 is as follows:
 
2023
    $ 11.9      
2024
      11.5      
2025
      11.1      
2026
      9.1      
2027
      6.3      
Thereafter
      8.9      
    
 
 
  
     $         58.8      
    
 
 
  
 
F-30
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 8:-
DEFERRED REVENUES
Deferred revenues consisted of the following:
 
                                           
    
December 31,
  
    
2022
     
2021
  
     
Security subscriptions
   
$
932.1
 
   
$
801.1
 
Software updates and maintenance
   
 
904.7
 
   
 
869.2
 
Other
   
 
41.0
 
   
 
36.8
 
    
 
 
     
 
 
  
     
    
$
    1,877.8
 
   
$
    1,707.1
 
    
 
 
     
 
 
  
The majority of the deferred revenues are recognized within one year or less and presented as current deferred revenues in the balance sheets. Substantially all of the remaining deferred revenues are presented as long term deferred revenues and are recognized for a period greater than one year and up to five years.
 
NOTE 9:-
ACCRUED EXPENSES AND OTHER LIABILITIES
The components of accrued expenses and other liabilities are as follows:
 
                                           
    
December 31,
    
2022
   
2021
     
Accrued products and licenses costs
   
$
84.4
 
   
$
102.5
 
Marketing expenses payable
   
 
8.7
 
   
 
9.8
 
Income tax payable
   
 
34.3
 
   
 
28.1
 
Legal accrual
   
 
32.0
 
   
 
39.5
 
Other accrued expenses
   
 
63.1
 
   
 
58.7
 
    
 
 
 
   
 
 
 
     
    
$
       222.5
 
   
$
       238.6
 
    
 
 
 
   
 
 
 
 
F-31
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 10:-
COMMITMENTS AND CONTINGENT LIABILITIES
 
  Litigations:
 
 
  a.
The Company is the defendant in various lawsuits, including employment-related litigation claims, construction claims and other legal proceedings in the normal course of its business. Litigation and governmental proceedings can be expensive, lengthy and disruptive to normal business operations, and can require extensive management attention and resources, regardless of their merit. While the Company intends to defend the aforementioned matters vigorously, it believes that a loss in excess of its accrued liability with respect to these claims is not probable.
 
  b.
In particular, following audits of our 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued in January 2023 orders for the years 2016 through 2019 challenging our positions on several issues, including matters such as our position to claim a tax credit made for foreign taxes withheld on income payments that was due to the Company outside of Israel, taxation of interest earned outside of Israel by a wholly-owned Singapore subsidiary which the ITA is seeking to tax in Israel and deductibility of expenses attributed to employee stock options. The ITA orders also contest the Company’s positions on various other issues. The ITA therefore demanded the payment of additional taxes in the aggregate amount of NIS 428 million (approximately $122 million), not including an amount of NIS 418 million (approximately $119 million) related to expenses that will be deductible in future years , with respect of these four tax years (these amounts include interest through December 31, 2022). We believe we have good arguments against these orders and intend to file an appeal.
In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes in the aggregate amount of NIS 74 million (approximately $21 million), not including an amount of NIS 94 million (approximately $27 million) related to expenses that will be deductible in future years, respect to this year (these amounts include interest t
hrou
gh December 31, 2022). There can be no assurance that the ITA will accept the Company’s positions on the matters raised and, if it does not, the ITA may also issue an order with respect to the 2020 tax year.
 
NOTE 11:-
TAXES ON INCOME
 
  a.
Israeli taxation:
 
  1.
Corporate tax:
Pursuant to Amendment 73 to the Investment Law adopted in 2017, a Company located in the Center of Israel that meets the conditions for “Preferred Technological Enterprises”, is subject to tax rate of 12%. The Company believes it meets those conditions.
Income not eligible for Preferred Enterprise benefits is taxed at a regular rate of 23%.
Reduced income under the Investment Law including the Preferred Enterprise Regime and Preferred Technological Enterprise Regime will be freely distributable as dividends, subject to a 15% or 20% withholding tax (or lower rate for
non-Israeli
resident shareholder, under an applicable tax treaty). However, upon the distribution of a dividend from Preferred Income and Technological Preferred Enterprise to an Israeli company, no withholding tax will be remitted.
 
F-32
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 11:-
TAXES ON INCOME (Cont.)
 
Pursuant to a temporary tax relief initiated by the Israeli government, a company that elected by November 11, 2013, to pay a reduced corporate tax rate as set forth in the temporary tax relief with respect to undistributed exempt income generated under the Investment Law accumulated by the Company until December 31, 2011 (“Trapped Earnings”) is entitled to distribute a dividend from such income without being required to pay additional corporate tax with respect to such dividend. A company that has so elected must make certain qualified investments in Israel over five-year period. A company that has elected to apply the temporary tax relief cannot withdraw from its election. The Company has elected to apply the temporary tax relief by the respective date and believes it meets those conditions.
In particular, following audits of our 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued in January 2023 orders for the years 2016 through 2019 challenging our positions on several issues, including matters such as our position to claim a tax credit made for foreign taxes withheld on income payments that was due to the Company outside of Israel, taxation of interest earned outside of Israel by a wholly-owned Singapore subsidiary which the ITA is seeking to tax in Israel and deductibility of expenses attributed to employee stock options. The ITA orders also contest the Company’s positions on various other issues. The ITA therefore demanded the payment of additional taxes in the aggregate amount of NIS 428 million (approximately $122 million), not including an amount of NIS 418 million (approximately $119 million) related to expenses that will be deductible in future years, with respect of these four tax years (these amounts include interest through December 31, 2022). We believe we have good arguments against these orders and intend to file an appeal. In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes in the aggregate amount of NIS 74 million (approximately $21 million), not including an amount of NIS 94 million (approximately $27 million) related to expenses that will be deductible in future years, with respect to this year (these amounts include interest through December 31, 2022). There can be no assurance that the ITA will accept the Company’s positions on the matters raised and, if it does not, the ITA may also issue an order with respect to the 2020 tax year.
Company’s tax assessments through 2015 tax year are considered final.

 
  2.
Foreign Exchange Regulations:
Under the Foreign Exchange Regulations, Check Point Ltd. and its Israeli subsidiaries calculate their tax liability in dollar according to certain orders.
The tax liability, as calculated in dollar is translated into New Israeli Shekels according to the exchange rate as of December 31 of each year.
 
  b.
Income taxes of
non-Israeli
subsidiaries:
Non-Israeli
subsidiaries are taxed according to the tax laws in their respective countries of residence.
The Company does not provide deferred tax liabilities when it intends to reinvest earnings of foreign subsidiaries indefinitely or if distributed, no tax liability will be imposed. Undistributed earnings of foreign subsidiaries that are not distributed amounted to $450.3 and unrecognized deferred tax liability related to such earning amounted to $73.9 as of December 31, 2022.
 
F-33
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 11:-
TAXES ON INCOME (Cont.)
 
  c.
Deferred tax assets and liabilities:
Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. As of December 31, 2022 and 2021, the Company’s deferred taxes were in respect of the following:
 
    
December 31,
    
2022
  
2021
Carry forward tax losses
    $ 38.7     $ 83.7  
Employee stock based compensation
      34.9       29.2  
Deferred revenues
      3.5       5.6  
Tax credits
      29.8       23.9  
Unrealized gains on marketable securities, net
      29.6       1.2  
Accrued employee costs
      8.1       10.3  
Other
      16.3       18.4  
    
 
 
 
  
 
 
 
     
Deferred tax assets before valuation allowance
      160.9       172.3  
Valuation allowance – mainly in respect to carryforward losses
      (17.5 )      (56.7 ) 
    
 
 
 
  
 
 
 
     
Deferred tax asset
      143.4       115.6  
    
 
 
 
  
 
 
 
Intangible assets
      (32.8 )      (31.3 ) 
Undistributed earnings of subsidiary
      (9.9 )      (9.9 ) 
Other
      (6.5 )      (8.1 ) 
    
 
 
 
  
 
 
 
     
Deferred tax liability
      (49.2 )      (49.3 ) 
    
 
 
 
  
 
 
 
     
Deferred tax asset, net
    $       94.2     $       66.3  
    
 
 
 
  
 
 
 
*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset.
Through December 31, 2022, the U.S. subsidiaries had a U.S. federal loss carry-forward of approximately $126.7 expiring gradually beginning 2023 mainly resulting from tax benefits related to employees’ stock option exercises that can be carried forward and offset against taxable income. Through December 31, 2022, the U.S. subsidiaries had a U.S. state net loss carry forward of approximately $80.3, expiring gradually beginning 2023 and is subject to limitation on their utilization.
 
F-34
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 11:-
TAXES ON INCOME (Cont.)
 
Through December 31, 2022, the U.S. subsidiaries had federal and states research and development tax credits of approximately $25.6, which expire between fiscal years 2023 and fiscal 2042 and are subject to limitations on their utilization.
 
  d.
Income before taxes on income is comprised as follows:
 
    
Year ended

December 31,
  
    
2022
     
2021
     
2020
  
       
Domestic
      $ 897.4        $ 917.9        $ 896.8  
Foreign
      30.9        31.7        74.0  
    
 
 
     
 
 
     
 
 
  
       
       $      928.3        $      949.6        $      970.8  
    
 
 
     
 
 
     
 
 
  
 
  e.
Taxes on income are comprised of the following:
 
    
Year ended

December 31,
    
2022
  
2021
  
2020
       
Domestic taxes:
                         
Current
      $ 117.7       $ 130.9       $ 112.0  
Deferred
      (1.3 )      (1.1 )      0.8  
    
 
 
 
  
 
 
 
  
 
 
 
       
       116.4       129.8       112.8  
    
 
 
 
  
 
 
 
  
 
 
 
Foreign taxes:
                         
Current
      12.7       7.1       1.7  
Deferred
      2.3       (2.9 )      9.7  
    
 
 
 
  
 
 
 
  
 
 
 
       
       15.0       4.2       11.4  
    
 
 
 
  
 
 
 
  
 
 
 
       
Taxes on income
      $     131.4       $     134.0       $     124.2  
    
 
 
 
  
 
 
 
  
 
 
 
 
  f.
The Company operates its business in various countries, and accordingly attempts to utilize an efficient operating model to structure its tax payments based on the laws in the countries in which the Company operates. This can cause disputes between the Company and various tax authorities in different parts of the world.
 
F-35
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 11:-
TAXES ON INCOME (Cont.)
 
A reconciliation of the beginning and ending amount of unrecognized tax benefits related to uncertain tax positions is as follows:
 
    
December 31,
    
2022
  
2021
     
Beginning balance
    $       469.5     $       442.8  
Increases (decreases) related to tax positions taken during prior years
      (85.4 )      47.2  
Decreases related to statute of limitations
      -       (77.2 ) 
Increases related to tax positions taken during the current year
      52.2       56.7  
    
 
 
 
  
 
 
 
     
Ending balance
    $ *)436.3     $ *)469.5  
    
 
 
 
  
 
 
 
*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset.
Substantially all the balance of unrecognized tax benefits, if recognized, would reduce the Company’s annual effective tax rate.
The Company adjusts the unrecognized tax benefit liability and income tax expense in the period in which the uncertain tax position is effectively settled, the statute of limitations expires or when new information is available. There is a reasonable possibility that a portion of the unrecognized tax benefit liability will be adjusted within 12 months due to statute of limitations. An estimate of the range of the statute of limitations amount cannot be made since the relevant years are subject to the ITA orders (refer also to footnote 10b).
During the years ended December 31, 2022, 2021 and 2020, the Company recorded $15.9, $9.7 and $(0.6), respectively for interest expense (income) related to uncertain tax positions. As of December 31, 2022 and 2021, the Company had accrued interest liability related to uncertain tax positions in the amounts of $60.0 and $44.1, respectively, which is included within income tax accrual on the balance sheets. The Company did not accrue penalties during the years ended December 31, 2022, 2021 and 2020.
The Company files federal and state income tax returns in the U.S. All of the U.S subsidiaries’ tax years are subject to examination by the U.S. federal and most U.S. state tax authorities due to their carry-forward tax losses and overall credit carry-forward position, except for Check Point Software Technologies Inc. that the assessment statue period for tax years throughout 2017 have expired.
The Company believes that it has adequately provided for any reasonably foreseeable outcomes related to tax audits and settlement. The final tax outcome of its tax audits could be different from that which is reflected in the Company’s income tax provisions and accruals. Such differences could have a material effect on the Company’s income tax provision and net income in the period in which such determination is made. The Company believes it had adequately provided for all of its uncertain tax positions, including those items currently under dispute.
 
F-36
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 11:-
TAXES ON INCOME (Cont.)
 
  g.
Reconciliation of the theoretical tax expenses:
Reconciliation between the theoretical tax expenses, assuming all income is taxed at the statutory rate in Israel and the actual income tax as reported in the statements of income is as follows:
 
    
Year ended December 31,
    
2022
  
2021
  
2020
       
Income before taxes as reported in the statements of income
    $       928.3     $       949.6     $       970.8  
    
 
 
 
  
 
 
 
  
 
 
 
       
Statutory tax rate in Israel
      23 %      23 %      23 % 
       
Decrease in taxes resulting from:
                         
Effect of “Preferred Enterprise” status *)
      (13 %)      (11 %)      (11 %) 
Others, net
      4 %      2 %      1 % 
    
 
 
 
  
 
 
 
  
 
 
 
       
Effective tax rate
      14 %      14 %      13 % 
    
 
 
 
  
 
 
 
  
 
 
 
       
*)   Basic earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status
    $ 0.95     $ 0.80     $ 0.73  
    
 
 
 
  
 
 
 
  
 
 
 
       
*)   Diluted earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status
    $ 0.94     $ 0.80     $ 0.72  
    
 
 
 
  
 
 
 
  
 
 
 
 
NOTE 12:-
SHAREHOLDERS’ EQUITY
 
  a.
General:
Ordinary shares confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends if declared.
 
F-37
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except share and per share data)
 
NOTE 12:-
SHAREHOLDERS’ EQUITY (Cont.)
 
  b.
Share repurchase:
On February 13, 2023 the Company announced the expansion of the Company’s
on-going
share repurchase program by an additional $2,000. Under the share repurchase program, as extended, the Company is authorized to continue to repurchase up to $325 each quarter.
As of December 31, 2022, the Company repurchased ordinary shares for an aggregate amount of $13,085.1. During 2022, 2021 and 2020 the Company repurchased 10,324,181, 10,900,938, and 11,376,531 shares for an aggregate amount of $1,299.9, $1,299.5 and $1,297.7, respectively.
 
  c.
Stock Options, RSUs and PSUs:
In 2005, the Company adopted two new equity incentive plans, which were subsequently amended in January 2014 and in July 2018: the 2005 United States Equity Incentive Plan and the 2005 Israel Equity Incentive Plan together are referred to as the Equity Incentive Plans.
Under the Equity Incentive Plans, the Company may grant options to employees, officers and directors at an exercise price equal to at least the fair market value of the ordinary shares at the date of grant and are granted for periods not to exceed seven years. The Company grants under the Equity Incentive Plans options, Restricted Stock Units (“RSUs”) and Performance stock units (“PSUs”) and can also grant a variety of other equity incentives. Options granted under the Equity Incentive Plans generally vest over a period of four years of employment. Options, RSUs and PSUs that are cancelled or forfeited before expiration become available for future grants. RSUs generally vest over a four years period of employment from the grant date while PSUs generally vest over a two to four years period of employment from the grant date. PSUs are subject to certain performance criteria; accordingly, compensation expense is recognized for such awards when it becomes probable that the related performance condition will be satisfied.
Under the Equity Incentive Plans, the Company’s
non-employee
directors receive on an annual basis options and RSUs grant. Following the amendments to the Equity Incentive Plans in July 2018, commencing December 31, 2018, on December 31st of each year, the number of Reserved and Authorized Shares (as defined below) under both Equity Incentive Plans together shall be annually reset on such date to equal 10% of the sum of (i) the number of ordinary shares issued and outstanding on such date and (ii) the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding awards granted under the Equity Incentive Plans as of such date (provided, however, that in no event shall the number of Reserved and Authorized Shares be less than the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding awards granted under the Equity Incentive Plans as of such date).
 
F-38
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except share and per share data)
 
NOTE 12:-
SHAREHOLDERS’ EQUITY (Cont.)
 
The number of “Reserved and Authorized Shares” under the Equity Plans shall equal the sum of (i) the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding options, RSUs, PSUs and other awards granted under the Equity Incentive Plans as of such date, and (ii) the number of ordinary shares reserved, authorized and available for issuance under the Equity Incentive Plans on such date.
As of December 31, 2022, the number of Reserved and Authorized Shares under the Equity Incentive Plans is as detailed below:
 
         
        
Stock Options outstanding
      7,778,108  
RSU outstanding
   
 
2,219,853
 
PSU outstanding
   
 
188,493
 
Ordinary shares available for issuance under the Equity Incentive Plans
   
 
2,905,777
 
    
 
 
 
Total Reserved and Authorized Shares as of December 31, 2022
   
 
13,092,231
 
    
 
 
 
As of December 31, 2022 the aggregate number of shares, stock options, RSU and PSU outstanding is 130,948,425.
A summary of the Company’s stock option activity and related information is as follows:
 
    
  Number of  
options
  
    Weighted    

average

exercise

price
     
    Aggregate    

intrinsic

value
  
                           
    
2022
       
Outstanding at beginning of year
      8,160,625     $ 113.06      $ 37.1  
Granted
      710,000     $ 125.54           
Exercised
      (1,009,329 )    $ 99.89           
Forfeited
      (83,188 )    $ 122.41           
    
 
 
 
  
 
 
     
 
 
  
       
Outstanding at December 31, 2022
      7,778,108     $ 115.05      $ 82.5  
    
 
 
 
  
 
 
     
 
 
  
       
Exercisable at December 31, 2022
      5,666,608     $ 114.61      $ 65.4  
    
 
 
 
  
 
 
     
 
 
  
The weighted average fair values at grant date of options granted for the years ended December 31, 2022, 2021 and 2020 with an exercise price equal to the market value at the date of grant were $34.6, $25.9 and $22.0 per share, respectively.
The total intrinsic value of options exercised during the years 2022, 2021 and 2020 was $32.9, $65.1 and $81.7, respectively.
 
F-39
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except share and per share data)
 
NOTE 12:-
SHAREHOLDERS’ EQUITY (Cont.)
 
The aggregate intrinsic value of the outstanding stock options as of December 31, 2022 and 2021, represents the intrinsic value of 7,651,858 and 6,484,417 outstanding options that are
in-the-money
as of such dates. The remaining 126,250 and 1,676,208 outstanding options are
out-of-the-money
as of December 31, 2022 and 2021, and their intrinsic value was considered as zero.
A summary of the Company’s RSUs and PSUs activity is as follows:
 
    
Year ended

December 31, 2022
    
    RSUs    
  
    PSUs    
  
    Total    
       
Unvested at beginning of year
      2,231,167       105,595       2,336,762  
Granted
      958,157       160,423       1,118,580  
Vested
      (706,738)       (5,799)       (712,537)  
Forfeited
      (262,733)       (71,726)       (334,459)  
    
 
 
 
  
 
 
 
  
 
 
 
       
       2,219,853       188,493       2,408,346  
    
 
 
 
  
 
 
 
  
 
 
 
*) Represents an amount lower than 0.1
The weighted average fair values at grant date of RSUs and PSUs granted for the years ended December 31, 2022, 2021 and 2020 were $126.3, $120.1 and $105.3 per share, respectively.
The total fair value of shares vested during the years 2022, 2021 and 2020 was $89.4, $66.8 and $49.6, respectively.
As of December 31, 2022, the Company had approximately $265.8 of unrecognized compensation expense related to
non-vested
stock options and
non-vested
RSU’s and PSU’s, expected to be recognized over a weighted average period of 1.9 years.
 
  d.
Employee Stock Purchase Plan (“ESPP”):
In 1996, the Company adopted an ESPP, which was subsequently amended in 2015. According to the amendments, commencing the purchase period that begins February 1, 2017, 568,478 ordinary shares are authorized for issuance under the US ESPP, and Commencing June 19, 2019 the Pool of shares for the US ESPP was set on 750,000 shares and 1,096,795 ordinary shares are authorized for issuance under the rest of the world (ROW).
As of December 31, 2022, 2,250,867 ordinary shares had been issued under the amended ESPP plan.
Eligible employees may use up to 15% of their salaries to purchase ordinary shares but no more than 1,250 single shares per participant on any purchase date. The ESPP is implemented through an offering every six months. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date.
 
F-40
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except share and per share data)
 
NOTE 12:-
SHAREHOLDERS’ EQUITY (Cont.)
 
During 2022, 2021 and 2020, employees purchased 372,242, 361,675 and 364,859 ordinary shares at average prices of $103.5, $105.3 and $95.4 per share, respectively.
In accordance with ASC No. 718, the ESPP is compensatory and as such results in recognition of compensation cost. For the years ended December 31, 2022, 2021 and 2020, the Company recognized $9.9, $10.9 and $10.2, respectively, of compensation expense in connection with the ESPP.
 
  e.
Stock-Based Compensation:
Stock-based compensation expense related to stock options, RSUs and PSUs is included in the consolidated statements of income as follows:
 
    
Year ended

December 31,
  
    
        2022    
     
      2021      
     
      2020      
  
       
Cost of revenues
      $ 5.4        $ 4.8        $ 4.5  
Research and development
      42.0        31.8        23.5  
Selling and marketing
      43.2        42.8        36.8  
General and administrative
      40.8        40.9        47.7  
    
 
 
     
 
 
     
 
 
  
       
       $ 131.4        $ 120.3        $ 112.5  
    
 
 
     
 
 
     
 
 
  
 
NOTE 13:-
EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share:
 
    
Year ended

December 31,
    
2022
   
2021
   
2020
       
Net income
      $ 796.9        $ 815.6        $ 846.6  
    
 
 
 
   
 
 
 
   
 
 
 
       
Weighted average ordinary shares outstanding
      125,205,504        133,121,763        140,495,886  
    
 
 
 
   
 
 
 
   
 
 
 
       
Dilutive effect:
                           
Employee stock options, RSUs and PSUs
      1,133,485        988,285        1,482,106  
    
 
 
 
   
 
 
 
   
 
 
 
       
Diluted weighted average ordinary shares outstanding
          126,338,989            134,110,048            141,977,992  
    
 
 
 
   
 
 
 
   
 
 
 
       
Basic earnings per ordinary share
      $ 6.37        $ 6.13        $ 6.03  
    
 
 
 
   
 
 
 
   
 
 
 
       
Diluted earnings per ordinary share
      $ 6.31        $ 6.08        $ 5.96  
    
 
 
 
   
 
 
 
   
 
 
 
 
F-41
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 14:-
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
 
    
Unrealized

Gains (losses)
  on marketable  
securities
  
    Unrealized    

Gains
(losses) on
cash flow
hedges
  
        Total        
       
Beginning balance
      $ (1.2 )      $ 0.6       $ (0.6 ) 
Other comprehensive income before reclassifications
      (93.4 )      (25.4 )      (118.8 ) 
Amounts reclassified from accumulated other comprehensive income
      * )      21.5       21.5  
Net current period other comprehensive income
      (93.4 )      (3.9 )      (97.3 ) 
    
 
 
 
  
 
 
 
  
 
 
 
       $ (94.6 )      $ (3.3 )      $ (97.9 ) 
 
NOTE 15:-
GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA
 
  a.
Summary information about geographical areas:
The Company operates in one reportable segment (see Note 1 for a brief description of the Company’s business). The total revenues are attributed to geographic areas based on the location of the Company’s channel partners which are considered as end customers, as well as direct customers of the Company.
The following table presents total revenues and property and equipment, net, by geographic area:
1. Revenues based on the channel partners’ location:
 
    
Year ended

December 31,
  
    
      2022      
     
      2021      
     
      2020      
  
       
Americas
      $ 991.1        $ 922.8        $ 929.8  
Europe, Middle East and Africa
      1,049.5        980.8        891.4  
Asia Pacific
      289.3        263.2        243.7  
    
 
 
     
 
 
     
 
 
  
       $ 2,329.9        $ 2,166.8        $ 2,064.9  
    
 
 
     
 
 
     
 
 
  
 
F-42
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 15:- GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA (Cont.)
 
2. Property and equipment, net and ROU assets:
 
    
December 31,
    
        2022        
  
        2021        
     
Israel
     $ 73.9       $ 74.4   
U.S.
      12.8       16.9  
Rest of the world
      16.8       14.1  
    
 
 
 
  
 
 
 
     
      $ 103.5      $ 105.4  
    
 
 
 
  
 
 
 
 
  b.
Summary information about product lines:
The Company’s products can be classified by three main product lines. The following table presents total revenues for the years ended December 31, 2022, 2021 and 2020 by product lines:
 
    
Year ended

December 31,
    
      2022      
  
      2021      
  
      2020      
       
Product and licenses:
                         
Network security Gateways
        $ 507.8          $ 480.5          $ 472.4   
Other *)
      47.1       33.4       41.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
       554.9       513.9       513.6  
Security subscriptions
      858.0       755.2       671.1  
Software updates and maintenance
      917.0       897.7       880.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
Total revenues
        $ 2,329.9         $ 2,166.8         $ 2,064.9  
    
 
 
 
  
 
 
 
  
 
 
 
 
  *)
Comprised of Endpoint security, Mobile security and Security management products, each comprising of less than 10% of products and licenses revenues.
 
F-43
CHECK POINT SOFTWARE TECHNOLOGIES LTD.
AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
 
In millions (except per share data)
 
NOTE 15:-
GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA (Cont.)
 
  c.
Financial income, net:
 
    
Year ended

December 31,
    
      2022      
   
      2021      
  
      2020      
       
Financial income:
                          
Interest income
      $ 67.6        $ 66.1       $ 78.2  
    
 
 
 
   
 
 
 
  
 
 
 
Financial expense:
                          
Amortization of marketable securities premium and accretion of discount, net
      18.5        21.0       9.4  
Realized gain on sale of marketable securities, net
      –        (1.4 )      (4.5 ) 
Foreign currency
re-measurement
(gain) loss
      3.3        (0.2 )      4.5  
Others
      1.8        4.6       2.2  
    
 
 
 
   
 
 
 
  
 
 
 
       
       23.6        24.0       11.6  
    
 
 
 
   
 
 
 
  
 
 
 
       
       $ 44.0        $ 42.1       $ 66.6  
    
 
 
 
   
 
 
 
  
 
 
 
 
NOTE 16:-
SUBSEQUENT EVENTS
 
  a.
Following audits of the Company’s 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued o
rd
ers for the years 2016 through 2019 challenging the Company’s positions on several issues.
In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes.
See also further details in Note 10b.
 
  b.
On February 13, 2023 the Company announced the expansion of the Company’s
on-going
share repurchase program (see Note 12b).
— — — ——
 
F-44
EX-12.1 2 d473301dex121.htm EX-12.1 EX-12.1

Exhibit 12.1

CERTIFICATION

I, Gil Shwed, certify that:

 

1.

I have reviewed this Annual Report on Form 20-F of Check Point Software Technologies Ltd.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4.

The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

5.

The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

Date: April 27, 2023     By:  

/s/ Gil Shwed

      Gil Shwed
      Chief Executive Officer
 EX-12.2 3 d473301dex122.htm EX-12.2 EX-12.2

Exhibit 12.2

CERTIFICATION

I, Roei Golan, certify that:

 

1.

I have reviewed this Annual Report on Form 20-F of Check Point Software Technologies Ltd.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4.

The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d)

Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

 

5.

The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

 

Date: April 27, 2023

    

By:

  

/s/ Roei Golan

     

Roei Golan

     

Acting Chief Financial Officer

 EX-13.1 4 d473301dex131.htm EX-13.1 EX-13.1

Exhibit 13.1

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF

TITLE 18, UNITED STATES CODE)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned Chief Executive Officer of Check Point Software Technologies Ltd., a company organized under the laws of the State of Israel (the “Company”), does hereby certify that the Annual Report on Form 20-F for the year ended December 31, 2022 (the “Form 20-F”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Annual Report on Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 27, 2023

    

By:

  

/s/ Gil Shwed

     

Gil Shwed

     

Chief Executive Officer

 EX-13.2 5 d473301dex132.htm EX-13.2 EX-13.2

Exhibit 13.2

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF

TITLE 18, UNITED STATES CODE)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned Acting Chief Financial Officer of Check Point Software Technologies Ltd., a company organized under the laws of the State of Israel (the “Company”), does hereby certify that the Annual Report on Form 20-F for the year ended December 31, 2022 (the “Form 20-F”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Annual Report on Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 27, 2023

    

By:

  

/s/ Roei Golan

     

Roei Golan

     

Acting Chief Finance Officer

 EX-15 6 d473301dex15.htm EX-15 EX-15

Exhibit 15

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

 

(1)

Registration Statement (Form S-8 No. 333-132954) 2005 Israel Equity Incentive Plan, 2005 United States Equity Incentive Plan.,

 

(2)

Registration Statements (Form S-8 No.’s 333-207335, 333-235322) Check Point Software Technologies Ltd. Employee Stock Purchase Plan, as amended and restated.,

 

(3)

Registration Statement (Form S-8 No.’s 333-211113, 333-240141) Check Point Software Technologies Ltd. Employee Stock Purchase Plan (Non-U.S. Employees)., and

 

(4)

Registration Statement (Form S-8 No. 333-228075) Dome9 Security Ltd. 2011 Share Option Plan and the 2016 Equity Incentive Subplan.;

of our reports dated April 27, 2023, with respect to the consolidated financial statements of Check Point Software Technologies Ltd. and the effectiveness of internal control over financial reporting of Check Point Software Technologies Ltd. included in this Annual Report (Form 20-F) for the year ended December 31, 2022.

 

/s/ KOST FORER GABBAY & KASIERER

A Member of EY Global

 

Tel Aviv, Israel

April 27, 2023

 EX-101.SCH 7 chkp-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - CONSOLIDATED STATEMENTS OF INCOME link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - GENERAL link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - ACQUISITION link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - DEFERRED REVENUES link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - TAXES ON INCOME link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - SHAREHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - EARNINGS PER SHARE link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES (Tables) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - DEFERRED REVENUES (Tables) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - TAXES ON INCOME (Tables) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - SHAREHOLDERS' EQUITY (Tables) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA (Tables) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - General - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Summary of Annual Rate of Depreciation on Property and Equipment (Detail) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Weighted Average Assumptions of Options Granted (Detail) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Acquisition - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities - Schedule Of Cash And Cash Equivalents And Short Term Investments (Detail) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Cash And Cash Equivalents, Short-Contractual Obligation Fiscal Year Maturity Schedule TableTerm Bank Deposits And Marketable Securities - (Detail) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities- Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Financial Assets Measured at Fair Value on Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1047 - Disclosure - Property and Equipment Net (Detail) link:presentationLink link:definitionLink link:calculationLink 1048 - Disclosure - Schedule of Goodwill (Detail) link:presentationLink link:definitionLink link:calculationLink 1049 - Disclosure - Other Intangible Assets, Net (Detail) link:presentationLink link:definitionLink link:calculationLink 1050 - Disclosure - Estimated Future Amortization Expense of Other Intangible Assets (Detail) link:presentationLink link:definitionLink link:calculationLink 1051 - Disclosure - Deferred Revenues (Detail) link:presentationLink link:definitionLink link:calculationLink 1052 - Disclosure - Accrued Expenses and Other Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1053 - Disclosure - Commitments And Contingent Liabilities - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1054 - Disclosure - Taxes On Income - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1055 - Disclosure - Components of Deferred Tax Assets and Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1056 - Disclosure - Income Before Taxes (Detail) link:presentationLink link:definitionLink link:calculationLink 1057 - Disclosure - Components of Income Tax Expense (Detail) link:presentationLink link:definitionLink link:calculationLink 1058 - Disclosure - Reconciliation of Unrecognized Tax Benefits (Detail) link:presentationLink link:definitionLink link:calculationLink 1059 - Disclosure - Reconciliation of Unrecognized Tax Benefits (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1060 - Disclosure - Effective Income Tax Reconciliation (Detail) link:presentationLink link:definitionLink link:calculationLink 1061 - Disclosure - Effective Income Tax Reconciliation (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1062 - Disclosure - Shareholders' Equity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1063 - Disclosure - Number of Reserved and Authorized Shares Under the Equity Incentive Plans (Detail) link:presentationLink link:definitionLink link:calculationLink 1064 - Disclosure - Stock Option Activity and Related Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1065 - Disclosure - Summary of Performance Stock Units Activity (Detail) link:presentationLink link:definitionLink link:calculationLink 1066 - Disclosure - Shareholders' Equity - Stock-based Compensation Expense Related to Stock Options, RSUs and PSUs (Detail) link:presentationLink link:definitionLink link:calculationLink 1067 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted Earnings per Share (Detail) link:presentationLink link:definitionLink link:calculationLink 1068 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule Of Accumulated Other Comprehensive Income Loss (Detail) link:presentationLink link:definitionLink link:calculationLink 1069 - Disclosure - Revenue by Geographic Area (Detail) link:presentationLink link:definitionLink link:calculationLink 1070 - Disclosure - Property and Equipment, Net and Right of Use Assets by Geographic Area (Detail) link:presentationLink link:definitionLink link:calculationLink 1071 - Disclosure - Revenues by Product Lines (Detail) link:presentationLink link:definitionLink link:calculationLink 1072 - Disclosure - Revenues by Product Lines (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 1073 - Disclosure - Geographic Information and Selected Statements of Income Data - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1074 - Disclosure - Financial Income, Net (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 chkp-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 chkp-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 chkp-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 chkp-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 12 g473301dsp70.jpg GRAPHIC begin 644 g473301dsp70.jpg M_]C_X 02D9)1@ ! $ 8 !@ #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC M+B!6,2XP,0#_VP"$ (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" M @(" @,# @(# @(" P0# P,#! 0$ @,$! 0$! ,$! ,! @(" @(" @(" @," M @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# M P,# P,# __$ :( $% 0$! 0$! ! @,$!08'" D*"P$ P$! M 0$! 0$! 0 $" P0%!@<("0H+$ " 0,# @0#!04$! 7T! @, M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I M*C0U-CH.$A8:' MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7 MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1 (! @0$ P0'!00$ $"=P ! @,1 M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_ !$( (8 =@,!$0 "$0$#$0'_V@ , M P$ A$#$0 _ /W\H * "@ H * "@ H C.D5;F][=:/;;<5EUZ$9;T &/P MZ5YN(QE>HW]77+'I\4>UMGZA%4X_+T&%L#J!@>N.E7XB*NUMMK_P#J]%OS?Z;:W;((S*FXH. MB\GBOT[AKB#^WLKIX^W*I2<$N64=%&$EI*4G]KN<4Z3HODENEG^>E<4L53I5I0>CC;JET3V+4=$1O($'7&/PKGQ6:4:,- MTK6^U'O8:5NA0>ZB_P"6I557G)8*!CWR.U?&XSBG+J"ZZ)Z%1H2K-0BFW'79^G3U.9U'QCI-D&B$WFR@86.,AF)!' (SCC-?E_%'C MKP]D=*I1H8JDZD5))+$85OW7#I-M[2/3PN25ZK7N/[I>?;T.!U'QO?7#&.W5 M+1.BR.%+GGCMUK^7N)O'C.HX MI\K7+KHJG9'+W=Y>7#[KFXFF([,QXQTXK\LSWCG.^)ZE#"X^HXPG-1?-1HPT MG%4WK3A%['T6 R[#QMHHI=+M=?4@0DXX(&3QUQ^[>O'669?A,PR_VU>G:I"H MYKVC6T7WEIJ=&-HX>C#M9?S/NEW/=O!O'AW3_P#<;'_?9K_4O@_"X3#\/X"& M":=%TZ/?TJ70E_S_E'R+5.W784R$*>2, _ABL*]>.#I5*L MI\T:,7)WOM%7Z)OIT'&G:2ZZK0:K;EXD((^HKCP^94,?#]U5]C>VL5+UZI=K M$U8..RY;%62<1C/G2':<=U48](;&QWR37Z*1_RS4F3H!@ *#BORSB'CS 9'[?%RS.6(44Y6E&LE[D M8]J;:WL>MALLQ.)4:E--0ETO&VFFEVNW0XN_\?2296RMW7 PLDIPK>C 9.T> MQ K^?.(_I&JM4J8/ TZ<90E*/-&KB8OW*COHZ"2NEKJ>_A(ER)\ MLKM)ZWMIMU/I<'D>&BW;#PBTM^6-]UYF8'1 0IZ_KBOR[,\96S&;EC)RE)WN MY/G>O+?\D>Q2R^G2MRQ4;>20S(R/E''J/2O/HX3#4[N.83HO72,']VGW':H\ ML;K@:%3$T^>.'C.K&[C)M74DVDTW:S5CBHNG!:>[ M;LA<,L?[HL7+*H0 R;258'&T&OH>'\IQF(S2D\=E=/&4X.:BJLZETGZI'EYG)2B_>>G_R2/?\ P:"/#VGAA@JC Y0IC#'^$@8ZU_I)X;3JU^&: M,JM%4)4ZLH*"::484Z25GY;6\C\US!ZM:Z?QTY'&H^3E4I6O4BKV;WT.J&&KR5TK);?%_D7\R/ML%D.!C%>T:7_;T?+O$PE+R?,&.]N2&5B^1QSEF'Y5\?6XFQ%:I+ M XF.)J.%HMJ$VGS)/>4W?2W0]5/!8.*P\;?PTY=&8SS'#4]$TK>4?3^8T8O# MNMW./*T\HG7YVQCM]W;[UZ=/PLXYQG+35"C[&+32OB4[[/\ YAVMF<=3/J-! M>Z]?1?I)&W:^!=3EV[WA@)]0S$<>G%?:Y)X!Y_C''Z]3A%:7Y:M6/25_BPK[ M(X*W$R6SM;^[Z?WSH+;X?1*!]JNB2/\ GD-G\PU?I^7_ $9L!.$98BM.,U;1 M8M)7LGL\'WN>75XFJJ_+:WI;\I,W;;P3I5M_K(GFQ_SVD#=/]U%K]&R3P/RW M*'%UX*48M:>UA+[7-UPT>AY#S^O:T9./FE9_^E,U[?0M(M"&CLT4JT*,NCCUIQ[G-4S7$U59U96]'?\S;M8HXX0D09 M44D*#@8[_P (''-?;X18.=%?4:7LJ$7R\KC&'O)*^D=.VIQ3JRJ2YGHR<3@= M5Z?W2'Z?0"O66*PO_01!6_O&23]"K/J=M;!C,?)50"7E(2/Z!SW]J\O,,^P. M AS.I"K;HII;1;ZI]K&T:$I;,X_5/'.DPD);JUY.NX*L!W*#\N,L%QSC]*_. MLZX]P=:E*-+#.%>BFJ?[V+';^!QZ[6?4]:CA\%0MSRA*WFU^OD4%\)ZW>2+/=[F+"T:MIKOJ>BLQRZA!I8 M?GLG91F_EZ&O;^ 97.Z:Z13_ '$C8$?\"5Q_*NW ^"V3XMKZQ@HR]7BET;^S MB%U1C_;F&@O>*?;OB'V/,K9QB*G\.?LNR2B^_='1V?A/2;:*,):Q J#U#MCYB>K M,3^9K[G*/ W@Z6&H8K$Y93J8F5W.3JXR-VI22]V.*45[J2T73N>=+,L1=ISY MGU=HK\+6-6/2;>'_ %<<28Z;4XXXYR3S7V^!\-\@RV,5@,)3P[BDDU+$2V7+ M]NM+IH,?C7HPP=:*M*NI?]NV)<[]+">0?[W3VQT^E1++ MI-I^U2M_=[?,SM^ XPY[]/Z5I7PF(K/7$I173E7:W2Q5H?RVMYC3!Q@$#'MG MI^-73R["*"C6I*JU:[O);>2D7&4(?9V\R1(BBXR.#G@8_2MH86A0CR8>G[&G M>_+=O7J[MM]$$IIO12.?N_>^H/8UQ5LEARVIUIIZ;-@6*)0/7&T>PZUY]7@K*<%.G5Q24V[M*5*G-:63V3[HN=:I9 M1X:*HX?+<*YQ25WAXIZ)1WY-]#GE/$>= MO\7_ 1SQDLHV[0"!P0>GN>:UKY36Q%&.,?ATKJH14*4(Q7*HWLMNKZ"N.K8 H * " M@ H * "@"HC+Q@CYLA<$<[>3CUP!7G^RQ-71RC&WJOT-=NI*!]>/Z4X8.I!W M4XW7F_\ (ENWR&.C<8P,>N1]/Y5NVJ:2K0=2WP\BO:V][V\K>A4)J-[]-B+( M099D &>20 O!Y/H>M*-2A>TA)E=W7[I /(XP,\^G%:36(> MD)0C3ZII\UNMK+?L9>TZ6M\AX9#]UE."1PP."OWAP>H[BN9TY+;IZ_Y#22\K M "A'# CKP0>.@Z'U%"H2>FUO4+)?(E0KM&""!D<$'H<'\C773C[.$8?R_P"9 M.WR#>@_B4 #/W@, <9Z],U8"@CL1Z\4 +0 4 % !0 4 ?!'[9&I:MI5OX1.G M:C?V)EGNEG.G7%S8#9Y;C)$-SSQ0!\-?\)5XI4L$\2Z^RJY"G^VM47@=!@W) MZ>M&P;"'Q;XI4J/^$EUX$G"I_;6J%B3W!^TX4*,]?6C8-CZF_9X\?SZNVM_# M?Q3JU[/%KMN_]B7EU=W/GQW:Q@&".\-R65C(P.,=J /!O&__ G_ (%\3:QX M:U#Q'XC6XTNYGABWZK?I% M,I/#'B#5;N\L/$<)BM+C4+Z6Y:TU*)?,@2,S=[A5DCQ_?=*/T#]#[/\ C%X[ MMOA_X"UG6C*%O9H3I^E$$)(]WZ4 ?D;+XR\6SSS2W7B;7 M1<3R.\S+K-^BJC-N$@2*=54$L5P /N4;!L?H3^RWX/UFWT.?QKXFO]5GN]: MCTNPU#4KZXM8;!5$2W!BED;+.ZE^HX:C8-C['M#AF0[BT:A=YX5NGW5.2!QU MS0!>H * "@ H * /@C]MH 6W@XX /VBZ&>AP(I.,T ?!NFI'/K6GPR@SJU_; M1RP%B 8FN8E;.T@XVD]Z-@V/UTTCX/?"273=/FE\*Z"TDEC:.[-\I,C1 N?] M:/FR>?\ Z] &Q;?"3X5V-Q;7&G>&=%M+N"=7M9K5]LT,VS5$B3#3Z6)"9YKF-1\[0J7V2,,H$7:1@4?H'Z M'YUVE[:-PP;JKAE!R""",T;>5@V\K'L?Q@ M^,6H?%$^&XI4>TLM"TA%GB+,%O-2N&6*_N9$)P\R);6NQR"5$[X(W'(!A_"# MXZM/LR(]-BDRZ.Q&&,F/D4YRQ MG6$6GV4"06EE'%:00* (X8K>-8DA10, 1A A(^\5+'))- &SM4'=M ;&-V # M@=L^E "T % !0 4 % 'P1^VW_P >O@W_ *^;K_T5)0!^?4X9G*,&,9!X.3GK0!^/?QH^'MS\-O'&LZ2L6W2KN7[;I$JC,;V5S('"QMZP@JA/ M7+#-&P;'E*(UPJQ1(SSR&.*%6RED'F6MLR 6UJ6(RJB+$BKT!F8]2:-OD&WR/I&R 6-L97$C*$/&T M*2HSZD@9SWSF@"Y0 4 % !0 4 % 'P1^VW_QZ^#?^OFZ_P#14E 'P?IK11ZM MI[2M&BK?VZNTC$*(Q=0R2,1M(("H1C'?\S8-C]@TZPBN-7\*PNMA M9[E>W@=Q*(ML@9A:G)!4=?6@#57XE_!ZW(EM?$'A:&>(AHWBA2)T8="'2V4C M\Z .UT#Q1X=\3+._AW6+/4T@D:.YDM7,GDR%!8=4\#@' M.VQU10=H!\IKBW(B8]\$#!]NE'Z!^A\;>&CO\0^'XY0&5M8TK@#;A!?P(Z=\ M[E<#/^S[T ?NC;VR+;P(F$B6WA1(U7&P)&JIAL_PH%7I_#0!;1-@QG)&,G&, MX&,GWH ?0 4 % !0 4 % 'P9^VC#\FZC;R#;R.>_;4@GN]3\%FV@FG$5AJ1D,44D@CQ<6X ? M8IVDYZ4 ?&?AJPU!/$7AU_[.U#8NL::&;['/A +^W?PD4&ZM[2<6 M^[8)8(7\GG:6JX:RL4VX !M[=?E)"J0$0#!) 'U% M$G]GZ2"J_9+$,WW5\B($X]!L]J (9=/TLHR)9V+,,9406Y(!)7)#H1C*D?A0 M 06L$"21P6MM:&1L.JP1Q;RC^5$Q\I5X957!].E #;G3[>Z(>XBMI-I(C$MO M;RE1O61T7SHV()*#@4 0M8Z9@%;.S&/)DW1PQH05\UE(**,'='CB@#9MY8O* MC DY;<0KOE]Q.]EY.?EW#CL,4 2">#G]['A25;YU^5EX8'G@@@\4 .$L702) M\I*_>'#)]X?4=Z $,T2'!D13\W!8#[@!;OV!&?K0 ":'"XD3##.M'>"%T2SN[G0M%M+R-[K,B[@KW:^7@-]Y^G< YN7 MXP^)H/ -M#I5A=ZMKJ>!QXBUK5Q=P6\.DF[O[RVM 8I9E=R?LDA!52..O- & MI:?%G4O#[:A)-9ZGXCO)#X)TZWTUKVVC>:_U?1]):5[9YKA4VM=W+\E@/4XH M Z3_ (75<1V"0+X3U$^+#XB/AD:"T]@DPNA:W=T&^TM=B+FUM+A\[_X* .X\ M$>/#XL\*ZOXBGT]M%?2M0U#3;RRO+J!&273+=)"/M0E,29>:'+\0;[PG;ZPEU926^F.;YK+3[*.V:Y$K_ /++<5C( MW$CK0!+9_M#66MWNMZ;HVGQ2%M-UJ7PY>"]TX2WEWI=E&/[-6"+^TI]._M!;[3DGGU:VMHY7,VG MF[$OV43M+"'"$$PG% '7_#3X@ZMX_L_[6NO#4^BZ*ZK_ &7?W%Q#>BZGM[IK M5OW%O)(]MS&>9%7% 'MMN288B5"DHI*A@P''0,."/>@":@#Q?QWX(/B[4=$O MK7Q-J/AK4M#2\6SO-.,376R^AD@EFV7,( 5%E;+#LM &,?@SH;Z;]G77M8_M MN378_$K>)FGMI+PZXD,\7VGR5@6,0-;W%R@&>L@Y- %.R^"6D6$&F07'B'4+ M^6SU#Q+J,EYL?!_B%+);55NH/GU73XKYY,[V^SZBIV("2&&".X!L:-\/O" M.N7:ZM8ZMJ0^P>(-%"M>6OV;?=^ VM;!T@B8$F%ETK)8GH2<4 6O$_PN@N6U MW6;'4=0M];GUN'Q3I7* CIF@"3X?> KW3 M?AM?^%O$(+[4KO49$OD$L2["@#3\$_#"S\': M[+K?]O7NI78TBT\/A+NWM$@%M927#VT<0MBC?:3'."2XR2?2@#+M?@[IL?B* M36Y/$VN3V1\7-XPET"5K)-)&K2Z@;^W=S&CRIY4I12"1PE %72O ?A3P?XNA MTA-;O#;>);;68-'\-/:6!MH$E@E;4)?MT=L9XBJ;E7G'S\T 5X? V@17&@> M[;QEK2Z_X?FN/%6AF'[/YVD:;"[V=W;PR&%ED5O[15/FYPYP,T ;VF_"+2K' MQ!VFO)H!:RSSS269G24O$S?NV49)]: /1_!/A2T M\%>'M/\ #-E++=6VGQA5N)E"9(.22%)Y+9)]^: .U3A%Z< ?=&!QZ#TH =0! M\M_'K3_$2-X;U#PJVH/:UAO6$M[;QZGAG4[K5I_$:V.B:KX5\(:M_9TUXE_>:%IURJ:IJ$++(3$]Q.EN M7FBV.$W[7 )R;?(-OD6=-T?6]?U+P=I@O/%">"Y_&>LKI;75YJ2:B=)CTE&= M;^[%PLS*+AAY9=\Y!YY.0"R^D:_HGQ,\17WV>_\ ^$!L/&7AJUO$$MZFH:C- M)X5T"WMM0:Y2827$5L+?#;BR[F;-&WD&WD7M)T;4?$7B?1M-U.?Q!;:3+\1? MB3)=);:IJEMFS6YU>2UM1+!<(ZV\L7EA"'!)<<\T 8=]/J,.A^&5\2W7BJ[T M.PL_%]C:7-C=:K%JO=*LLP;S))#;VSHRNS!@^"#@8 /&O#$7Q2 MU;6-.^VS:LK:]9:E\0C&\EU'':SPS3Z39:83&ZA6\K2XYUB /VD94T 9<3> M(QH>K/H$OC26];P!J\WC-[RXO!'-XL2RN WV(.2;:5IU4HML8D&0%44;?(-O MD>D:EX5O_#VL^!I/#[:S=Z@_@KQ?>2WU_=WVH7$&K2:!>/!(6NII!$S710K$ M $W!<+0!4^"MI:R?%&UN[6W\0-N\$7BZW>:O+?R^7KLFIV#3VL$MU,WEPR+% MO\M,(/*&T 9R ?:P@B4Y"X/'1FXVEF&!NP.68_C0 _8H[=/4D]/QH =C'MC\ M,8H * *QMLD$RN2K;EW8;80NT$ YP01GZT 1M8QE2H9TW#$FTX$H(*L)%Z-N M0L.0>N>HH %L8Q'Y3,S '*X C*;2-OE[,>60!C(QG/- #DM%C4JKON^;YVP[ MG#0!@:WX0T_ M7]+GT>_N+\6-S&(9UMKR>UFFCR!)')<02+(\+Q[D:,L5PYXH U-.T2QTC3[; M2M.C%M86D(MX;< ,BQ*H4(=V<\;LYZ[C0!:^Q*!&/,91%@((P(]JKD(BE,%4 M5<#:..,GDT .%HBJ5&%+?ZQA&@\TCJTBXPQ/ XML 13 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
 12 Months Ended
Dec. 31, 2022
shares
Document Information [Line Items]  
Document Type 20-F
Amendment Flag false
Document Period End Date Dec. 31, 2022
Document Fiscal Year Focus 2022
Document Fiscal Period Focus FY
Trading Symbol CHKP
Entity Registrant Name CHECK POINT SOFTWARE TECHNOLOGIES LTD.
Entity Central Index Key 0001015922
Current Fiscal Year End Date --12-31
Entity Well-known Seasoned Issuer Yes
Entity Filer Category Large Accelerated Filer
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 120,761,971
Title of 12(b) Security Ordinary shares
Security Exchange Name NASDAQ
Document Transition Report false
Document Shell Company Report false
Document Annual Report true
Entity Current Reporting Status Yes
Entity Voluntary Filers No
Entity Interactive Data Current Yes
Entity File Number 000-28584
Entity Incorporation, State or Country Code L3
Entity Address, Address Line One 5 Shlomo Kaplan Street Tel Aviv
Entity Address, City or Town Israel
Entity Address, Postal Zip Code 6789159
Entity Address, Country IL
Document Registration Statement false
Document Accounting Standard U.S. GAAP
ICFR Auditor Attestation Flag true
Auditor Name Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global
Auditor Firm ID 1281
Auditor Location Tel-Aviv, Israel
Business Contact [Member]  
Document Information [Line Items]  
Entity Address, Address Line One 5 Shlomo Kaplan Street Tel Aviv
Entity Address, City or Town Israel
Entity Address, Postal Zip Code 6789159
Entity Address, Country IL
Local Phone Number 3-753-4555
City Area Code 972
Contact Personnel Name Shira Yashar, Adv.
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
CURRENT ASSETS:    
Cash and cash equivalents $ 196.0 $ 271.9
Short-term bank deposits 431.1 492.5
Marketable securities 1,010.5 929.3
Trade receivables, net 644.2 597.8
Prepaid expenses and other assets 50.0 46.4
Total current assets 2,331.8 2,337.9
LONG-TERM ASSETS:    
Marketable securities 1,865.6 2,089.7
Property and equipment, net 82.8 83.4
Deferred tax asset, net 77.6 51.7
Intangible assets, net 58.8 61.0
Goodwill 1,236.7 1,196.2
Other assets 71.5 80.3
Total long-term assets 3,393.0 3,562.3
Total assets 5,724.8 5,900.2
CURRENT LIABILITIES:    
Trade payables 29.6 9.8
Employees and payroll accruals 223.7 206.3
Deferred revenues 1,363.4 1,257.4
Accrued expenses and other liabilities 222.5 238.6
Total current liabilities 1,839.2 1,712.1
LONG-TERM LIABILITIES:    
Deferred revenues 514.4 449.7
Income tax accrual 419.7 454.9
Other liabilities 22.2 26.4
Total long-term liabilities 956.3 931.0
Total liabilities 2,795.5 2,643.1
SHAREHOLDERS' EQUITY:    
Ordinary shares, NIS 0.01 par value, 500,000,000 shares authorized at December 31, 2022 and 2021; 261,223,970 shares issued at December 31, 2022 and 2021; 120,761,971 and 129,065,690 shares outstanding at December 31, 2022 and 2021, respectively 0.8 0.8
Additional paid-in capital 2,500.7 2,276.7
Treasury shares at cost, 140,462,677 and 132,181,781 ordinary shares at December 31, 2022 and 2021, respectively (11,802.1) (10,550.7)
Accumulated other comprehensive loss (97.9) (0.6)
Retained earnings 12,327.8 11,530.9
Total shareholders' equity 2,929.3 3,257.1
Total liabilities and shareholders' equity $ 5,724.8 $ 5,900.2
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - ₪ / shares
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Ordinary shares, par value ₪ 0.01 ₪ 0.01
Ordinary shares, shares authorized 500,000,000 500,000,000
Ordinary shares, shares issued 261,223,970 261,223,970
Ordinary shares, shares outstanding 120,761,971 129,065,690
Treasury shares, shares 140,462,677 132,181,781
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:      
Total revenues $ 2,329.9 $ 2,166.8 $ 2,064.9
Operating expenses:      
Total cost of revenues 304.4 258.1 226.5
Research and development 349.9 292.7 252.8
Selling and marketing 675.2 597.8 569.9
General and administrative 116.1 110.7 111.5
Total operating expenses 1,445.6 1,259.3 1,160.7
Operating income 884.3 907.5 904.2
Financial income, net 44.0 42.1 66.6
Income before taxes on income 928.3 949.6 970.8
Taxes on income 131.4 134.0 124.2
Net income $ 796.9 $ 815.6 $ 846.6
Basic earnings per ordinary share $ 6.37 $ 6.13 $ 6.03
Number of shares used in computing basic earnings per share 125,205,504 133,121,763 140,495,886
Diluted earnings per ordinary share $ 6.31 $ 6.08 $ 5.96
Number of shares used in computing diluted earnings per share 126,338,989 134,110,048 141,977,992
Products and licenses      
Revenues:      
Total revenues $ 554.9 $ 513.9 $ 513.6
Operating expenses:      
Total cost of revenues 145.6 110.7 96.8
Security subscriptions      
Revenues:      
Total revenues 858.0 755.2 671.1
Operating expenses:      
Total cost of revenues 41.4 35.9 26.4
Software updates and maintenance      
Revenues:      
Total revenues 917.0 897.7 880.2
Operating expenses:      
Total cost of revenues 105.5 103.0 96.7
Amortization of technology      
Operating expenses:      
Total cost of revenues $ 11.9 $ 8.5 $ 6.6
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]      
Net income $ 796.9 $ 815.6 $ 846.6
Change in unrealized gains (losses) on marketable securities:      
Unrealized gains (losses) arising during the period, net of tax (93.4) (38.5) 21.2
Gains reclassified into earnings, net of tax [1] (1.7) (3.4)
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Total (93.4) (40.2) 17.8
Change in unrealized gains (losses) on cash flow hedges:      
Unrealized gains (losses) arising during the period, net of tax (25.4) (0.1) 6.4
Losses (gains) reclassified into earnings, net of tax 21.5 (1.0) (5.2)
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Total (3.9) (1.1) 1.2
Other comprehensive income (loss), net of tax (97.3) (41.3) 19.0
Comprehensive income $ 699.6 $ 774.3 $ 865.6
[1] Represents an amount lower than 0.1
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Ordinary shares
Additional paid-in capital
Treasury shares at cost
Accumulated other comprehensive income (loss)
Retained earnings
Balance at Dec. 31, 2019 $ 3,568.8 $ 0.8 $ 1,770.3 $ (8,092.7) $ 21.7 $ 9,868.7
Issuance of treasury shares under stock purchase plans, upon exercise of options and vesting of restricted stock units 216.8   145.4 71.4    
Treasury shares at cost (1,297.7)     (1,297.7)    
Stock-based compensation 112.5   112.5      
Other comprehensive income (loss), net of tax 19.0       19.0  
Fair value of awards attributable to pre-acquisition services 0.2   0.2      
Net income 846.6         846.6
Balance at Dec. 31, 2020 3,466.2 0.8 2,028.4 (9,319.0) 40.7 10,715.3
Issuance of treasury shares under stock purchase plans, upon exercise of options and vesting of restricted stock units 194.0   126.2 67.8    
Treasury shares at cost (1,299.5)     (1,299.5)    
Stock-based compensation 120.3   120.3      
Other comprehensive income (loss), net of tax (41.3)       (41.3)  
Fair value of awards attributable to pre-acquisition services 1.8   1.8      
Net income 815.6         815.6
Balance at Dec. 31, 2021 3,257.1 0.8 2,276.7 (10,550.7) (0.6) 11,530.9
Issuance of treasury shares under stock purchase plans, upon exercise of options and vesting of restricted stock units 141.1   92.6 48.5    
Treasury shares at cost (1,299.9)     (1,299.9)    
Stock-based compensation 131.4   131.4      
Other comprehensive income (loss), net of tax (97.3)       (97.3)  
Net income 796.9         796.9
Balance at Dec. 31, 2022 $ 2,929.3 $ 0.8 $ 2,500.7 $ (11,802.1) $ (97.9) $ 12,327.8
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Stockholders' Equity [Abstract]      
Treasury shares 10,324,181 10,900,938 11,376,531
Treasury stock reissued 2,094,108 2,872,272 3,118,665
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 796.9 $ 815.6 $ 846.6
Adjustments required to reconcile net income to net cash provided by operating activities:      
Depreciation of property and equipment 22.7 20.6 18.9
Amortization of premium and accretion of discount on marketable securities, net 18.5 21.0 9.4
Realized loss (gain) on sale of marketable securities, net 0.0 (1.4) (4.5)
Amortization of intangible assets 13.5 10.1 8.2
Stock-based compensation 131.4 120.3 112.5
Deferred income tax expense (benefit) (0.5) (4.0) 10.5
Increase in trade receivables, net (46.1) (51.6) (45.0)
Decrease in prepaid expenses and other assets 0.1 1.2 20.2
Increase (decrease) in trade payables 19.8 (7.7) 1.6
Increase (decrease) in employees and payroll accruals 26.3 (8.9) 36.1
Increase (decrease) in income tax accrual and accrued expenses and other liabilities (54.6) 66.4 46.1
Increase in deferred revenues 170.3 216.8 95.2
Other 0.2 5.5 5.2
Net cash provided by operating activities 1,098.5 1,203.9 1,161.0
Cash flows from investing activities:      
Proceeds from short-term bank deposits 538.4 214.5 0.0
Proceeds from maturity of marketable securities 1,056.6 1,551.7 2,299.7
Proceeds from sale of marketable securities 9.1 184.1 318.6
Investment in marketable securities (1,063.1) (1,297.5) (2,460.2)
Investment in short-term bank deposits (477.0) (492.5) (213.9)
Cash paid in conjunction with acquisitions, net of acquired cash (48.3) (219.7) (23.1)
Purchase of property and equipment (22.1) (15.9) (19.3)
Net cash used in investing activities (6.4) (75.3) (98.2)
Cash flows from financing activities:      
Proceeds from issuance of treasury shares upon exercise of options 141.2 194.0 216.8
Purchase of treasury shares at cost (1,299.9) (1,299.5) (1,297.7)
Payments related to shares withheld for taxes (9.3) (6.9) (5.4)
Net cash used in financing activities (1,168.0) (1,112.4) (1,086.3)
Increase (decrease) in cash and cash equivalents (75.9) 16.2 (23.5)
Cash and cash equivalents at the beginning of the year 271.9 255.7 279.2
Cash and cash equivalents at the end of the year 196.0 271.9 255.7
Supplemental disclosure of cash flow information:      
Cash paid during the year for taxes on income 113.5 101.0 90.8
Non-cash investing activity      
Fair value of awards attributable to pre-acquisition services 0.0 1.8 0.2
Operating lease liabilities arising from obtaining right of use assets $ 8.0 $ 1.4 $ 10.3
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.23.1
GENERAL
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GENERAL
NOTE 1:-
GENERAL
 
  a.
Check Point Software Technologies Ltd., an Israeli
corporation
(“Check Point Ltd.”), and subsidiaries (collectively, the “Company” or “Check
Point
”), develop, market and support wide range of products and services for IT security, by offering a multilevel security architecture that defends enterprises’ cloud, network and mobile device held information.
 
    
The Company operates in one operating and reportable segment and its revenues are mainly derived from the sales of its network and data security products, including licenses, related software updates, maintenance and security subscriptions. The Company sells its products worldwide primarily through multiple distribution channels (“channel partners”), including distributors, resellers, system integrators, Original Equipment Manufacturers (“OEMs”) and Managed Security Service Providers (“MSPs”).
 
  b.
During 2022, 2021 and 2020, approximately 40%, 40% and 39% of the Company’s revenues were derived from two channel partners, respectively. Revenues derived from one channel partner in 2022, 2021 and 2020 were 25%, 24% and 22%, respectively, and revenues derived from the other channel partner in 2022, 2021 and 2020 were 15%, 16%, and 17%, respectively, of the Company’s revenues in such years. Trade receivable balances from these two channel partners aggregated to $301.2 and $271.8 as of December 31, 2022 and 2021, respectively.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES
The consolidated financial
statements
are prepared in
conformity
with United States generally accepted accounting principles (“U.S. GAAP”).
 
  a.
Use of estimates:
 
    
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
 
  b.
Financial statements in United States dollars:
 
    
Most of the Company’s revenues and costs are denominated in United States dollar (“dollar”). The Company’s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company’s functional and reporting currency.
 
    
Accordingly,
non-dollar
denominated transactions and balances have been
re-measured
into the functional currency in accordance with Accounting Standard Code (“ASC”) No. 830, “Foreign Currency M
a
tters”.
 

   
All transaction gains and losses from the
re-measured
monetary balance sheet items are
reflected
in the
statements
of income as financial income or expenses, as appropriate.
 
  c.
Principles of consolidation:
 
   
The consolidated financial statements include the accounts of Check Point Ltd. and subsidiaries. Intercompany transactions and balances have been eliminated upon consolidation.
 
  d.
Cash equivalents:
 
   
Cash equivalents are short-term unrestricted highly liquid investments that are readily convertible to cash and with original maturities of three months or less at investment.
 
  e.
Short-term bank deposits:
 
   
Bank deposits with maturities of more than three months at investment but less than one year are included in short-term bank deposits. Such deposits are stated at cost which approximates fair values.
 
  f.
Trade Receivables:
 
   
Trade receivables are recorded net of credit losses allowance for any potential uncollectible amounts.
 
   
The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based upon its assessment of various factors, including historical collectability experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.
 
   
As of December 31, 2022 and 2021, the allowances for credit losses of trade receivable were insignificant.
 
   
The Company writes off receivables when they are deemed uncollectible, having exhausted all collection efforts. Actual collection experience may not meet expectations and may result in increased bad debt
expense
.
Allowance
for credit losses and total write offs expenses during 2022, 2021 and 2020 were insignificant.
 
  g.
Investments in marketable securities:
 
   
The Company accounts for investments in marketable securities in accordance with ASC No. 320, “Investments - Debt Securities”.
 
   
Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determinations at each balance sheet date. The Company classifies all of its debt securities as
available-for-sale
(“AFS”).
Available-for-sale
debt securities are carried at fair value, with the unrealized gains and losses, net of tax, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses on sale of investments are included in financial income, net and are derived using the specific identification method for determining the cost of securities sold.
 
   
The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization together with interest on securities is included in financial income, net.
 
   
At each reporting period, the Company evaluates whether declines in fair value below amortized cost are due to expected credit losses, as well as the company’s ability and intent to hold the investment until a forecasted recovery occurs in accordance with ASC 326, Financial Instrument- Credit losses. Allowance for credit losses on AFS debt securities are recognized in the Company’s consolidated statements of income, and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in stockholders’ equity.
 
   
No credit losses were recorded for the years ended December 31, 2022, 2021 and 2020.
 
  h.
Property and equipment, net:
 
   
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:
 
    
%
   
Computers and peripheral equipment
    33 – 50
Office furniture and equipment
    10 – 20
Building
    4
Leasehold improvements
    The shorter of term of the lease or the useful life of the asset
 
  i.
Leases:
The company’s operating leases comprised of office leases.
The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability or
right-of-use
(“ROU”) asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate
non-lease
components for its leases.
ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate on similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option. The ROU assets are included in Prepaid expenses and other assets in the consolidated balance sheet, while the short-term portion of lease liabilities are included in Accrued expenses and other liabilities, and the long-term portion of lease liabilities are included in Other liabilities.
As of December 31, 2022, the Company had total ROU assets of $20.8, with corresponding liabilities of $20.3 on the consolidated balance sheets.
Rent expenses for the years ended December 31, 2022, 2021 and 2020, were $6.3, $8.1 and $13.1 respectively.
 
  j.
Business combination:
The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill.
 
When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks and tradenames from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred (see also Note 3).
 
  k.
Goodwill:
Goodwill has been recorded as a result of acquisitions. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable net tangible and intangible assets acquired. Goodwill is not amortized, but rather is subject to an impairment test.
ASC No. 350, “Intangibles - Goodwill and other” (“ASC No. 350”) requires goodwill to be tested for impairment at the reporting unit level at least annually or between annual tests in certain circumstances, and written down when impaired.
ASC No. 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the quantitative goodwill impairment test is performed. Alternatively, ASC No. 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment test. If the carrying value of a reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB Accounting Standards Update (“ASU”)
No. 2017-04,
Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment.
The Company operates in one operating segment, and this segment is the only reporting unit. The Company performs the quantitative goodwill impairment test during the fourth quarter of each fiscal year, or more frequently if impairment indicators are present and compares the fair value of the reporting unit with its carrying value.
During the years 2022, 2021 and 2020, no Goodwill impairment losses have been identified.
  l.
Intangible assets, net:
Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives, which range from 4 to 20 years. These intangible assets consist of core technology, customer relationship, trademarks and trade names which are amortized over their estimated useful lives.
 
  m.
Impairment of long-lived assets including intangible assets subject to amortization and ROU assets:
The Company’s long-lived assets are reviewed for impairment in accordance with ASC No. 360, “Property, Plant and Equipment,” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years 2022, 2021 and 2020, no impairment losses have been identified.
 
  n.
Manufacturing partner and supplier liabilities:
The Company purchases manufactured products from its original design manufacture (“ODM”). The Company generally does not own the manufactured products. ODM’s provide services of design, manufacture, orders fulfillment and support with a full
turn-key
solution to meet the Company’s detailed requirements. If the actual demand is significantly lower than forecast, the Company records a liability for its commitment in excess of the actual demand. As of December 31, 2022 and 2021, the Company has not accrued any significant liability in respect with this exposure.
 
  o.
Research and development costs:
Research and development costs are charged to the statements of income as incurred. ASC
No. 985-20,
“Software - Costs of Software to Be Sold, Leased, or Marketed”, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility.
Based on the Company’s product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release, have been insignificant. Therefore, all research and development costs are expensed as incurred.
 
  p.
Revenue recognition:
The Company derives its revenues mainly from sales of products and licenses, security subscriptions and software updates and maintenance. The Company’s products are generally integrated with software that is essential to the functionality of the product. The Company sells its products primarily through channel partners including distributors, resellers, OEMs (Original Equipment Manufacturers), system integrators and MSPs (Managed Service Providers), all of whom are considered
end-users.
The Company’s security subscriptions provide customers with access to its suite of security solutions and is sold as a service.
The Company’s software updates and maintenance provide customers with rights to unspecified software product upgrades released during the term of the agreement and include maintenance services to
end-user
customers, through primarily telephone access to technical support personnel as well as hardware support services.
The Company recognizes revenues in accordance with ASC No. 606, “Revenue from Contracts with Customers”. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation.
Revenues from sales of products and licenses are recognized when control of the promised goods is transferred to the customer, or upon electronic transfer of the Certificate Key to the Customer. Revenues from security subscriptions and from software updates and maintenance are recognized ratably over the term of the agreement.
The Company’s arrangements typically contain various combinations of its products and licenses, security subscriptions and software updates and maintenance, which are distinct and are accounted for as separate performance obligations. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price using the prices charged for a performance obligation when sold separately.
Deferred revenues represent mainly the unrecognized revenue billed for security subscriptions and for software updates and maintenance. Such revenues are recognized ratably over the term of the related agreement. The amount of revenues recognized in the period that was included in the opening deferred revenues balance was $1,257.4 and $1,108.6 for the year ended December 31, 2022 and December 31, 2021, respectively.
Revenues expected to be recognized from remaining performance obligations were $2,146.1 and $2,013.6 as of December 31, 2022 and December 31, 2021, respectively. Of the balance as of December 31, 2022 the Company expects to recognize approximately $1,437.3 over the next 12 months and the remainder thereafter.
 
The Company records a provision for estimated sales returns, rebates, stock rotations and other rights provided to customers on product and services based on historical sales returns, analysis of credit memo data, rebate plans, stock rotation arrangements and other known factors. This provision is accounted for as variable consideration that is deducted from revenue in the period in which the revenue is recognized. Such provision amounted to $9.5 and $10.4 as of December 31, 2022 and 2021, respectively, and is included in accrued expenses and other liabilities in the consolidated balance sheets.
Sales commissions earned by the Company’s sales force are considered incremental and recoverable costs of obtaining a contract with a customer. These costs are deferred and then amortized over a period of benefit which is typically over the term of the customer contracts as initial commission rates are commensurate with the renewal commission rates. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of income. If the amortization period of those costs is one year or less, the costs are expensed as incurred. As of December 31, 2022 and 2021, the amount of deferred commission was $15.3 and $17.1, respectively, and is included in other long term assets on the balance sheets. During the years ended on December 31, 2022, 2021 and 2020 the Company recorded amortization expenses in connection with deferred commissions in the amount of $10.4, $11.6 and $15.3, respectively.
For information regarding disaggregated revenues, please refer to Note 15 below.
 
  q.
Cost of revenues:
Cost of products and licenses is comprised of cost of software and hardware production, manuals, packaging and shipping.
Cost of security subscriptions is comprised of costs paid to third parties, hosting and infrastructure costs and costs of customer support related to these services.
Cost of software updates and maintenance is mainly comprised of cost of post-sale customer support.
Amortization of technology is comprised of amortization of core technology assets which are used in the Company’s operations, and is presented separately as part of cost of revenues.
 
  r.
Severance pay:
Effective January 1, 2007, the Company’s agreements with employees in Israel, are under Section 14 of the Severance Pay Law, 1963. The Company’s contributions for severance pay have extinguished its severance obligation. Upon contribution of the full amount based on the employee’s monthly salary for each year of service, no additional obligation exists regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheets, as the Company is legally released from the obligation to employees once the required deposit amounts have been paid.
 
  s.
Employee benefit plan:
The Company has a 401(K) defined contribution plan covering certain employees in the U.S. The Company matches 50% of employee contributions to the plan up to a limit of 6% of their eligible compensation. The Company’s matching contribution to the plan were insignificant for the years ended December 31, 2022, 2021 and 2020.
 
  t.
Income taxes:
The Company accounts for income taxes in accordance with ASC No. 740, “Income Taxes” (“ASC No. 740”). ASC No. 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined for temporary differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. The Company accrues interest and indexation related to unrecognized tax benefits on its taxes on income.
ASC No. 740 contains a
two-step
approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes.
The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
 
  u.
Advertising costs:
Advertising costs are expensed as incurred. Advertising expenses for the years ended December 31, 2022, 2021 and 2020, were $4.6, $4.1 and $3.7 respectively.
 
  v.
Concentrations of credit risk:
Financial instruments that could potentially expose the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, short-term bank deposits, marketable securities, trade receivables and foreign currency derivative contracts.
The majority of the Company’s cash and cash equivalents and short-term bank deposits are deposited in major banks in the U.S., Israel and Europe. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions. Marketable securities are held mainly by Check Point Ltd., the Company’s Singaporean subsidiary, Canadian subsidiary and the U.S. subsidiary, and are invested in securities denominated in US dollar.
The Company’s marketable securities consist of investments in government, corporate and government sponsored enterprises debentures. The Company’s investment policy, approved by the Board of Directors, limits the amount that the Company may invest in any one type of investment, or issuer, thereby reducing credit risk concentrations.
The Company’s trade receivables are geographically dispersed and derived from sales to channel partners mainly in the United States, Europe and Asia. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures.
 
  w.
Derivatives and hedging:
The Company accounts for derivatives and hedging based on ASC No. 815, “Derivatives and Hedging” (“ASC No. 815”). ASC No. 815 requires the Company to recognize all derivatives on the balance sheets at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, as well as the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. If the derivatives meet the definition of a hedge and are designated as such, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in accumulated other comprehensive income until the hedged item is recognized in earnings.
 
The Company entered into forward contracts to hedge the fair value of assets and liabilities denominated in several foreign currencies. As of December 31, 2022 and 2021, the Company had outstanding forward contracts that did not meet the requirement for hedge accounting, in the notional amount of $207.9 and $171.1, respectively. The Company measured the fair value of the contracts in accordance with ASC No. 820, “Fair Value Measurement” (“ASC No. 820”) (classified as level 2 of the fair value hierarchy). The net gains (losses) resulting from these forward contracts recognized in financial income, net during 2022, 2021 and 2020 were $(19.5), $(0.6) and $24.8, respectively. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant.
The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekel, in Euro, and in British Pound. As of December 31, 2022 and 2021, the Company had outstanding forward contracts for payroll and related expenses in the notional amount of $266.2 and $155.0, respectively. These contracts were for a period of up to twelve months.
The Company measured the fair value of the contracts in accordance with ASC No. 820 (classified as level 2 of the fair value hierarchy). These contracts met the requirement for cash flow hedge accounting and, as such, gains (losses) on the contracts are recognized initially as component of Accumulated Other Comprehensive Income in the balance sheets and reclassified to the statements of income in the period the related hedged items affect earnings.
During 2022, 2021 and 2020 gains (losses) in the amount of $(24.4), $1.1 and $5.9, respectively, were reclassified when the related expenses were incurred and recognized in operating expenses. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant.
 
  x.
Basic and diluted earnings per share:
Basic earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year. Diluted earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year, plus dilutive potential ordinary shares outstanding during the year, in accordance with ASC No. 260, “Earnings Per Share”.
The total weighted average number of shares related to the outstanding options excluded from the calculations of diluted earnings per share, since it would have an anti-dilutive effect, was 1.7, 4.9 and 6.2 for 2022, 2021 and 2020, respectively.
 
  y.
Accounting for stock-based compensation:
The Company accounts for stock-based compensation in accordance with ASC No. 718, “Compensation-Stock Compensation” (“ASC No. 718”). ASC No. 718 requires companies to estimate the fair value of equity-based payment awards on the grant date using an option-pricing model.
The Company recognizes compensation expenses for the value of awards granted, based on the straight line method for service based awards and based on the accelerated method for performance-based awards. Compensation expense is recognized over the requisite service period of the awards. The Company recognizes forfeitures of awards as they occur.
The Company selected the Black-Scholes-Merton option pricing model as the most appropriate model for determining the fair value for its stock options awards and Employee Stock Purchase Plan, whereas the fair value of restricted stock units is based on the closing market value of the underlying shares at the date of grant. The option-pricing model requires a number of assumptions, the most significant of which are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options.
The expected term of options granted is based upon historical experience and represents the period of time between when the options are granted and when they are expected to be exercised. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term to the expected term of the options. The Company has historically not paid dividends and has no plans to pay dividends in the foreseeable future.
The fair value of options granted and Employee Stock Purchase Plan in 2022, 2021 and 2020 is estimated at the date of grant using the following weighted average assumptions:
 
    
        Year ended December 31,        
       
    
        2022        
  
        2021        
  
        2020        
       
Employee Stock Options
             
Expected volatility
    25.56%   25.28%   23.63%
Risk-free interest rate
    3.16%   0.65%   0.32%
Dividend yield
    0.0%   0.0%   0.0%
Expected term (years)
    4.75   4.22   4.15
       
Employee Stock Purchase Plan
             
       
Expected volatility
    22.16%   22.44%   36.58%
Risk-free interest rate
    2.56%   0.24%   0.05%
Dividend yield
    0.0%   0.0%   0.0%
Expected term (years)
    0.5   0.5   0.5
 
  z.
Fair value of financial instruments:
The Company measures its investments in money market funds (classified as cash equivalents), short-term bank deposits, marketable securities and its foreign currency derivative contracts at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:
 
  Level 1 -
Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
 
  Level 2 -
Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
 
  Level 3 -
Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
 
  aa.
Comprehensive income:
The Company accounts for comprehensive income in accordance with ASC No. 220, “Comprehensive Income”. Comprehensive income generally represents all changes in shareholders’ equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on hedging derivative instruments and unrealized gains and losses on
available-for-sale
debt securities.
 
  ab.
Treasury shares:
The Company repurchases its ordinary shares from time to time on the open market and holds such shares as treasury shares. The Company presents the cost to repurchase treasury stock as a separate component of shareholders’ equity.
The Company reissues treasury shares under the stock purchase plan, upon exercise of options and upon vesting of restricted stock units. Reissuance of treasury shares is accounted for in accordance with ASC
No. 505-30
whereby gains are credited to additional
paid-in
capital and losses are charged to additional
paid-in
capital to the extent that previous net gains are included therein; otherwise to retained earnings.
  ac.
Legal contingencies:
The Company is currently involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss.
 
  ad.
Recently Adopted Accounting Pronouncements:
The Company has reviewed recent accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on the consolidated financial statements as a result of their future adoption.
 
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.23.1
ACQUISITION
 12 Months Ended
Dec. 31, 2022
Business Combinations [Abstract]  
ACQUISITION
NOTE 3:-
ACQUISITIONS
 
  a.
On September 17, 2020 the Company completed the acquisition of all outstanding shares of Odo Security Ltd., a privately-held Israeli-based company, and a developer of a cloud-based, clientless Secure Access Service Edge (SASE) technology that delivers secure remote access.
 
  b.
On September 1, 2021, the Company completed the acquisition of all outstanding shares of Avanan Inc. (“Avanan”), a privately-held
US-based
company providing cloud email security, and the developer of a patented application-programming interface (API) solution to stop email threats before arriving to the inbox (inline), for both internal and external emails using AI based engines. The Company acquired Avanan for total consideration of approximately $227.1.
 
  c.
On February 3, 2022, the Company completed the acquisition of all outstanding shares of Spectral Cyber Technologies Ltd. (“Spectral”), a privately-held Israeli-based company, is a key innovator in developer security with a thriving open-source community. Spectral’s developer-first approach to security focuses on code safety and trust, fast code scanning and simple and cool developer experience.
The Company accounted for this transaction as a business combination and allocated the purchase consideration to tangible and intangible assets acquired and liabilities assumed based on their estimated fair values.
In addition, the transactions included additional consideration related to compensation for post combination services which were recorded as prepaid expenses and other long term assets and will be recognized over the requisite service period.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.23.1
CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES
 12 Months Ended
Dec. 31, 2022
Cash, Cash Equivalents, and Short-term Investments [Abstract]  
Cash, Cash Equivalents, and Short-term Investments [Text Block]
NOTE 4:-
CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES
 
    
December 31,
  
    
2022
     
2021
  
Cash and cash equivalents:
                  
Cash
    $ 65.8          $ 170.8      
Money market funds
      95.5            6.6      
Short term deposits
      34.7            94.5      
    
 
 
     
 
 
  
     
Total Cash and cash equivalents
      196.0            271.9      
     
Short-term bank deposits:
      431.1            492.5      
Marketable securities:
                  
Government and corporate debentures - fixed interest rate
      2,025.8            2,262.5      
Government-sponsored enterprises debentures
      755.0            641.4      
Government and corporate debentures - floating interest rate
      95.3            115.1      
    
 
 
     
 
 
  
Total Marketable securities
      2,876.1            3,019.0      
Total Cash and cash equivalents, short-term bank deposits and marketable securities
    $     3,503.2          $     3,783.4      
    
 
 
     
 
 
  
The gross unrealized gains on the Company’s marketable securities were $0.1 and $14.2 as of December 31, 2022 and 2021, respectively. The gross unrealized losses on the Company’s marketable securities were $123.4 and $15.7 as of December 31, 2022 and 2021, respectively. From the total of $123.4 unrealized losses as of December 31, 2022, $87.3 was in continuous unrealized loss for more than 12 months. The unrealized losses are mainly driven by the higher interest rate environment and the recent interest rate hikes by global central banks during 2022, which was due mainly to elevated inflation rates, therefore negatively impacted the fair value of securities in our portfolio, and increased the unrealized
The following table classifies the Company’s marketable securities by contractual maturities:
 
    
December 31,
  
    
2022
     
2021
  
    
Fair Value
     
Amortized

Cost
     
Fair Value
     
Amortized

Cost
  
Contractual maturity year:
                                    
Within one year
    $ 1,010.5       $ 1,024.9      $ 929.3       $ 925.8   
After one year through five years
      1,865.6         1,974.5        2,089.7         2,094.7   
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
    $     2,876.1       $     2,999.4      $     3,019.0       $     3,020.5   
    
 
 
     
 
 
     
 
 
     
 
 
  
As of December 31, 2022 and 2021, interest receivable amounted to $15.6 and $15.3, respectively, and is included within prepaid expenses and other assets in the balance sheets.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 5:-
FAIR VALUE MEASUREMENTS
In accordance with ASC No. 820, the Company measures its money market funds, short-term bank deposits, marketable securities and foreign currency derivative contracts at fair value. Money market funds and marketable securities are classified within Level 1 or Level 2. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments.
The Company’s financial assets measured at fair value on a recurring basis, excluding accrued interest components, consisted of the following types of instruments as of the following dates:
 
    
December 31,
  
    
2022
     
2021
  
    
Fair value measurements using input type
     
Fair value measurements using input type
  
    
Level 1
     
Level 2
     
Total
     
Level 1
     
Level 2
     
Total
  
Cash
    $ 65.8      $ -        $ 65.8      $ 170.8      $ -        $ 170.8  
Cash equivalents
                                                      
Money market funds
      95.5     
-          95.5        6.6        -          6.6  
Short term deposits
      34.7        -          34.7        94.5        -          94.5  
Short-term bank deposits
      431.1        -          431.1        492.5        -          492.5  
Marketable securities:
                                                      
Government and corporate debentures-fixed interest rate
      -          2,025.8        2,025.8        -          2,262.5        2,262.5  
Government-sponsored enterprises debentures
      -          755.0        755.0        -          641.4        641.4  
Government and corporate debentures - floating interest rate
      -          95.3        95.3        -          115.1        115.1  
Foreign currency derivative contracts
      -          (3.6)        (3.6)        -          0.7        0.7  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Total financial assets
    $     627.1      $     2,872.5      $     3,499.6      $     764.4      $     3,019.7      $     3,784.1  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT, NET
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET
NOTE 6:-
PROPERTY AND EQUIPMENT, NET
 
    
December 31,
    
2022
   
2021
Cost:
                  
Computers and peripheral equipment
    $ 78.1        $ 66.8    
Office furniture and equipment
      7.8          7.4    
Building
      78.7          78.5    
Leasehold improvements
      30.9          28.5    
    
 
 
 
   
 
 
 
     
       195.5              181.2    
Accumulated depreciation
          112.7          97.8    
    
 
 
 
   
 
 
 
     
Property and equipment, net
    $ 82.8        $ 83.4    
    
 
 
 
   
 
 
 
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND OTHER INTANGIBLE ASSETS, NET
 12 Months Ended
Dec. 31, 2022
Text Block [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS, NET
NOTE 7:-
GOODWILL AND INTANGIBLE ASSETS, NET
 
  a.
Goodwill:
 
    
    2022    
     
    2021    
  
Balance as of January 1
    $ 1,196.2      $ 1,002.2  
Acquisitions
      40.5        194.0  
    
 
 
     
 
 
  
Balance as of December 31
    $     1,236.7      $     1,196.2  
    
 
 
     
 
 
  
 
  b.
Intangible assets, net:
 
    
Useful
     
December 31,
    
Life
     
2022
  
2021
Original amount:
                          
Core technology
      8      $ 93.5       $ 82.2    
Trademarks and trade names
      15 – 20        25.5       25.5  
Customer relationship
      4        5.8       5.8  
             
 
 
 
  
 
 
 
       
                124.8       113.5  
             
 
 
 
  
 
 
 
       
Accumulated amortization:
                          
Core technology
               39.6       28.0  
Trademarks and trade names
               24.5       24.0  
Customer relationship
               1.9       0.5  
             
 
 
 
  
 
 
 
       
                66.0       52.5  
             
 
 
 
  
 
 
 
       
Intangible assets, net:
                          
Core technology
               53.9       54.2  
Trademarks and trade names
               1.0       1.5  
Customer relationship
               3.9       5.3  
             
 
 
 
  
 
 
 
       
              $         58.8     $         61.0  
             
 
 
 
  
 
 
 
Intangible assets which were fully amortized as of the prior year, are disposed from the original amount and the accumulated amortization balances.
The estimated future amortization expense of Intangible assets as of December 31, 2022 is as follows:
 
2023
    $ 11.9      
2024
      11.5      
2025
      11.1      
2026
      9.1      
2027
      6.3      
Thereafter
      8.9      
    
 
 
  
     $         58.8      
    
 
 
  
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.23.1
DEFERRED REVENUES
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
DEFERRED REVENUES
NOTE 8:-
DEFERRED REVENUES
Deferred revenues consisted of the following:
 
                                           
    
December 31,
  
    
2022
     
2021
  
     
Security subscriptions
   
$
932.1
 
   
$
801.1
 
Software updates and maintenance
   
 
904.7
 
   
 
869.2
 
Other
   
 
41.0
 
   
 
36.8
 
    
 
 
     
 
 
  
     
    
$
    1,877.8
 
   
$
    1,707.1
 
    
 
 
     
 
 
  
The majority of the deferred revenues are recognized within one year or less and presented as current deferred revenues in the balance sheets. Substantially all of the remaining deferred revenues are presented as long term deferred revenues and are recognized for a period greater than one year and up to five years.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED EXPENSES AND OTHER LIABILITIES
 12 Months Ended
Dec. 31, 2022
Text Block [Abstract]  
ACCRUED EXPENSES AND OTHER LIABILITIES
NOTE 9:-
ACCRUED EXPENSES AND OTHER LIABILITIES
The components of accrued expenses and other liabilities are as follows:
 
                                           
    
December 31,
    
2022
   
2021
     
Accrued products and licenses costs
   
$
84.4
 
   
$
102.5
 
Marketing expenses payable
   
 
8.7
 
   
 
9.8
 
Income tax payable
   
 
34.3
 
   
 
28.1
 
Legal accrual
   
 
32.0
 
   
 
39.5
 
Other accrued expenses
   
 
63.1
 
   
 
58.7
 
    
 
 
 
   
 
 
 
     
    
$
       222.5
 
   
$
       238.6
 
    
 
 
 
   
 
 
 
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENT LIABILITIES
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES
NOTE 10:-
COMMITMENTS AND CONTINGENT LIABILITIES
 
  Litigations:
 
 
  a.
The Company is the defendant in various lawsuits, including employment-related litigation claims, construction claims and other legal proceedings in the normal course of its business. Litigation and governmental proceedings can be expensive, lengthy and disruptive to normal business operations, and can require extensive management attention and resources, regardless of their merit. While the Company intends to defend the aforementioned matters vigorously, it believes that a loss in excess of its accrued liability with respect to these claims is not probable.
 
  b.
In particular, following audits of our 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued in January 2023 orders for the years 2016 through 2019 challenging our positions on several issues, including matters such as our position to claim a tax credit made for foreign taxes withheld on income payments that was due to the Company outside of Israel, taxation of interest earned outside of Israel by a wholly-owned Singapore subsidiary which the ITA is seeking to tax in Israel and deductibility of expenses attributed to employee stock options. The ITA orders also contest the Company’s positions on various other issues. The ITA therefore demanded the payment of additional taxes in the aggregate amount of NIS 428 million (approximately $122 million), not including an amount of NIS 418 million (approximately $119 million) related to expenses that will be deductible in future years , with respect of these four tax years (these amounts include interest through December 31, 2022). We believe we have good arguments against these orders and intend to file an appeal.
In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes in the aggregate amount of NIS 74 million (approximately $21 million), not including an amount of NIS 94 million (approximately $27 million) related to expenses that will be deductible in future years, respect to this year (these amounts include interest t
hrou
gh December 31, 2022). There can be no assurance that the ITA will accept the Company’s positions on the matters raised and, if it does not, the ITA may also issue an order with respect to the 2020 tax year.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.23.1
TAXES ON INCOME
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
TAXES ON INCOME
NOTE 11:-
TAXES ON INCOME
 
  a.
Israeli taxation:
 
  1.
Corporate tax:
Pursuant to Amendment 73 to the Investment Law adopted in 2017, a Company located in the Center of Israel that meets the conditions for “Preferred Technological Enterprises”, is subject to tax rate of 12%. The Company believes it meets those conditions.
Income not eligible for Preferred Enterprise benefits is taxed at a regular rate of 23%.
Reduced income under the Investment Law including the Preferred Enterprise Regime and Preferred Technological Enterprise Regime will be freely distributable as dividends, subject to a 15% or 20% withholding tax (or lower rate for
non-Israeli
resident shareholder, under an applicable tax treaty). However, upon the distribution of a dividend from Preferred Income and Technological Preferred Enterprise to an Israeli company, no withholding tax will be remitted.
 
 
Pursuant to a temporary tax relief initiated by the Israeli government, a company that elected by November 11, 2013, to pay a reduced corporate tax rate as set forth in the temporary tax relief with respect to undistributed exempt income generated under the Investment Law accumulated by the Company until December 31, 2011 (“Trapped Earnings”) is entitled to distribute a dividend from such income without being required to pay additional corporate tax with respect to such dividend. A company that has so elected must make certain qualified investments in Israel over five-year period. A company that has elected to apply the temporary tax relief cannot withdraw from its election. The Company has elected to apply the temporary tax relief by the respective date and believes it meets those conditions.
In particular, following audits of our 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued in January 2023 orders for the years 2016 through 2019 challenging our positions on several issues, including matters such as our position to claim a tax credit made for foreign taxes withheld on income payments that was due to the Company outside of Israel, taxation of interest earned outside of Israel by a wholly-owned Singapore subsidiary which the ITA is seeking to tax in Israel and deductibility of expenses attributed to employee stock options. The ITA orders also contest the Company’s positions on various other issues. The ITA therefore demanded the payment of additional taxes in the aggregate amount of NIS 428 million (approximately $122 million), not including an amount of NIS 418 million (approximately $119 million) related to expenses that will be deductible in future years, with respect of these four tax years (these amounts include interest through December 31, 2022). We believe we have good arguments against these orders and intend to file an appeal. In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes in the aggregate amount of NIS 74 million (approximately $21 million), not including an amount of NIS 94 million (approximately $27 million) related to expenses that will be deductible in future years, with respect to this year (these amounts include interest through December 31, 2022). There can be no assurance that the ITA will accept the Company’s positions on the matters raised and, if it does not, the ITA may also issue an order with respect to the 2020 tax year.
Company’s tax assessments through 2015 tax year are considered final.

 
  2.
Foreign Exchange Regulations:
Under the Foreign Exchange Regulations, Check Point Ltd. and its Israeli subsidiaries calculate their tax liability in dollar according to certain orders.
The tax liability, as calculated in dollar is translated into New Israeli Shekels according to the exchange rate as of December 31 of each year.
 
  b.
Income taxes of
non-Israeli
subsidiaries:
Non-Israeli
subsidiaries are taxed according to the tax laws in their respective countries of residence.
The Company does not provide deferred tax liabilities when it intends to reinvest earnings of foreign subsidiaries indefinitely or if distributed, no tax liability will be imposed. Undistributed earnings of foreign subsidiaries that are not distributed amounted to $450.3 and unrecognized deferred tax liability related to such earning amounted to $73.9 as of December 31, 2022.
 
 
  c.
Deferred tax assets and liabilities:
Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. As of December 31, 2022 and 2021, the Company’s deferred taxes were in respect of the following:
 
    
December 31,
    
2022
  
2021
Carry forward tax losses
    $ 38.7     $ 83.7  
Employee stock based compensation
      34.9       29.2  
Deferred revenues
      3.5       5.6  
Tax credits
      29.8       23.9  
Unrealized gains on marketable securities, net
      29.6       1.2  
Accrued employee costs
      8.1       10.3  
Other
      16.3       18.4  
    
 
 
 
  
 
 
 
     
Deferred tax assets before valuation allowance
      160.9       172.3  
Valuation allowance – mainly in respect to carryforward losses
      (17.5 )      (56.7 ) 
    
 
 
 
  
 
 
 
     
Deferred tax asset
      143.4       115.6  
    
 
 
 
  
 
 
 
Intangible assets
      (32.8 )      (31.3 ) 
Undistributed earnings of subsidiary
      (9.9 )      (9.9 ) 
Other
      (6.5 )      (8.1 ) 
    
 
 
 
  
 
 
 
     
Deferred tax liability
      (49.2 )      (49.3 ) 
    
 
 
 
  
 
 
 
     
Deferred tax asset, net
    $       94.2     $       66.3  
    
 
 
 
  
 
 
 
*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset.
Through December 31, 2022, the U.S. subsidiaries had a U.S. federal loss carry-forward of approximately $126.7 expiring gradually beginning 2023 mainly resulting from tax benefits related to employees’ stock option exercises that can be carried forward and offset against taxable income. Through December 31, 2022, the U.S. subsidiaries had a U.S. state net loss carry forward of approximately $80.3, expiring gradually beginning 2023 and is subject to limitation on their utilization.
 
 
Through December 31, 2022, the U.S. subsidiaries had federal and states research and development tax credits of approximately $25.6, which expire between fiscal years 2023 and fiscal 2042 and are subject to limitations on their utilization.
 
  d.
Income before taxes on income is comprised as follows:
 
    
Year ended

December 31,
  
    
2022
     
2021
     
2020
  
       
Domestic
      $ 897.4        $ 917.9        $ 896.8  
Foreign
      30.9        31.7        74.0  
    
 
 
     
 
 
     
 
 
  
       
       $      928.3        $      949.6        $      970.8  
    
 
 
     
 
 
     
 
 
  
 
  e.
Taxes on income are comprised of the following:
 
    
Year ended

December 31,
    
2022
  
2021
  
2020
       
Domestic taxes:
                         
Current
      $ 117.7       $ 130.9       $ 112.0  
Deferred
      (1.3 )      (1.1 )      0.8  
    
 
 
 
  
 
 
 
  
 
 
 
       
       116.4       129.8       112.8  
    
 
 
 
  
 
 
 
  
 
 
 
Foreign taxes:
                         
Current
      12.7       7.1       1.7  
Deferred
      2.3       (2.9 )      9.7  
    
 
 
 
  
 
 
 
  
 
 
 
       
       15.0       4.2       11.4  
    
 
 
 
  
 
 
 
  
 
 
 
       
Taxes on income
      $     131.4       $     134.0       $     124.2  
    
 
 
 
  
 
 
 
  
 
 
 
 
  f.
The Company operates its business in various countries, and accordingly attempts to utilize an efficient operating model to structure its tax payments based on the laws in the countries in which the Company operates. This can cause disputes between the Company and various tax authorities in different parts of the world.
 
 
A reconciliation of the beginning and ending amount of unrecognized tax benefits related to uncertain tax positions is as follows:
 
    
December 31,
    
2022
  
2021
     
Beginning balance
    $       469.5     $       442.8  
Increases (decreases) related to tax positions taken during prior years
      (85.4 )      47.2  
Decreases related to statute of limitations
      -       (77.2 ) 
Increases related to tax positions taken during the current year
      52.2       56.7  
    
 
 
 
  
 
 
 
     
Ending balance
    $ *)436.3     $ *)469.5  
    
 
 
 
  
 
 
 
*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset.
Substantially all the balance of unrecognized tax benefits, if recognized, would reduce the Company’s annual effective tax rate.
The Company adjusts the unrecognized tax benefit liability and income tax expense in the period in which the uncertain tax position is effectively settled, the statute of limitations expires or when new information is available. There is a reasonable possibility that a portion of the unrecognized tax benefit liability will be adjusted within 12 months due to statute of limitations. An estimate of the range of the statute of limitations amount cannot be made since the relevant years are subject to the ITA orders (refer also to footnote 10b).
During the years ended December 31, 2022, 2021 and 2020, the Company recorded $15.9, $9.7 and $(0.6), respectively for interest expense (income) related to uncertain tax positions. As of December 31, 2022 and 2021, the Company had accrued interest liability related to uncertain tax positions in the amounts of $60.0 and $44.1, respectively, which is included within income tax accrual on the balance sheets. The Company did not accrue penalties during the years ended December 31, 2022, 2021 and 2020.
The Company files federal and state income tax returns in the U.S. All of the U.S subsidiaries’ tax years are subject to examination by the U.S. federal and most U.S. state tax authorities due to their carry-forward tax losses and overall credit carry-forward position, except for Check Point Software Technologies Inc. that the assessment statue period for tax years throughout 2017 have expired.
The Company believes that it has adequately provided for any reasonably foreseeable outcomes related to tax audits and settlement. The final tax outcome of its tax audits could be different from that which is reflected in the Company’s income tax provisions and accruals. Such differences could have a material effect on the Company’s income tax provision and net income in the period in which such determination is made. The Company believes it had adequately provided for all of its uncertain tax positions, including those items currently under dispute.
 
 
  g.
Reconciliation of the theoretical tax expenses:
Reconciliation between the theoretical tax expenses, assuming all income is taxed at the statutory rate in Israel and the actual income tax as reported in the statements of income is as follows:
 
    
Year ended December 31,
    
2022
  
2021
  
2020
       
Income before taxes as reported in the statements of income
    $       928.3     $       949.6     $       970.8  
    
 
 
 
  
 
 
 
  
 
 
 
       
Statutory tax rate in Israel
      23 %      23 %      23 % 
       
Decrease in taxes resulting from:
                         
Effect of “Preferred Enterprise” status *)
      (13 %)      (11 %)      (11 %) 
Others, net
      4 %      2 %      1 % 
    
 
 
 
  
 
 
 
  
 
 
 
       
Effective tax rate
      14 %      14 %      13 % 
    
 
 
 
  
 
 
 
  
 
 
 
       
*)   Basic earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status
    $ 0.95     $ 0.80     $ 0.73  
    
 
 
 
  
 
 
 
  
 
 
 
       
*)   Diluted earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status
    $ 0.94     $ 0.80     $ 0.72  
    
 
 
 
  
 
 
 
  
 
 
 
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.23.1
SHAREHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2022
Text Block [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 12:-
SHAREHOLDERS’ EQUITY
 
  a.
General:
Ordinary shares confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends if declared.
 
 
 
  b.
Share repurchase:
On February 13, 2023 the Company announced the expansion of the Company’s
on-going
share repurchase program by an additional $2,000. Under the share repurchase program, as extended, the Company is authorized to continue to repurchase up to $325 each quarter.
As of December 31, 2022, the Company repurchased ordinary shares for an aggregate amount of $13,085.1. During 2022, 2021 and 2020 the Company repurchased 10,324,181, 10,900,938, and 11,376,531 shares for an aggregate amount of $1,299.9, $1,299.5 and $1,297.7, respectively.
 
  c.
Stock Options, RSUs and PSUs:
In 2005, the Company adopted two new equity incentive plans, which were subsequently amended in January 2014 and in July 2018: the 2005 United States Equity Incentive Plan and the 2005 Israel Equity Incentive Plan together are referred to as the Equity Incentive Plans.
Under the Equity Incentive Plans, the Company may grant options to employees, officers and directors at an exercise price equal to at least the fair market value of the ordinary shares at the date of grant and are granted for periods not to exceed seven years. The Company grants under the Equity Incentive Plans options, Restricted Stock Units (“RSUs”) and Performance stock units (“PSUs”) and can also grant a variety of other equity incentives. Options granted under the Equity Incentive Plans generally vest over a period of four years of employment. Options, RSUs and PSUs that are cancelled or forfeited before expiration become available for future grants. RSUs generally vest over a four years period of employment from the grant date while PSUs generally vest over a two to four years period of employment from the grant date. PSUs are subject to certain performance criteria; accordingly, compensation expense is recognized for such awards when it becomes probable that the related performance condition will be satisfied.
Under the Equity Incentive Plans, the Company’s
non-employee
directors receive on an annual basis options and RSUs grant. Following the amendments to the Equity Incentive Plans in July 2018, commencing December 31, 2018, on December 31st of each year, the number of Reserved and Authorized Shares (as defined below) under both Equity Incentive Plans together shall be annually reset on such date to equal 10% of the sum of (i) the number of ordinary shares issued and outstanding on such date and (ii) the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding awards granted under the Equity Incentive Plans as of such date (provided, however, that in no event shall the number of Reserved and Authorized Shares be less than the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding awards granted under the Equity Incentive Plans as of such date).
 
 
 
The number of “Reserved and Authorized Shares” under the Equity Plans shall equal the sum of (i) the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding options, RSUs, PSUs and other awards granted under the Equity Incentive Plans as of such date, and (ii) the number of ordinary shares reserved, authorized and available for issuance under the Equity Incentive Plans on such date.
As of December 31, 2022, the number of Reserved and Authorized Shares under the Equity Incentive Plans is as detailed below:
 
         
        
Stock Options outstanding
      7,778,108  
RSU outstanding
   
 
2,219,853
 
PSU outstanding
   
 
188,493
 
Ordinary shares available for issuance under the Equity Incentive Plans
   
 
2,905,777
 
    
 
 
 
Total Reserved and Authorized Shares as of December 31, 2022
   
 
13,092,231
 
    
 
 
 
As of December 31, 2022 the aggregate number of shares, stock options, RSU and PSU outstanding is 130,948,425.
A summary of the Company’s stock option activity and related information is as follows:
 
    
  Number of  
options
  
    Weighted    

average

exercise

price
     
    Aggregate    

intrinsic

value
  
                           
    
2022
       
Outstanding at beginning of year
      8,160,625     $ 113.06      $ 37.1  
Granted
      710,000     $ 125.54           
Exercised
      (1,009,329 )    $ 99.89           
Forfeited
      (83,188 )    $ 122.41           
    
 
 
 
  
 
 
     
 
 
  
       
Outstanding at December 31, 2022
      7,778,108     $ 115.05      $ 82.5  
    
 
 
 
  
 
 
     
 
 
  
       
Exercisable at December 31, 2022
      5,666,608     $ 114.61      $ 65.4  
    
 
 
 
  
 
 
     
 
 
  
The weighted average fair values at grant date of options granted for the years ended December 31, 2022, 2021 and 2020 with an exercise price equal to the market value at the date of grant were $34.6, $25.9 and $22.0 per share, respectively.
The total intrinsic value of options exercised during the years 2022, 2021 and 2020 was $32.9, $65.1 and $81.7, respectively.
 
 
 
The aggregate intrinsic value of the outstanding stock options as of December 31, 2022 and 2021, represents the intrinsic value of 7,651,858 and 6,484,417 outstanding options that are
in-the-money
as of such dates. The remaining 126,250 and 1,676,208 outstanding options are
out-of-the-money
as of December 31, 2022 and 2021, and their intrinsic value was considered as zero.
A summary of the Company’s RSUs and PSUs activity is as follows:
 
    
Year ended

December 31, 2022
    
    RSUs    
  
    PSUs    
  
    Total    
       
Unvested at beginning of year
      2,231,167       105,595       2,336,762  
Granted
      958,157       160,423       1,118,580  
Vested
      (706,738)       (5,799)       (712,537)  
Forfeited
      (262,733)       (71,726)       (334,459)  
    
 
 
 
  
 
 
 
  
 
 
 
       
       2,219,853       188,493       2,408,346  
    
 
 
 
  
 
 
 
  
 
 
 
*) Represents an amount lower than 0.1
The weighted average fair values at grant date of RSUs and PSUs granted for the years ended December 31, 2022, 2021 and 2020 were $126.3, $120.1 and $105.3 per share, respectively.
The total fair value of shares vested during the years 2022, 2021 and 2020 was $89.4, $66.8 and $49.6, respectively.
As of December 31, 2022, the Company had approximately $265.8 of unrecognized compensation expense related to
non-vested
stock options and
non-vested
RSU’s and PSU’s, expected to be recognized over a weighted average period of 1.9 years.
 
  d.
Employee Stock Purchase Plan (“ESPP”):
In 1996, the Company adopted an ESPP, which was subsequently amended in 2015. According to the amendments, commencing the purchase period that begins February 1, 2017, 568,478 ordinary shares are authorized for issuance under the US ESPP, and Commencing June 19, 2019 the Pool of shares for the US ESPP was set on 750,000 shares and 1,096,795 ordinary shares are authorized for issuance under the rest of the world (ROW).
As of December 31, 2022, 2,250,867 ordinary shares had been issued under the amended ESPP plan.
Eligible employees may use up to 15% of their salaries to purchase ordinary shares but no more than 1,250 single shares per participant on any purchase date. The ESPP is implemented through an offering every six months. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date.
 
 
 
During 2022, 2021 and 2020, employees purchased 372,242, 361,675 and 364,859 ordinary shares at average prices of $103.5, $105.3 and $95.4 per share, respectively.
In accordance with ASC No. 718, the ESPP is compensatory and as such results in recognition of compensation cost. For the years ended December 31, 2022, 2021 and 2020, the Company recognized $9.9, $10.9 and $10.2, respectively, of compensation expense in connection with the ESPP.
 
  e.
Stock-Based Compensation:
Stock-based compensation expense related to stock options, RSUs and PSUs is included in the consolidated statements of income as follows:
 
    
Year ended

December 31,
  
    
        2022    
     
      2021      
     
      2020      
  
       
Cost of revenues
      $ 5.4        $ 4.8        $ 4.5  
Research and development
      42.0        31.8        23.5  
Selling and marketing
      43.2        42.8        36.8  
General and administrative
      40.8        40.9        47.7  
    
 
 
     
 
 
     
 
 
  
       
       $ 131.4        $ 120.3        $ 112.5  
    
 
 
     
 
 
     
 
 
  
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
NOTE 13:-
EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share:
 
    
Year ended

December 31,
    
2022
   
2021
   
2020
       
Net income
      $ 796.9        $ 815.6        $ 846.6  
    
 
 
 
   
 
 
 
   
 
 
 
       
Weighted average ordinary shares outstanding
      125,205,504        133,121,763        140,495,886  
    
 
 
 
   
 
 
 
   
 
 
 
       
Dilutive effect:
                           
Employee stock options, RSUs and PSUs
      1,133,485        988,285        1,482,106  
    
 
 
 
   
 
 
 
   
 
 
 
       
Diluted weighted average ordinary shares outstanding
          126,338,989            134,110,048            141,977,992  
    
 
 
 
   
 
 
 
   
 
 
 
       
Basic earnings per ordinary share
      $ 6.37        $ 6.13        $ 6.03  
    
 
 
 
   
 
 
 
   
 
 
 
       
Diluted earnings per ordinary share
      $ 6.31        $ 6.08        $ 5.96  
    
 
 
 
   
 
 
 
   
 
 
 
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.23.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
NOTE 14:-
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
 
    
Unrealized

Gains (losses)
  on marketable  
securities
  
    Unrealized    

Gains
(losses) on
cash flow
hedges
  
        Total        
       
Beginning balance
      $ (1.2 )      $ 0.6       $ (0.6 ) 
Other comprehensive income before reclassifications
      (93.4 )      (25.4 )      (118.8 ) 
Amounts reclassified from accumulated other comprehensive income
      * )      21.5       21.5  
Net current period other comprehensive income
      (93.4 )      (3.9 )      (97.3 ) 
    
 
 
 
  
 
 
 
  
 
 
 
       $ (94.6 )      $ (3.3 )      $ (97.9 ) 
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.23.1
GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA
 12 Months Ended
Dec. 31, 2022
Text Block [Abstract]  
GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA
NOTE 15:-
GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA
 
  a.
Summary information about geographical areas:
The Company operates in one reportable segment (see Note 1 for a brief description of the Company’s business). The total revenues are attributed to geographic areas based on the location of the Company’s channel partners which are considered as end customers, as well as direct customers of the Company.
The following table presents total revenues and property and equipment, net, by geographic area:
1. Revenues based on the channel partners’ location:
 
    
Year ended

December 31,
  
    
      2022      
     
      2021      
     
      2020      
  
       
Americas
      $ 991.1        $ 922.8        $ 929.8  
Europe, Middle East and Africa
      1,049.5        980.8        891.4  
Asia Pacific
      289.3        263.2        243.7  
    
 
 
     
 
 
     
 
 
  
       $ 2,329.9        $ 2,166.8        $ 2,064.9  
    
 
 
     
 
 
     
 
 
  
 
 
2. Property and equipment, net and ROU assets:
 
    
December 31,
    
        2022        
  
        2021        
     
Israel
     $ 73.9       $ 74.4   
U.S.
      12.8       16.9  
Rest of the world
      16.8       14.1  
    
 
 
 
  
 
 
 
     
      $ 103.5      $ 105.4  
    
 
 
 
  
 
 
 
 
  b.
Summary information about product lines:
The Company’s products can be classified by three main product lines. The following table presents total revenues for the years ended December 31, 2022, 2021 and 2020 by product lines:
 
    
Year ended

December 31,
    
      2022      
  
      2021      
  
      2020      
       
Product and licenses:
                         
Network security Gateways
        $ 507.8          $ 480.5          $ 472.4   
Other *)
      47.1       33.4       41.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
       554.9       513.9       513.6  
Security subscriptions
      858.0       755.2       671.1  
Software updates and maintenance
      917.0       897.7       880.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
Total revenues
        $ 2,329.9         $ 2,166.8         $ 2,064.9  
    
 
 
 
  
 
 
 
  
 
 
 
 
  *)
Comprised of Endpoint security, Mobile security and Security management products, each comprising of less than 10% of products and licenses revenues.
 
 
  c.
Financial income, net:
 
    
Year ended

December 31,
    
      2022      
   
      2021      
  
      2020      
       
Financial income:
                          
Interest income
      $ 67.6        $ 66.1       $ 78.2  
    
 
 
 
   
 
 
 
  
 
 
 
Financial expense:
                          
Amortization of marketable securities premium and accretion of discount, net
      18.5        21.0       9.4  
Realized gain on sale of marketable securities, net
      –        (1.4 )      (4.5 ) 
Foreign currency
re-measurement
(gain) loss
      3.3        (0.2 )      4.5  
Others
      1.8        4.6       2.2  
    
 
 
 
   
 
 
 
  
 
 
 
       
       23.6        24.0       11.6  
    
 
 
 
   
 
 
 
  
 
 
 
       
       $ 44.0        $ 42.1       $ 66.6  
    
 
 
 
   
 
 
 
  
 
 
 
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
NOTE 16:-
SUBSEQUENT EVENTS
 
  a.
Following audits of the Company’s 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued o
rd
ers for the years 2016 through 2019 challenging the Company’s positions on several issues.
In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes.
See also further details in Note 10b.
 
  b.
On February 13, 2023 the Company announced the expansion of the Company’s
on-going
share repurchase program (see Note 12b).
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Use of Estimates
  a.
Use of estimates:
 
    
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Financial Statements in United States Dollars
  b.
Financial statements in United States dollars:
 
    
Most of the Company’s revenues and costs are denominated in United States dollar (“dollar”). The Company’s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company’s functional and reporting currency.
 
    
Accordingly,
non-dollar
denominated transactions and balances have been
re-measured
into the functional currency in accordance with Accounting Standard Code (“ASC”) No. 830, “Foreign Currency M
a
tters”.
 

   
All transaction gains and losses from the
re-measured
monetary balance sheet items are
reflected
in the
statements
of income as financial income or expenses, as appropriate.
 
Principles of Consolidation
  c.
Principles of consolidation:
 
   
The consolidated financial statements include the accounts of Check Point Ltd. and subsidiaries. Intercompany transactions and balances have been eliminated upon consolidation.
Cash Equivalents
  d.
Cash equivalents:
 
   
Cash equivalents are short-term unrestricted highly liquid investments that are readily convertible to cash and with original maturities of three months or less at investment.
Short-Term Bank Deposit
  e.
Short-term bank deposits:
 
   
Bank deposits with maturities of more than three months at investment but less than one year are included in short-term bank deposits. Such deposits are stated at cost which approximates fair values.
Trade Receivables
  f.
Trade Receivables:
 
   
Trade receivables are recorded net of credit losses allowance for any potential uncollectible amounts.
 
   
The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based upon its assessment of various factors, including historical collectability experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.
 
   
As of December 31, 2022 and 2021, the allowances for credit losses of trade receivable were insignificant.
 
   
The Company writes off receivables when they are deemed uncollectible, having exhausted all collection efforts. Actual collection experience may not meet expectations and may result in increased bad debt
expense
.
Allowance
for credit losses and total write offs expenses during 2022, 2021 and 2020 were insignificant.
 
Investments in Marketable Securities
  g.
Investments in marketable securities:
 
   
The Company accounts for investments in marketable securities in accordance with ASC No. 320, “Investments - Debt Securities”.
 
   
Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determinations at each balance sheet date. The Company classifies all of its debt securities as
available-for-sale
(“AFS”).
Available-for-sale
debt securities are carried at fair value, with the unrealized gains and losses, net of tax, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses on sale of investments are included in financial income, net and are derived using the specific identification method for determining the cost of securities sold.
 
   
The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization together with interest on securities is included in financial income, net.
 
   
At each reporting period, the Company evaluates whether declines in fair value below amortized cost are due to expected credit losses, as well as the company’s ability and intent to hold the investment until a forecasted recovery occurs in accordance with ASC 326, Financial Instrument- Credit losses. Allowance for credit losses on AFS debt securities are recognized in the Company’s consolidated statements of income, and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in stockholders’ equity.
 
   
No credit losses were recorded for the years ended December 31, 2022, 2021 and 2020.
Property and equipment, net
  h.
Property and equipment, net:
 
   
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:
 
    
%
   
Computers and peripheral equipment
    33 – 50
Office furniture and equipment
    10 – 20
Building
    4
Leasehold improvements
    The shorter of term of the lease or the useful life of the asset
Leases
  i.
Leases:
The company’s operating leases comprised of office leases.
The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability or
right-of-use
(“ROU”) asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate
non-lease
components for its leases.
ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate on similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option. The ROU assets are included in Prepaid expenses and other assets in the consolidated balance sheet, while the short-term portion of lease liabilities are included in Accrued expenses and other liabilities, and the long-term portion of lease liabilities are included in Other liabilities.
As of December 31, 2022, the Company had total ROU assets of $20.8, with corresponding liabilities of $20.3 on the consolidated balance sheets.
Rent expenses for the years ended December 31, 2022, 2021 and 2020, were $6.3, $8.1 and $13.1 respectively.
 
Business combination
  j.
Business combination:
The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill.
 
When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks and tradenames from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred (see also Note 3).
 
Goodwill
  k.
Goodwill:
Goodwill has been recorded as a result of acquisitions. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable net tangible and intangible assets acquired. Goodwill is not amortized, but rather is subject to an impairment test.
ASC No. 350, “Intangibles - Goodwill and other” (“ASC No. 350”) requires goodwill to be tested for impairment at the reporting unit level at least annually or between annual tests in certain circumstances, and written down when impaired.
ASC No. 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the quantitative goodwill impairment test is performed. Alternatively, ASC No. 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment test. If the carrying value of a reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB Accounting Standards Update (“ASU”)
No. 2017-04,
Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment.
The Company operates in one operating segment, and this segment is the only reporting unit. The Company performs the quantitative goodwill impairment test during the fourth quarter of each fiscal year, or more frequently if impairment indicators are present and compares the fair value of the reporting unit with its carrying value.
During the years 2022, 2021 and 2020, no Goodwill impairment losses have been identified.
Intangible Assets, Net
  l.
Intangible assets, net:
Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives, which range from 4 to 20 years. These intangible assets consist of core technology, customer relationship, trademarks and trade names which are amortized over their estimated useful lives.
 
Impairment of long-lived assets including intangible assets subject to amortization
  m.
Impairment of long-lived assets including intangible assets subject to amortization and ROU assets:
The Company’s long-lived assets are reviewed for impairment in accordance with ASC No. 360, “Property, Plant and Equipment,” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years 2022, 2021 and 2020, no impairment losses have been identified.
 
Manufacturing partner and supplier liabilities
  n.
Manufacturing partner and supplier liabilities:
The Company purchases manufactured products from its original design manufacture (“ODM”). The Company generally does not own the manufactured products. ODM’s provide services of design, manufacture, orders fulfillment and support with a full
turn-key
solution to meet the Company’s detailed requirements. If the actual demand is significantly lower than forecast, the Company records a liability for its commitment in excess of the actual demand. As of December 31, 2022 and 2021, the Company has not accrued any significant liability in respect with this exposure.
 
Research and Development Costs
  o.
Research and development costs:
Research and development costs are charged to the statements of income as incurred. ASC
No. 985-20,
“Software - Costs of Software to Be Sold, Leased, or Marketed”, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility.
Based on the Company’s product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release, have been insignificant. Therefore, all research and development costs are expensed as incurred.
Revenue Recognition
  p.
Revenue recognition:
The Company derives its revenues mainly from sales of products and licenses, security subscriptions and software updates and maintenance. The Company’s products are generally integrated with software that is essential to the functionality of the product. The Company sells its products primarily through channel partners including distributors, resellers, OEMs (Original Equipment Manufacturers), system integrators and MSPs (Managed Service Providers), all of whom are considered
end-users.
The Company’s security subscriptions provide customers with access to its suite of security solutions and is sold as a service.
The Company’s software updates and maintenance provide customers with rights to unspecified software product upgrades released during the term of the agreement and include maintenance services to
end-user
customers, through primarily telephone access to technical support personnel as well as hardware support services.
The Company recognizes revenues in accordance with ASC No. 606, “Revenue from Contracts with Customers”. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation.
Revenues from sales of products and licenses are recognized when control of the promised goods is transferred to the customer, or upon electronic transfer of the Certificate Key to the Customer. Revenues from security subscriptions and from software updates and maintenance are recognized ratably over the term of the agreement.
The Company’s arrangements typically contain various combinations of its products and licenses, security subscriptions and software updates and maintenance, which are distinct and are accounted for as separate performance obligations. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price using the prices charged for a performance obligation when sold separately.
Deferred revenues represent mainly the unrecognized revenue billed for security subscriptions and for software updates and maintenance. Such revenues are recognized ratably over the term of the related agreement. The amount of revenues recognized in the period that was included in the opening deferred revenues balance was $1,257.4 and $1,108.6 for the year ended December 31, 2022 and December 31, 2021, respectively.
Revenues expected to be recognized from remaining performance obligations were $2,146.1 and $2,013.6 as of December 31, 2022 and December 31, 2021, respectively. Of the balance as of December 31, 2022 the Company expects to recognize approximately $1,437.3 over the next 12 months and the remainder thereafter.
 
The Company records a provision for estimated sales returns, rebates, stock rotations and other rights provided to customers on product and services based on historical sales returns, analysis of credit memo data, rebate plans, stock rotation arrangements and other known factors. This provision is accounted for as variable consideration that is deducted from revenue in the period in which the revenue is recognized. Such provision amounted to $9.5 and $10.4 as of December 31, 2022 and 2021, respectively, and is included in accrued expenses and other liabilities in the consolidated balance sheets.
Sales commissions earned by the Company’s sales force are considered incremental and recoverable costs of obtaining a contract with a customer. These costs are deferred and then amortized over a period of benefit which is typically over the term of the customer contracts as initial commission rates are commensurate with the renewal commission rates. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of income. If the amortization period of those costs is one year or less, the costs are expensed as incurred. As of December 31, 2022 and 2021, the amount of deferred commission was $15.3 and $17.1, respectively, and is included in other long term assets on the balance sheets. During the years ended on December 31, 2022, 2021 and 2020 the Company recorded amortization expenses in connection with deferred commissions in the amount of $10.4, $11.6 and $15.3, respectively.
For information regarding disaggregated revenues, please refer to Note 15 below.
Cost of Revenues
  q.
Cost of revenues:
Cost of products and licenses is comprised of cost of software and hardware production, manuals, packaging and shipping.
Cost of security subscriptions is comprised of costs paid to third parties, hosting and infrastructure costs and costs of customer support related to these services.
Cost of software updates and maintenance is mainly comprised of cost of post-sale customer support.
Amortization of technology is comprised of amortization of core technology assets which are used in the Company’s operations, and is presented separately as part of cost of revenues.
Severance Pay
  r.
Severance pay:
Effective January 1, 2007, the Company’s agreements with employees in Israel, are under Section 14 of the Severance Pay Law, 1963. The Company’s contributions for severance pay have extinguished its severance obligation. Upon contribution of the full amount based on the employee’s monthly salary for each year of service, no additional obligation exists regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheets, as the Company is legally released from the obligation to employees once the required deposit amounts have been paid.
 
Employee Benefit Plan
  s.
Employee benefit plan:
The Company has a 401(K) defined contribution plan covering certain employees in the U.S. The Company matches 50% of employee contributions to the plan up to a limit of 6% of their eligible compensation. The Company’s matching contribution to the plan were insignificant for the years ended December 31, 2022, 2021 and 2020.
 
Income Taxes
  t.
Income taxes:
The Company accounts for income taxes in accordance with ASC No. 740, “Income Taxes” (“ASC No. 740”). ASC No. 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined for temporary differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. The Company accrues interest and indexation related to unrecognized tax benefits on its taxes on income.
ASC No. 740 contains a
two-step
approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes.
The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income.
Advertising Costs
  u.
Advertising costs:
Advertising costs are expensed as incurred. Advertising expenses for the years ended December 31, 2022, 2021 and 2020, were $4.6, $4.1 and $3.7 respectively.
 
Concentrations of Credit Risk
  v.
Concentrations of credit risk:
Financial instruments that could potentially expose the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, short-term bank deposits, marketable securities, trade receivables and foreign currency derivative contracts.
The majority of the Company’s cash and cash equivalents and short-term bank deposits are deposited in major banks in the U.S., Israel and Europe. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions. Marketable securities are held mainly by Check Point Ltd., the Company’s Singaporean subsidiary, Canadian subsidiary and the U.S. subsidiary, and are invested in securities denominated in US dollar.
The Company’s marketable securities consist of investments in government, corporate and government sponsored enterprises debentures. The Company’s investment policy, approved by the Board of Directors, limits the amount that the Company may invest in any one type of investment, or issuer, thereby reducing credit risk concentrations.
The Company’s trade receivables are geographically dispersed and derived from sales to channel partners mainly in the United States, Europe and Asia. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures.
 
Derivatives and Hedging
  w.
Derivatives and hedging:
The Company accounts for derivatives and hedging based on ASC No. 815, “Derivatives and Hedging” (“ASC No. 815”). ASC No. 815 requires the Company to recognize all derivatives on the balance sheets at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, as well as the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. If the derivatives meet the definition of a hedge and are designated as such, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in accumulated other comprehensive income until the hedged item is recognized in earnings.
 
The Company entered into forward contracts to hedge the fair value of assets and liabilities denominated in several foreign currencies. As of December 31, 2022 and 2021, the Company had outstanding forward contracts that did not meet the requirement for hedge accounting, in the notional amount of $207.9 and $171.1, respectively. The Company measured the fair value of the contracts in accordance with ASC No. 820, “Fair Value Measurement” (“ASC No. 820”) (classified as level 2 of the fair value hierarchy). The net gains (losses) resulting from these forward contracts recognized in financial income, net during 2022, 2021 and 2020 were $(19.5), $(0.6) and $24.8, respectively. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant.
The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekel, in Euro, and in British Pound. As of December 31, 2022 and 2021, the Company had outstanding forward contracts for payroll and related expenses in the notional amount of $266.2 and $155.0, respectively. These contracts were for a period of up to twelve months.
The Company measured the fair value of the contracts in accordance with ASC No. 820 (classified as level 2 of the fair value hierarchy). These contracts met the requirement for cash flow hedge accounting and, as such, gains (losses) on the contracts are recognized initially as component of Accumulated Other Comprehensive Income in the balance sheets and reclassified to the statements of income in the period the related hedged items affect earnings.
During 2022, 2021 and 2020 gains (losses) in the amount of $(24.4), $1.1 and $5.9, respectively, were reclassified when the related expenses were incurred and recognized in operating expenses. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant.
 
Basic and Diluted Earnings per Share
  x.
Basic and diluted earnings per share:
Basic earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year. Diluted earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year, plus dilutive potential ordinary shares outstanding during the year, in accordance with ASC No. 260, “Earnings Per Share”.
The total weighted average number of shares related to the outstanding options excluded from the calculations of diluted earnings per share, since it would have an anti-dilutive effect, was 1.7, 4.9 and 6.2 for 2022, 2021 and 2020, respectively.
 
Accounting for stock-based compensation
  y.
Accounting for stock-based compensation:
The Company accounts for stock-based compensation in accordance with ASC No. 718, “Compensation-Stock Compensation” (“ASC No. 718”). ASC No. 718 requires companies to estimate the fair value of equity-based payment awards on the grant date using an option-pricing model.
The Company recognizes compensation expenses for the value of awards granted, based on the straight line method for service based awards and based on the accelerated method for performance-based awards. Compensation expense is recognized over the requisite service period of the awards. The Company recognizes forfeitures of awards as they occur.
The Company selected the Black-Scholes-Merton option pricing model as the most appropriate model for determining the fair value for its stock options awards and Employee Stock Purchase Plan, whereas the fair value of restricted stock units is based on the closing market value of the underlying shares at the date of grant. The option-pricing model requires a number of assumptions, the most significant of which are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options.
The expected term of options granted is based upon historical experience and represents the period of time between when the options are granted and when they are expected to be exercised. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term to the expected term of the options. The Company has historically not paid dividends and has no plans to pay dividends in the foreseeable future.
The fair value of options granted and Employee Stock Purchase Plan in 2022, 2021 and 2020 is estimated at the date of grant using the following weighted average assumptions:
 
    
        Year ended December 31,        
       
    
        2022        
  
        2021        
  
        2020        
       
Employee Stock Options
             
Expected volatility
    25.56%   25.28%   23.63%
Risk-free interest rate
    3.16%   0.65%   0.32%
Dividend yield
    0.0%   0.0%   0.0%
Expected term (years)
    4.75   4.22   4.15
       
Employee Stock Purchase Plan
             
       
Expected volatility
    22.16%   22.44%   36.58%
Risk-free interest rate
    2.56%   0.24%   0.05%
Dividend yield
    0.0%   0.0%   0.0%
Expected term (years)
    0.5   0.5   0.5
Fair Value of Financial Instruments
  z.
Fair value of financial instruments:
The Company measures its investments in money market funds (classified as cash equivalents), short-term bank deposits, marketable securities and its foreign currency derivative contracts at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:
 
  Level 1 -
Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
 
  Level 2 -
Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
 
  Level 3 -
Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
Comprehensive Income
  aa.
Comprehensive income:
The Company accounts for comprehensive income in accordance with ASC No. 220, “Comprehensive Income”. Comprehensive income generally represents all changes in shareholders’ equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on hedging derivative instruments and unrealized gains and losses on
available-for-sale
debt securities.
 
Treasury Shares
  ab.
Treasury shares:
The Company repurchases its ordinary shares from time to time on the open market and holds such shares as treasury shares. The Company presents the cost to repurchase treasury stock as a separate component of shareholders’ equity.
The Company reissues treasury shares under the stock purchase plan, upon exercise of options and upon vesting of restricted stock units. Reissuance of treasury shares is accounted for in accordance with ASC
No. 505-30
whereby gains are credited to additional
paid-in
capital and losses are charged to additional
paid-in
capital to the extent that previous net gains are included therein; otherwise to retained earnings.
Legal Contingencies
  ac.
Legal contingencies:
The Company is currently involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss.
 
Recently Adopted Accounting Pronouncements
  ad.
Recently Adopted Accounting Pronouncements:
The Company has reviewed recent accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on the consolidated financial statements as a result of their future adoption.
 
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Annual Rate of Depreciation on Property and Equipment Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates:
    
%
   
Computers and peripheral equipment
    33 – 50
Office furniture and equipment
    10 – 20
Building
    4
Leasehold improvements
    The shorter of term of the lease or the useful life of the asset
 
Weighted Average Assumptions Used to Estimate the Fair Value of Employee Stock Purchase Plans
The fair value of options granted and Employee Stock Purchase Plan in 2022, 2021 and 2020 is estimated at the date of grant using the following weighted average assumptions:
 
    
        Year ended December 31,        
       
    
        2022        
  
        2021        
  
        2020        
       
Employee Stock Options
             
Expected volatility
    25.56%   25.28%   23.63%
Risk-free interest rate
    3.16%   0.65%   0.32%
Dividend yield
    0.0%   0.0%   0.0%
Expected term (years)
    4.75   4.22   4.15
       
Employee Stock Purchase Plan
             
       
Expected volatility
    22.16%   22.44%   36.58%
Risk-free interest rate
    2.56%   0.24%   0.05%
Dividend yield
    0.0%   0.0%   0.0%
Expected term (years)
    0.5   0.5   0.5
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.23.1
CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Cash, Cash Equivalents, and Short-term Investments [Abstract]  
Summary of Cash, Cash Equivalents and Investments
    
December 31,
  
    
2022
     
2021
  
Cash and cash equivalents:
                  
Cash
    $ 65.8          $ 170.8      
Money market funds
      95.5            6.6      
Short term deposits
      34.7            94.5      
    
 
 
     
 
 
  
     
Total Cash and cash equivalents
      196.0            271.9      
     
Short-term bank deposits:
      431.1            492.5      
Marketable securities:
                  
Government and corporate debentures - fixed interest rate
      2,025.8            2,262.5      
Government-sponsored enterprises debentures
      755.0            641.4      
Government and corporate debentures - floating interest rate
      95.3            115.1      
    
 
 
     
 
 
  
Total Marketable securities
      2,876.1            3,019.0      
Total Cash and cash equivalents, short-term bank deposits and marketable securities
    $     3,503.2          $     3,783.4      
    
 
 
     
 
 
  
Summary of Contractual Obligation, Fiscal Year Maturity
The following table classifies the Company’s marketable securities by contractual maturities:
 
    
December 31,
  
    
2022
     
2021
  
    
Fair Value
     
Amortized

Cost
     
Fair Value
     
Amortized

Cost
  
Contractual maturity year:
                                    
Within one year
    $ 1,010.5       $ 1,024.9      $ 929.3       $ 925.8   
After one year through five years
      1,865.6         1,974.5        2,089.7         2,094.7   
    
 
 
     
 
 
     
 
 
     
 
 
  
Total
    $     2,876.1       $     2,999.4      $     3,019.0       $     3,020.5   
    
 
 
     
 
 
     
 
 
     
 
 
  
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Financial Assets Measured at Fair Value on Recurring Basis
The Company’s financial assets measured at fair value on a recurring basis, excluding accrued interest components, consisted of the following types of instruments as of the following dates:
 
    
December 31,
  
    
2022
     
2021
  
    
Fair value measurements using input type
     
Fair value measurements using input type
  
    
Level 1
     
Level 2
     
Total
     
Level 1
     
Level 2
     
Total
  
Cash
    $ 65.8      $ -        $ 65.8      $ 170.8      $ -        $ 170.8  
Cash equivalents
                                                      
Money market funds
      95.5     
-          95.5        6.6        -          6.6  
Short term deposits
      34.7        -          34.7        94.5        -          94.5  
Short-term bank deposits
      431.1        -          431.1        492.5        -          492.5  
Marketable securities:
                                                      
Government and corporate debentures-fixed interest rate
      -          2,025.8        2,025.8        -          2,262.5        2,262.5  
Government-sponsored enterprises debentures
      -          755.0        755.0        -          641.4        641.4  
Government and corporate debentures - floating interest rate
      -          95.3        95.3        -          115.1        115.1  
Foreign currency derivative contracts
      -          (3.6)        (3.6)        -          0.7        0.7  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
Total financial assets
    $     627.1      $     2,872.5      $     3,499.6      $     764.4      $     3,019.7      $     3,784.1  
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
     
 
 
  
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.23.1
PROPERTY AND EQUIPMENT, NET (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net
    
December 31,
    
2022
   
2021
Cost:
                  
Computers and peripheral equipment
    $ 78.1        $ 66.8    
Office furniture and equipment
      7.8          7.4    
Building
      78.7          78.5    
Leasehold improvements
      30.9          28.5    
    
 
 
 
   
 
 
 
     
       195.5              181.2    
Accumulated depreciation
          112.7          97.8    
    
 
 
 
   
 
 
 
     
Property and equipment, net
    $ 82.8        $ 83.4    
    
 
 
 
   
 
 
 
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.23.1
GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)
 12 Months Ended
Dec. 31, 2022
Text Block [Abstract]  
Schedule of Goodwill
  a.
Goodwill:
 
    
    2022    
     
    2021    
  
Balance as of January 1
    $ 1,196.2      $ 1,002.2  
Acquisitions
      40.5        194.0  
    
 
 
     
 
 
  
Balance as of December 31
    $     1,236.7      $     1,196.2  
    
 
 
     
 
 
  
Other Intangible Assets, Net
  b.
Intangible assets, net:
 
    
Useful
     
December 31,
    
Life
     
2022
  
2021
Original amount:
                          
Core technology
      8      $ 93.5       $ 82.2    
Trademarks and trade names
      15 – 20        25.5       25.5  
Customer relationship
      4        5.8       5.8  
             
 
 
 
  
 
 
 
       
                124.8       113.5  
             
 
 
 
  
 
 
 
       
Accumulated amortization:
                          
Core technology
               39.6       28.0  
Trademarks and trade names
               24.5       24.0  
Customer relationship
               1.9       0.5  
             
 
 
 
  
 
 
 
       
                66.0       52.5  
             
 
 
 
  
 
 
 
       
Intangible assets, net:
                          
Core technology
               53.9       54.2  
Trademarks and trade names
               1.0       1.5  
Customer relationship
               3.9       5.3  
             
 
 
 
  
 
 
 
       
              $         58.8     $         61.0  
             
 
 
 
  
 
 
 
Estimated Future Amortization Expense of Other Intangible Assets
The estimated future amortization expense of Intangible assets as of December 31, 2022 is as follows:
 
2023
    $ 11.9      
2024
      11.5      
2025
      11.1      
2026
      9.1      
2027
      6.3      
Thereafter
      8.9      
    
 
 
  
     $         58.8      
    
 
 
  
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.23.1
DEFERRED REVENUES (Tables)
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Deferred Revenues
                                           
    
December 31,
  
    
2022
     
2021
  
     
Security subscriptions
   
$
932.1
 
   
$
801.1
 
Software updates and maintenance
   
 
904.7
 
   
 
869.2
 
Other
   
 
41.0
 
   
 
36.8
 
    
 
 
     
 
 
  
     
    
$
    1,877.8
 
   
$
    1,707.1
 
    
 
 
     
 
 
  
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2022
Text Block [Abstract]  
Schedule of Accrued Expenses and Other Liabilities
The components of accrued expenses and other liabilities are as follows:
 
                                           
    
December 31,
    
2022
   
2021
     
Accrued products and licenses costs
   
$
84.4
 
   
$
102.5
 
Marketing expenses payable
   
 
8.7
 
   
 
9.8
 
Income tax payable
   
 
34.3
 
   
 
28.1
 
Legal accrual
   
 
32.0
 
   
 
39.5
 
Other accrued expenses
   
 
63.1
 
   
 
58.7
 
    
 
 
 
   
 
 
 
     
    
$
       222.5
 
   
$
       238.6
 
    
 
 
 
   
 
 
 
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.23.1
TAXES ON INCOME (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Components of Deferred Tax Assets and Liabilities As of December 31, 2022 and 2021, the Company’s deferred taxes were in respect of the following:
 
    
December 31,
    
2022
  
2021
Carry forward tax losses
    $ 38.7     $ 83.7  
Employee stock based compensation
      34.9       29.2  
Deferred revenues
      3.5       5.6  
Tax credits
      29.8       23.9  
Unrealized gains on marketable securities, net
      29.6       1.2  
Accrued employee costs
      8.1       10.3  
Other
      16.3       18.4  
    
 
 
 
  
 
 
 
     
Deferred tax assets before valuation allowance
      160.9       172.3  
Valuation allowance – mainly in respect to carryforward losses
      (17.5 )      (56.7 ) 
    
 
 
 
  
 
 
 
     
Deferred tax asset
      143.4       115.6  
    
 
 
 
  
 
 
 
Intangible assets
      (32.8 )      (31.3 ) 
Undistributed earnings of subsidiary
      (9.9 )      (9.9 ) 
Other
      (6.5 )      (8.1 ) 
    
 
 
 
  
 
 
 
     
Deferred tax liability
      (49.2 )      (49.3 ) 
    
 
 
 
  
 
 
 
     
Deferred tax asset, net
    $       94.2     $       66.3  
    
 
 
 
  
 
 
 
*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset.
Schedule of Income Before Taxes
  d.
Income before taxes on income is comprised as follows:
 
    
Year ended

December 31,
  
    
2022
     
2021
     
2020
  
       
Domestic
      $ 897.4        $ 917.9        $ 896.8  
Foreign
      30.9        31.7        74.0  
    
 
 
     
 
 
     
 
 
  
       
       $      928.3        $      949.6        $      970.8  
    
 
 
     
 
 
     
 
 
  
Components of Income Tax Expense
  e.
Taxes on income are comprised of the following:
 
    
Year ended

December 31,
    
2022
  
2021
  
2020
       
Domestic taxes:
                         
Current
      $ 117.7       $ 130.9       $ 112.0  
Deferred
      (1.3 )      (1.1 )      0.8  
    
 
 
 
  
 
 
 
  
 
 
 
       
       116.4       129.8       112.8  
    
 
 
 
  
 
 
 
  
 
 
 
Foreign taxes:
                         
Current
      12.7       7.1       1.7  
Deferred
      2.3       (2.9 )      9.7  
    
 
 
 
  
 
 
 
  
 
 
 
       
       15.0       4.2       11.4  
    
 
 
 
  
 
 
 
  
 
 
 
       
Taxes on income
      $     131.4       $     134.0       $     124.2  
    
 
 
 
  
 
 
 
  
 
 
 
Reconciliation Of Unrecognized Tax Benefits
A reconciliation of the beginning and ending amount of unrecognized tax benefits related to uncertain tax positions is as follows:
 
    
December 31,
    
2022
  
2021
     
Beginning balance
    $       469.5     $       442.8  
Increases (decreases) related to tax positions taken during prior years
      (85.4 )      47.2  
Decreases related to statute of limitations
      -       (77.2 ) 
Increases related to tax positions taken during the current year
      52.2       56.7  
    
 
 
 
  
 
 
 
     
Ending balance
    $ *)436.3     $ *)469.5  
    
 
 
 
  
 
 
 
*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset.
Schedule of Effective Income Tax Reconciliation
  g.
Reconciliation of the theoretical tax expenses:
Reconciliation between the theoretical tax expenses, assuming all income is taxed at the statutory rate in Israel and the actual income tax as reported in the statements of income is as follows:
 
    
Year ended December 31,
    
2022
  
2021
  
2020
       
Income before taxes as reported in the statements of income
    $       928.3     $       949.6     $       970.8  
    
 
 
 
  
 
 
 
  
 
 
 
       
Statutory tax rate in Israel
      23 %      23 %      23 % 
       
Decrease in taxes resulting from:
                         
Effect of “Preferred Enterprise” status *)
      (13 %)      (11 %)      (11 %) 
Others, net
      4 %      2 %      1 % 
    
 
 
 
  
 
 
 
  
 
 
 
       
Effective tax rate
      14 %      14 %      13 % 
    
 
 
 
  
 
 
 
  
 
 
 
       
*)   Basic earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status
    $ 0.95     $ 0.80     $ 0.73  
    
 
 
 
  
 
 
 
  
 
 
 
       
*)   Diluted earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status
    $ 0.94     $ 0.80     $ 0.72  
    
 
 
 
  
 
 
 
  
 
 
 
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.23.1
SHAREHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2022
Text Block [Abstract]  
Number of Reserved and Authorized Shares Under the Equity Incentive Plans
As of December 31, 2022, the number of Reserved and Authorized Shares under the Equity Incentive Plans is as detailed below:
 
         
        
Stock Options outstanding
      7,778,108  
RSU outstanding
   
 
2,219,853
 
PSU outstanding
   
 
188,493
 
Ordinary shares available for issuance under the Equity Incentive Plans
   
 
2,905,777
 
    
 
 
 
Total Reserved and Authorized Shares as of December 31, 2022
   
 
13,092,231
 
    
 
 
 
Summary of Stock Option Activity and Related Information
A summary of the Company’s stock option activity and related information is as follows:
 
    
  Number of  
options
  
    Weighted    

average

exercise

price
     
    Aggregate    

intrinsic

value
  
                           
    
2022
       
Outstanding at beginning of year
      8,160,625     $ 113.06      $ 37.1  
Granted
      710,000     $ 125.54           
Exercised
      (1,009,329 )    $ 99.89           
Forfeited
      (83,188 )    $ 122.41           
    
 
 
 
  
 
 
     
 
 
  
       
Outstanding at December 31, 2022
      7,778,108     $ 115.05      $ 82.5  
    
 
 
 
  
 
 
     
 
 
  
       
Exercisable at December 31, 2022
      5,666,608     $ 114.61      $ 65.4  
    
 
 
 
  
 
 
     
 
 
  
Summary of Restricted Stock Units Activity
A summary of the Company’s RSUs and PSUs activity is as follows:
 
    
Year ended

December 31, 2022
    
    RSUs    
  
    PSUs    
  
    Total    
       
Unvested at beginning of year
      2,231,167       105,595       2,336,762  
Granted
      958,157       160,423       1,118,580  
Vested
      (706,738)       (5,799)       (712,537)  
Forfeited
      (262,733)       (71,726)       (334,459)  
    
 
 
 
  
 
 
 
  
 
 
 
       
       2,219,853       188,493       2,408,346  
    
 
 
 
  
 
 
 
  
 
 
 
*) Represents an amount lower than 0.1
Stock-based Compensation Expense Related to Stock Options, RSUs and PSUs
Stock-based compensation expense related to stock options, RSUs and PSUs is included in the consolidated statements of income as follows:
 
    
Year ended

December 31,
  
    
        2022    
     
      2021      
     
      2020      
  
       
Cost of revenues
      $ 5.4        $ 4.8        $ 4.5  
Research and development
      42.0        31.8        23.5  
Selling and marketing
      43.2        42.8        36.8  
General and administrative
      40.8        40.9        47.7  
    
 
 
     
 
 
     
 
 
  
       
       $ 131.4        $ 120.3        $ 112.5  
    
 
 
     
 
 
     
 
 
  
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Earnings per Share
The following table sets forth the computation of basic and diluted earnings per share:
 
    
Year ended

December 31,
    
2022
   
2021
   
2020
       
Net income
      $ 796.9        $ 815.6        $ 846.6  
    
 
 
 
   
 
 
 
   
 
 
 
       
Weighted average ordinary shares outstanding
      125,205,504        133,121,763        140,495,886  
    
 
 
 
   
 
 
 
   
 
 
 
       
Dilutive effect:
                           
Employee stock options, RSUs and PSUs
      1,133,485        988,285        1,482,106  
    
 
 
 
   
 
 
 
   
 
 
 
       
Diluted weighted average ordinary shares outstanding
          126,338,989            134,110,048            141,977,992  
    
 
 
 
   
 
 
 
   
 
 
 
       
Basic earnings per ordinary share
      $ 6.37        $ 6.13        $ 6.03  
    
 
 
 
   
 
 
 
   
 
 
 
       
Diluted earnings per ordinary share
      $ 6.31        $ 6.08        $ 5.96  
    
 
 
 
   
 
 
 
   
 
 
 
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.23.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
    
Unrealized

Gains (losses)
  on marketable  
securities
  
    Unrealized    

Gains
(losses) on
cash flow
hedges
  
        Total        
       
Beginning balance
      $ (1.2 )      $ 0.6       $ (0.6 ) 
Other comprehensive income before reclassifications
      (93.4 )      (25.4 )      (118.8 ) 
Amounts reclassified from accumulated other comprehensive income
      * )      21.5       21.5  
Net current period other comprehensive income
      (93.4 )      (3.9 )      (97.3 ) 
    
 
 
 
  
 
 
 
  
 
 
 
       $ (94.6 )      $ (3.3 )      $ (97.9 ) 
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.23.1
GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA (Tables)
 12 Months Ended
Dec. 31, 2022
Text Block [Abstract]  
Summary of Revenue by Geographic Area
1. Revenues based on the channel partners’ location:
 
    
Year ended

December 31,
  
    
      2022      
     
      2021      
     
      2020      
  
       
Americas
      $ 991.1        $ 922.8        $ 929.8  
Europe, Middle East and Africa
      1,049.5        980.8        891.4  
Asia Pacific
      289.3        263.2        243.7  
    
 
 
     
 
 
     
 
 
  
       $ 2,329.9        $ 2,166.8        $ 2,064.9  
    
 
 
     
 
 
     
 
 
  
Property and Equipment, Net and Right of Use Assets by Geographic Area
2. Property and equipment, net and ROU assets:
 
    
December 31,
    
        2022        
  
        2021        
     
Israel
     $ 73.9       $ 74.4   
U.S.
      12.8       16.9  
Rest of the world
      16.8       14.1  
    
 
 
 
  
 
 
 
     
      $ 103.5      $ 105.4  
    
 
 
 
  
 
 
 
Total Revenues by Product Lines
  b.
Summary information about product lines:
The Company’s products can be classified by three main product lines. The following table presents total revenues for the years ended December 31, 2022, 2021 and 2020 by product lines:
 
    
Year ended

December 31,
    
      2022      
  
      2021      
  
      2020      
       
Product and licenses:
                         
Network security Gateways
        $ 507.8          $ 480.5          $ 472.4   
Other *)
      47.1       33.4       41.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
       554.9       513.9       513.6  
Security subscriptions
      858.0       755.2       671.1  
Software updates and maintenance
      917.0       897.7       880.2  
    
 
 
 
  
 
 
 
  
 
 
 
       
Total revenues
        $ 2,329.9         $ 2,166.8         $ 2,064.9  
    
 
 
 
  
 
 
 
  
 
 
 
 
  *)
Comprised of Endpoint security, Mobile security and Security management products, each comprising of less than 10% of products and licenses revenues.
Summary of Financial Income, Net
  c.
Financial income, net:
 
    
Year ended

December 31,
    
      2022      
   
      2021      
  
      2020      
       
Financial income:
                          
Interest income
      $ 67.6        $ 66.1       $ 78.2  
    
 
 
 
   
 
 
 
  
 
 
 
Financial expense:
                          
Amortization of marketable securities premium and accretion of discount, net
      18.5        21.0       9.4  
Realized gain on sale of marketable securities, net
      –        (1.4 )      (4.5 ) 
Foreign currency
re-measurement
(gain) loss
      3.3        (0.2 )      4.5  
Others
      1.8        4.6       2.2  
    
 
 
 
   
 
 
 
  
 
 
 
       
       23.6        24.0       11.6  
    
 
 
 
   
 
 
 
  
 
 
 
       
       $ 44.0        $ 42.1       $ 66.6  
    
 
 
 
   
 
 
 
  
 
 
 
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.23.1
General - Additional Information (Detail)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Segment
Dec. 31, 2021
USD ($)
Dec. 31, 2020
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Number of operating segments 1    
Number of Reportable segment 1    
Trade receivables | $ $ 301.2 $ 271.8  
Revenue | Two Channel Partner | Customer Concentration Risk      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Percentage of revenue derived from distribution channels 40.00% 40.00% 39.00%
Revenue | One Channel Partner | Customer Concentration Risk      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Percentage of revenue derived from distribution channels 25.00% 24.00% 22.00%
Revenue | Other Channel Partner | Customer Concentration Risk      
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]      
Percentage of revenue derived from distribution channels 15.00% 16.00% 17.00%
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Annual Rate of Depreciation on Property and Equipment (Detail)
 12 Months Ended
Dec. 31, 2022
Building  
Property, Plant and Equipment [Line Items]  
Annual rate of depreciation on property and equipment 4.00%
Leasehold improvements  
Property, Plant and Equipment [Line Items]  
Leasehold improvements The shorter of term of the lease or the useful life of the asset
Minimum | Computers and peripheral equipment  
Property, Plant and Equipment [Line Items]  
Annual rate of depreciation on property and equipment 33.00%
Minimum | Office furniture and equipment  
Property, Plant and Equipment [Line Items]  
Annual rate of depreciation on property and equipment 10.00%
Maximum | Computers and peripheral equipment  
Property, Plant and Equipment [Line Items]  
Annual rate of depreciation on property and equipment 50.00%
Maximum | Office furniture and equipment  
Property, Plant and Equipment [Line Items]  
Annual rate of depreciation on property and equipment 20.00%
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies - Additional Information (Detail)
$ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Segment
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Significant Accounting Policies [Line Items]      
Number of operating segments | Segment 1    
Goodwill impairment losses $ 0.0 $ 0.0 $ 0.0
Deferred revenue 1,877.8 1,707.1  
Revenue expected to be recognized from remaining performance obligations 2,146.1 2,013.6  
Revenue expected to be recognized from remaining performance obligations, 2019 1,437.3    
Provision for estimated sales returns, rebates, stock rotations, and other customer rights $ 9.5 10.4  
Percentage of employee contributions contributed by employer towards employee benefit plan 50.00%    
Maximum percentage of employee's eligible compensation 6.00%    
Minimum percentage of tax benefit realized upon settlement 50.00%    
Advertising expenses $ 4.6 $ 4.1 $ 3.7
Anti-dilutive shares excluded from computation of earnings per share amount | shares 1,700,000 4,900,000 6,200,000
Right of use assets $ 20.8    
Lease liabilities 20.3    
Rent expenses $ 6.3 $ 8.1 $ 13.1
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other Assets, Noncurrent    
Operating Lease, Liability, Statement of Financial Position [Extensible List] Lease liabilities    
Manufacturing partner and supplier liabilities      
Significant Accounting Policies [Line Items]      
Significant costs associated with exposure $ 0.0 0.0  
Other Long Term Assets      
Significant Accounting Policies [Line Items]      
Deferred commission 15.3 17.1  
Amortisation of contracted capitalised costs 10.4 11.6 15.3
Security Subscriptions and Software Updates and Maintenance      
Significant Accounting Policies [Line Items]      
Deferred revenue 1,257.4 1,108.6  
Foreign Exchange Forward Contracts | Not Designated as Hedging Instrument      
Significant Accounting Policies [Line Items]      
Derivative, notional amount 207.9 171.1  
Foreign Exchange Forward Contracts | Designated as Hedging Instrument | Cash Flow Hedging      
Significant Accounting Policies [Line Items]      
Derivative, notional amount 266.2 155.0  
Foreign Exchange Forward Contracts | Financial Income | Not Designated as Hedging Instrument      
Significant Accounting Policies [Line Items]      
Derivative, net gain (loss) (19.5) (0.6) 24.8
Foreign Exchange Forward Contracts | Operating Expenses | Designated as Hedging Instrument | Cash Flow Hedging      
Significant Accounting Policies [Line Items]      
Derivative, net gain (loss) $ (24.4) $ 1.1 $ 5.9
Minimum      
Significant Accounting Policies [Line Items]      
Estimated useful lives of intangible assets 4 years    
Maximum      
Significant Accounting Policies [Line Items]      
Estimated useful lives of intangible assets 20 years    
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Weighted Average Assumptions of Options Granted (Detail)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Employee Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected volatility 25.56% 25.28% 23.63%
Risk-free interest rate 3.16% 0.65% 0.32%
Dividend yield 0.00% 0.00% 0.00%
Expected term (years) 4 years 9 months 4 years 2 months 19 days 4 years 1 month 24 days
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected volatility 22.16% 22.44% 36.58%
Risk-free interest rate 2.56% 0.24% 0.05%
Dividend yield 0.00% 0.00% 0.00%
Expected term (years) 15 days 15 days 15 days
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Acquisition - Additional Information (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Avanan Member      
Business Acquisition [Line Items]      
Acquisition date   Sep. 01, 2021  
Business combination, consideration transferred $ 227.1    
Odo Security Ltd [Member]      
Business Acquisition [Line Items]      
Acquisition date     Sep. 17, 2020
Spectral Cyber Technologies Ltd [Member]      
Business Acquisition [Line Items]      
Acquisition date Feb. 03, 2022    
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities - Schedule Of Cash And Cash Equivalents And Short Term Investments (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]    
Cash $ 65.8 $ 170.8
Money market funds 95.5 6.6
Short term deposits 34.7 94.5
Total Cash and cash equivalents 196.0 271.9
Short-term bank deposits 431.1 492.5
Marketable securities:    
Government and corporate debentures 1,010.5 929.3
Total Marketable securities 2,876.1 3,019.0
Total Cash and cash equivalents, short-term bank deposits and marketable securities 3,503.2 3,783.4
Government And Corporate Debentures Fixed Interest Rate [Member]    
Marketable securities:    
Government and corporate debentures 2,025.8 2,262.5
Government Sponsored Enterprises Debentures [Member]    
Marketable securities:    
Government and corporate debentures 755.0 641.4
Government And Corporate Debentures Floating Interest Rate [Member]    
Marketable securities:    
Government and corporate debentures $ 95.3 $ 115.1
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Cash And Cash Equivalents, Short-Contractual Obligation Fiscal Year Maturity Schedule TableTerm Bank Deposits And Marketable Securities - (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Contractual Obligation Fiscal Year Maturity Schedule [Line Items]    
Fair value of marketable securities by contractual maturities $ 2,876.1 $ 3,019.0
Amortized Cost of marketable securities by contractual maturities 2,999.4 3,020.5
Within One Year [Member]    
Contractual Obligation Fiscal Year Maturity Schedule [Line Items]    
Fair value of marketable securities by contractual maturities 1,010.5 929.3
Amortized Cost of marketable securities by contractual maturities 1,024.9 925.8
After One Year Through Five Years [Member]    
Contractual Obligation Fiscal Year Maturity Schedule [Line Items]    
Fair value of marketable securities by contractual maturities 1,865.6 2,089.7
Amortized Cost of marketable securities by contractual maturities $ 1,974.5 $ 2,094.7
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities- Additional Information (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]    
Gross unrealized gains on the marketable securities $ 123.4 $ 15.7
Gross unrealized Losses on the marketable securities 123.4  
Continuous Unrealized Loss Position 87.3  
Prepaid Expenses and Other Current Assets [Member]    
Debt Securities, Available-for-sale [Line Items]    
Interest receivable 15.6 15.3
Marketable securites [Member]    
Debt Securities, Available-for-sale [Line Items]    
Gross unrealized gains on the marketable securities $ 0.1 $ 14.2
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Assets Measured at Fair Value on Recurring Basis (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Short-term bank deposits $ 431.1 $ 492.5
Foreign currency derivative contracts (3.6) 0.7
Total financial assets 3,499.6 3,784.1
Cash [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 65.8 170.8
Money Market Funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 95.5 6.6
Government And Corporate Debentures Fixed Interest Rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 2,025.8 2,262.5
Government And Corporate Debentures Floating Interest Rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 95.3 115.1
Short term deposits    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 34.7 94.5
Government Sponsored Enterprises Debentures    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 755.0 641.4
Fair Value, Inputs, Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Short-term bank deposits 431.1 492.5
Total financial assets 627.1 764.4
Fair Value, Inputs, Level 1 | Cash [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 65.8 170.8
Fair Value, Inputs, Level 1 | Money Market Funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 95.5 6.6
Fair Value, Inputs, Level 1 | Short term deposits    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents 34.7 94.5
Fair Value, Inputs, Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Foreign currency derivative contracts (3.6) 0.7
Total financial assets 2,872.5 3,019.7
Fair Value, Inputs, Level 2 | Government And Corporate Debentures Fixed Interest Rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 2,025.8 2,262.5
Fair Value, Inputs, Level 2 | Government And Corporate Debentures Floating Interest Rate    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities 95.3 115.1
Fair Value, Inputs, Level 2 | Government Sponsored Enterprises Debentures    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities $ 755.0 $ 641.4
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment Net (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 195.5 $ 181.2
Leasehold improvements 30.9 28.5
Accumulated depreciation 112.7 97.8
Property and equipment, net 82.8 83.4
Computers and peripheral equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 78.1 66.8
Office furniture and equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 7.8 7.4
Building    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 78.7 $ 78.5
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Goodwill (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
Balance as of January 1 $ 1,196.2 $ 1,002.2
Acquisitions 40.5 194.0
Balance as of December 31 $ 1,236.7 $ 1,196.2
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Other Intangible Assets, Net (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Original amount $ 124.8 $ 113.5
Accumulated amortization 66.0 52.5
Other intangible assets, net $ 58.8 61.0
Minimum    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives of intangible assets 4 years  
Maximum    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives of intangible assets 20 years  
Core Technology    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives of intangible assets 8 years  
Original amount $ 93.5 82.2
Accumulated amortization 39.6 28.0
Other intangible assets, net 53.9 54.2
Trademarks and trade names    
Finite-Lived Intangible Assets [Line Items]    
Original amount 25.5 25.5
Accumulated amortization 24.5 24.0
Other intangible assets, net $ 1.0 1.5
Trademarks and trade names | Minimum    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives of intangible assets 15 years  
Trademarks and trade names | Maximum    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives of intangible assets 20 years  
Customer relationship    
Finite-Lived Intangible Assets [Line Items]    
Estimated useful lives of intangible assets 4 years  
Original amount $ 5.8 5.8
Accumulated amortization 1.9 0.5
Other intangible assets, net $ 3.9 $ 5.3
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Estimated Future Amortization Expense of Other Intangible Assets (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]    
2023 $ 11.9  
2024 11.5  
2025 11.1  
2026 9.1  
2027 6.3  
Thereafter 8.9  
Other intangible assets, net $ 58.8 $ 61.0
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Deferred Revenues (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Deferred Revenue Arrangement [Line Items]    
Deferred revenue $ 1,877.8 $ 1,707.1
Security subscriptions    
Deferred Revenue Arrangement [Line Items]    
Deferred revenue 932.1 801.1
Software updates and maintenance    
Deferred Revenue Arrangement [Line Items]    
Deferred revenue 904.7 869.2
Other    
Deferred Revenue Arrangement [Line Items]    
Deferred revenue $ 41.0 $ 36.8
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Accrued Expenses and Other Liabilities (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Accrued Liabilities and Other Liabilities [Abstract]    
Accrued products and licenses costs $ 84.4 $ 102.5
Marketing expenses payable 8.7 9.8
Income tax payable 34.3 28.1
Legal accrual 32.0 39.5
Other accrued expenses 63.1 58.7
Accrued expenses and other liabilities total $ 222.5 $ 238.6
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments And Contingent Liabilities - Additional Information (Detail) - Jan. 01, 2023 - Israel Tax Authority [Member] - Subsequent Event [Member]
₪ in Millions, $ in Millions
ILS (₪)
USD ($)
USD ($)
Tax Year 2016 Through 2019 [Member]      
Loss Contingencies [Line Items]      
Additional payment of income tax ₪ 428   $ 122
payment related to timing differences 418 $ 119  
Tax Year 2020 [Member]      
Loss Contingencies [Line Items]      
Additional payment of income tax ₪ 74   $ 21
Year under Income Tax Examination 2020 2020  
payment related to timing differences ₪ 94 $ 27  
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Taxes On Income - Additional Information (Detail)
₪ in Millions, $ in Millions
 12 Months Ended
Jan. 01, 2023
ILS (₪)
Jan. 01, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jan. 01, 2023
USD ($)
Operating Loss Carryforwards [Line Items]            
Corporate tax rate     23.00%      
Undistributed earnings of foreign subsidiaries     $ 450.3      
Unrecognized deferred tax liability on undistributed earnings of foreign subsidiaries     73.9      
Uncertain tax positions interest expense     15.9 $ 9.7 $ 0.6  
Uncertain tax positions accrued interest     $ 60.0 $ 44.1    
Maximum            
Operating Loss Carryforwards [Line Items]            
Dividend income tax rate     20.00%      
Minimum            
Operating Loss Carryforwards [Line Items]            
Dividend income tax rate     15.00%      
U S Federal            
Operating Loss Carryforwards [Line Items]            
U.S. loss carry forward     $ 126.7      
Operating loss carry forward expiration years     2023      
U S State            
Operating Loss Carryforwards [Line Items]            
U.S. loss carry forward     $ 80.3      
Operating loss carry forward expiration years     2023      
Research And Development Tax Credit            
Operating Loss Carryforwards [Line Items]            
U.S. loss carry forward     $ 25.6      
Research And Development Tax Credit | Maximum            
Operating Loss Carryforwards [Line Items]            
Operating loss carry forward expiration years     2042      
Research And Development Tax Credit | Minimum            
Operating Loss Carryforwards [Line Items]            
Operating loss carry forward expiration years     2023      
Technological Preferred Enterprise            
Operating Loss Carryforwards [Line Items]            
Enacted effective income tax rate     12.00%      
Subsequent Event [Member] | Tax Year 2016 Through 2019 [Member] | Israel Tax Authority [Member]            
Operating Loss Carryforwards [Line Items]            
Additional payment of income tax ₪ 428         $ 122.0
payment related to timing differences 418 $ 119.0        
Subsequent Event [Member] | Tax Year 2020 [Member] | Israel Tax Authority [Member]            
Operating Loss Carryforwards [Line Items]            
Additional payment of income tax ₪ 74         $ 21.0
Year under Income Tax Examination 2020 2020        
payment related to timing differences ₪ 94 $ 27.0        
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Components of Deferred Tax Assets and Liabilities (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Carry forward tax losses $ 38.7 $ 83.7
Employee stock based compensation 34.9 29.2
Deferred revenues 3.5 5.6
Tax credits 29.8 23.9
Unrealized gains on marketable securities, net 29.6 1.2
Accrued employee costs 8.1 10.3
Other 16.3 18.4
Deferred tax assets before valuation allowance 160.9 172.3
Valuation allowance - mainly in respect to carryforward losses (17.5) (56.7)
Deferred tax asset 143.4 115.6
Intangible assets (32.8) (31.3)
Undistributed earnings of subsidiary (9.9) (9.9)
Other (6.5) (8.1)
Deferred tax liability (49.2) (49.3)
Deferred tax asset, net $ 94.2 $ 66.3
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Income Before Taxes (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Domestic $ 897.4 $ 917.9 $ 896.8
Foreign 30.9 31.7 74.0
Income before taxes on income $ 928.3 $ 949.6 $ 970.8
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Components of Income Tax Expense (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Expense Benefit [Line Items]      
Taxes on income $ 131.4 $ 134.0 $ 124.2
Domestic Tax Authority      
Income Tax Expense Benefit [Line Items]      
Current 117.7 130.9 112.0
Deferred (1.3) (1.1) 0.8
Domestic 116.4 129.8 112.8
U.S.      
Income Tax Expense Benefit [Line Items]      
Foreign taxes, Current 12.7 7.1 1.7
Foreign taxes, Deferred 2.3 (2.9) 9.7
Foreign $ 15.0 $ 4.2 $ 11.4
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Reconciliation of Unrecognized Tax Benefits (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Beginning balance $ 469.5 [1] $ 442.8
Increases (decreases) related to tax positions taken during prior years (85.4) 47.2
Decreases related to statute of limitations 0.0 (77.2)
Increases related to tax positions taken during the current year 52.2 56.7
Ending balance [1] $ 436.3 $ 469.5
[1] As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset.
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.23.1
Reconciliation of Unrecognized Tax Benefits (Parenthetical) (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Unrecognized tax benefit $ 16.6 $ 14.6
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.23.1
Effective Income Tax Reconciliation (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Income before taxes as reported in the statements of income $ 928.3 $ 949.6 $ 970.8
Statutory tax rate in Israel 23.00% 23.00% 23.00%
Effect of "Preferred Enterprise" status (13.00%) (11.00%) (11.00%)
Others, net 4.00% 2.00% 1.00%
Effective tax rate 14.00% 14.00% 13.00%
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Effective Income Tax Reconciliation (Parenthetical) (Detail) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]      
Basic earnings per share amounts of the benefit resulting from the "Technological preferred or Preferred Enterprise" status $ 0.95 $ 0.8 $ 0.73
Diluted earnings per share amounts of the benefit resulting from the "Technological preferred or Preferred Enterprise" status $ 0.94 $ 0.8 $ 0.72
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Feb. 13, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Aggregate ordinary shares repurchase $ 13,085.1      
Shares repurchase, shares 10,324,181 10,900,938 11,376,531  
Shares repurchase, value $ 1,299.9 $ 1,299.5 $ 1,297.7  
Weighted average fair value granted under options $ 34.6 $ 25.9 $ 22  
Total intrinsic value of options exercised $ 32.9 $ 65.1 $ 81.7  
Total fair value of restricted stock units vested 89.4 66.8 $ 49.6  
Unrecognized compensation expense $ 265.8      
Unrecognized compensation expense expected period of recognition (in years) 1 year 10 months 24 days      
Options to purchase ordinary shares reserved for issuance 13,092,231      
Share based compensation arrangement by share based payment award options outstanding intrinsic value $ 82.5 $ 37.1    
Share based compensation arrangement by share based payment award equity instruments other than options non vested number 2,408,346 2,336,762    
Share Based Compensation Aggregate Amount Including Options And Units Aggregate Share Outstanding 130,948,425      
Options In The Money        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share based compensation arrangement by share based payment award options nonvested number of shares 7,651,858 6,484,417    
Options Out Of Money        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share based compensation arrangement by share based payment award options nonvested number of shares 126,250 1,676,208    
Share based compensation arrangement by share based payment award options outstanding intrinsic value $ 0.0 $ 0.0    
Share Repurchase Program        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Authorized amount under share repurchase programs per quarter       $ 2,000.0
Authorized amount under share repurchase programs       $ 325.0
Two Thousand Five Equity Incentive Plans        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Reserved and Authorized Shares, percent of ordinary shares issued and outstanding at year end 10.00%      
Employee Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Ordinary shares issued 2,250,867      
Percentage of salary to purchase Ordinary shares     15.00%  
Ordinary shares per employee, maximum     1,250  
Price of Ordinary shares purchased under ESPP, percentage of lower of fair market value of Ordinary share on subscription date of each offering period or on purchase date     85.00%  
Purchase of Ordinary shares by employees 372,242 361,675 364,859  
Average price per share purchased by employees $ 103.5 $ 105.3 $ 95.4  
Compensation expense recognized $ 9.9 $ 10.9 $ 10.2  
US ESPP        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options to purchase ordinary shares reserved for issuance 568,478      
Number of shares available under ESPP 750,000      
Rest of the World ESPP        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options to purchase ordinary shares reserved for issuance 1,096,795      
Performance Stock Units PSU        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period 4 years      
Share based compensation arrangement by share based payment award equity instruments other than options non vested number 188,493 105,595    
Performance Stock Units PSU | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share based compensation arrangement by share based payment award equity instruments other than options non vested number 0.1      
Phantom Share Units (PSUs) [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Weighted average fair value of stock units granted $ 126.3 $ 120.1 $ 105.3  
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.23.1
Number of Reserved and Authorized Shares Under the Equity Incentive Plans (Detail) - shares
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock Options outstanding 7,778,108 8,160,625
Stock unit outstanding 2,408,346 2,336,762
Ordinary shares available for issuance under the Equity Incentive Plans 2,905,777  
Total Reserved and Authorized Shares as of December 31, 2022 13,092,231  
Restricted Stock Units (RSUs)    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock unit outstanding 2,219,853 2,231,167
Performance Stock Units PSU    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Stock unit outstanding 188,493 105,595
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Option Activity and Related Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Options, Outstanding at beginning of year 8,160,625  
Options, Granted 710,000  
Options, Exercised (1,009,329)  
Options, Forfeited (83,188)  
Outstanding at December 31, 2022 7,778,108  
Options, Exercisable at December 31, 2022 5,666,608  
Weighted average exercise price, Outstanding at beginning of year $ 113.06  
Weighted average exercise price, Granted 125.54  
Weighted average exercise price, Exercised 99.89  
Weighted average exercise price, Forfeited 122.41  
Weighted average exercise price, Outstanding at December 31, 2022 115.05  
Weighted average exercise price, Exercisable at December 31, 2022 $ 114.61  
Aggregate intrinsic value, Outstanding $ 82.5 $ 37.1
Aggregate intrinsic value, Exercisable as of December 31, 2022 $ 65.4  
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Performance Stock Units Activity (Detail)
 12 Months Ended
Dec. 31, 2022
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unvested at beginning of year 2,336,762
Granted 1,118,580
Vested (712,537)
Forfeited (334,459)
Unvested the end of the year 2,408,346
Performance Stock Units PSU  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unvested at beginning of year 105,595
Granted 160,423
Vested (5,799)
Forfeited (71,726)
Unvested the end of the year 188,493
Restricted Stock Units (RSUs) [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unvested at beginning of year 2,231,167
Granted 958,157
Vested (706,738)
Forfeited (262,733)
Unvested the end of the year 2,219,853
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders' Equity - Stock-based Compensation Expense Related to Stock Options, RSUs and PSUs (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation $ 131.4 $ 120.3 $ 112.5
Cost of Revenues      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation 5.4 4.8 4.5
Research and Development      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation 42.0 31.8 23.5
Selling and Marketing      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation 43.2 42.8 36.8
General and Administrative      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Stock-based compensation $ 40.8 $ 40.9 $ 47.7
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE - Computation of Basic and Diluted Earnings per Share (Detail) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Earnings Per Share [Abstract]      
Net income $ 796.9 $ 815.6 $ 846.6
Weighted average ordinary shares outstanding 125,205,504 133,121,763 140,495,886
Employee stock options, RSUs and PSUs 1,133,485 988,285 1,482,106
Diluted weighted average ordinary shares outstanding 126,338,989 134,110,048 141,977,992
Basic earnings per ordinary share $ 6.37 $ 6.13 $ 6.03
Diluted earnings per ordinary share $ 6.31 $ 6.08 $ 5.96
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.23.1
Accumulated Other Comprehensive Income (Loss) - Schedule Of Accumulated Other Comprehensive Income Loss (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning balance $ (0.6)    
Other comprehensive income before reclassifications (118.8)    
Amounts reclassified from accumulated other comprehensive income 21.5    
Net current period other comprehensive income (97.3) $ (41.3) $ 19.0
Ending balance (97.9) (0.6)  
Unrealized Gains (losses) on marketable securities      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning balance (1.2)    
Other comprehensive income before reclassifications (93.4)    
Amounts reclassified from accumulated other comprehensive income    
Net current period other comprehensive income (93.4)    
Ending balance (94.6) (1.2)  
Unrealized Gains (losses) on cash flow hedges      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning balance 0.6    
Other comprehensive income before reclassifications (25.4)    
Amounts reclassified from accumulated other comprehensive income 21.5    
Net current period other comprehensive income (3.9)    
Ending balance $ (3.3) $ 0.6  
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue by Geographic Area (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Geographical Information [Line Items]      
Total revenues $ 2,329.9 $ 2,166.8 $ 2,064.9
Americas      
Schedule Of Geographical Information [Line Items]      
Total revenues 991.1 922.8 929.8
Europe, Middle East and Africa      
Schedule Of Geographical Information [Line Items]      
Total revenues 1,049.5 980.8 891.4
Asia Pacific      
Schedule Of Geographical Information [Line Items]      
Total revenues $ 289.3 $ 263.2 $ 243.7
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment, Net and Right of Use Assets by Geographic Area (Detail) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Geographical Information [Line Items]    
Property and equipment, net and ROU assets $ 103.5 $ 105.4
Israel    
Schedule Of Geographical Information [Line Items]    
Property and equipment, net and ROU assets 73.9 74.4
U.S.    
Schedule Of Geographical Information [Line Items]    
Property and equipment, net and ROU assets 12.8 16.9
Rest of the world    
Schedule Of Geographical Information [Line Items]    
Property and equipment, net and ROU assets $ 16.8 $ 14.1
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.23.1
Revenues by Product Lines (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue from External Customer [Line Items]      
Total revenues $ 2,329.9 $ 2,166.8 $ 2,064.9
Network Security Gateways      
Revenue from External Customer [Line Items]      
Total revenues 507.8 480.5 472.4
Other      
Revenue from External Customer [Line Items]      
Total revenues 47.1 33.4 41.2
Products and licenses      
Revenue from External Customer [Line Items]      
Total revenues 554.9 513.9 513.6
Security subscriptions      
Revenue from External Customer [Line Items]      
Total revenues 858.0 755.2 671.1
Software updates and maintenance      
Revenue from External Customer [Line Items]      
Total revenues $ 917.0 $ 897.7 $ 880.2
XML 84 R72.htm IDEA: XBRL DOCUMENT v3.23.1
Revenues by Product Lines (Parenthetical) (Detail)
 12 Months Ended
Dec. 31, 2022
Products and Licenses Revenues | Product Concentration Risk | Other  
Revenue from External Customer [Line Items]  
Concentration Risk, Percentage 10.00%
XML 85 R73.htm IDEA: XBRL DOCUMENT v3.23.1
Geographic Information and Selected Statements of Income Data - Additional Information (Detail)
 12 Months Ended
Dec. 31, 2022
Product
Segment Reporting [Abstract]  
Number of main product lines 3
XML 86 R74.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Income, Net (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule of Trading Securities and Other Trading Assets [Line Items]      
Amortization of marketable securities premium and accretion of discount, net $ 18.5 $ 21.0 $ 9.4
Realized gain on sale of marketable securities, net 0.0 (1.4) (4.5)
Financial income, net 44.0 42.1 66.6
Financial Income      
Schedule of Trading Securities and Other Trading Assets [Line Items]      
Interest income 67.6 66.1 78.2
Financial Expense      
Schedule of Trading Securities and Other Trading Assets [Line Items]      
Amortization of marketable securities premium and accretion of discount, net 18.5 21.0 9.4
Realized gain on sale of marketable securities, net 0.0 (1.4) (4.5)
Foreign currency re-measurement (gain) loss 3.3 (0.2) 4.5
Others 1.8 4.6 2.2
Total financial expense $ 23.6 $ 24.0 $ 11.6
XML 87 d473301d20f_htm.xml IDEA: XBRL DOCUMENT 0001015922 2021-12-31 0001015922 2022-12-31 0001015922 2022-01-01 2022-12-31 0001015922 2021-01-01 2021-12-31 0001015922 2020-01-01 2020-12-31 0001015922 2020-12-31 0001015922 2019-12-31 0001015922 us-gaap:CashMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001015922 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001015922 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001015922 us-gaap:CashMember 2021-12-31 0001015922 us-gaap:MoneyMarketFundsMember 2021-12-31 0001015922 us-gaap:BankTimeDepositsMember 2021-12-31 0001015922 us-gaap:SubscriptionArrangementMember 2021-12-31 0001015922 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2021-12-31 0001015922 chkp:OtherArrangementMember 2021-12-31 0001015922 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFixedInterestRateMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFixedInterestRateMember 2021-12-31 0001015922 us-gaap:FairValueInputsLevel2Member chkp:GovernmentSponsoredEnterprisesDebenturesMember 2021-12-31 0001015922 chkp:GovernmentSponsoredEnterprisesDebenturesMember 2021-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFloatingInterestRateMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFloatingInterestRateMember 2021-12-31 0001015922 country:IL 2021-12-31 0001015922 country:US 2021-12-31 0001015922 chkp:RestOfWorldMember 2021-12-31 0001015922 chkp:CoreTechnologyMember 2021-12-31 0001015922 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001015922 us-gaap:CustomerRelationshipsMember 2021-12-31 0001015922 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001015922 us-gaap:ComputerEquipmentMember 2021-12-31 0001015922 us-gaap:OfficeEquipmentMember 2021-12-31 0001015922 us-gaap:BuildingMember 2021-12-31 0001015922 chkp:ManufacturingPartnerAndSupplierLiabilitiesMember 2021-12-31 0001015922 chkp:SecuritySubscriptionsAndSoftwareUpdatesAndMaintenanceMember 2021-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2021-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2021-12-31 0001015922 chkp:OptionsInTheMoneyMember 2021-12-31 0001015922 chkp:OptionsOutOfMoneyMember 2021-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2021-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001015922 chkp:GovernmentSponsoredEnterprisesDebenturesMember 2021-12-31 0001015922 chkp:WithinOneYearMember 2021-12-31 0001015922 chkp:AfterOneYearThroughFiveYearsMember 2021-12-31 0001015922 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2021-12-31 0001015922 us-gaap:CashMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001015922 us-gaap:CashMember 2022-12-31 0001015922 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001015922 us-gaap:MoneyMarketFundsMember 2022-12-31 0001015922 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001015922 us-gaap:BankTimeDepositsMember 2022-12-31 0001015922 us-gaap:SubscriptionArrangementMember 2022-12-31 0001015922 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2022-12-31 0001015922 chkp:OtherArrangementMember 2022-12-31 0001015922 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001015922 chkp:PerformanceStockUnitsPsuMember 2022-12-31 0001015922 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFixedInterestRateMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFixedInterestRateMember 2022-12-31 0001015922 us-gaap:FairValueInputsLevel2Member chkp:GovernmentSponsoredEnterprisesDebenturesMember 2022-12-31 0001015922 chkp:GovernmentSponsoredEnterprisesDebenturesMember 2022-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFloatingInterestRateMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001015922 chkp:GovernmentAndCorporateDebenturesFloatingInterestRateMember 2022-12-31 0001015922 country:IL 2022-12-31 0001015922 country:US 2022-12-31 0001015922 chkp:RestOfWorldMember 2022-12-31 0001015922 chkp:CoreTechnologyMember 2022-12-31 0001015922 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001015922 us-gaap:CustomerRelationshipsMember 2022-12-31 0001015922 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001015922 us-gaap:ComputerEquipmentMember 2022-12-31 0001015922 us-gaap:OfficeEquipmentMember 2022-12-31 0001015922 us-gaap:BuildingMember 2022-12-31 0001015922 chkp:ManufacturingPartnerAndSupplierLiabilitiesMember 2022-12-31 0001015922 chkp:SecuritySubscriptionsAndSoftwareUpdatesAndMaintenanceMember 2022-12-31 0001015922 chkp:ResearchAndDevelopmentTaxCreditMember 2022-12-31 0001015922 chkp:USFederalMember 2022-12-31 0001015922 chkp:USStateMember 2022-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2022-12-31 0001015922 chkp:EmployeeStockPurchasePlanDomesticMember 2022-12-31 0001015922 chkp:EmployeeStockPurchasePlanForeignMember 2022-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2022-12-31 0001015922 chkp:OptionsInTheMoneyMember 2022-12-31 0001015922 chkp:OptionsOutOfMoneyMember 2022-12-31 0001015922 srt:MinimumMember chkp:PerformanceStockUnitsPsuMember 2022-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001015922 chkp:GovernmentSponsoredEnterprisesDebenturesMember 2022-12-31 0001015922 chkp:WithinOneYearMember 2022-12-31 0001015922 chkp:AfterOneYearThroughFiveYearsMember 2022-12-31 0001015922 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2022-12-31 0001015922 chkp:OdoSecurityLtdMember 2020-01-01 2020-12-31 0001015922 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2020-01-01 2020-12-31 0001015922 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001015922 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001015922 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-12-31 0001015922 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001015922 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember chkp:TwoChannelPartnerMember 2020-01-01 2020-12-31 0001015922 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember chkp:OneChannelPartnerMember 2020-01-01 2020-12-31 0001015922 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember chkp:OtherChannelPartnerMember 2020-01-01 2020-12-31 0001015922 chkp:FinancialExpenseMember 2020-01-01 2020-12-31 0001015922 chkp:FinancialIncomeMember 2020-01-01 2020-12-31 0001015922 srt:AmericasMember 2020-01-01 2020-12-31 0001015922 us-gaap:EMEAMember 2020-01-01 2020-12-31 0001015922 srt:AsiaPacificMember 2020-01-01 2020-12-31 0001015922 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0001015922 chkp:NetworkSecurityGatewaysMember 2020-01-01 2020-12-31 0001015922 chkp:OtherProductMember 2020-01-01 2020-12-31 0001015922 chkp:ProductAndLicensingMember 2020-01-01 2020-12-31 0001015922 chkp:SecuritySubscriptionsMember 2020-01-01 2020-12-31 0001015922 chkp:SoftwareUpdatesAndMaintenanceMember 2020-01-01 2020-12-31 0001015922 country:US 2020-01-01 2020-12-31 0001015922 chkp:AmortizationOfTechnologyMember 2020-01-01 2020-12-31 0001015922 us-gaap:PhantomShareUnitsPSUsMember 2020-01-01 2020-12-31 0001015922 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001015922 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember chkp:FinancialIncomeMember 2020-01-01 2020-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OperatingExpenseMember 2020-01-01 2020-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2020-01-01 2020-12-31 0001015922 chkp:AvananMember 2021-01-01 2021-12-31 0001015922 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2021-01-01 2021-12-31 0001015922 us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001015922 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-12-31 0001015922 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-12-31 0001015922 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001015922 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember chkp:TwoChannelPartnerMember 2021-01-01 2021-12-31 0001015922 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember chkp:OneChannelPartnerMember 2021-01-01 2021-12-31 0001015922 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember chkp:OtherChannelPartnerMember 2021-01-01 2021-12-31 0001015922 chkp:FinancialExpenseMember 2021-01-01 2021-12-31 0001015922 chkp:FinancialIncomeMember 2021-01-01 2021-12-31 0001015922 srt:AmericasMember 2021-01-01 2021-12-31 0001015922 us-gaap:EMEAMember 2021-01-01 2021-12-31 0001015922 srt:AsiaPacificMember 2021-01-01 2021-12-31 0001015922 us-gaap:DomesticCountryMember 2021-01-01 2021-12-31 0001015922 chkp:NetworkSecurityGatewaysMember 2021-01-01 2021-12-31 0001015922 chkp:OtherProductMember 2021-01-01 2021-12-31 0001015922 chkp:ProductAndLicensingMember 2021-01-01 2021-12-31 0001015922 chkp:SecuritySubscriptionsMember 2021-01-01 2021-12-31 0001015922 chkp:SoftwareUpdatesAndMaintenanceMember 2021-01-01 2021-12-31 0001015922 country:US 2021-01-01 2021-12-31 0001015922 chkp:AmortizationOfTechnologyMember 2021-01-01 2021-12-31 0001015922 us-gaap:PhantomShareUnitsPSUsMember 2021-01-01 2021-12-31 0001015922 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001015922 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember chkp:FinancialIncomeMember 2021-01-01 2021-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OperatingExpenseMember 2021-01-01 2021-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2021-01-01 2021-12-31 0001015922 chkp:MarketableSecuritesMember 2021-01-01 2021-12-31 0001015922 chkp:SpectralCyberTechnologiesLtdMember 2022-01-01 2022-12-31 0001015922 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001015922 chkp:EmployeeStockPurchasePlanMember 2022-01-01 2022-12-31 0001015922 chkp:TechnologicalPreferredEnterpriseMember 2022-01-01 2022-12-31 0001015922 us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001015922 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-12-31 0001015922 us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-12-31 0001015922 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001015922 chkp:OtherProductMember chkp:ProductsAndLicensesRevenuesMember us-gaap:ProductConcentrationRiskMember 2022-01-01 2022-12-31 0001015922 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember chkp:TwoChannelPartnerMember 2022-01-01 2022-12-31 0001015922 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember chkp:OneChannelPartnerMember 2022-01-01 2022-12-31 0001015922 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember chkp:OtherChannelPartnerMember 2022-01-01 2022-12-31 0001015922 srt:MinimumMember 2022-01-01 2022-12-31 0001015922 srt:MaximumMember 2022-01-01 2022-12-31 0001015922 chkp:CoreTechnologyMember 2022-01-01 2022-12-31 0001015922 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001015922 srt:MinimumMember us-gaap:TrademarksAndTradeNamesMember 2022-01-01 2022-12-31 0001015922 srt:MaximumMember us-gaap:TrademarksAndTradeNamesMember 2022-01-01 2022-12-31 0001015922 chkp:FinancialExpenseMember 2022-01-01 2022-12-31 0001015922 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001015922 chkp:PerformanceStockUnitsPsuMember 2022-01-01 2022-12-31 0001015922 chkp:FinancialIncomeMember 2022-01-01 2022-12-31 0001015922 srt:AmericasMember 2022-01-01 2022-12-31 0001015922 us-gaap:EMEAMember 2022-01-01 2022-12-31 0001015922 srt:AsiaPacificMember 2022-01-01 2022-12-31 0001015922 us-gaap:DomesticCountryMember 2022-01-01 2022-12-31 0001015922 us-gaap:BuildingMember 2022-01-01 2022-12-31 0001015922 srt:MinimumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001015922 srt:MaximumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001015922 srt:MinimumMember us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001015922 srt:MaximumMember us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001015922 chkp:NetworkSecurityGatewaysMember 2022-01-01 2022-12-31 0001015922 chkp:OtherProductMember 2022-01-01 2022-12-31 0001015922 chkp:ProductAndLicensingMember 2022-01-01 2022-12-31 0001015922 chkp:SecuritySubscriptionsMember 2022-01-01 2022-12-31 0001015922 chkp:SoftwareUpdatesAndMaintenanceMember 2022-01-01 2022-12-31 0001015922 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001015922 country:US 2022-01-01 2022-12-31 0001015922 srt:MinimumMember chkp:ResearchAndDevelopmentTaxCreditMember 2022-01-01 2022-12-31 0001015922 srt:MaximumMember chkp:ResearchAndDevelopmentTaxCreditMember 2022-01-01 2022-12-31 0001015922 chkp:USFederalMember 2022-01-01 2022-12-31 0001015922 chkp:USStateMember 2022-01-01 2022-12-31 0001015922 chkp:TwoThousandFiveEquityIncentivePlansMember 2022-01-01 2022-12-31 0001015922 chkp:AmortizationOfTechnologyMember 2022-01-01 2022-12-31 0001015922 us-gaap:PhantomShareUnitsPSUsMember 2022-01-01 2022-12-31 0001015922 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001015922 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember chkp:FinancialIncomeMember 2022-01-01 2022-12-31 0001015922 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OperatingExpenseMember 2022-01-01 2022-12-31 0001015922 dei:BusinessContactMember 2022-01-01 2022-12-31 0001015922 us-gaap:OtherNoncurrentAssetsMember 2022-01-01 2022-12-31 0001015922 chkp:MarketableSecuritesMember 2022-01-01 2022-12-31 0001015922 chkp:AvananMember 2022-01-01 2022-12-31 0001015922 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2022-01-01 2022-12-31 0001015922 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-01-01 2022-12-31 0001015922 us-gaap:IsraelTaxAuthorityMember us-gaap:SubsequentEventMember us-gaap:TaxYear2020Member 2023-01-01 2023-01-01 0001015922 us-gaap:IsraelTaxAuthorityMember us-gaap:SubsequentEventMember chkp:TaxYearTwoThousandSixteenThroughTwoThousandAndNineteenMember 2023-01-01 2023-01-01 0001015922 us-gaap:IsraelTaxAuthorityMember us-gaap:SubsequentEventMember us-gaap:TaxYear2020Member 2023-01-01 0001015922 us-gaap:IsraelTaxAuthorityMember us-gaap:SubsequentEventMember chkp:TaxYearTwoThousandSixteenThroughTwoThousandAndNineteenMember 2023-01-01 0001015922 chkp:ShareRepurchaseProgramMember 2023-02-13 0001015922 chkp:EmployeeStockPurchasePlanMember 2020-12-31 0001015922 us-gaap:RetainedEarningsMember 2019-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001015922 us-gaap:TreasuryStockMember 2019-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001015922 us-gaap:CommonStockMember 2019-12-31 0001015922 us-gaap:RetainedEarningsMember 2020-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001015922 us-gaap:TreasuryStockMember 2020-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001015922 us-gaap:CommonStockMember 2020-12-31 0001015922 us-gaap:RetainedEarningsMember 2021-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001015922 us-gaap:TreasuryStockMember 2021-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001015922 us-gaap:CommonStockMember 2021-12-31 0001015922 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001015922 chkp:PerformanceStockUnitsPsuMember 2021-12-31 0001015922 us-gaap:CommonStockMember 2022-12-31 0001015922 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001015922 us-gaap:TreasuryStockMember 2022-12-31 0001015922 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001015922 us-gaap:RetainedEarningsMember 2022-12-31 0001015922 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2021-12-31 0001015922 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2021-12-31 0001015922 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2022-12-31 0001015922 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2022-12-31 iso4217:USD pure shares utr:Year utr:Month iso4217:ILS iso4217:ILS shares chkp:Segment iso4217:USD shares chkp:Product false FY 0001015922 L3 20-F false true 2022-12-31 --12-31 2022 false false 000-28584 CHECK POINT SOFTWARE TECHNOLOGIES LTD. 5 Shlomo Kaplan Street Tel Aviv 6789159 IL Israel Shira Yashar, Adv. 5 Shlomo Kaplan Street Tel Aviv 6789159 IL Israel 972 3-753-4555 Ordinary shares CHKP NASDAQ 120761971 Yes No Yes Yes Large Accelerated Filer false true U.S. GAAP false 1281 Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#OperatingLeaseLiability Tel-Aviv, Israel 196000000 271900000 431100000 492500000 1010500000 929300000 644200000 597800000 50000000 46400000 2331800000 2337900000 1865600000 2089700000 82800000 83400000 77600000 51700000 58800000 61000000 1236700000 1196200000 71500000 80300000 3393000000 3562300000 5724800000 5900200000 29600000 9800000 223700000 206300000 1363400000 1257400000 222500000 238600000 1839200000 1712100000 514400000 449700000 419700000 454900000 22200000 26400000 956300000 931000000 2795500000 2643100000 0.01 0.01 500000000 500000000 261223970 261223970 120761971 129065690 800000 800000 2500700000 2276700000 140462677 132181781 11802100000 10550700000 -97900000 -600000 12327800000 11530900000 2929300000 3257100000 5724800000 5900200000 554900000 513900000 513600000 858000000 755200000 671100000 917000000 897700000 880200000 2329900000 2166800000 2064900000 145600000 110700000 96800000 41400000 35900000 26400000 105500000 103000000 96700000 11900000 8500000 6600000 304400000 258100000 226500000 349900000 292700000 252800000 675200000 597800000 569900000 116100000 110700000 111500000 1445600000 1259300000 1160700000 884300000 907500000 904200000 44000000 42100000 66600000 928300000 949600000 970800000 131400000 134000000 124200000 796900000 815600000 846600000 6.37 6.13 6.03 125205504 133121763 140495886 6.31 6.08 5.96 126338989 134110048 141977992 796900000 815600000 846600000 -93400000 -38500000 21200000 1700000 3400000 -93400000 -40200000 17800000 -25400000 -100000 6400000 21500000 -1000000 -5200000 -3900000 -1100000 1200000 -97300000 -41300000 19000000 699600000 774300000 865600000 800000 1770300000 -8092700000 21700000 9868700000 3568800000 3118665 145400000 71400000 216800000 11376531 1297700000 1297700000 112500000 112500000 19000000 19000000 200000 200000 846600000 846600000 800000 2028400000 -9319000000 40700000 10715300000 3466200000 2872272 126200000 67800000 194000000 10900938 1299500000 1299500000 120300000 120300000 -41300000 -41300000 1800000 1800000 815600000 815600000 800000 2276700000 -10550700000 -600000 11530900000 3257100000 2094108 92600000 48500000 141100000 10324181 1299900000 1299900000 131400000 131400000 -97300000 -97300000 796900000 796900000 800000 2500700000 -11802100000 -97900000 12327800000 2929300000 796900000 815600000 846600000 22700000 20600000 18900000 18500000 21000000 9400000 0 1400000 4500000 13500000 10100000 8200000 131400000 120300000 112500000 -500000 -4000000 10500000 46100000 51600000 45000000 -100000 -1200000 -20200000 19800000 -7700000 1600000 26300000 -8900000 36100000 -54600000 66400000 46100000 170300000 216800000 95200000 200000 5500000 5200000 1098500000 1203900000 1161000000 538400000 214500000 0 1056600000 1551700000 2299700000 9100000 184100000 318600000 1063100000 1297500000 2460200000 477000000 492500000 213900000 48300000 219700000 23100000 22100000 15900000 19300000 -6400000 -75300000 -98200000 141200000 194000000 216800000 1299900000 1299500000 1297700000 9300000 6900000 5400000 -1168000000 -1112400000 -1086300000 -75900000 16200000 -23500000 271900000 255700000 279200000 196000000 271900000 255700000 113500000 101000000 90800000 0 1800000 200000 8000000 1400000 10300000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 1:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">GENERAL </div></div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Check Point Software Technologies Ltd., an Israeli <div style="letter-spacing: 0px; top: 0px;;display:inline;">corporation</div> (“Check Point Ltd.”), and subsidiaries (collectively, the “Company” or “Check <div style="letter-spacing: 0px; top: 0px;;display:inline;">Point</div>”), develop, market and support wide range of products and services for IT security, by offering a multilevel security architecture that defends enterprises’ cloud, network and mobile device held information. </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">  </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The Company operates in one operating and reportable segment and its revenues are mainly derived from the sales of its network and data security products, including licenses, related software updates, maintenance and security subscriptions. The Company sells its products worldwide primarily through multiple distribution channels (“channel partners”), including distributors, resellers, system integrators, Original Equipment Manufacturers (“OEMs”) and Managed Security Service Providers (“MSPs”). </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">During 2022, 2021 and 2020, approximately 40%, 40% and 39% of the Company’s revenues were derived from two channel partners, respectively. Revenues derived from one channel partner in 2022, 2021 and 2020 were 25%, 24% and 22%, respectively, and revenues derived from the other channel partner in 2022, 2021 and 2020 were 15%, 16%, and 17%, respectively, of the Company’s revenues in such years. Trade receivable balances from these two channel partners aggregated to $301.2 and $271.8 as of December 31, 2022 and 2021, respectively. </div></td></tr></table> 1 1 0.40 0.40 0.39 0.25 0.24 0.22 0.15 0.16 0.17 301200000 271800000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 2:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">SIGNIFICANT ACCOUNTING POLICIES </div></div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:11pt; font-family:Times New Roman;text-align:justify"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;">statements</div> are prepared in <div style="letter-spacing: 0px; top: 0px;;display:inline;">conformity </div>with United States generally accepted accounting principles (“U.S. GAAP”). </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Use of estimates: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">  </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. </div></td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Financial statements in United States dollars: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">  </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Most of the Company’s revenues and costs are denominated in United States dollar (“dollar”). The Company’s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company’s functional and reporting currency. </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">  </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Accordingly, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-dollar</div> denominated transactions and balances have been <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> into the functional currency in accordance with Accounting Standard Code (“ASC”) No. 830, “Foreign Currency M<div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>tters”. </div></td></tr></table><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="text-align: center; margin-bottom: 1em; margin-top: 1em"/><div style="text-align: center; margin-bottom: 1em; margin-top: 1em"/><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"><br/></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">All transaction gains and losses from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> monetary balance sheet items are <div style="letter-spacing: 0px; top: 0px;;display:inline;">reflected </div>in the <div style="letter-spacing: 0px; top: 0px;;display:inline;">statements </div>of income as financial income or expenses, as appropriate. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Principles of consolidation: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The consolidated financial statements include the accounts of Check Point Ltd. and subsidiaries. Intercompany transactions and balances have been eliminated upon consolidation. </div></td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">d.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Cash equivalents: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Cash equivalents are short-term unrestricted highly liquid investments that are readily convertible to cash and with original maturities of three months or less at investment.</div></td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">e.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Short-term bank deposits: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Bank deposits with maturities of more than three months at investment but less than one year are included in short-term bank deposits. Such deposits are stated at cost which approximates fair values.</div></td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">f.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Trade Receivables: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Trade receivables are recorded net of credit losses allowance for any potential uncollectible amounts. </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based upon its assessment of various factors, including historical collectability experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">As of December 31, 2022 and 2021, the allowances for credit losses of trade receivable were insignificant. </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The Company writes off receivables when they are deemed uncollectible, having exhausted all collection efforts. Actual collection experience may not meet expectations and may result in increased bad debt <div style="letter-spacing: 0px; top: 0px;;display:inline;">expense</div>. <div style="letter-spacing: 0px; top: 0px;;display:inline;">Allowance </div>for credit losses and total write offs expenses during 2022, 2021 and 2020 were insignificant. </div></td></tr></table><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="text-align: center; margin-bottom: 1em; margin-top: 1em"><div style="letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 16px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: center; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;"/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="margin-top: 1em; margin-bottom: 1em"/><div style="width:790px"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">g.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments in marketable securities: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The Company accounts for investments in marketable securities in accordance with ASC No. 320, “Investments - Debt Securities”. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determinations at each balance sheet date. The Company classifies all of its debt securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> (“AFS”). <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> debt securities are carried at fair value, with the unrealized gains and losses, net of tax, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses on sale of investments are included in financial income, net and are derived using the specific identification method for determining the cost of securities sold. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization together with interest on securities is included in financial income, net. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">At each reporting period, the Company evaluates whether declines in fair value below amortized cost are due to expected credit losses, as well as the company’s ability and intent to hold the investment until a forecasted recovery occurs in accordance with ASC 326, Financial Instrument- Credit losses. Allowance for credit losses on AFS debt securities are recognized in the Company’s consolidated statements of income, and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in stockholders’ equity. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">No credit losses were recorded for the years ended December 31, 2022, 2021 and 2020. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">h.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Property and equipment, net: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:51%"/> <td style="vertical-align:bottom;width:3%"/> <td style="width:46%"/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">%</div></div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="2" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Computers and peripheral equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">33 – 50</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Office furniture and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">10 – 20</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Building</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">4</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">The shorter of term of the lease or the useful life of the asset</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">i.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Leases: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The company’s operating leases comprised of office leases. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components for its leases. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate on similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option. The ROU assets are included in Prepaid expenses and other assets in the consolidated balance sheet, while the short-term portion of lease liabilities are included in Accrued expenses and other liabilities, and the long-term portion of lease liabilities are included in Other liabilities. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">As of December 31, 2022, the Company had total <span style="-sec-ix-hidden:hidden76986405">ROU assets</span> of $20.8, with corresponding <span style="-sec-ix-hidden:hidden76986406">liabilities</span> of $20.3 on the consolidated balance sheets. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Rent expenses for the years ended December 31, 2022, 2021 and 2020, were $6.3, $8.1 and $13.1 respectively. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">j.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Business combination: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/><div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks and tradenames from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred (see also Note 3).</div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">k.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Goodwill: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Goodwill has been recorded as a result of acquisitions. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable net tangible and intangible assets acquired. Goodwill is not amortized, but rather is subject to an impairment test. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">ASC No. 350, “Intangibles - Goodwill and other” (“ASC No. 350”) requires goodwill to be tested for impairment at the reporting unit level at least annually or between annual tests in certain circumstances, and written down when impaired. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">ASC No. 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the quantitative goodwill impairment test is performed. Alternatively, ASC No. 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment test. If the carrying value of a reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-04,</div> Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company operates in one operating segment, and this segment is the only reporting unit. The Company performs the quantitative goodwill impairment test during the fourth quarter of each fiscal year, or more frequently if impairment indicators are present and compares the fair value of the reporting unit with its carrying value. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">During the years 2022, 2021 and 2020, no Goodwill impairment losses have been identified. </div><div style="width:790px"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">l.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Intangible assets, net: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives, which range from 4 to 20 years. These intangible assets consist of core technology, customer relationship, trademarks and trade names which are amortized over their estimated useful lives. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">m.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Impairment of long-lived assets including intangible assets subject to amortization and ROU assets: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s long-lived assets are reviewed for impairment in accordance with ASC No. 360, “Property, Plant and Equipment,” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years 2022, 2021 and 2020, no impairment losses have been identified. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">n.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Manufacturing partner and supplier liabilities: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company purchases manufactured products from its original design manufacture (“ODM”). The Company generally does not own the manufactured products. ODM’s provide services of design, manufacture, orders fulfillment and support with a full <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">turn-key</div> solution to meet the Company’s detailed requirements. If the actual demand is significantly lower than forecast, the Company records a liability for its commitment in excess of the actual demand. As of December 31, 2022 and 2021, the Company has not accrued any significant liability in respect with this exposure. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">o.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Research and development costs: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Research and development costs are charged to the statements of income as incurred. ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 985-20,</div> “Software - Costs of Software to Be Sold, Leased, or Marketed”, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Based on the Company’s product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release, have been insignificant. Therefore, all research and development costs are expensed as incurred. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">p.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Revenue recognition: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company derives its revenues mainly from sales of products and licenses, security subscriptions and software updates and maintenance. The Company’s products are generally integrated with software that is essential to the functionality of the product. The Company sells its products primarily through channel partners including distributors, resellers, OEMs (Original Equipment Manufacturers), system integrators and MSPs (Managed Service Providers), all of whom are considered <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">end-users.</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/> </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s security subscriptions provide customers with access to its suite of security solutions and is sold as a service. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s software updates and maintenance provide customers with rights to unspecified software product upgrades released during the term of the agreement and include maintenance services to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">end-user</div> customers, through primarily telephone access to technical support personnel as well as hardware support services. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company recognizes revenues in accordance with ASC No. 606, “Revenue from Contracts with Customers”. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Revenues from sales of products and licenses are recognized when control of the promised goods is transferred to the customer, or upon electronic transfer of the Certificate Key to the Customer. Revenues from security subscriptions and from software updates and maintenance are recognized ratably over the term of the agreement. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s arrangements typically contain various combinations of its products and licenses, security subscriptions and software updates and maintenance, which are distinct and are accounted for as separate performance obligations. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price using the prices charged for a performance obligation when sold separately. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Deferred revenues represent mainly the unrecognized revenue billed for security subscriptions and for software updates and maintenance. Such revenues are recognized ratably over the term of the related agreement. The amount of revenues recognized in the period that was included in the opening deferred revenues balance was $1,257.4 and $1,108.6 for the year ended December 31, 2022 and December 31, 2021, respectively. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Revenues expected to be recognized from remaining performance obligations were $2,146.1 and $2,013.6 as of December 31, 2022 and December 31, 2021, respectively. Of the balance as of December 31, 2022 the Company expects to recognize approximately $1,437.3 over the next 12 months and the remainder thereafter. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/><div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company records a provision for estimated sales returns, rebates, stock rotations and other rights provided to customers on product and services based on historical sales returns, analysis of credit memo data, rebate plans, stock rotation arrangements and other known factors. This provision is accounted for as variable consideration that is deducted from revenue in the period in which the revenue is recognized. Such provision amounted to $9.5 and $10.4 as of December 31, 2022 and 2021, respectively, and is included in accrued expenses and other liabilities in the consolidated balance sheets. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Sales commissions earned by the Company’s sales force are considered incremental and recoverable costs of obtaining a contract with a customer. These costs are deferred and then amortized over a period of benefit which is typically over the term of the customer contracts as initial commission rates are commensurate with the renewal commission rates. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of income. If the amortization period of those costs is one year or less, the costs are expensed as incurred. As of December 31, 2022 and 2021, the amount of deferred commission was $15.3 and $17.1, respectively, and is included in other long term assets on the balance sheets. During the years ended on December 31, 2022, 2021 and 2020 the Company recorded amortization expenses in connection with deferred commissions in the amount of $10.4, $11.6 and $15.3, respectively. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">For information regarding disaggregated revenues, please refer to Note 15 below. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">q.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Cost of revenues: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Cost of products and licenses is comprised of cost of software and hardware production, manuals, packaging and shipping. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Cost of security subscriptions is comprised of costs paid to third parties, hosting and infrastructure costs and costs of customer support related to these services. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Cost of software updates and maintenance is mainly comprised of cost of post-sale customer support. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Amortization of technology is comprised of amortization of core technology assets which are used in the Company’s operations, and is presented separately as part of cost of revenues. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">r.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Severance pay: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Effective January 1, 2007, the Company’s agreements with employees in Israel, are under Section 14 of the Severance Pay Law, 1963. The Company’s contributions for severance pay have extinguished its severance obligation. Upon contribution of the full amount based on the employee’s monthly salary for each year of service, no additional obligation exists regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheets, as the Company is legally released from the obligation to employees once the required deposit amounts have been paid. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">s.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Employee benefit plan: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company has a 401(K) defined contribution plan covering certain employees in the U.S. The Company matches 50% of employee contributions to the plan up to a limit of 6% of their eligible compensation. The Company’s matching contribution to the plan were insignificant for the years ended December 31, 2022, 2021 and 2020. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">t.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Income taxes: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company accounts for income taxes in accordance with ASC No. 740, “Income Taxes” (“ASC No. 740”). ASC No. 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined for temporary differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. The Company accrues interest and indexation related to unrecognized tax benefits on its taxes on income. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">ASC No. 740 contains a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">u.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Advertising costs: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Advertising costs are expensed as incurred. Advertising expenses for the years ended December 31, 2022, 2021 and 2020, were $4.6, $4.1 and $3.7 respectively. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">v.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Concentrations of credit risk: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Financial instruments that could potentially expose the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, short-term bank deposits, marketable securities, trade receivables and foreign currency derivative contracts. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The majority of the Company’s cash and cash equivalents and short-term bank deposits are deposited in major banks in the U.S., Israel and Europe. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions. Marketable securities are held mainly by Check Point Ltd., the Company’s Singaporean subsidiary, Canadian subsidiary and the U.S. subsidiary, and are invested in securities denominated in US dollar. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s marketable securities consist of investments in government, corporate and government sponsored enterprises debentures. The Company’s investment policy, approved by the Board of Directors, limits the amount that the Company may invest in any one type of investment, or issuer, thereby reducing credit risk concentrations. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s trade receivables are geographically dispersed and derived from sales to channel partners mainly in the United States, Europe and Asia. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">w.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Derivatives and hedging: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company accounts for derivatives and hedging based on ASC No. 815, “Derivatives and Hedging” (“ASC No. 815”). ASC No. 815 requires the Company to recognize all derivatives on the balance sheets at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, as well as the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. If the derivatives meet the definition of a hedge and are designated as such, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in accumulated other comprehensive income until the hedged item is recognized in earnings. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/><div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company entered into forward contracts to hedge the fair value of assets and liabilities denominated in several foreign currencies. As of December 31, 2022 and 2021, the Company had outstanding forward contracts that did not meet the requirement for hedge accounting, in the notional amount of $207.9 and $171.1, respectively. The Company measured the fair value of the contracts in accordance with ASC No. 820, “Fair Value Measurement” (“ASC No. 820”) (classified as level 2 of the fair value hierarchy). The net gains (losses) resulting from these forward contracts recognized in financial income, net during 2022, 2021 and 2020 were $(19.5), $(0.6) and $24.8, respectively. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekel, in Euro, and in British Pound. As of December 31, 2022 and 2021, the Company had outstanding forward contracts for payroll and related expenses in the notional amount of $266.2 and $155.0, respectively. These contracts were for a period of up to twelve months. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company measured the fair value of the contracts in accordance with ASC No. 820 (classified as level 2 of the fair value hierarchy). These contracts met the requirement for cash flow hedge accounting and, as such, gains (losses) on the contracts are recognized initially as component of Accumulated Other Comprehensive Income in the balance sheets and reclassified to the statements of income in the period the related hedged items affect earnings. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">During 2022, 2021 and 2020 gains (losses) in the amount of $(24.4), $1.1 and $5.9, respectively, were reclassified when the related expenses were incurred and recognized in operating expenses. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">x.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Basic and diluted earnings per share: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Basic earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year. Diluted earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year, plus dilutive potential ordinary shares outstanding during the year, in accordance with ASC No. 260, “Earnings Per Share”. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The total weighted average number of shares related to the outstanding options excluded from the calculations of diluted earnings per share, since it would have an anti-dilutive effect, was 1.7, 4.9 and 6.2 for 2022, 2021 and 2020, respectively. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div/><div style="width:790px"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">y.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Accounting for stock-based compensation: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company accounts for stock-based compensation in accordance with ASC No. 718, “Compensation-Stock Compensation” (“ASC No. 718”). ASC No. 718 requires companies to estimate the fair value of equity-based payment awards on the grant date using an option-pricing model. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company recognizes compensation expenses for the value of awards granted, based on the straight line method for service based awards and based on the accelerated method for performance-based awards. Compensation expense is recognized over the requisite service period of the awards. The Company recognizes forfeitures of awards as they occur. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company selected the Black-Scholes-Merton option pricing model as the most appropriate model for determining the fair value for its stock options awards and Employee Stock Purchase Plan, whereas the fair value of restricted stock units is based on the closing market value of the underlying shares at the date of grant. The option-pricing model requires a number of assumptions, the most significant of which are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The expected term of options granted is based upon historical experience and represents the period of time between when the options are granted and when they are expected to be exercised. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term to the expected term of the options. The Company has historically not paid dividends and has no plans to pay dividends in the foreseeable future. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The fair value of options granted and Employee Stock Purchase Plan in 2022, 2021 and 2020 is estimated at the date of grant using the following weighted average assumptions: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:85%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:85%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="5" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        Year ended December 31,        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:3pt"> </td> <td colspan="2" style="height:3pt"> </td> <td colspan="2" style="height:3pt"> </td> <td colspan="2" style="height:3pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2022        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2021        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2020        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee Stock Options</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">25.56%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">25.28%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">23.63%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">3.16%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.65%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.32%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">4.75</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">4.22</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">4.15</td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee Stock Purchase Plan</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">22.16%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">22.44%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">36.58%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">2.56%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.24%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.05%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">0.5</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.5</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.5</td></tr></table></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">z.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fair value of financial instruments: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company measures its investments in money market funds (classified as cash equivalents), short-term bank deposits, marketable securities and its foreign currency derivative contracts at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:11%;vertical-align:top;text-align:left;">Level 1 -</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:11%;vertical-align:top;text-align:left;">Level 2 -</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:11%;vertical-align:top;text-align:left;">Level 3 -</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Valuations based on inputs that are unobservable and significant to the overall fair value measurement. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">aa.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Comprehensive income: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company accounts for comprehensive income in accordance with ASC No. 220, “Comprehensive Income”. Comprehensive income generally represents all changes in shareholders’ equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on hedging derivative instruments and unrealized gains and losses on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt securities. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">ab.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Treasury shares: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company repurchases its ordinary shares from time to time on the open market and holds such shares as treasury shares. The Company presents the cost to repurchase treasury stock as a separate component of shareholders’ equity. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company reissues treasury shares under the stock purchase plan, upon exercise of options and upon vesting of restricted stock units. Reissuance of treasury shares is accounted for in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 505-30</div> whereby gains are credited to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and losses are charged to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital to the extent that previous net gains are included therein; otherwise to retained earnings. </div> <div style="width:790px"/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">ac.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Legal contingencies: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company is currently involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">ad.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Recently Adopted Accounting Pronouncements: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company has reviewed recent accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on the consolidated financial statements as a result of their future adoption. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Use of estimates: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">  </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Financial statements in United States dollars: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">  </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Most of the Company’s revenues and costs are denominated in United States dollar (“dollar”). The Company’s management believes that the dollar is the primary currency of the economic environment in which the Company and each of its subsidiaries operate. Thus, the dollar is the Company’s functional and reporting currency. </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">  </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Accordingly, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-dollar</div> denominated transactions and balances have been <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> into the functional currency in accordance with Accounting Standard Code (“ASC”) No. 830, “Foreign Currency M<div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>tters”. </div></td></tr></table><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"/></div></div><div style="text-align: center; margin-bottom: 1em; margin-top: 1em"/><div style="text-align: center; margin-bottom: 1em; margin-top: 1em"/><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top: 1em; margin-bottom: 1em"/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"><br/></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">All transaction gains and losses from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> monetary balance sheet items are <div style="letter-spacing: 0px; top: 0px;;display:inline;">reflected </div>in the <div style="letter-spacing: 0px; top: 0px;;display:inline;">statements </div>of income as financial income or expenses, as appropriate. </div></td></tr></table>  <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Principles of consolidation: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The consolidated financial statements include the accounts of Check Point Ltd. and subsidiaries. Intercompany transactions and balances have been eliminated upon consolidation. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">d.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Cash equivalents: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Cash equivalents are short-term unrestricted highly liquid investments that are readily convertible to cash and with original maturities of three months or less at investment.</div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">e.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Short-term bank deposits: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Bank deposits with maturities of more than three months at investment but less than one year are included in short-term bank deposits. Such deposits are stated at cost which approximates fair values.</div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">f.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Trade Receivables: </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Trade receivables are recorded net of credit losses allowance for any potential uncollectible amounts. </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based upon its assessment of various factors, including historical collectability experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers. </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">As of December 31, 2022 and 2021, the allowances for credit losses of trade receivable were insignificant. </div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The Company writes off receivables when they are deemed uncollectible, having exhausted all collection efforts. Actual collection experience may not meet expectations and may result in increased bad debt <div style="letter-spacing: 0px; top: 0px;;display:inline;">expense</div>. <div style="letter-spacing: 0px; top: 0px;;display:inline;">Allowance </div>for credit losses and total write offs expenses during 2022, 2021 and 2020 were insignificant. </div></td></tr></table>  <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">g.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments in marketable securities: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The Company accounts for investments in marketable securities in accordance with ASC No. 320, “Investments - Debt Securities”. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Management determines the appropriate classification of its investments at the time of purchase and reevaluates such determinations at each balance sheet date. The Company classifies all of its debt securities as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> (“AFS”). <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> debt securities are carried at fair value, with the unrealized gains and losses, net of tax, reported in accumulated other comprehensive income (loss) in shareholders’ equity. Realized gains and losses on sale of investments are included in financial income, net and are derived using the specific identification method for determining the cost of securities sold. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization together with interest on securities is included in financial income, net. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">At each reporting period, the Company evaluates whether declines in fair value below amortized cost are due to expected credit losses, as well as the company’s ability and intent to hold the investment until a forecasted recovery occurs in accordance with ASC 326, Financial Instrument- Credit losses. Allowance for credit losses on AFS debt securities are recognized in the Company’s consolidated statements of income, and any remaining unrealized losses, net of taxes, are included in accumulated other comprehensive income (loss) in stockholders’ equity. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">No credit losses were recorded for the years ended December 31, 2022, 2021 and 2020. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">h.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Property and equipment, net: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:51%"/> <td style="vertical-align:bottom;width:3%"/> <td style="width:46%"/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">%</div></div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="2" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Computers and peripheral equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">33 – 50</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Office furniture and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">10 – 20</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Building</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">4</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">The shorter of term of the lease or the useful life of the asset</td></tr></table> Depreciation is calculated using the straight-line method over the estimated useful lives of the assets at the following annual rates: <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:51%"/> <td style="vertical-align:bottom;width:3%"/> <td style="width:46%"/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">%</div></div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="2" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Computers and peripheral equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">33 – 50</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Office furniture and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">10 – 20</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Building</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">4</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">The shorter of term of the lease or the useful life of the asset</td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> 0.33 0.50 0.10 0.20 0.04 The shorter of term of the lease or the useful life of the asset <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">i.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Leases: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The company’s operating leases comprised of office leases. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefits from the use of the asset throughout the period, and (3) whether the Company has a right to direct the use of the asset. The Company elected to not recognize a lease liability or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) asset for leases with a term of twelve months or less. The Company also elected the practical expedient to not separate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components for its leases. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments arising from the lease. ROU assets are initially measured at amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred. The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Company uses its Incremental Borrowing Rate (“IBR”) based on the information available at commencement date in determining the present value of lease payments. The Company’s IBR is estimated to approximate the interest rate on similar terms and payments and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain that the Company will exercise that option. An option to terminate is considered unless it is reasonably certain that the Company will not exercise the option. The ROU assets are included in Prepaid expenses and other assets in the consolidated balance sheet, while the short-term portion of lease liabilities are included in Accrued expenses and other liabilities, and the long-term portion of lease liabilities are included in Other liabilities. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">As of December 31, 2022, the Company had total <span style="-sec-ix-hidden:hidden76986405">ROU assets</span> of $20.8, with corresponding <span style="-sec-ix-hidden:hidden76986406">liabilities</span> of $20.3 on the consolidated balance sheets. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Rent expenses for the years ended December 31, 2022, 2021 and 2020, were $6.3, $8.1 and $13.1 respectively. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> 20800000 20300000 6300000 8100000 13100000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">j.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Business combination: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/><div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks and tradenames from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred (see also Note 3).</div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">k.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Goodwill: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Goodwill has been recorded as a result of acquisitions. Goodwill represents the excess of the purchase price in a business combination over the fair value of identifiable net tangible and intangible assets acquired. Goodwill is not amortized, but rather is subject to an impairment test. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">ASC No. 350, “Intangibles - Goodwill and other” (“ASC No. 350”) requires goodwill to be tested for impairment at the reporting unit level at least annually or between annual tests in certain circumstances, and written down when impaired. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">ASC No. 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the quantitative goodwill impairment test is performed. Alternatively, ASC No. 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the quantitative goodwill impairment test. If the carrying value of a reporting unit exceeds its fair value, the Company recognizes an impairment of goodwill for the amount of this excess, in accordance with the guidance in FASB Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2017-04,</div> Intangibles - Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company operates in one operating segment, and this segment is the only reporting unit. The Company performs the quantitative goodwill impairment test during the fourth quarter of each fiscal year, or more frequently if impairment indicators are present and compares the fair value of the reporting unit with its carrying value. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">During the years 2022, 2021 and 2020, no Goodwill impairment losses have been identified. </div> 1 0 0 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">l.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Intangible assets, net: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Intangible assets that are not considered to have an indefinite useful life are amortized over their estimated useful lives, which range from 4 to 20 years. These intangible assets consist of core technology, customer relationship, trademarks and trade names which are amortized over their estimated useful lives. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> P4Y P20Y <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">m.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Impairment of long-lived assets including intangible assets subject to amortization and ROU assets: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s long-lived assets are reviewed for impairment in accordance with ASC No. 360, “Property, Plant and Equipment,” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During the years 2022, 2021 and 2020, no impairment losses have been identified. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">n.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Manufacturing partner and supplier liabilities: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company purchases manufactured products from its original design manufacture (“ODM”). The Company generally does not own the manufactured products. ODM’s provide services of design, manufacture, orders fulfillment and support with a full <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">turn-key</div> solution to meet the Company’s detailed requirements. If the actual demand is significantly lower than forecast, the Company records a liability for its commitment in excess of the actual demand. As of December 31, 2022 and 2021, the Company has not accrued any significant liability in respect with this exposure. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> 0 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">o.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Research and development costs: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Research and development costs are charged to the statements of income as incurred. ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 985-20,</div> “Software - Costs of Software to Be Sold, Leased, or Marketed”, requires capitalization of certain software development costs subsequent to the establishment of technological feasibility. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Based on the Company’s product development process, technological feasibility is established upon completion of a working model. Costs incurred by the Company between completion of the working models and the point at which the products are ready for general release, have been insignificant. Therefore, all research and development costs are expensed as incurred. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">p.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Revenue recognition: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company derives its revenues mainly from sales of products and licenses, security subscriptions and software updates and maintenance. The Company’s products are generally integrated with software that is essential to the functionality of the product. The Company sells its products primarily through channel partners including distributors, resellers, OEMs (Original Equipment Manufacturers), system integrators and MSPs (Managed Service Providers), all of whom are considered <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">end-users.</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"/> </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s security subscriptions provide customers with access to its suite of security solutions and is sold as a service. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s software updates and maintenance provide customers with rights to unspecified software product upgrades released during the term of the agreement and include maintenance services to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">end-user</div> customers, through primarily telephone access to technical support personnel as well as hardware support services. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company recognizes revenues in accordance with ASC No. 606, “Revenue from Contracts with Customers”. As such, the Company identifies a contract with a customer, identifies the performance obligations in the contract, determines the transaction price, allocates the transaction price to each performance obligation in the contract and recognizes revenues when (or as) the Company satisfies a performance obligation. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Revenues from sales of products and licenses are recognized when control of the promised goods is transferred to the customer, or upon electronic transfer of the Certificate Key to the Customer. Revenues from security subscriptions and from software updates and maintenance are recognized ratably over the term of the agreement. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s arrangements typically contain various combinations of its products and licenses, security subscriptions and software updates and maintenance, which are distinct and are accounted for as separate performance obligations. The Company allocates the transaction price to each performance obligation based on its relative standalone selling price using the prices charged for a performance obligation when sold separately. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Deferred revenues represent mainly the unrecognized revenue billed for security subscriptions and for software updates and maintenance. Such revenues are recognized ratably over the term of the related agreement. The amount of revenues recognized in the period that was included in the opening deferred revenues balance was $1,257.4 and $1,108.6 for the year ended December 31, 2022 and December 31, 2021, respectively. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Revenues expected to be recognized from remaining performance obligations were $2,146.1 and $2,013.6 as of December 31, 2022 and December 31, 2021, respectively. Of the balance as of December 31, 2022 the Company expects to recognize approximately $1,437.3 over the next 12 months and the remainder thereafter. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/><div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company records a provision for estimated sales returns, rebates, stock rotations and other rights provided to customers on product and services based on historical sales returns, analysis of credit memo data, rebate plans, stock rotation arrangements and other known factors. This provision is accounted for as variable consideration that is deducted from revenue in the period in which the revenue is recognized. Such provision amounted to $9.5 and $10.4 as of December 31, 2022 and 2021, respectively, and is included in accrued expenses and other liabilities in the consolidated balance sheets. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Sales commissions earned by the Company’s sales force are considered incremental and recoverable costs of obtaining a contract with a customer. These costs are deferred and then amortized over a period of benefit which is typically over the term of the customer contracts as initial commission rates are commensurate with the renewal commission rates. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of income. If the amortization period of those costs is one year or less, the costs are expensed as incurred. As of December 31, 2022 and 2021, the amount of deferred commission was $15.3 and $17.1, respectively, and is included in other long term assets on the balance sheets. During the years ended on December 31, 2022, 2021 and 2020 the Company recorded amortization expenses in connection with deferred commissions in the amount of $10.4, $11.6 and $15.3, respectively. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">For information regarding disaggregated revenues, please refer to Note 15 below. </div> 1257400000 1108600000 2146100000 2013600000 1437300000 9500000 10400000 15300000 17100000 10400000 11600000 15300000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">q.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Cost of revenues: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Cost of products and licenses is comprised of cost of software and hardware production, manuals, packaging and shipping. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Cost of security subscriptions is comprised of costs paid to third parties, hosting and infrastructure costs and costs of customer support related to these services. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Cost of software updates and maintenance is mainly comprised of cost of post-sale customer support. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Amortization of technology is comprised of amortization of core technology assets which are used in the Company’s operations, and is presented separately as part of cost of revenues. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">r.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Severance pay: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Effective January 1, 2007, the Company’s agreements with employees in Israel, are under Section 14 of the Severance Pay Law, 1963. The Company’s contributions for severance pay have extinguished its severance obligation. Upon contribution of the full amount based on the employee’s monthly salary for each year of service, no additional obligation exists regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheets, as the Company is legally released from the obligation to employees once the required deposit amounts have been paid. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">s.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Employee benefit plan: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company has a 401(K) defined contribution plan covering certain employees in the U.S. The Company matches 50% of employee contributions to the plan up to a limit of 6% of their eligible compensation. The Company’s matching contribution to the plan were insignificant for the years ended December 31, 2022, 2021 and 2020. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> 0.50 0.06 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">t.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Income taxes: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company accounts for income taxes in accordance with ASC No. 740, “Income Taxes” (“ASC No. 740”). ASC No. 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined for temporary differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to amounts more likely than not to be realized. The Company accrues interest and indexation related to unrecognized tax benefits on its taxes on income. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">ASC No. 740 contains a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> approach to recognizing and measuring a liability for uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement. The Company classifies interest related to unrecognized tax benefits in taxes on income. </div> 0.50 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">u.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Advertising costs: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Advertising costs are expensed as incurred. Advertising expenses for the years ended December 31, 2022, 2021 and 2020, were $4.6, $4.1 and $3.7 respectively. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> 4600000 4100000 3700000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">v.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Concentrations of credit risk: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Financial instruments that could potentially expose the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, short-term bank deposits, marketable securities, trade receivables and foreign currency derivative contracts. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The majority of the Company’s cash and cash equivalents and short-term bank deposits are deposited in major banks in the U.S., Israel and Europe. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions. Marketable securities are held mainly by Check Point Ltd., the Company’s Singaporean subsidiary, Canadian subsidiary and the U.S. subsidiary, and are invested in securities denominated in US dollar. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s marketable securities consist of investments in government, corporate and government sponsored enterprises debentures. The Company’s investment policy, approved by the Board of Directors, limits the amount that the Company may invest in any one type of investment, or issuer, thereby reducing credit risk concentrations. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s trade receivables are geographically dispersed and derived from sales to channel partners mainly in the United States, Europe and Asia. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">w.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Derivatives and hedging: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company accounts for derivatives and hedging based on ASC No. 815, “Derivatives and Hedging” (“ASC No. 815”). ASC No. 815 requires the Company to recognize all derivatives on the balance sheets at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, as well as the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. If the derivatives meet the definition of a hedge and are designated as such, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in accumulated other comprehensive income until the hedged item is recognized in earnings. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"> </div><div style="width:790px"/><div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company entered into forward contracts to hedge the fair value of assets and liabilities denominated in several foreign currencies. As of December 31, 2022 and 2021, the Company had outstanding forward contracts that did not meet the requirement for hedge accounting, in the notional amount of $207.9 and $171.1, respectively. The Company measured the fair value of the contracts in accordance with ASC No. 820, “Fair Value Measurement” (“ASC No. 820”) (classified as level 2 of the fair value hierarchy). The net gains (losses) resulting from these forward contracts recognized in financial income, net during 2022, 2021 and 2020 were $(19.5), $(0.6) and $24.8, respectively. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekel, in Euro, and in British Pound. As of December 31, 2022 and 2021, the Company had outstanding forward contracts for payroll and related expenses in the notional amount of $266.2 and $155.0, respectively. These contracts were for a period of up to twelve months. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company measured the fair value of the contracts in accordance with ASC No. 820 (classified as level 2 of the fair value hierarchy). These contracts met the requirement for cash flow hedge accounting and, as such, gains (losses) on the contracts are recognized initially as component of Accumulated Other Comprehensive Income in the balance sheets and reclassified to the statements of income in the period the related hedged items affect earnings. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">During 2022, 2021 and 2020 gains (losses) in the amount of $(24.4), $1.1 and $5.9, respectively, were reclassified when the related expenses were incurred and recognized in operating expenses. The change in fair value of the Company’s outstanding forward contracts vs. the notional amounts at December 31, 2022 and 2021 was insignificant. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> 207900000 171100000 -19500000 -600000 24800000 266200000 155000000 -24400000 1100000 5900000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">x.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Basic and diluted earnings per share: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Basic earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year. Diluted earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year, plus dilutive potential ordinary shares outstanding during the year, in accordance with ASC No. 260, “Earnings Per Share”. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The total weighted average number of shares related to the outstanding options excluded from the calculations of diluted earnings per share, since it would have an anti-dilutive effect, was 1.7, 4.9 and 6.2 for 2022, 2021 and 2020, respectively. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> 1700000 4900000 6200000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">y.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Accounting for stock-based compensation: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company accounts for stock-based compensation in accordance with ASC No. 718, “Compensation-Stock Compensation” (“ASC No. 718”). ASC No. 718 requires companies to estimate the fair value of equity-based payment awards on the grant date using an option-pricing model. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company recognizes compensation expenses for the value of awards granted, based on the straight line method for service based awards and based on the accelerated method for performance-based awards. Compensation expense is recognized over the requisite service period of the awards. The Company recognizes forfeitures of awards as they occur. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company selected the Black-Scholes-Merton option pricing model as the most appropriate model for determining the fair value for its stock options awards and Employee Stock Purchase Plan, whereas the fair value of restricted stock units is based on the closing market value of the underlying shares at the date of grant. The option-pricing model requires a number of assumptions, the most significant of which are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements over the most recent periods ending on the grant date, equal to the expected term of the options. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The expected term of options granted is based upon historical experience and represents the period of time between when the options are granted and when they are expected to be exercised. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term to the expected term of the options. The Company has historically not paid dividends and has no plans to pay dividends in the foreseeable future. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The fair value of options granted and Employee Stock Purchase Plan in 2022, 2021 and 2020 is estimated at the date of grant using the following weighted average assumptions: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:85%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:85%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="5" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        Year ended December 31,        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:3pt"> </td> <td colspan="2" style="height:3pt"> </td> <td colspan="2" style="height:3pt"> </td> <td colspan="2" style="height:3pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2022        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2021        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2020        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee Stock Options</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">25.56%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">25.28%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">23.63%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">3.16%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.65%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.32%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">4.75</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">4.22</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">4.15</td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee Stock Purchase Plan</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">22.16%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">22.44%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">36.58%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">2.56%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.24%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.05%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">0.5</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.5</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.5</td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The fair value of options granted and Employee Stock Purchase Plan in 2022, 2021 and 2020 is estimated at the date of grant using the following weighted average assumptions: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:85%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:85%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/> <td style="vertical-align:bottom;width:3%"/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="5" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        Year ended December 31,        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:3pt"> </td> <td colspan="2" style="height:3pt"> </td> <td colspan="2" style="height:3pt"> </td> <td colspan="2" style="height:3pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2022        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2021        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2020        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee Stock Options</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">25.56%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">25.28%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">23.63%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">3.16%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.65%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.32%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">4.75</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">4.22</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">4.15</td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td> <td colspan="2" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee Stock Purchase Plan</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td> <td colspan="2" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">22.16%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">22.44%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">36.58%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">2.56%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.24%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.05%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">0.5</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.5</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.5</td></tr></table> 0.2556 0.2528 0.2363 0.0316 0.0065 0.0032 0 0 0 P4Y9M P4Y2M19D P4Y1M24D 0.2216 0.2244 0.3658 0.0256 0.0024 0.0005 0 0 0 P0M15D P0M15D P0M15D <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">z.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Fair value of financial instruments: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company measures its investments in money market funds (classified as cash equivalents), short-term bank deposits, marketable securities and its foreign currency derivative contracts at fair value. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:11%;vertical-align:top;text-align:left;">Level 1 -</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:11%;vertical-align:top;text-align:left;">Level 2 -</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:11%;vertical-align:top;text-align:left;">Level 3 -</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Valuations based on inputs that are unobservable and significant to the overall fair value measurement. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">aa.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Comprehensive income: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company accounts for comprehensive income in accordance with ASC No. 220, “Comprehensive Income”. Comprehensive income generally represents all changes in shareholders’ equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on hedging derivative instruments and unrealized gains and losses on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> debt securities. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">ab.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Treasury shares: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company repurchases its ordinary shares from time to time on the open market and holds such shares as treasury shares. The Company presents the cost to repurchase treasury stock as a separate component of shareholders’ equity. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company reissues treasury shares under the stock purchase plan, upon exercise of options and upon vesting of restricted stock units. Reissuance of treasury shares is accounted for in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 505-30</div> whereby gains are credited to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and losses are charged to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital to the extent that previous net gains are included therein; otherwise to retained earnings. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">ac.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Legal contingencies: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company is currently involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">ad.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Recently Adopted Accounting Pronouncements: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company has reviewed recent accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on the consolidated financial statements as a result of their future adoption. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 3:-</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">ACQUISITIONS </div></div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal; text-align: justify;">On September 17, 2020 the Company completed the acquisition of all outstanding shares of Odo Security Ltd., a privately-held Israeli-based company, and a developer of a cloud-based, clientless Secure Access Service Edge (SASE) technology that delivers secure remote access. </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal; text-align: justify;">On September 1, 2021, the Company completed the acquisition of all outstanding shares of Avanan Inc. (“Avanan”), a privately-held <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">US-based</div> company providing cloud email security, and the developer of a patented application-programming interface (API) solution to stop email threats before arriving to the inbox (inline), for both internal and external emails using AI based engines. The Company acquired Avanan for total consideration of approximately $227.1. </div> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal; text-align: justify;">On February 3, 2022, the Company completed the acquisition of all outstanding shares of Spectral Cyber Technologies Ltd. (“Spectral”), a privately-held Israeli-based company, is a key innovator in developer security with a thriving open-source community. Spectral’s developer-first approach to security focuses on code safety and trust, fast code scanning and simple and cool developer experience. </div> </td> </tr> </table> <div style="margin-top: 12pt; margin-bottom: 0pt; margin-left: 10%; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify;">The Company accounted for this transaction as a business combination and allocated the purchase consideration to tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. </div> In addition, the transactions included additional consideration related to compensation for post combination services which were recorded as prepaid expenses and other long term assets and will be recognized over the requisite service period. 2020-09-17 2021-09-01 227100000 2022-02-03 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 4:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES </div></div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:76%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">65.8    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">170.8    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money market funds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.6    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short term deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34.7    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:1.5pt"> </td> <td colspan="4" style="height:1.5pt"> </td> <td colspan="4" style="height:1.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">196.0    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271.9    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term bank deposits:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">431.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">492.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Marketable securities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government and corporate debentures - fixed interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,025.8    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,262.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government-sponsored enterprises debentures</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">755.0    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">641.4    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government and corporate debentures - floating interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.3    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Marketable securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,876.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,019.0    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Cash and cash equivalents, short-term bank deposits and marketable securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,503.2    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,783.4    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table></div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The gross unrealized gains on the Company’s marketable securities were $0.1 and $14.2 as of December 31, 2022 and 2021, respectively. The gross unrealized losses on the Company’s marketable securities were $123.4 and $15.7 as of December 31, 2022 and 2021, respectively. From the total of $123.4 unrealized losses as of December 31, 2022, $87.3 was in continuous unrealized loss for more than 12 months. The unrealized losses are mainly driven by the higher interest rate environment and the recent interest rate hikes by global central banks during 2022, which was due mainly to elevated inflation rates, therefore negatively impacted the fair value of securities in our portfolio, and increased the unrealized </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The following table classifies the Company’s marketable securities by contractual maturities: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div><div/><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contractual maturity year:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Within one year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,010.5 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,024.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">929.3 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">925.8 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">After one year through five years</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,865.6 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,974.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,089.7 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,094.7 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    2,876.1 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    2,999.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,019.0 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,020.5 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">As of December 31, 2022 and 2021, interest receivable amounted to $15.6 and $15.3, respectively, and is included within prepaid expenses and other assets in the balance sheets. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:76%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">65.8    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">170.8    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money market funds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.6    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short term deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34.7    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:1.5pt"> </td> <td colspan="4" style="height:1.5pt"> </td> <td colspan="4" style="height:1.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">196.0    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271.9    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short-term bank deposits:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">431.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">492.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Marketable securities:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government and corporate debentures - fixed interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,025.8    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,262.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government-sponsored enterprises debentures</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">755.0    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">641.4    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government and corporate debentures - floating interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.3    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Marketable securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,876.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,019.0    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Cash and cash equivalents, short-term bank deposits and marketable securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,503.2    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,783.4    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 65800000 170800000 95500000 6600000 34700000 94500000 196000000 271900000 431100000 492500000 2025800000 2262500000 755000000 641400000 95300000 115100000 2876100000 3019000000 3503200000 3783400000 100000 14200000 123400000 15700000 123400000 87300000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The following table classifies the Company’s marketable securities by contractual maturities: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div><div/> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:61%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Contractual maturity year:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Within one year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,010.5 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,024.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">929.3 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">925.8 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">After one year through five years</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,865.6 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,974.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,089.7 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,094.7 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    2,876.1 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    2,999.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,019.0 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,020.5 </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1010500000 1024900000 929300000 925800000 1865600000 1974500000 2089700000 2094700000 2876100000 2999400000 3019000000 3020500000 15600000 15300000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 5:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">FAIR VALUE MEASUREMENTS </div></div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:13%; font-size:11pt; font-family:Times New Roman;text-align:justify">In accordance with ASC No. 820, the Company measures its money market funds, short-term bank deposits, marketable securities and foreign currency derivative contracts at fair value. Money market funds and marketable securities are classified within Level 1 or Level 2. This is because these assets are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:13%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s financial assets measured at fair value on a recurring basis, excluding accrued interest components, consisted of the following types of instruments as of the following dates: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:30%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="22" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measurements using input type</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measurements using input type</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">65.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">65.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">170.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">170.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash equivalents</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money market funds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short term deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Short-term bank deposits</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">431.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">431.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">492.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">492.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Marketable securities:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government and corporate debentures-fixed interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,025.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,025.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,262.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,262.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government-sponsored enterprises debentures</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">755.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">755.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">641.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">641.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government and corporate debentures - floating interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Foreign currency derivative contracts</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3.6)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3.6)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total financial assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    627.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    2,872.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,499.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    764.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,019.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,784.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:13%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s financial assets measured at fair value on a recurring basis, excluding accrued interest components, consisted of the following types of instruments as of the following dates: </div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:30%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td style="vertical-align:bottom;width:3%"/> <td/> <td/> <td style="vertical-align:bottom;width:3%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="22" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measurements using input type</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value measurements using input type</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">65.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">65.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">170.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">170.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash equivalents</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Money market funds</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><br/></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Short term deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Short-term bank deposits</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">431.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">431.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">492.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">492.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Marketable securities:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government and corporate debentures-fixed interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,025.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,025.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,262.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,262.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government-sponsored enterprises debentures</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">755.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">755.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">641.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">641.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Government and corporate debentures - floating interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">95.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Foreign currency derivative contracts</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3.6)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3.6)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total financial assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    627.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    2,872.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,499.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    764.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,019.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    3,784.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 65800000 65800000 170800000 170800000 95500000 95500000 6600000 6600000 34700000 34700000 94500000 94500000 431100000 431100000 492500000 492500000 2025800000 2025800000 2262500000 2262500000 755000000 755000000 641400000 641400000 95300000 95300000 115100000 115100000 -3600000 -3600000 700000 700000 627100000 2872500000 3499600000 764400000 3019700000 3784100000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 6:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">PROPERTY AND EQUIPMENT, NET </div></div></td></tr></table><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:90%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:82%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Computers and peripheral equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.1  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66.8  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Office furniture and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.8  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.4  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Building</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.7  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.5  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30.9  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28.5  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195.5  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    181.2  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated depreciation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    112.7  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.8  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82.8  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">83.4  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:90%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:82%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Computers and peripheral equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.1  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66.8  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Office furniture and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.8  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.4  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Building</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.7  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.5  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30.9  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28.5  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195.5  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    181.2  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated depreciation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    112.7  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.8  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82.8  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">83.4  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> 78100000 66800000 7800000 7400000 78700000 78500000 30900000 28500000 195500000 181200000 112700000 97800000 82800000 83400000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 7:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">GOODWILL AND INTANGIBLE ASSETS, NET </div></div></td></tr></table><div style="font-size:13pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Goodwill: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2022    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2021    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of January 1</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">1,196.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">1,002.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Acquisitions</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">40.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">194.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of December 31</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">    1,236.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">    1,196.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Intangible assets, net: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:90%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Original amount:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Core technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:center;">8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">93.5</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82.2</td> <td style="white-space:nowrap;vertical-align:bottom">   </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks and trade names</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:center;">15 – 20</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:center;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated amortization:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Core technology</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks and trade names</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Core technology</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks and trade names</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        58.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        61.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Intangible assets which were fully amortized as of the prior year, are disposed from the original amount and the accumulated amortization balances. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The estimated future amortization expense of Intangible assets as of December 31, 2022 is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.9    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.3    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.9    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        58.8    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Goodwill: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2022    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2021    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of January 1</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">1,196.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">1,002.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Acquisitions</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">40.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">194.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of December 31</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">    1,236.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">    1,196.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1196200000 1002200000 40500000 194000000 1236700000 1196200000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Intangible assets, net: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:90%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Original amount:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Core technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:center;">8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">93.5</td> <td style="white-space:nowrap;vertical-align:bottom">   </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82.2</td> <td style="white-space:nowrap;vertical-align:bottom">   </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks and trade names</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:center;">15 – 20</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:center;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated amortization:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Core technology</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks and trade names</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Core technology</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks and trade names</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td> <td colspan="4" style="height:3.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        58.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        61.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> P8Y 93500000 82200000 P15Y P20Y 25500000 25500000 P4Y 5800000 5800000 124800000 113500000 39600000 28000000 24500000 24000000 1900000 500000 66000000 52500000 53900000 54200000 1000000 1500000 3900000 5300000 58800000 61000000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The estimated future amortization expense of Intangible assets as of December 31, 2022 is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"/> <td style="vertical-align:bottom;width:5%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.9    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.5    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.1    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.3    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Thereafter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.9    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">        58.8    </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 11900000 11500000 11100000 9100000 6300000 8900000 58800000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 8:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">DEFERRED REVENUES </div></div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:11pt; font-family:Times New Roman;text-align:justify">Deferred revenues consisted of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div/><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Def.-Times; font-size:11pt;width:89%;border:0;margin-left:auto"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:80%"> </td> <td style="vertical-align:bottom;width:2%"> </td> <td> </td> <td style="white-space:nowrap">              </td> <td> </td> <td style="vertical-align:bottom;width:2%"> </td> <td> </td> <td style="white-space:nowrap">              </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security subscriptions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">932.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">801.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software updates and maintenance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">904.7</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">869.2</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">41.0</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">36.8</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    1,877.8</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    1,707.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table></div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:11pt; font-family:Times New Roman;text-align:justify">The majority of the deferred revenues are recognized within one year or less and presented as current deferred revenues in the balance sheets. Substantially all of the remaining deferred revenues are presented as long term deferred revenues and are recognized for a period greater than one year and up to five years. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Def.-Times; font-size:11pt;width:89%;border:0;margin-left:auto"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:80%"> </td> <td style="vertical-align:bottom;width:2%"> </td> <td> </td> <td style="white-space:nowrap">              </td> <td> </td> <td style="vertical-align:bottom;width:2%"> </td> <td> </td> <td style="white-space:nowrap">              </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security subscriptions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">932.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">801.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software updates and maintenance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">904.7</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">869.2</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">41.0</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">36.8</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    1,877.8</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">    1,707.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 932100000 801100000 904700000 869200000 41000000 36800000 1877800000 1707100000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 9:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">ACCRUED EXPENSES AND OTHER LIABILITIES </div></div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:11pt; font-family:Times New Roman;text-align:justify">The components of accrued expenses and other liabilities are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Def.-Times; font-size:11pt;width:89%;border:0;margin-left:auto"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:80%"> </td> <td style="vertical-align:bottom;width:2%"> </td> <td> </td> <td style="white-space:nowrap">              </td> <td> </td> <td style="vertical-align:bottom;width:2%"> </td> <td> </td> <td style="white-space:nowrap">              </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued products and licenses costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">84.4</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">102.5</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Marketing expenses payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">8.7</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">9.8</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">34.3</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">28.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Legal accrual</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">32.0</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">39.5</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">63.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">58.7</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">       222.5</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">       238.6</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:11%; font-size:11pt; font-family:Times New Roman;text-align:justify">The components of accrued expenses and other liabilities are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Def.-Times; font-size:11pt;width:89%;border:0;margin-left:auto"> <tr style="visibility:hidden; line-height:0pt; color:white"> <td style="width:80%"> </td> <td style="vertical-align:bottom;width:2%"> </td> <td> </td> <td style="white-space:nowrap">              </td> <td> </td> <td style="vertical-align:bottom;width:2%"> </td> <td> </td> <td style="white-space:nowrap">              </td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued products and licenses costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">84.4</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">102.5</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Marketing expenses payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">8.7</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">9.8</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">34.3</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">28.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Legal accrual</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">32.0</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">39.5</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">63.1</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">58.7</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td> <td colspan="4" style="height:12pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">       222.5</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">       238.6</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> 84400000 102500000 8700000 9800000 34300000 28100000 32000000 39500000 63100000 58700000 222500000 238600000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 10:-</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">COMMITMENTS AND CONTINGENT LIABILITIES </div></div> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">Litigations:</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"> </div> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The Company is the defendant in various lawsuits, including employment-related litigation claims, construction claims and other legal proceedings in the normal course of its business. Litigation and governmental proceedings can be expensive, lengthy and disruptive to normal business operations, and can require extensive management attention and resources, regardless of their merit. While the Company intends to defend the aforementioned matters vigorously, it believes that a loss in excess of its accrued liability with respect to these claims is not probable. </div> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">In particular, following audits of our 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued in January 2023 orders for the years 2016 through 2019 challenging our positions on several issues, including matters such as our position to claim a tax credit made for foreign taxes withheld on income payments that was due to the Company outside of Israel, taxation of interest earned outside of Israel by a wholly-owned Singapore subsidiary which the ITA is seeking to tax in Israel and deductibility of expenses attributed to employee stock options. The ITA orders also contest the Company’s positions on various other issues. The ITA therefore demanded the payment of additional taxes in the aggregate amount of NIS 428 million (approximately $122 million), not including an amount of NIS 418 million (approximately $119 million) related to expenses that will be deductible in future years , with respect of these four tax years (these amounts include interest through December 31, 2022). We believe we have good arguments against these orders and intend to file an appeal. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes in the aggregate amount of NIS 74 million (approximately $21 million), not including an amount of NIS 94 million (approximately $27 million) related to expenses that will be deductible in future years, respect to this year (these amounts include interest t<div style="letter-spacing: 0px; top: 0px;;display:inline;">hrou</div>gh December 31, 2022). There can be no assurance that the ITA will accept the Company’s positions on the matters raised and, if it does not, the ITA may also issue an order with respect to the 2020 tax year. </div> 428000000 122000000 418000000 119000000 2020 74000000 21000000 94000000 27000000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 11:-</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">TAXES ON INCOME </div></div> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Israeli taxation: </div> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">1.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Corporate tax: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:21%; font-size:11pt; font-family:Times New Roman;text-align:justify">Pursuant to Amendment 73 to the Investment Law adopted in 2017, a Company located in the Center of Israel that meets the conditions for “Preferred Technological Enterprises”, is subject to tax rate of 12%. The Company believes it meets those conditions. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:21%; font-size:11pt; font-family:Times New Roman;text-align:justify">Income not eligible for Preferred Enterprise benefits is taxed at a regular rate of 23%. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:21%; font-size:11pt; font-family:Times New Roman;text-align:justify">Reduced income under the Investment Law including the Preferred Enterprise Regime and Preferred Technological Enterprise Regime will be freely distributable as dividends, subject to a 15% or 20% withholding tax (or lower rate for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-Israeli</div> resident shareholder, under an applicable tax treaty). However, upon the distribution of a dividend from Preferred Income and Technological Preferred Enterprise to an Israeli company, no withholding tax will be remitted. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/> <div style="width:790px"/> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:21%; font-size:11pt; font-family:Times New Roman;text-align:justify">Pursuant to a temporary tax relief initiated by the Israeli government, a company that elected by November 11, 2013, to pay a reduced corporate tax rate as set forth in the temporary tax relief with respect to undistributed exempt income generated under the Investment Law accumulated by the Company until December 31, 2011 (“Trapped Earnings”) is entitled to distribute a dividend from such income without being required to pay additional corporate tax with respect to such dividend. A company that has so elected must make certain qualified investments in Israel over five-year period. A company that has elected to apply the temporary tax relief cannot withdraw from its election. The Company has elected to apply the temporary tax relief by the respective date and believes it meets those conditions. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:21%; font-size:11pt; font-family:Times New Roman;text-align:justify">In particular, following audits of our 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued in January 2023 orders for the years 2016 through 2019 challenging our positions on several issues, including matters such as our position to claim a tax credit made for foreign taxes withheld on income payments that was due to the Company outside of Israel, taxation of interest earned outside of Israel by a wholly-owned Singapore subsidiary which the ITA is seeking to tax in Israel and deductibility of expenses attributed to employee stock options. The ITA orders also contest the Company’s positions on various other issues. The ITA therefore demanded the payment of additional taxes in the aggregate amount of NIS 428 million (approximately $122 million), not including an amount of NIS 418 million (approximately $119 million) related to expenses that will be deductible in future years, with respect of these four tax years (these amounts include interest through December 31, 2022). We believe we have good arguments against these orders and intend to file an appeal. In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes in the aggregate amount of NIS 74 million (approximately $21 million), not including an amount of NIS 94 million (approximately $27 million) related to expenses that will be deductible in future years, with respect to this year (these amounts include interest through December 31, 2022). There can be no assurance that the ITA will accept the Company’s positions on the matters raised and, if it does not, the ITA may also issue an order with respect to the 2020 tax year.</div> <div style="text-align: justify; font-family: Times New Roman; font-size: 11pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 21%;;text-indent: 0px;"><div style="font-size: 11pt;;display:inline;">Company’s tax assessments through 2015 tax year are considered final.</div><br/></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">2.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Foreign Exchange Regulations: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:21%; font-size:11pt; font-family:Times New Roman;text-align:justify">Under the Foreign Exchange Regulations, Check Point Ltd. and its Israeli subsidiaries calculate their tax liability in dollar according to certain orders. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:21%; font-size:11pt; font-family:Times New Roman;text-align:justify">The tax liability, as calculated in dollar is translated into New Israeli Shekels according to the exchange rate as of December 31 of each year. </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Income taxes of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-Israeli</div> subsidiaries: </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Israeli</div> subsidiaries are taxed according to the tax laws in their respective countries of residence. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company does not provide deferred tax liabilities when it intends to reinvest earnings of foreign subsidiaries indefinitely or if distributed, no tax liability will be imposed. Undistributed earnings of foreign subsidiaries that are not distributed amounted to $450.3 and unrecognized deferred tax liability related to such earning amounted to $73.9 as of December 31, 2022. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/> <div style="width:790px"/><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Deferred tax assets and liabilities: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. As of December 31, 2022 and 2021, the Company’s deferred taxes were in respect of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:92%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carry forward tax losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">83.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Employee stock based compensation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tax credits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized gains on marketable securities, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued employee costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets before valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">172.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance – mainly in respect to carryforward losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(56.7</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax asset</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">143.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(32.8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Undistributed earnings of subsidiary</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8.1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(49.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(49.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax asset, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      94.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      66.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Through December 31, 2022, the U.S. subsidiaries had a U.S. federal loss carry-forward of approximately $126.7 expiring gradually beginning 2023 mainly resulting from tax benefits related to employees’ stock option exercises that can be carried forward and offset against taxable income. Through December 31, 2022, the U.S. subsidiaries had a U.S. state net loss carry forward of approximately $80.3, expiring gradually beginning 2023 and is subject to limitation on their utilization. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/><div style="width:790px"/><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Through December 31, 2022, the U.S. subsidiaries had federal and states research and development tax credits of approximately $25.6, which expire between fiscal years 2023 and fiscal 2042 and are subject to limitations on their utilization. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">d.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Income before taxes on income is comprised as follows: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:70%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Domestic</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">897.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">917.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">896.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">     928.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">     949.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">     970.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">e.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Taxes on income are comprised of the following: </div></td></tr></table></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:70%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Domestic taxes:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">117.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">130.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign taxes:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Taxes on income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    131.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    134.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    124.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">f.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">The Company operates its business in various countries, and accordingly attempts to utilize an efficient operating model to structure its tax payments based on the laws in the countries in which the Company operates. This can cause disputes between the Company and various tax authorities in different parts of the world. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/><div style="width:790px"/> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">A reconciliation of the beginning and ending amount of unrecognized tax benefits related to uncertain tax positions is as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> </tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      469.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      442.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Increases (decreases) related to tax positions taken during prior years</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decreases related to statute of limitations</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(77.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Increases related to tax positions taken during the current year</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">56.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">*)436.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">*)469.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Substantially all the balance of unrecognized tax benefits, if recognized, would reduce the Company’s annual effective tax rate. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company adjusts the unrecognized tax benefit liability and income tax expense in the period in which the uncertain tax position is effectively settled, the statute of limitations expires or when new information is available. There is a reasonable possibility that a portion of the unrecognized tax benefit liability will be adjusted within 12 months due to statute of limitations. An estimate of the range of the statute of limitations amount cannot be made since the relevant years are subject to the ITA orders (refer also to footnote 10b). </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">During the years ended December 31, 2022, 2021 and 2020, the Company recorded $15.9, $9.7 and $(0.6), respectively for interest expense (income) related to uncertain tax positions. As of December 31, 2022 and 2021, the Company had accrued interest liability related to uncertain tax positions in the amounts of $60.0 and $44.1, respectively, which is included within income tax accrual on the balance sheets. The Company did not accrue penalties during the years ended December 31, 2022, 2021 and 2020. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company files federal and state income tax returns in the U.S. All of the U.S subsidiaries’ tax years are subject to examination by the U.S. federal and most U.S. state tax authorities due to their carry-forward tax losses and overall credit carry-forward position, except for Check Point Software Technologies Inc. that the assessment statue period for tax years throughout 2017 have expired. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company believes that it has adequately provided for any reasonably foreseeable outcomes related to tax audits and settlement. The final tax outcome of its tax audits could be different from that which is reflected in the Company’s income tax provisions and accruals. Such differences could have a material effect on the Company’s income tax provision and net income in the period in which such determination is made. The Company believes it had adequately provided for all of its uncertain tax positions, including those items currently under dispute. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/> <div style="width:790px"/> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">g.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Reconciliation of the theoretical tax expenses: </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Reconciliation between the theoretical tax expenses, assuming all income is taxed at the statutory rate in Israel and the actual income tax as reported in the statements of income is as follows: </div> <div style="font-size:24pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:64%"/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income before taxes as reported in the statements of income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      928.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      949.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      970.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Statutory tax rate in Israel</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decrease in taxes resulting from:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effect of “Preferred Enterprise” status *)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(13</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others, net</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effective tax rate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5em; text-indent: -2.5em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">*)   Basic earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.95</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.80</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5em; text-indent: -2.5em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">*)   Diluted earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.94</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.80</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.72</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> 0.12 0.23 0.15 0.20 428000000 122000000 418000000 119000000 2020 74000000 21000000 94000000 27000000 450300000 73900000 As of December 31, 2022 and 2021, the Company’s deferred taxes were in respect of the following: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:92%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carry forward tax losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">83.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Employee stock based compensation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tax credits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized gains on marketable securities, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued employee costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax assets before valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">172.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance – mainly in respect to carryforward losses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(56.7</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax asset</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">143.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(32.8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Undistributed earnings of subsidiary</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8.1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(49.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(49.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred tax asset, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      94.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      66.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset. </div> 38700000 83700000 34900000 29200000 3500000 5600000 29800000 23900000 29600000 1200000 8100000 10300000 16300000 18400000 160900000 172300000 17500000 56700000 143400000 115600000 32800000 31300000 9900000 9900000 6500000 8100000 49200000 49300000 94200000 66300000 16600000 14600000 126700000 2023 80300000 2023 25600000 2023 2042 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">d.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Income before taxes on income is comprised as follows: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:70%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Domestic</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">897.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">917.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">896.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">     928.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">     949.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">     970.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 897400000 917900000 896800000 30900000 31700000 74000000 928300000 949600000 970800000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">e.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Taxes on income are comprised of the following: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:70%"/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:4%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Domestic taxes:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">117.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">130.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign taxes:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Taxes on income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    131.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    134.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">  $</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">    124.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> 117700000 130900000 112000000 -1300000 -1100000 800000 116400000 129800000 112800000 12700000 7100000 1700000 2300000 -2900000 9700000 15000000 4200000 11400000 131400000 134000000 124200000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">A reconciliation of the beginning and ending amount of unrecognized tax benefits related to uncertain tax positions is as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:80%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> </tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      469.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      442.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Increases (decreases) related to tax positions taken during prior years</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decreases related to statute of limitations</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">-</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(77.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Increases related to tax positions taken during the current year</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">56.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending balance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">*)436.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">*)469.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">*) As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset. </div> 469500000 442800000 -85400000 47200000 0 77200000 52200000 56700000 436300000 469500000 16600000 14600000 15900000 9700000 600000 60000000 44100000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">g.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Reconciliation of the theoretical tax expenses: </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Reconciliation between the theoretical tax expenses, assuming all income is taxed at the statutory rate in Israel and the actual income tax as reported in the statements of income is as follows: </div> <div style="font-size:24pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:64%"/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended December 31,</div></div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income before taxes as reported in the statements of income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      928.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      949.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">      970.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Statutory tax rate in Israel</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decrease in taxes resulting from:</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effect of “Preferred Enterprise” status *)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(13</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others, net</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Effective tax rate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5em; text-indent: -2.5em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">*)   Basic earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.95</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.80</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.5em; text-indent: -2.5em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">*)   Diluted earnings per share amounts of the benefit resulting from the “Technological preferred or Preferred Enterprise” status</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.94</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.80</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.72</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> </tr> </table> 928300000 949600000 970800000 0.23 0.23 0.23 -0.13 -0.11 -0.11 0.04 0.02 0.01 0.14 0.14 0.13 0.95 0.8 0.73 0.94 0.8 0.72 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 12:-</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">SHAREHOLDERS’ EQUITY </div></div> </td> </tr> </table> <div style="font-size:16pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">General: </div> </td> </tr> </table> <div style="margin-top:16pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Ordinary shares confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends if declared. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/> <div/><div> <div style="background-color:white;display: inline;"> </div> </div><div style="width:790px"/><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Share repurchase: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">On February 13, 2023 the Company announced the expansion of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on-going</div> share repurchase program by an additional $2,000. Under the share repurchase program, as extended, the Company is authorized to continue to repurchase up to $325 each quarter. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">As of December 31, 2022, the Company repurchased ordinary shares for an aggregate amount of $13,085.1. During 2022, 2021 and 2020 the Company repurchased 10,324,181, 10,900,938, and 11,376,531 shares for an aggregate amount of $1,299.9, $1,299.5 and $1,297.7, respectively. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Stock Options, RSUs and PSUs: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">In 2005, the Company adopted two new equity incentive plans, which were subsequently amended in January 2014 and in July 2018: the 2005 United States Equity Incentive Plan and the 2005 Israel Equity Incentive Plan together are referred to as the Equity Incentive Plans. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Under the Equity Incentive Plans, the Company may grant options to employees, officers and directors at an exercise price equal to at least the fair market value of the ordinary shares at the date of grant and are granted for periods not to exceed seven years. The Company grants under the Equity Incentive Plans options, Restricted Stock Units (“RSUs”) and Performance stock units (“PSUs”) and can also grant a variety of other equity incentives. Options granted under the Equity Incentive Plans generally vest over a period of four years of employment. Options, RSUs and PSUs that are cancelled or forfeited before expiration become available for future grants. RSUs generally vest over a four years period of employment from the grant date while PSUs generally vest over a two to four years period of employment from the grant date. PSUs are subject to certain performance criteria; accordingly, compensation expense is recognized for such awards when it becomes probable that the related performance condition will be satisfied. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Under the Equity Incentive Plans, the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee</div> directors receive on an annual basis options and RSUs grant. Following the amendments to the Equity Incentive Plans in July 2018, commencing December 31, 2018, on December 31st of each year, the number of Reserved and Authorized Shares (as defined below) under both Equity Incentive Plans together shall be annually reset on such date to equal 10% of the sum of (i) the number of ordinary shares issued and outstanding on such date and (ii) the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding awards granted under the Equity Incentive Plans as of such date (provided, however, that in no event shall the number of Reserved and Authorized Shares be less than the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding awards granted under the Equity Incentive Plans as of such date). </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/><div style="width:790px"/><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The number of “Reserved and Authorized Shares” under the Equity Plans shall equal the sum of (i) the number of ordinary shares reserved and authorized under the Equity Incentive Plans for outstanding options, RSUs, PSUs and other awards granted under the Equity Incentive Plans as of such date, and (ii) the number of ordinary shares reserved, authorized and available for issuance under the Equity Incentive Plans on such date. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">As of December 31, 2022, the number of Reserved and Authorized Shares under the Equity Incentive Plans is as detailed below:</div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:86%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:4%"/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="3" style="vertical-align:bottom"> </td> <td rowspan="8" style="vertical-align:bottom">  </td> <td rowspan="8" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Options outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">7,778,108</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RSU outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom;text-align:right;"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;">2,219,853</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PSU outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom;text-align:right;"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;">188,493</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ordinary shares available for issuance under the Equity Incentive Plans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom;text-align:right;"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;">2,905,777</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Reserved and Authorized Shares as of December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">13,092,231</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">As of December 31, 2022 the aggregate number of shares, stock options, RSU and PSU outstanding is 130,948,425. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">A summary of the Company’s stock option activity and related information is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  Number of  <br/> options</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Weighted    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">exercise</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Aggregate    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">intrinsic</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding at beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">8,160,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">113.06</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">37.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">710,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">125.54</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercised</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(1,009,329</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">99.89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(83,188</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">122.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding at December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">7,778,108</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">115.05</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">82.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable at December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5,666,608</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">114.61</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">65.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table></div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The weighted average fair values at grant date of options granted for the years ended December 31, 2022, 2021 and 2020 with an exercise price equal to the market value at the date of grant were $34.6, $25.9 and $22.0 per share, respectively. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The total intrinsic value of options exercised during the years 2022, 2021 and 2020 was $32.9, $65.1 and $81.7, respectively. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/><div style="width:790px"/> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The aggregate intrinsic value of the outstanding stock options as of December 31, 2022 and 2021, represents the intrinsic value of 7,651,858 and 6,484,417 outstanding options that are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-the-money</div></div> as of such dates. The remaining 126,250 and 1,676,208 outstanding options are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">out-of-the-money</div></div></div> as of December 31, 2022 and 2021, and their intrinsic value was considered as zero. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">A summary of the Company’s RSUs and PSUs activity is as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:71%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    RSUs    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    PSUs    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Total    </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested at beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,231,167</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">105,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,336,762</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">958,157</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">160,423</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,118,580</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(706,738)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(5,799)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(712,537)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(262,733)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(71,726)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(334,459)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,219,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">188,493</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,408,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">*) Represents an amount lower than 0.1 </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The weighted average fair values at grant date of RSUs and PSUs granted for the years ended December 31, 2022, 2021 and 2020 were $126.3, $120.1 and $105.3 per share, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The total fair value of shares vested during the years 2022, 2021 and 2020 was $89.4, $66.8 and $49.6, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">As of December 31, 2022, the Company had approximately $265.8 of unrecognized compensation expense related to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-vested</div> stock options and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-vested</div> RSU’s and PSU’s, expected to be recognized over a weighted average period of 1.9 years. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">d.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Employee Stock Purchase Plan (“ESPP”): </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">In 1996, the Company adopted an ESPP, which was subsequently amended in 2015. According to the amendments, commencing the purchase period that begins February 1, 2017, 568,478 ordinary shares are authorized for issuance under the US ESPP, and Commencing June 19, 2019 the Pool of shares for the US ESPP was set on 750,000 shares and 1,096,795 ordinary shares are authorized for issuance under the rest of the world (ROW). </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">As of December 31, 2022, 2,250,867 ordinary shares had been issued under the amended ESPP plan. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Eligible employees may use up to 15% of their salaries to purchase ordinary shares but no more than 1,250 single shares per participant on any purchase date. The ESPP is implemented through an offering every six months. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/> <div style="width:790px"/> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">During 2022, 2021 and 2020, employees purchased 372,242, 361,675 and 364,859 ordinary shares at average prices of $103.5, $105.3 and $95.4 per share, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">In accordance with ASC No. 718, the ESPP is compensatory and as such results in recognition of compensation cost. For the years ended December 31, 2022, 2021 and 2020, the Company recognized $9.9, $10.9 and $10.2, respectively, of compensation expense in connection with the ESPP. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">e.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Stock-Based Compensation: </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Stock-based compensation expense related to stock options, RSUs and PSUs is included in the consolidated statements of income as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2022    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2020      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">5.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">4.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">4.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">42.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">31.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">23.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Selling and marketing</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">43.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">42.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">36.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">40.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">40.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">47.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">131.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">120.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">112.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 2000000000 325000000 13085100000 10324181 10900938 11376531 1299900000 1299500000 1297700000 P4Y 0.10 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">As of December 31, 2022, the number of Reserved and Authorized Shares under the Equity Incentive Plans is as detailed below:</div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:86%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td style="width:4%"/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="3" style="vertical-align:bottom"> </td> <td rowspan="8" style="vertical-align:bottom">  </td> <td rowspan="8" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock Options outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">7,778,108</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RSU outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom;text-align:right;"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;">2,219,853</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PSU outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom;text-align:right;"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;">188,493</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ordinary shares available for issuance under the Equity Incentive Plans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom;text-align:right;"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;">2,905,777</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 11pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Reserved and Authorized Shares as of December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align:bottom;text-align:right;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">13,092,231</div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> 7778108 2219853 188493 2905777 13092231 130948425 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">A summary of the Company’s stock option activity and related information is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  Number of  <br/> options</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Weighted    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">exercise</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">price</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Aggregate    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">intrinsic</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding at beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">8,160,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">113.06</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">37.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">710,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">125.54</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercised</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(1,009,329</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">99.89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(83,188</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">122.41</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding at December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">7,778,108</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">115.05</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">82.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Exercisable at December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">5,666,608</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">114.61</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">$</td> <td style="vertical-align:bottom;text-align:right;">65.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 8160625 113.06 37100000 710000 125.54 1009329 99.89 83188 122.41 7778108 115.05 82500000 5666608 114.61 65400000 34.6 25.9 22 32900000 65100000 81700000 7651858 6484417 126250 1676208 0 0 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">A summary of the Company’s RSUs and PSUs activity is as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:71%"/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:2%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    RSUs    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    PSUs    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Total    </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested at beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,231,167</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">105,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,336,762</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">958,157</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">160,423</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,118,580</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(706,738)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(5,799)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(712,537)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forfeited</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(262,733)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(71,726)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(334,459)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,219,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">188,493</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2,408,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">*) Represents an amount lower than 0.1 </div> 2231167 105595 2336762 958157 160423 1118580 706738 5799 712537 262733 71726 334459 2219853 188493 2408346 0.1 126.3 120.1 105.3 89400000 66800000 49600000 265800000 P1Y10M24D 568478 750000 1096795 2250867 0.15 1250 0.85 372242 361675 364859 103.5 105.3 95.4 9900000 10900000 10200000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">Stock-based compensation expense related to stock options, RSUs and PSUs is included in the consolidated statements of income as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2022    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2020      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">5.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">4.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">4.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Research and development</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">42.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">31.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">23.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Selling and marketing</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">43.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">42.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">36.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">40.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">40.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">47.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">131.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">120.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">112.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 5400000 4800000 4500000 42000000 31800000 23500000 43200000 42800000 36800000 40800000 40900000 47700000 131400000 120300000 112500000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:12%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 13:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">EARNINGS PER SHARE </div></div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">The following table sets forth the computation of basic and diluted earnings per share: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">796.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">815.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">846.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average ordinary shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">125,205,504</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">133,121,763</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">140,495,886</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dilutive effect:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Employee stock options, RSUs and PSUs</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,133,485</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">988,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,482,106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diluted weighted average ordinary shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">    126,338,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">    134,110,048</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">    141,977,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic earnings per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.37</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.03</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diluted earnings per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.08</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">5.96</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">The following table sets forth the computation of basic and diluted earnings per share: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">796.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">815.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">846.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average ordinary shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">125,205,504</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">133,121,763</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">140,495,886</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Dilutive effect:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Employee stock options, RSUs and PSUs</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,133,485</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">988,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,482,106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diluted weighted average ordinary shares outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">    126,338,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">    134,110,048</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">    141,977,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic earnings per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.37</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.03</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td> <td colspan="4" style="height:6pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diluted earnings per ordinary share</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">6.08</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">5.96</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> 796900000 815600000 846600000 125205504 133121763 140495886 1133485 988285 1482106 126338989 134110048 141977992 6.37 6.13 6.03 6.31 6.08 5.96 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 14:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) </div></div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:88%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gains (losses)<br/>   on marketable  <br/> securities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Unrealized    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gains<br/> (losses) on<br/> cash flow<br/> hedges</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        Total        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(1.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">0.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(0.6</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other comprehensive income before reclassifications</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(93.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(25.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(118.8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts reclassified from accumulated other comprehensive income</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">*</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">21.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">21.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net current period other comprehensive income</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(93.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(3.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(97.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(94.6</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(3.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(97.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:88%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gains (losses)<br/>   on marketable  <br/> securities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Unrealized    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gains<br/> (losses) on<br/> cash flow<br/> hedges</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        Total        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning balance</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(1.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">0.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(0.6</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other comprehensive income before reclassifications</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(93.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(25.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(118.8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts reclassified from accumulated other comprehensive income</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">*</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">21.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">21.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net current period other comprehensive income</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(93.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(3.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(97.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(94.6</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(3.3</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">(97.9</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> -1200000 600000 -600000 -93400000 -25400000 -118800000 21500000 21500000 -93400000 -3900000 -97300000 -94600000 -3300000 -97900000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 15:-</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA </div></div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Summary information about geographical areas: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company operates in one reportable segment (see Note 1 for a brief description of the Company’s business). The total revenues are attributed to geographic areas based on the location of the Company’s channel partners which are considered as end customers, as well as direct customers of the Company. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The following table presents total revenues and property and equipment, net, by geographic area: </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">1. Revenues based on the channel partners’ location: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2022      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2020      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Americas</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">991.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">922.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">929.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Europe, Middle East and Africa</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,049.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">980.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">891.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asia Pacific</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">289.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">263.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">243.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">2,329.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">2,166.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">2,064.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/><div style="width:790px"/><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">2. Property and equipment, net and ROU assets: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:82%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:74%"/> <td style="vertical-align:bottom;width:9%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:9%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2022        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2021        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Israel</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">73.9</td> <td style="white-space:nowrap;vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">74.4</td> <td style="white-space:nowrap;vertical-align:bottom">  </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">U.S.</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">12.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">16.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Rest of the world</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">16.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">14.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">103.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">105.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Summary information about product lines: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s products can be classified by three main product lines. The following table presents total revenues for the years ended December 31, 2022, 2021 and 2020 by product lines: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:67%"/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2022      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2020      </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Product and licenses:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Network security Gateways</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">507.8</td> <td style="white-space:nowrap;vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">480.5</td> <td style="white-space:nowrap;vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">472.4</td> <td style="white-space:nowrap;vertical-align:bottom">  </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other *)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">47.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">33.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">41.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">554.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">513.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">513.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security subscriptions</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">858.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">755.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">671.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software updates and maintenance</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">917.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">897.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">880.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">2,329.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">2,166.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">2,064.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:6%;vertical-align:top;text-align:left;">*)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Comprised of Endpoint security, Mobile security and Security management products, each comprising of less than 10% of products and licenses revenues. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;text-align:center"/><div/><div><div style="background-color:white;display: inline;"/></div><div style="width:790px"/><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Financial income, net: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:86%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:89%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2022      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2020      </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financial income:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest income</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">67.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">66.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">78.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financial expense:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of marketable securities premium and accretion of discount, net</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">18.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">21.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">9.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Realized gain on sale of marketable securities, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">–</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(1.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(4.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> (gain) loss</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">3.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(0.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">4.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">4.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">23.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">24.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">11.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">44.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">42.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">66.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">1. Revenues based on the channel partners’ location: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:91%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2022      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2020      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Americas</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">991.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">922.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">929.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Europe, Middle East and Africa</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1,049.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">980.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">891.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asia Pacific</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">289.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">263.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">243.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">2,329.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">2,166.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">2,064.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 991100000 922800000 929800000 1049500000 980800000 891400000 289300000 263200000 243700000 2329900000 2166800000 2064900000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">2. Property and equipment, net and ROU assets: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:82%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:74%"/> <td style="vertical-align:bottom;width:9%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:9%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="7" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2022        </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">        2021        </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Israel</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">73.9</td> <td style="white-space:nowrap;vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">74.4</td> <td style="white-space:nowrap;vertical-align:bottom">  </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">U.S.</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">12.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">16.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Rest of the world</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">16.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">14.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">103.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> $</td> <td style="vertical-align:bottom;text-align:right;">105.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> 73900000 74400000 12800000 16900000 16800000 14100000 103500000 105400000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Summary information about product lines: </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">The Company’s products can be classified by three main product lines. The following table presents total revenues for the years ended December 31, 2022, 2021 and 2020 by product lines: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div><div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:84%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:67%"/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:6%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2022      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2020      </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Product and licenses:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Network security Gateways</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">507.8</td> <td style="white-space:nowrap;vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">480.5</td> <td style="white-space:nowrap;vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">472.4</td> <td style="white-space:nowrap;vertical-align:bottom">  </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other *)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">47.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">33.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">41.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">554.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">513.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">513.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Security subscriptions</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">858.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">755.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">671.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software updates and maintenance</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">917.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">897.7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">880.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td> <td colspan="4" style="height:9.75pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">2,329.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">2,166.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">    $</td> <td style="vertical-align:bottom;text-align:right;">2,064.9</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:16%"> </td> <td style="width:6%;vertical-align:top;text-align:left;">*)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Comprised of Endpoint security, Mobile security and Security management products, each comprising of less than 10% of products and licenses revenues. </div></td></tr></table> 3 507800000 480500000 472400000 47100000 33400000 41200000 554900000 513900000 513600000 858000000 755200000 671100000 917000000 897700000 880200000 2329900000 2166800000 2064900000 0.10 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Financial income, net: </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;width:86%;border:0;margin-left:auto"> <tr style="font-size: 0px;"> <td style="width:89%"/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/> <td style="vertical-align:bottom;width:1%"/> <td/> <td/> <td/></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="11" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2022      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2020      </div></div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financial income:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest income</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">67.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">66.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">78.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financial expense:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of marketable securities premium and accretion of discount, net</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">18.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">21.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">9.4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Realized gain on sale of marketable securities, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">–</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(1.4</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(4.5</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign currency <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> (gain) loss</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">3.3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">(0.2</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">4.5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2em; text-indent: -1em; font-size: 11pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Others</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">1.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">4.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">2.2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">23.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">24.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">11.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td></tr> <tr style="font-size:1pt"> <td style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td> <td colspan="4" style="height:7.5pt"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">44.0</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">42.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  $</td> <td style="vertical-align:bottom;text-align:right;">66.6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td></tr></table> 67600000 66100000 78200000 18500000 21000000 9400000 0 1400000 4500000 -3300000 200000 -4500000 1800000 4600000 2200000 23600000 24000000 11600000 44000000 42100000 66600000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%;vertical-align:top;text-align:left;"><div style="font-weight:bold;display:inline;">NOTE 16:-</div></td> <td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman;font-weight:bold;text-align:left">SUBSEQUENT EVENTS </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">Following audits of the Company’s 2016 through 2020 corporate tax returns, the Israeli Tax Authority (the “ITA”) issued o<div style="display:inline;">rd</div>ers for the years 2016 through 2019 challenging the Company’s positions on several issues. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">In addition, the ITA has issued tax assessment for the 2020 tax year in which it demanded the payment of additional taxes. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:16%; font-size:11pt; font-family:Times New Roman;text-align:justify">See also further details in Note 10b. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:11%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b.</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 11pt; font-family: &quot;Times New Roman&quot;; text-align: justify; line-height: normal;">On February 13, 2023 the Company announced the expansion of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on-going</div> share repurchase program (see Note 12b). </div></td></tr></table> Represents an amount lower than 0.1 As of December 31, 2022 and 2021 unrecognized tax benefit in the amounts of $16.6 and $14.6 was presented net from deferred tax asset. EXCEL 88 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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Ð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end XML 89 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 90 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 91 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 243 368 1 true 91 0 false 10 false false R1.htm 1001 - Document - Cover Sheet http://www.checkpoint.com/role/Cover Cover Cover 1 false false R2.htm 1002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.checkpoint.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.checkpoint.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - CONSOLIDATED STATEMENTS OF INCOME Sheet http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome CONSOLIDATED STATEMENTS OF INCOME Statements 4 false false R5.htm 1005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 5 false false R6.htm 1006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Sheet http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Statements 6 false false R7.htm 1007 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) Sheet http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquityParenthetical STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 1008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 1009 - Disclosure - GENERAL Sheet http://www.checkpoint.com/role/General GENERAL Notes 9 false false R10.htm 1010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.checkpoint.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 1011 - Disclosure - ACQUISITION Sheet http://www.checkpoint.com/role/Acquisition ACQUISITION Notes 11 false false R12.htm 1012 - Disclosure - CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES Sheet http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecurities CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES Notes 12 false false R13.htm 1013 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://www.checkpoint.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 13 false false R14.htm 1014 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://www.checkpoint.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 14 false false R15.htm 1015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET Sheet http://www.checkpoint.com/role/GoodwillAndOtherIntangibleAssetsNet GOODWILL AND OTHER INTANGIBLE ASSETS, NET Notes 15 false false R16.htm 1016 - Disclosure - DEFERRED REVENUES Sheet http://www.checkpoint.com/role/DeferredRevenues DEFERRED REVENUES Notes 16 false false R17.htm 1017 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES Sheet http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilities ACCRUED EXPENSES AND OTHER LIABILITIES Notes 17 false false R18.htm 1018 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES Sheet http://www.checkpoint.com/role/CommitmentsAndContingentLiabilities COMMITMENTS AND CONTINGENT LIABILITIES Notes 18 false false R19.htm 1019 - Disclosure - TAXES ON INCOME Sheet http://www.checkpoint.com/role/TaxesOnIncome TAXES ON INCOME Notes 19 false false R20.htm 1020 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://www.checkpoint.com/role/ShareholdersEquity SHAREHOLDERS' EQUITY Notes 20 false false R21.htm 1021 - Disclosure - EARNINGS PER SHARE Sheet http://www.checkpoint.com/role/EarningsPerShare EARNINGS PER SHARE Notes 21 false false R22.htm 1022 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Sheet http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLoss ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Notes 22 false false R23.htm 1023 - Disclosure - GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA Sheet http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeData GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA Notes 23 false false R24.htm 1024 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.checkpoint.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 24 false false R25.htm 1025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 1026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.checkpoint.com/role/SignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.checkpoint.com/role/SignificantAccountingPolicies 26 false false R27.htm 1027 - Disclosure - CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES (Tables) Sheet http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesTables CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES (Tables) Tables http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecurities 27 false false R28.htm 1028 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.checkpoint.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://www.checkpoint.com/role/FairValueMeasurements 28 false false R29.htm 1029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://www.checkpoint.com/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://www.checkpoint.com/role/PropertyAndEquipmentNet 29 false false R30.htm 1030 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables) Sheet http://www.checkpoint.com/role/GoodwillAndOtherIntangibleAssetsNetTables GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables) Tables http://www.checkpoint.com/role/GoodwillAndOtherIntangibleAssetsNet 30 false false R31.htm 1031 - Disclosure - DEFERRED REVENUES (Tables) Sheet http://www.checkpoint.com/role/DeferredRevenuesTables DEFERRED REVENUES (Tables) Tables http://www.checkpoint.com/role/DeferredRevenues 31 false false R32.htm 1032 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) Sheet http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesTables ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) Tables http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilities 32 false false R33.htm 1033 - Disclosure - TAXES ON INCOME (Tables) Sheet http://www.checkpoint.com/role/TaxesOnIncomeTables TAXES ON INCOME (Tables) Tables http://www.checkpoint.com/role/TaxesOnIncome 33 false false R34.htm 1034 - Disclosure - SHAREHOLDERS' EQUITY (Tables) Sheet http://www.checkpoint.com/role/ShareholdersEquityTables SHAREHOLDERS' EQUITY (Tables) Tables http://www.checkpoint.com/role/ShareholdersEquity 34 false false R35.htm 1035 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.checkpoint.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://www.checkpoint.com/role/EarningsPerShare 35 false false R36.htm 1036 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) Sheet http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossTables ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) Tables http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLoss 36 false false R37.htm 1037 - Disclosure - GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA (Tables) Sheet http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeDataTables GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA (Tables) Tables http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeData 37 false false R38.htm 1038 - Disclosure - General - Additional Information (Detail) Sheet http://www.checkpoint.com/role/GeneralAdditionalInformationDetail General - Additional Information (Detail) Details 38 false false R39.htm 1039 - Disclosure - Summary of Annual Rate of Depreciation on Property and Equipment (Detail) Sheet http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail Summary of Annual Rate of Depreciation on Property and Equipment (Detail) Details 39 false false R40.htm 1040 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail Significant Accounting Policies - Additional Information (Detail) Details 40 false false R41.htm 1041 - Disclosure - Weighted Average Assumptions of Options Granted (Detail) Sheet http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail Weighted Average Assumptions of Options Granted (Detail) Details 41 false false R42.htm 1042 - Disclosure - Acquisition - Additional Information (Detail) Sheet http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail Acquisition - Additional Information (Detail) Details 42 false false R43.htm 1043 - Disclosure - Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities - Schedule Of Cash And Cash Equivalents And Short Term Investments (Detail) Sheet http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities - Schedule Of Cash And Cash Equivalents And Short Term Investments (Detail) Details 43 false false R44.htm 1044 - Disclosure - Cash And Cash Equivalents, Short-Contractual Obligation Fiscal Year Maturity Schedule TableTerm Bank Deposits And Marketable Securities - (Detail) Sheet http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail Cash And Cash Equivalents, Short-Contractual Obligation Fiscal Year Maturity Schedule TableTerm Bank Deposits And Marketable Securities - (Detail) Details 44 false false R45.htm 1045 - Disclosure - Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities- Additional Information (Detail) Sheet http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities- Additional Information (Detail) Details 45 false false R46.htm 1046 - Disclosure - Financial Assets Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail Financial Assets Measured at Fair Value on Recurring Basis (Detail) Details 46 false false R47.htm 1047 - Disclosure - Property and Equipment Net (Detail) Sheet http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail Property and Equipment Net (Detail) Details 47 false false R48.htm 1048 - Disclosure - Schedule of Goodwill (Detail) Sheet http://www.checkpoint.com/role/ScheduleOfGoodwillDetail Schedule of Goodwill (Detail) Details 48 false false R49.htm 1049 - Disclosure - Other Intangible Assets, Net (Detail) Sheet http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail Other Intangible Assets, Net (Detail) Details 49 false false R50.htm 1050 - Disclosure - Estimated Future Amortization Expense of Other Intangible Assets (Detail) Sheet http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail Estimated Future Amortization Expense of Other Intangible Assets (Detail) Details 50 false false R51.htm 1051 - Disclosure - Deferred Revenues (Detail) Sheet http://www.checkpoint.com/role/DeferredRevenuesDetail Deferred Revenues (Detail) Details 51 false false R52.htm 1052 - Disclosure - Accrued Expenses and Other Liabilities (Detail) Sheet http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail Accrued Expenses and Other Liabilities (Detail) Details 52 false false R53.htm 1053 - Disclosure - Commitments And Contingent Liabilities - Additional Information (Detail) Sheet http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail Commitments And Contingent Liabilities - Additional Information (Detail) Details 53 false false R54.htm 1054 - Disclosure - Taxes On Income - Additional Information (Detail) Sheet http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail Taxes On Income - Additional Information (Detail) Details 54 false false R55.htm 1055 - Disclosure - Components of Deferred Tax Assets and Liabilities (Detail) Sheet http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail Components of Deferred Tax Assets and Liabilities (Detail) Details 55 false false R56.htm 1056 - Disclosure - Income Before Taxes (Detail) Sheet http://www.checkpoint.com/role/IncomeBeforeTaxesDetail Income Before Taxes (Detail) Details 56 false false R57.htm 1057 - Disclosure - Components of Income Tax Expense (Detail) Sheet http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail Components of Income Tax Expense (Detail) Details 57 false false R58.htm 1058 - Disclosure - Reconciliation of Unrecognized Tax Benefits (Detail) Sheet http://www.checkpoint.com/role/ReconciliationOfUnrecognizedTaxBenefitsDetail Reconciliation of Unrecognized Tax Benefits (Detail) Details 58 false false R59.htm 1059 - Disclosure - Reconciliation of Unrecognized Tax Benefits (Parenthetical) (Detail) Sheet http://www.checkpoint.com/role/ReconciliationOfUnrecognizedTaxBenefitsParentheticalDetail Reconciliation of Unrecognized Tax Benefits (Parenthetical) (Detail) Details 59 false false R60.htm 1060 - Disclosure - Effective Income Tax Reconciliation (Detail) Sheet http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail Effective Income Tax Reconciliation (Detail) Details 60 false false R61.htm 1061 - Disclosure - Effective Income Tax Reconciliation (Parenthetical) (Detail) Sheet http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationParentheticalDetail Effective Income Tax Reconciliation (Parenthetical) (Detail) Details 61 false false R62.htm 1062 - Disclosure - Shareholders' Equity - Additional Information (Detail) Sheet http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail Shareholders' Equity - Additional Information (Detail) Details 62 false false R63.htm 1063 - Disclosure - Number of Reserved and Authorized Shares Under the Equity Incentive Plans (Detail) Sheet http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail Number of Reserved and Authorized Shares Under the Equity Incentive Plans (Detail) Details 63 false false R64.htm 1064 - Disclosure - Stock Option Activity and Related Information (Detail) Sheet http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail Stock Option Activity and Related Information (Detail) Details 64 false false R65.htm 1065 - Disclosure - Summary of Performance Stock Units Activity (Detail) Sheet http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail Summary of Performance Stock Units Activity (Detail) Details 65 false false R66.htm 1066 - Disclosure - Shareholders' Equity - Stock-based Compensation Expense Related to Stock Options, RSUs and PSUs (Detail) Sheet http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail Shareholders' Equity - Stock-based Compensation Expense Related to Stock Options, RSUs and PSUs (Detail) Details 66 false false R67.htm 1067 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted Earnings per Share (Detail) Sheet http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail EARNINGS PER SHARE - Computation of Basic and Diluted Earnings per Share (Detail) Details 67 false false R68.htm 1068 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule Of Accumulated Other Comprehensive Income Loss (Detail) Sheet http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail Accumulated Other Comprehensive Income (Loss) - Schedule Of Accumulated Other Comprehensive Income Loss (Detail) Details 68 false false R69.htm 1069 - Disclosure - Revenue by Geographic Area (Detail) Sheet http://www.checkpoint.com/role/RevenueByGeographicAreaDetail Revenue by Geographic Area (Detail) Details 69 false false R70.htm 1070 - Disclosure - Property and Equipment, Net and Right of Use Assets by Geographic Area (Detail) Sheet http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail Property and Equipment, Net and Right of Use Assets by Geographic Area (Detail) Details 70 false false R71.htm 1071 - Disclosure - Revenues by Product Lines (Detail) Sheet http://www.checkpoint.com/role/RevenuesByProductLinesDetail Revenues by Product Lines (Detail) Details 71 false false R72.htm 1072 - Disclosure - Revenues by Product Lines (Parenthetical) (Detail) Sheet http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail Revenues by Product Lines (Parenthetical) (Detail) Details 72 false false R73.htm 1073 - Disclosure - Geographic Information and Selected Statements of Income Data - Additional Information (Detail) Sheet http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeDataAdditionalInformationDetail Geographic Information and Selected Statements of Income Data - Additional Information (Detail) Details 73 false false R74.htm 1074 - Disclosure - Financial Income, Net (Detail) Sheet http://www.checkpoint.com/role/FinancialIncomeNetDetail Financial Income, Net (Detail) Details 74 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d473301d20f.htm 6162 [dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 10 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d473301d20f.htm 7270, 7330, 7356, 7520, 7580, 7606, 7770, 7830, 7856, 7994 [dq-0542-Deprecated-Concept] Concept PropertyPlantAndEquipmentEstimatedUsefulLives in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. d473301d20f.htm 9022 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityIncorporationStateCountryCode - d473301d20f.htm 9 d473301d20f.htm chkp-20221231.xsd chkp-20221231_cal.xml chkp-20221231_def.xml chkp-20221231_lab.xml chkp-20221231_pre.xml d473301dex121.htm d473301dex122.htm d473301dex131.htm d473301dex132.htm d473301dex15.htm g473301dsp70.jpg http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 94 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d473301d20f.htm": { "axisCustom": 2, "axisStandard": 27, "baseTaxonomies": { "http://fasb.org/srt/2022": 1, "http://fasb.org/us-gaap/2022": 876, "http://xbrl.sec.gov/dei/2022": 41 }, "contextCount": 243, "dts": { "calculationLink": { "local": [ "chkp-20221231_cal.xml" ] }, "definitionLink": { "local": [ "chkp-20221231_def.xml" ] }, "inline": { "local": [ "d473301d20f.htm" ] }, "labelLink": { "local": [ "chkp-20221231_lab.xml" ] }, "presentationLink": { "local": [ "chkp-20221231_pre.xml" ] }, "schema": { "local": [ "chkp-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 606, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 2, "http://xbrl.sec.gov/dei/2022": 4, "total": 6 }, "keyCustom": 45, "keyStandard": 323, "memberCustom": 39, "memberStandard": 49, "nsprefix": "chkp", "nsuri": "http://www.checkpoint.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://www.checkpoint.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "10", "role": "http://www.checkpoint.com/role/SignificantAccountingPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - ACQUISITION", "menuCat": "Notes", "order": "11", "role": "http://www.checkpoint.com/role/Acquisition", "shortName": "ACQUISITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES", "menuCat": "Notes", "order": "12", "role": "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecurities", "shortName": "CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - FAIR VALUE MEASUREMENTS", "menuCat": "Notes", "order": "13", "role": "http://www.checkpoint.com/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - PROPERTY AND EQUIPMENT, NET", "menuCat": "Notes", "order": "14", "role": "http://www.checkpoint.com/role/PropertyAndEquipmentNet", "shortName": "PROPERTY AND EQUIPMENT, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET", "menuCat": "Notes", "order": "15", "role": "http://www.checkpoint.com/role/GoodwillAndOtherIntangibleAssetsNet", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - DEFERRED REVENUES", "menuCat": "Notes", "order": "16", "role": "http://www.checkpoint.com/role/DeferredRevenues", "shortName": "DEFERRED REVENUES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:AccruedExpensesAndOtherLiabilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES", "menuCat": "Notes", "order": "17", "role": "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilities", "shortName": "ACCRUED EXPENSES AND OTHER LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:AccruedExpensesAndOtherLiabilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES", "menuCat": "Notes", "order": "18", "role": "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilities", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - TAXES ON INCOME", "menuCat": "Notes", "order": "19", "role": "http://www.checkpoint.com/role/TaxesOnIncome", "shortName": "TAXES ON INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://www.checkpoint.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "lang": null, "name": "chkp:ShortTermDeposit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:StockholdersEquityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - SHAREHOLDERS' EQUITY", "menuCat": "Notes", "order": "20", "role": "http://www.checkpoint.com/role/ShareholdersEquity", "shortName": "SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:StockholdersEquityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - EARNINGS PER SHARE", "menuCat": "Notes", "order": "21", "role": "http://www.checkpoint.com/role/EarningsPerShare", "shortName": "EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)", "menuCat": "Notes", "order": "22", "role": "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLoss", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:SegmentReportingForeignCountriesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA", "menuCat": "Notes", "order": "23", "role": "http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeData", "shortName": "GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:SegmentReportingForeignCountriesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "24", "role": "http://www.checkpoint.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "25", "role": "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:ScheduleOfAnnualRateOfDepreciationOnPropertyAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.checkpoint.com/role/SignificantAccountingPoliciesTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:ScheduleOfAnnualRateOfDepreciationOnPropertyAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesTables", "shortName": "CASH AND CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND MARKETABLE SECURITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.checkpoint.com/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.checkpoint.com/role/PropertyAndEquipmentNetTables", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_ILS_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.checkpoint.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_ILS_per_Share", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "chkp:GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.checkpoint.com/role/GoodwillAndOtherIntangibleAssetsNetTables", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "chkp:GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:DeferredRevenueByArrangementAndResidualValueObligationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - DEFERRED REVENUES (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.checkpoint.com/role/DeferredRevenuesTables", "shortName": "DEFERRED REVENUES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:DeferredRevenueByArrangementAndResidualValueObligationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "chkp:AccruedExpensesAndOtherLiabilitiesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesTables", "shortName": "ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "chkp:AccruedExpensesAndOtherLiabilitiesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - TAXES ON INCOME (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.checkpoint.com/role/TaxesOnIncomeTables", "shortName": "TAXES ON INCOME (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:ScheduleOfReservedAndAuthorizedSharesUnderEquityIncentivePlansTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - SHAREHOLDERS' EQUITY (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.checkpoint.com/role/ShareholdersEquityTables", "shortName": "SHAREHOLDERS' EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "chkp:ScheduleOfReservedAndAuthorizedSharesUnderEquityIncentivePlansTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1035 - Disclosure - EARNINGS PER SHARE (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.checkpoint.com/role/EarningsPerShareTables", "shortName": "EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1036 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossTables", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "chkp:SegmentReportingForeignCountriesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1037 - Disclosure - GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA (Tables)", "menuCat": "Tables", "order": "37", "role": "http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeDataTables", "shortName": "GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "chkp:SegmentReportingForeignCountriesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:NumberOfReportableSegments", "div", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unitRef": "Unit_Segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1038 - Disclosure - General - Additional Information (Detail)", "menuCat": "Details", "order": "38", "role": "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail", "shortName": "General - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "INF", "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "Unit_Segment", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_BuildingMemberusgaapPropertyPlantAndEquipmentByTypeAxis", "decimals": "INF", "first": true, "lang": null, "name": "chkp:AnnualRateOfDepreciationOnPropertyAndEquipment", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1039 - Disclosure - Summary of Annual Rate of Depreciation on Property and Equipment (Detail)", "menuCat": "Details", "order": "39", "role": "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail", "shortName": "Summary of Annual Rate of Depreciation on Property and Equipment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_BuildingMemberusgaapPropertyPlantAndEquipmentByTypeAxis", "decimals": "INF", "first": true, "lang": null, "name": "chkp:AnnualRateOfDepreciationOnPropertyAndEquipment", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - CONSOLIDATED STATEMENTS OF INCOME", "menuCat": "Statements", "order": "4", "role": "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "shortName": "CONSOLIDATED STATEMENTS OF INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:NumberOfReportableSegments", "div", "td", "tr", "table", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unitRef": "Unit_Segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1040 - Disclosure - Significant Accounting Policies - Additional Information (Detail)", "menuCat": "Details", "order": "40", "role": "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillImpairmentLoss", "us-gaap:GoodwillImpairmentLoss", "div", "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-6", "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1041 - Disclosure - Weighted Average Assumptions of Options Granted (Detail)", "menuCat": "Details", "order": "41", "role": "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail", "shortName": "Weighted Average Assumptions of Options Granted (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2021To12_31_2021_AvananMemberusgaapBusinessAcquisitionAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1042 - Disclosure - Acquisition - Additional Information (Detail)", "menuCat": "Details", "order": "42", "role": "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail", "shortName": "Acquisition - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2021To12_31_2021_AvananMemberusgaapBusinessAcquisitionAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock", "div", "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1043 - Disclosure - Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities - Schedule Of Cash And Cash Equivalents And Short Term Investments (Detail)", "menuCat": "Details", "order": "43", "role": "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail", "shortName": "Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities - Schedule Of Cash And Cash Equivalents And Short Term Investments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock", "div", "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:FairValueOfMarketableSecuritiesByContractualMaturities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1044 - Disclosure - Cash And Cash Equivalents, Short-Contractual Obligation Fiscal Year Maturity Schedule TableTerm Bank Deposits And Marketable Securities - (Detail)", "menuCat": "Details", "order": "44", "role": "http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail", "shortName": "Cash And Cash Equivalents, Short-Contractual Obligation Fiscal Year Maturity Schedule TableTerm Bank Deposits And Marketable Securities - (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:FairValueOfMarketableSecuritiesByContractualMaturities", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedGain", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1045 - Disclosure - Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities- Additional Information (Detail)", "menuCat": "Details", "order": "45", "role": "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail", "shortName": "Cash And Cash Equivalents, Short-Term Bank Deposits And Marketable Securities- Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedGain", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:ShortTermBankDepositsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1046 - Disclosure - Financial Assets Measured at Fair Value on Recurring Basis (Detail)", "menuCat": "Details", "order": "46", "role": "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail", "shortName": "Financial Assets Measured at Fair Value on Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueMeasurementInputsDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:ShortTermBankDepositsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1047 - Disclosure - Property and Equipment Net (Detail)", "menuCat": "Details", "order": "47", "role": "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail", "shortName": "Property and Equipment Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1048 - Disclosure - Schedule of Goodwill (Detail)", "menuCat": "Details", "order": "48", "role": "http://www.checkpoint.com/role/ScheduleOfGoodwillDetail", "shortName": "Schedule of Goodwill (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "chkp:GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2020", "decimals": "-5", "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "chkp:GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1049 - Disclosure - Other Intangible Assets, Net (Detail)", "menuCat": "Details", "order": "49", "role": "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail", "shortName": "Other Intangible Assets, Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "chkp:GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "menuCat": "Statements", "order": "5", "role": "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "chkp:GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1050 - Disclosure - Estimated Future Amortization Expense of Other Intangible Assets (Detail)", "menuCat": "Details", "order": "50", "role": "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail", "shortName": "Estimated Future Amortization Expense of Other Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "chkp:GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "chkp:DeferredRevenueByArrangementAndResidualValueObligationsDisclosureTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredRevenue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1051 - Disclosure - Deferred Revenues (Detail)", "menuCat": "Details", "order": "51", "role": "http://www.checkpoint.com/role/DeferredRevenuesDetail", "shortName": "Deferred Revenues (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "chkp:DeferredRevenueByArrangementAndResidualValueObligationsDisclosureTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022_SubscriptionArrangementMemberusgaapDeferredRevenueArrangementTypeAxis", "decimals": "-5", "lang": null, "name": "us-gaap:DeferredRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:AccruedProductsAndLicensesCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1052 - Disclosure - Accrued Expenses and Other Liabilities (Detail)", "menuCat": "Details", "order": "52", "role": "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail", "shortName": "Accrued Expenses and Other Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:AccruedProductsAndLicensesCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn01_01_2023_IsraelTaxAuthorityMemberusgaapIncomeTaxAuthorityNameAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_TaxYearTwoThousandSixteenThroughTwoThousandAndNineteenMemberusgaapTaxPeriodAxis", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear", "reportCount": 1, "unitRef": "Unit_ILS", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1053 - Disclosure - Commitments And Contingent Liabilities - Additional Information (Detail)", "menuCat": "Details", "order": "53", "role": "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "shortName": "Commitments And Contingent Liabilities - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R54": { "firstAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "chkp:CorporateIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1054 - Disclosure - Taxes On Income - Additional Information (Detail)", "menuCat": "Details", "order": "54", "role": "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail", "shortName": "Taxes On Income - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "chkp:CorporateIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1055 - Disclosure - Components of Deferred Tax Assets and Liabilities (Detail)", "menuCat": "Details", "order": "55", "role": "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail", "shortName": "Components of Deferred Tax Assets and Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1056 - Disclosure - Income Before Taxes (Detail)", "menuCat": "Details", "order": "56", "role": "http://www.checkpoint.com/role/IncomeBeforeTaxesDetail", "shortName": "Income Before Taxes (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1057 - Disclosure - Components of Income Tax Expense (Detail)", "menuCat": "Details", "order": "57", "role": "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail", "shortName": "Components of Income Tax Expense (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_DomesticCountryMemberusgaapIncomeTaxAuthorityAxis", "decimals": "-5", "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "chkp:ReconciliationOfUnrecognizedTaxBenefitsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1058 - Disclosure - Reconciliation of Unrecognized Tax Benefits (Detail)", "menuCat": "Details", "order": "58", "role": "http://www.checkpoint.com/role/ReconciliationOfUnrecognizedTaxBenefitsDetail", "shortName": "Reconciliation of Unrecognized Tax Benefits (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "chkp:ReconciliationOfUnrecognizedTaxBenefitsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2020", "decimals": "-5", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:UnrecognizedTaxBenefitPresentedNetFromDeferredTaxAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1059 - Disclosure - Reconciliation of Unrecognized Tax Benefits (Parenthetical) (Detail)", "menuCat": "Details", "order": "59", "role": "http://www.checkpoint.com/role/ReconciliationOfUnrecognizedTaxBenefitsParentheticalDetail", "shortName": "Reconciliation of Unrecognized Tax Benefits (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:UnrecognizedTaxBenefitPresentedNetFromDeferredTaxAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2019", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY", "menuCat": "Statements", "order": "6", "role": "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity", "shortName": "STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2019", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1060 - Disclosure - Effective Income Tax Reconciliation (Detail)", "menuCat": "Details", "order": "60", "role": "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail", "shortName": "Effective Income Tax Reconciliation (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "2", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "2", "first": true, "lang": null, "name": "chkp:BasicEarningsPerSharesAmountResultingFromIssuanceOfStatus", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1061 - Disclosure - Effective Income Tax Reconciliation (Parenthetical) (Detail)", "menuCat": "Details", "order": "61", "role": "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationParentheticalDetail", "shortName": "Effective Income Tax Reconciliation (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "2", "first": true, "lang": null, "name": "chkp:BasicEarningsPerSharesAmountResultingFromIssuanceOfStatus", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:StockRepurchaseProgramCumulativeSharesRepurchasedValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1062 - Disclosure - Shareholders' Equity - Additional Information (Detail)", "menuCat": "Details", "order": "62", "role": "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "shortName": "Shareholders' Equity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:StockRepurchaseProgramCumulativeSharesRepurchasedValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1063 - Disclosure - Number of Reserved and Authorized Shares Under the Equity Incentive Plans (Detail)", "menuCat": "Details", "order": "63", "role": "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "shortName": "Number of Reserved and Authorized Shares Under the Equity Incentive Plans (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1064 - Disclosure - Stock Option Activity and Related Information (Detail)", "menuCat": "Details", "order": "64", "role": "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail", "shortName": "Stock Option Activity and Related Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1065 - Disclosure - Summary of Performance Stock Units Activity (Detail)", "menuCat": "Details", "order": "65", "role": "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail", "shortName": "Summary of Performance Stock Units Activity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1066 - Disclosure - Shareholders' Equity - Stock-based Compensation Expense Related to Stock Options, RSUs and PSUs (Detail)", "menuCat": "Details", "order": "66", "role": "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail", "shortName": "Shareholders' Equity - Stock-based Compensation Expense Related to Stock Options, RSUs and PSUs (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_CostOfSalesMemberusgaapIncomeStatementLocationAxis", "decimals": "-5", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1067 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted Earnings per Share (Detail)", "menuCat": "Details", "order": "67", "role": "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail", "shortName": "EARNINGS PER SHARE - Computation of Basic and Diluted Earnings per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2021", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1068 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule Of Accumulated Other Comprehensive Income Loss (Detail)", "menuCat": "Details", "order": "68", "role": "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail", "shortName": "Accumulated Other Comprehensive Income (Loss) - Schedule Of Accumulated Other Comprehensive Income Loss (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "lang": null, "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "chkp:SegmentReportingForeignCountriesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1069 - Disclosure - Revenue by Geographic Area (Detail)", "menuCat": "Details", "order": "69", "role": "http://www.checkpoint.com/role/RevenueByGeographicAreaDetail", "shortName": "Revenue by Geographic Area (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "chkp:SegmentReportingForeignCountriesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TreasuryStockSharesAcquired", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)", "menuCat": "Statements", "order": "7", "role": "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquityParenthetical", "shortName": "STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:PropertyPlantAndEquipmentNetAndRightOfUseAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1070 - Disclosure - Property and Equipment, Net and Right of Use Assets by Geographic Area (Detail)", "menuCat": "Details", "order": "70", "role": "http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail", "shortName": "Property and Equipment, Net and Right of Use Assets by Geographic Area (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "chkp:PropertyPlantAndEquipmentNetAndRightOfUseAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1071 - Disclosure - Revenues by Product Lines (Detail)", "menuCat": "Details", "order": "71", "role": "http://www.checkpoint.com/role/RevenuesByProductLinesDetail", "shortName": "Revenues by Product Lines (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_NetworkSecurityGatewaysMembersrtProductOrServiceAxis", "decimals": "-5", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_OtherProductMembersrtProductOrServiceAxis_ProductConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_ProductsAndLicensesRevenuesMemberusgaapConcentrationRiskByBenchmarkAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1072 - Disclosure - Revenues by Product Lines (Parenthetical) (Detail)", "menuCat": "Details", "order": "72", "role": "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail", "shortName": "Revenues by Product Lines (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_OtherProductMembersrtProductOrServiceAxis_ProductConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_ProductsAndLicensesRevenuesMemberusgaapConcentrationRiskByBenchmarkAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "chkp:NumberOfProductLines", "reportCount": 1, "unique": true, "unitRef": "Unit_Product", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1073 - Disclosure - Geographic Information and Selected Statements of Income Data - Additional Information (Detail)", "menuCat": "Details", "order": "73", "role": "http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeDataAdditionalInformationDetail", "shortName": "Geographic Information and Selected Statements of Income Data - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "chkp:NumberOfProductLines", "reportCount": 1, "unique": true, "unitRef": "Unit_Product", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmortizationOfDebtDiscountPremium", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1074 - Disclosure - Financial Income, Net (Detail)", "menuCat": "Details", "order": "74", "role": "http://www.checkpoint.com/role/FinancialIncomeNetDetail", "shortName": "Financial Income, Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022_FinancialIncomeMemberusgaapFinancialInstrumentAxis", "decimals": "-5", "lang": null, "name": "us-gaap:InvestmentIncomeInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "8", "role": "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - GENERAL", "menuCat": "Notes", "order": "9", "role": "http://www.checkpoint.com/role/General", "shortName": "GENERAL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d473301d20f.htm", "contextRef": "P01_01_2022To12_31_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 91, "tag": { "chkp_AccruedExpensesAndOtherLiabilitiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued expenses and other liabilities", "label": "Accrued Expenses And Other Liabilities [Text Block]", "verboseLabel": "ACCRUED EXPENSES AND OTHER LIABILITIES" } } }, "localname": "AccruedExpensesAndOtherLiabilitiesTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "chkp_AccruedInterestOnUncertainTaxPositions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of interest expense accrued as of the date of the statement of financial position for an underpayment of income taxes computed by applying the applicable statutory rate of interest to the difference between a tax position recognized for financial reporting purposes and the amount that might be imposed under tax return audit of the entity.", "label": "Accrued Interest on Uncertain Tax Positions", "terseLabel": "Uncertain tax positions accrued interest" } } }, "localname": "AccruedInterestOnUncertainTaxPositions", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chkp_AccruedProductsAndLicensesCosts": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Products and Licenses Costs", "label": "Accrued Products And Licenses Costs", "terseLabel": "Accrued products and licenses costs" } } }, "localname": "AccruedProductsAndLicensesCosts", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "chkp_AdjustmentsToAdditionalPaidInCapitalFairValueOfAwardsAttributableToPreAcquisitionServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital fair value of awards attributable to pre-acquisition services.", "label": "Adjustments to Additional Paid in Capital Fair Value of Awards Attributable to Pre Acquisition Services", "terseLabel": "Fair value of awards attributable to pre-acquisition services" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfAwardsAttributableToPreAcquisitionServices", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "chkp_AfterOneYearThroughFiveYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "After One Year Through Five Years Member", "label": "After One Year Through Five Years [Member]" } } }, "localname": "AfterOneYearThroughFiveYearsMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail" ], "xbrltype": "domainItemType" }, "chkp_AmortizationOfTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amortization of technology.", "label": "Amortization of technology [Member]", "terseLabel": "Amortization of technology" } } }, "localname": "AmortizationOfTechnologyMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "domainItemType" }, "chkp_AmortizedCostOfMarketableSecuritiesByContractualMaturities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortized Cost of marketable securities by contractual maturities", "label": "Amortized Cost of marketable securities by contractual maturities" } } }, "localname": "AmortizedCostOfMarketableSecuritiesByContractualMaturities", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail" ], "xbrltype": "monetaryItemType" }, "chkp_AnnualRateOfDepreciationOnPropertyAndEquipment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Annual rate of depreciation on property and equipment.", "label": "Annual Rate Of Depreciation On Property And Equipment", "terseLabel": "Annual rate of depreciation on property and equipment" } } }, "localname": "AnnualRateOfDepreciationOnPropertyAndEquipment", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "percentItemType" }, "chkp_AvananMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Avanan Member.", "label": "Avanan [Member]", "terseLabel": "Avanan Member" } } }, "localname": "AvananMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_BasicEarningsPerSharesAmountResultingFromIssuanceOfStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic Earnings Per Shares Amount Resulting From Issuance Of Status", "label": "Basic Earnings Per Shares Amount Resulting From Issuance Of Status", "terseLabel": "Basic earnings per share amounts of the benefit resulting from the \"Technological preferred or Preferred Enterprise\" status" } } }, "localname": "BasicEarningsPerSharesAmountResultingFromIssuanceOfStatus", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationParentheticalDetail" ], "xbrltype": "perShareItemType" }, "chkp_ConsolidationOfEntitySubsidiariesAndIntercompanyTransactionsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements (2) the accounting treatment for intercompany accounts and transactions.", "label": "Consolidation Of Entity Subsidiaries And Intercompany Transactions Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationOfEntitySubsidiariesAndIntercompanyTransactionsPolicyPolicyTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chkp_ContractualMaturitiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual Maturities Axis", "label": "Contractual Maturities [Axis]", "terseLabel": "Contractual Maturities Axis" } } }, "localname": "ContractualMaturitiesAxis", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail" ], "xbrltype": "stringItemType" }, "chkp_ContractualMaturitiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual Maturities", "label": "Contractual Maturities [Domain]", "terseLabel": "Contractual Maturities [Domain]" } } }, "localname": "ContractualMaturitiesDomain", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail" ], "xbrltype": "domainItemType" }, "chkp_ContractualObligationFiscalYearMaturityScheduleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual obligation fiscal year maturity schedule.", "label": "Contractual Obligation Fiscal Year Maturity Schedule [Line Items]", "terseLabel": "Contractual Obligation Fiscal Year Maturity Schedule [Line Items]" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleLineItems", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail" ], "xbrltype": "stringItemType" }, "chkp_ContractualObligationFiscalYearMaturityScheduleTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual obligation fiscal year maturity schedule.", "label": "Contractual Obligation Fiscal Year Maturity Schedule [Table]" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTable", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail" ], "xbrltype": "stringItemType" }, "chkp_CoreTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Core Technology [Member]", "label": "Core Technology [Member]", "terseLabel": "Core Technology" } } }, "localname": "CoreTechnologyMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "chkp_CorporateIncomeTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The portion of the domestic federal statutory income tax rate and the taxable income tax.", "label": "Corporate Income Tax Rate", "terseLabel": "Corporate tax rate" } } }, "localname": "CorporateIncomeTaxRate", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "chkp_DeferredRevenueByArrangementAndResidualValueObligationsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Revenue, by Arrangement, and Residual Value Obligations Disclosure [Table Text Block]", "label": "Deferred Revenue, by Arrangement, and Residual Value Obligations Disclosure [Table Text Block]", "terseLabel": "Deferred Revenues" } } }, "localname": "DeferredRevenueByArrangementAndResidualValueObligationsDisclosureTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenuesTables" ], "xbrltype": "textBlockItemType" }, "chkp_DeferredTaxAssetsUnrealizedGainsOnMarketableSecuritiesNet": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets unrealized gains on marketable securities net.", "label": "Deferred Tax Assets Unrealized Gains On Marketable Securities Net", "terseLabel": "Unrealized gains on marketable securities, net" } } }, "localname": "DeferredTaxAssetsUnrealizedGainsOnMarketableSecuritiesNet", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "chkp_DilutedEarningsPerSharesAmountResultingFromIssuanceOfStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diluted Earnings Per Shares Amount Resulting From Issuance Of Status", "label": "Diluted Earnings Per Shares Amount Resulting From Issuance Of Status", "terseLabel": "Diluted earnings per share amounts of the benefit resulting from the \"Technological preferred or Preferred Enterprise\" status" } } }, "localname": "DilutedEarningsPerSharesAmountResultingFromIssuanceOfStatus", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationParentheticalDetail" ], "xbrltype": "perShareItemType" }, "chkp_EffectiveIncomeTaxRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The portion of the difference between the domestic federal statutory income tax rate and the expected income tax expense or benefit that is attributable to reduced tax rates (resulting from the effect of \"Approved, Privileged or Preferred Enterprise\" status).", "label": "Effective Income Tax Rate", "terseLabel": "Enacted effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRate", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "chkp_EmployeeStockPurchasePlanDomesticMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan Domestic [Member]", "label": "Employee Stock Purchase Plan Domestic [Member]", "terseLabel": "US ESPP" } } }, "localname": "EmployeeStockPurchasePlanDomesticMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_EmployeeStockPurchasePlanForeignMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan Foreign [Member]", "label": "Employee Stock Purchase Plan Foreign [Member]", "terseLabel": "Rest of the World ESPP" } } }, "localname": "EmployeeStockPurchasePlanForeignMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan [Member]", "label": "Employee Stock Purchase Plan [Member]", "terseLabel": "Employee Stock", "verboseLabel": "Employee Stock Purchase Plan" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "domainItemType" }, "chkp_FairValueOfAwardsAttributableToPreAcquisitionServices": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of awards attributable to pre-acquisition services.", "label": "Fair Value of Awards Attributable to Pre Acquisition Services", "terseLabel": "Fair value of awards attributable to pre-acquisition services" } } }, "localname": "FairValueOfAwardsAttributableToPreAcquisitionServices", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "chkp_FairValueOfMarketableSecuritiesByContractualMaturities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of marketable securities by contractual maturities", "label": "Fair value of marketable securities by contractual maturities" } } }, "localname": "FairValueOfMarketableSecuritiesByContractualMaturities", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail" ], "xbrltype": "monetaryItemType" }, "chkp_FinancialExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial Expense [Member]", "label": "Financial Expense [Member]", "terseLabel": "Financial Expense" } } }, "localname": "FinancialExpenseMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "domainItemType" }, "chkp_FinancialIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial Income [Member]", "label": "Financial Income [Member]", "terseLabel": "Financial Income" } } }, "localname": "FinancialIncomeMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/FinancialIncomeNetDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_ForeignCurrencyDerivativeContractAssetFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Foreign currency derivative contract asset fair value disclosure.", "label": "Foreign Currency Derivative Contract Asset Fair Value Disclosure", "terseLabel": "Foreign currency derivative contracts" } } }, "localname": "ForeignCurrencyDerivativeContractAssetFairValueDisclosure", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "chkp_ForeignCurrencyOtherThanEntitysFunctionalCurrencyTransactionsAndTranslationsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for transactions denominated in a currency other than the reporting enterprise's functional currency.", "label": "Foreign Currency Other Than Entitys Functional Currency Transactions And Translations Policy [Policy Text Block]", "terseLabel": "Financial Statements in United States Dollars" } } }, "localname": "ForeignCurrencyOtherThanEntitysFunctionalCurrencyTransactionsAndTranslationsPolicyPolicyTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chkp_GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the aggregate amount of goodwill and a description of amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period. It also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for goodwill, the changes in the carrying amount of goodwill during the period due to goodwill acquired.", "label": "Goodwill And Amortizable Intangible Assets Disclosure [Text Block]", "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS, NET" } } }, "localname": "GoodwillAndAmortizableIntangibleAssetsDisclosureTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/GoodwillAndOtherIntangibleAssetsNet" ], "xbrltype": "textBlockItemType" }, "chkp_GovernmentAndCorporateDebenturesFixedInterestRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government And Corporate Debentures Fixed Interest Rate [Member].", "label": "Government And Corporate Debentures Fixed Interest Rate [Member]", "terseLabel": "Government And Corporate Debentures Fixed Interest Rate" } } }, "localname": "GovernmentAndCorporateDebenturesFixedInterestRateMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail", "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "chkp_GovernmentAndCorporateDebenturesFloatingInterestRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government And Corporate Debentures Floating Interest Rate [Member].", "label": "Government And Corporate Debentures Floating Interest Rate [Member]", "terseLabel": "Government And Corporate Debentures Floating Interest Rate" } } }, "localname": "GovernmentAndCorporateDebenturesFloatingInterestRateMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail", "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "chkp_GovernmentSponsoredEnterprisesDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government Sponsored Enterprises Debentures [Member]", "label": "Government Sponsored Enterprises Debentures [Member]", "terseLabel": "Government Sponsored Enterprises Debentures" } } }, "localname": "GovernmentSponsoredEnterprisesDebenturesMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail", "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "chkp_IncomeTaxExpenseBenefitLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Tax Expense Benefit [Line Items]", "label": "Income Tax Expense Benefit [Line Items]", "terseLabel": "Income Tax Expense Benefit [Line Items]" } } }, "localname": "IncomeTaxExpenseBenefitLineItems", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail" ], "xbrltype": "stringItemType" }, "chkp_IncomeTaxExpenseBenefitTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Tax Expense Benefit [Table]", "label": "Income Tax Expense Benefit [Table]", "terseLabel": "Income Tax Expense Benefit [Table]" } } }, "localname": "IncomeTaxExpenseBenefitTable", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail" ], "xbrltype": "stringItemType" }, "chkp_InterestExpenseUncertainTaxPositions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents interest expense recognized for an underpayment of income taxes computed by applying the applicable statutory rate of interest to the difference between a tax position recognized for financial reporting purposes and the amount that might be imposed under tax return audit of the entity.", "label": "Interest Expense Uncertain Tax Positions", "terseLabel": "Uncertain tax positions interest expense" } } }, "localname": "InterestExpenseUncertainTaxPositions", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chkp_LegalCostsAndLossContingenciesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legal Costs And Loss Contingencies Policy", "label": "Legal Costs And Loss Contingencies [Policy Text Block]", "terseLabel": "Legal Contingencies" } } }, "localname": "LegalCostsAndLossContingenciesPolicyTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chkp_ManufacturingPartnerAndSupplierLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Manufacturing partner and supplier liabilities.", "label": "Manufacturing Partner And Supplier Liabilities [Member]", "terseLabel": "Manufacturing partner and supplier liabilities" } } }, "localname": "ManufacturingPartnerAndSupplierLiabilitiesMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_ManufacturingPartnerAndSupplierLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Manufacturing partner and supplier liabilities.", "label": "Manufacturing Partner and Supplier Liabilities [Policy Text Block]", "terseLabel": "Manufacturing partner and supplier liabilities" } } }, "localname": "ManufacturingPartnerAndSupplierLiabilitiesPolicyTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chkp_MarketableSecuritesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Marketable securites [Member]" } } }, "localname": "MarketableSecuritesMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_MaximumPercentageOfEmployeesEligibleCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum Percentage Of Employee's Eligible Compensation", "label": "Maximum Percentage Of Employees Eligible Compensation", "terseLabel": "Maximum percentage of employee's eligible compensation" } } }, "localname": "MaximumPercentageOfEmployeesEligibleCompensation", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "chkp_MinimumPercentageOfTaxBenefitRealizedUponSettlement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of tax benefit realized upon settlement", "label": "Minimum Percentage Of Tax Benefit Realized Upon Settlement", "terseLabel": "Minimum percentage of tax benefit realized upon settlement" } } }, "localname": "MinimumPercentageOfTaxBenefitRealizedUponSettlement", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "chkp_NetworkSecurityGatewaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Network Security Gateways [Member]", "label": "Network Security Gateways [Member]", "terseLabel": "Network Security Gateways" } } }, "localname": "NetworkSecurityGatewaysMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/RevenuesByProductLinesDetail" ], "xbrltype": "domainItemType" }, "chkp_NumberOfProductLines": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Product Lines", "label": "Number Of Product Lines", "terseLabel": "Number of main product lines" } } }, "localname": "NumberOfProductLines", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeDataAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "chkp_OdoSecurityLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Odo Security Ltd [Member]" } } }, "localname": "OdoSecurityLtdMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_OneChannelPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One channel partner.", "label": "One Channel Partner [Member]", "terseLabel": "One Channel Partner" } } }, "localname": "OneChannelPartnerMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_OperatingLossCarryforwardExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carryforward expiration date.", "label": "Operating Loss Carryforward Expiration Date", "terseLabel": "Operating loss carry forward expiration years" } } }, "localname": "OperatingLossCarryforwardExpirationDate", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chkp_OptionsInTheMoneyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options In The Money.", "label": "Options In The Money [Member]", "verboseLabel": "Options In The Money" } } }, "localname": "OptionsInTheMoneyMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_OptionsOutOfMoneyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options Out Of Money", "label": "Options Out Of Money [Member]", "verboseLabel": "Options Out Of Money" } } }, "localname": "OptionsOutOfMoneyMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_OtherArrangementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Arrangement [Member]", "label": "Other Arrangement [Member]", "terseLabel": "Other" } } }, "localname": "OtherArrangementMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenuesDetail" ], "xbrltype": "domainItemType" }, "chkp_OtherChannelPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other channel partner.", "label": "Other Channel Partner [Member]", "terseLabel": "Other Channel Partner" } } }, "localname": "OtherChannelPartnerMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_OtherProductMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Product [Member]", "label": "Other Product [Member]", "terseLabel": "Other" } } }, "localname": "OtherProductMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/RevenuesByProductLinesDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "domainItemType" }, "chkp_PercentageOfEmployeeContributionsContributedByEmployerTowardsEmployeeBenefitPlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of employee contributions contributed by employer towards employee benefit plan", "label": "Percentage Of Employee Contributions Contributed By Employer Towards Employee Benefit Plan", "terseLabel": "Percentage of employee contributions contributed by employer towards employee benefit plan" } } }, "localname": "PercentageOfEmployeeContributionsContributedByEmployerTowardsEmployeeBenefitPlan", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "chkp_PerformanceStockUnitsPsuMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Stock Units PSU [Member]", "label": "Performance Stock Units PSU [Member]", "terseLabel": "Performance Stock Units PSU" } } }, "localname": "PerformanceStockUnitsPsuMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail" ], "xbrltype": "domainItemType" }, "chkp_ProductAndLicensingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Products and licenses.", "label": "Product and Licensing [Member]", "terseLabel": "Products and licenses" } } }, "localname": "ProductAndLicensingMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/RevenuesByProductLinesDetail" ], "xbrltype": "domainItemType" }, "chkp_ProductsAndLicensesRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Products And Licenses Revenues [Member]", "label": "Products And Licenses Revenues [Member]", "terseLabel": "Products and Licenses Revenues" } } }, "localname": "ProductsAndLicensesRevenuesMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "domainItemType" }, "chkp_PropertyPlantAndEquipmentNetAndRightOfUseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Property plant and equipment net and right of use assets.", "label": "Property Plant And Equipment Net And Right Of Use Assets", "terseLabel": "Property and equipment, net and ROU assets" } } }, "localname": "PropertyPlantAndEquipmentNetAndRightOfUseAssets", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail" ], "xbrltype": "monetaryItemType" }, "chkp_ProvisionForEstimatedSalesReturnsRebatesStockRotationsAndOtherCustomerRights": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Provision for estimated sales returns rebates stock rotations and other customer rights.", "label": "Provision For Estimated Sales Returns Rebates Stock Rotations And Other Customer Rights", "terseLabel": "Provision for estimated sales returns, rebates, stock rotations, and other customer rights" } } }, "localname": "ProvisionForEstimatedSalesReturnsRebatesStockRotationsAndOtherCustomerRights", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chkp_ReconciliationOfUnrecognizedTaxBenefitsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reconciliation Of Unrecognized Tax Benefits Table", "label": "Reconciliation Of Unrecognized Tax Benefits [Table Text Block]", "terseLabel": "Reconciliation Of Unrecognized Tax Benefits" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsTableTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeTables" ], "xbrltype": "textBlockItemType" }, "chkp_ResearchAndDevelopmentTaxCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Research And Development Tax Credit [Member]", "label": "Research And Development Tax Credit [Member]", "terseLabel": "Research And Development Tax Credit" } } }, "localname": "ResearchAndDevelopmentTaxCreditMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_RestOfWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rest of the world [Member]", "label": "Rest of World [Member]", "terseLabel": "Rest of the world" } } }, "localname": "RestOfWorldMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "chkp_RevenueRemainingPerformanceObligationNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue remaining performance obligation next twelve months.", "label": "Revenue Remaining Performance Obligation Next Twelve Months", "terseLabel": "Revenue expected to be recognized from remaining performance obligations, 2019" } } }, "localname": "RevenueRemainingPerformanceObligationNextTwelveMonths", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chkp_ScheduleOfAnnualRateOfDepreciationOnPropertyAndEquipmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Annual Rate Of Depreciation On Property And Equipment", "label": "Schedule Of Annual Rate Of Depreciation On Property And Equipment [Table Text Block]", "terseLabel": "Summary of Annual Rate of Depreciation on Property and Equipment" } } }, "localname": "ScheduleOfAnnualRateOfDepreciationOnPropertyAndEquipmentTableTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "chkp_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of cash cash equivalents and short term investments.", "label": "Schedule Of Cash Cash Equivalents And Short Term Investments [Abstract]" } } }, "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsAbstract", "nsuri": "http://www.checkpoint.com/20221231", "xbrltype": "stringItemType" }, "chkp_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of cash cash equivalents and short term investments.", "label": "Schedule Of Cash Cash Equivalents And Short Term Investments [Line Items]" } } }, "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsLineItems", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail" ], "xbrltype": "stringItemType" }, "chkp_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of cash cash equivalents and short term investments.", "label": "Schedule Of Cash Cash Equivalents And Short Term Investments [Table]" } } }, "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTable", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail" ], "xbrltype": "stringItemType" }, "chkp_ScheduleOfGeographicalInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Geographical Information [Line Items]", "label": "Schedule Of Geographical Information [Line Items]", "terseLabel": "Schedule Of Geographical Information [Line Items]" } } }, "localname": "ScheduleOfGeographicalInformationLineItems", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail", "http://www.checkpoint.com/role/RevenueByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "chkp_ScheduleOfGeographicalInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Geographical Information [Table]", "label": "Schedule Of Geographical Information [Table]", "terseLabel": "Schedule Of Geographical Information [Table]" } } }, "localname": "ScheduleOfGeographicalInformationTable", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail", "http://www.checkpoint.com/role/RevenueByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "chkp_ScheduleOfReservedAndAuthorizedSharesUnderEquityIncentivePlansTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Reserved and Authorized Shares under Equity Incentive Plans [Table Text Block]", "label": "Schedule of Reserved and Authorized Shares under Equity Incentive Plans [Table Text Block]", "terseLabel": "Number of Reserved and Authorized Shares Under the Equity Incentive Plans" } } }, "localname": "ScheduleOfReservedAndAuthorizedSharesUnderEquityIncentivePlansTableTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "chkp_SecuritySubscriptionsAndSoftwareUpdatesAndMaintenanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security subscriptions and software updates and maintenance.", "label": "Security subscriptions and software updates and maintenance [Member]", "terseLabel": "Security Subscriptions and Software Updates and Maintenance" } } }, "localname": "SecuritySubscriptionsAndSoftwareUpdatesAndMaintenanceMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_SecuritySubscriptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security subscriptions.", "label": "Security Subscriptions [Member]", "terseLabel": "Security subscriptions" } } }, "localname": "SecuritySubscriptionsMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/RevenuesByProductLinesDetail" ], "xbrltype": "domainItemType" }, "chkp_SegmentReportingForeignCountriesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Segment Reporting Foreign Countries Disclosure [Text Block]", "terseLabel": "GEOGRAPHIC INFORMATION AND SELECTED STATEMENTS OF INCOME DATA" } } }, "localname": "SegmentReportingForeignCountriesDisclosureTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeData" ], "xbrltype": "textBlockItemType" }, "chkp_SeverancePayPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Severance Pay", "label": "Severance Pay [Policy Text Block]", "terseLabel": "Severance Pay" } } }, "localname": "SeverancePayPolicyTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chkp_ShareBasedCompensationAggregateAmountIncludingOptionsAndUnitsAggregateShareOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "share based compensation arrangement by share based payment award options and stock units outstanding share.", "label": "Share Based Compensation Aggregate Amount Including Options And Units Aggregate Share Outstanding" } } }, "localname": "ShareBasedCompensationAggregateAmountIncludingOptionsAndUnitsAggregateShareOutstanding", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "chkp_ShareRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share repurchase program", "label": "Share Repurchase Program [Member]", "terseLabel": "Share Repurchase Program" } } }, "localname": "ShareRepurchaseProgramMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_SharebasedPaymentArrangementOptionsCategoryAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sharebased Payment Arrangement Options Category [Axis]" } } }, "localname": "SharebasedPaymentArrangementOptionsCategoryAxis", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chkp_SharebasedPaymentArrangementOptionsCategoryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sharebased Payment Arrangement Options Category [Domain]" } } }, "localname": "SharebasedPaymentArrangementOptionsCategoryDomain", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_ShortTermBankDepositsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short term bank deposits fair value disclosure.", "label": "Short Term Bank Deposits Fair Value Disclosure", "verboseLabel": "Short-term bank deposits" } } }, "localname": "ShortTermBankDepositsFairValueDisclosure", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "chkp_ShortTermDeposit": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Bank deposits which are intended to be sold in less than a year.", "label": "Short Term Deposit", "terseLabel": "Short-term bank deposits" } } }, "localname": "ShortTermDeposit", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "chkp_ShortTermDepositPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Short-term deposit", "label": "Short Term Deposit [Policy Text Block]", "terseLabel": "Short-Term Bank Deposit" } } }, "localname": "ShortTermDepositPolicyTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chkp_SignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant Accounting Policies [Line Items]", "label": "Significant Accounting Policies [Line Items]", "terseLabel": "Significant Accounting Policies [Line Items]" } } }, "localname": "SignificantAccountingPoliciesLineItems", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chkp_SignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant Accounting Policies [Table]", "label": "Significant Accounting Policies [Table]", "terseLabel": "Significant Accounting Policies [Table]" } } }, "localname": "SignificantAccountingPoliciesTable", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "chkp_SoftwareUpdatesAndMaintenanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software updates and maintenance.", "label": "Software updates and maintenance [Member]", "terseLabel": "Software updates and maintenance" } } }, "localname": "SoftwareUpdatesAndMaintenanceMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/RevenuesByProductLinesDetail" ], "xbrltype": "domainItemType" }, "chkp_SpectralCyberTechnologiesLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spectral Cyber Technologies Ltd Member.", "label": "Spectral Cyber Technologies Ltd [Member]" } } }, "localname": "SpectralCyberTechnologiesLtdMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_StockRepurchaseProgramAuthorizedMaximumAmountForDefinedFrequency": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock repurchase program authorized maximum amount for defined frequency.", "label": "Stock Repurchase Program Authorized Maximum Amount For Defined Frequency", "terseLabel": "Authorized amount under share repurchase programs per quarter" } } }, "localname": "StockRepurchaseProgramAuthorizedMaximumAmountForDefinedFrequency", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chkp_StockRepurchaseProgramCumulativeSharesRepurchasedValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock Repurchase Program, Cumulative Shares Repurchased, Value", "label": "Stock Repurchase Program, Cumulative Shares Repurchased, Value", "terseLabel": "Aggregate ordinary shares repurchase" } } }, "localname": "StockRepurchaseProgramCumulativeSharesRepurchasedValue", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "chkp_StockholdersEquityDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, (6) retained earnings; (7) impact of change in accounting principle, initial adoption of new accounting principle; and shares held in trust for Employee Stock Ownership Plan (ESOP).", "label": "Stockholders Equity Disclosure [Text Block]", "terseLabel": "SHAREHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityDisclosureTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "chkp_TaxRateOnDividends": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The portion of the difference between the dividend amount and domestic federal statutory income tax attributable to the deduction for dividends paid under enacted tax laws.", "label": "Tax Rate On Dividends", "terseLabel": "Dividend income tax rate" } } }, "localname": "TaxRateOnDividends", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "chkp_TaxYearTwoThousandSixteenThroughTwoThousandAndNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax Year Two Thousand Sixteen Through Two Thousand And Nineteen [Member]", "terseLabel": "Tax Year 2016 Through 2019 [Member]" } } }, "localname": "TaxYearTwoThousandSixteenThroughTwoThousandAndNineteenMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_TechnologicalPreferredEnterpriseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Technological preferred enterprise.", "label": "Technological Preferred Enterprise [Member]", "terseLabel": "Technological Preferred Enterprise" } } }, "localname": "TechnologicalPreferredEnterpriseMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_TreasuryStockPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Treasury Stock", "label": "Treasury Stock [Policy Text Block]", "terseLabel": "Treasury Shares" } } }, "localname": "TreasuryStockPolicyTextBlock", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "chkp_TwoChannelPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two channel partner.", "label": "Two Channel Partner [Member]", "terseLabel": "Two Channel Partner" } } }, "localname": "TwoChannelPartnerMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_TwoThousandFiveEquityIncentivePlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Five Equity Incentive Plans [Member]", "label": "Two Thousand Five Equity Incentive Plans [Member]", "terseLabel": "Two Thousand Five Equity Incentive Plans" } } }, "localname": "TwoThousandFiveEquityIncentivePlansMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_USFederalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. Federal [Member]", "label": "U S Federal [Member]", "terseLabel": "U S Federal" } } }, "localname": "USFederalMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_USStateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. State [Member]", "label": "U S State [Member]", "terseLabel": "U S State" } } }, "localname": "USStateMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "chkp_UnrecognizedTaxBenefitPresentedNetFromDeferredTaxAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrecognized tax benefit presented net from deferred tax asset.", "label": "Unrecognized Tax Benefit Presented Net From Deferred Tax Asset", "terseLabel": "Unrecognized tax benefit" } } }, "localname": "UnrecognizedTaxBenefitPresentedNetFromDeferredTaxAsset", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ReconciliationOfUnrecognizedTaxBenefitsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "chkp_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrecognized Tax Benefits, Increases (Decreases) Resulting from Prior Period Tax Positions", "label": "Unrecognized Tax Benefits, Increases (Decreases) Resulting from Prior Period Tax Positions", "terseLabel": "Increases (decreases) related to tax positions taken during prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/ReconciliationOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "chkp_WithinOneYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Within One Year Member.", "label": "Within One Year [Member]" } } }, "localname": "WithinOneYearMember", "nsuri": "http://www.checkpoint.com/20221231", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortContractualObligationFiscalYearMaturityScheduleTabletermBankDepositsAndMarketableSecuritiesDetail" ], "xbrltype": "domainItemType" }, "country_IL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ILLINOIS", "terseLabel": "Israel" } } }, "localname": "IL", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "U.S." } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail", "http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r665", "r666" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name", "terseLabel": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard", "terseLabel": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement", "terseLabel": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report", "terseLabel": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r667" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesTable": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "Container of address information for the entity", "label": "Entity Addresses [Table]" } } }, "localname": "EntityAddressesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r668" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r662" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r669" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r664", "r665", "r666" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r661" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r663" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.checkpoint.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continents of North and South America.", "label": "Americas [Member]", "terseLabel": "Americas" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/RevenueByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region of Asia Pacific.", "label": "Asia Pacific [Member]", "terseLabel": "Asia Pacific" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/RevenueByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r780" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Summary of Contractual Obligation, Fiscal Year Maturity" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "srt_MaximumMember": { "auth_ref": [ "r348", "r349", "r350", "r351", "r386", "r566", "r587", "r619", "r620", "r642", "r650", "r659", "r711", "r763", "r764", "r765", "r766", "r767", "r768" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r348", "r349", "r350", "r351", "r386", "r566", "r587", "r619", "r620", "r642", "r650", "r659", "r711", "r763", "r764", "r765", "r766", "r767", "r768" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r298", "r568", "r643", "r657", "r706", "r707", "r712", "r771" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/RevenuesByProductLinesDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r298", "r568", "r643", "r657", "r706", "r707", "r712", "r771" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/RevenuesByProductLinesDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r348", "r349", "r350", "r351", "r379", "r386", "r416", "r417", "r418", "r542", "r566", "r587", "r619", "r620", "r642", "r650", "r659", "r702", "r711", "r764", "r765", "r766", "r767", "r768" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r348", "r349", "r350", "r351", "r379", "r386", "r416", "r417", "r418", "r542", "r566", "r587", "r619", "r620", "r642", "r650", "r659", "r702", "r711", "r764", "r765", "r766", "r767", "r768" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r299", "r300", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r621", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r644", "r658", "r712" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail", "http://www.checkpoint.com/role/RevenueByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r299", "r300", "r603", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r621", "r622", "r644", "r658", "r712" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetAndRightOfUseAssetsByGeographicAreaDetail", "http://www.checkpoint.com/role/RevenueByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r15", "r656" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 22.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Trade payables" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r581", "r604" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, Net", "terseLabel": "Trade receivables" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r302", "r303" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Trade receivables, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r4", "r175", "r185" ], "calculation": { "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "verboseLabel": "Income tax payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r7", "r175", "r185" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 28.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Income tax accrual" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Liabilities and Other Liabilities [Abstract]" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 25.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other liabilities", "totalLabel": "Accrued expenses and other liabilities total" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail", "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r178", "r189" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued Liabilities", "terseLabel": "Significant costs associated with exposure" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedMarketingCostsCurrent": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Marketing Costs, Current", "terseLabel": "Marketing expenses payable" } } }, "localname": "AccruedMarketingCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r93", "r209" ], "calculation": { "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": { "auth_ref": [ "r221", "r229", "r476", "r676", "r677" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.", "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]", "terseLabel": "Unrealized Gains (losses) on cash flow hedges" } } }, "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r217", "r218", "r219", "r221", "r229", "r676", "r677" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]", "terseLabel": "Unrealized Gains (losses) on marketable securities" } } }, "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r25", "r26", "r27", "r214", "r582", "r595", "r599" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 18.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail", "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r229", "r230", "r509", "r510", "r511", "r512", "r513", "r514" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r24", "r27", "r146", "r532", "r590", "r591", "r675", "r676", "r677", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r10" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r422", "r423", "r424", "r681", "r682", "r683", "r757" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": { "auth_ref": [ "r250", "r251", "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Adjustments for Change in Accounting Principle [Axis]", "terseLabel": "Adjustments for Change in Accounting Principle [Axis]" } } }, "localname": "AdjustmentsForChangeInAccountingPrincipleAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r198", "r199", "r200", "r201", "r202", "r250", "r251", "r252", "r253", "r262", "r307", "r308", "r315", "r316", "r317", "r318", "r319", "r320", "r422", "r423", "r424", "r449", "r450", "r451", "r452", "r468", "r469", "r470", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r516", "r517", "r518", "r519", "r520", "r521", "r527", "r528", "r529", "r530", "r531", "r532", "r570", "r571", "r572", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Adjustments for New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r117", "r118", "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments required to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Costs, Policy [Policy Text Block]", "terseLabel": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r428" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising expenses" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r420" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share-based Compensation Expense", "terseLabel": "Compensation expense recognized" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r40", "r54", "r172", "r362" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.checkpoint.com/role/FinancialIncomeNetDetail": { "order": 1.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of marketable securities premium and accretion of discount, net", "verboseLabel": "Amortization of premium and accretion of discount on marketable securities, net" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows", "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r54", "r83", "r88" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive shares excluded from computation of earnings per share amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements and Non-arrangement Transactions [Domain]", "terseLabel": "Arrangements and Non-arrangement Transactions [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r174", "r184", "r213", "r241", "r289", "r292", "r296", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r472", "r477", "r496", "r656", "r709", "r710", "r761" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r204", "r215", "r241", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r472", "r477", "r496", "r656", "r709", "r710", "r761" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "CURRENT ASSETS:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r162" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Total financial assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r241", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r472", "r477", "r496", "r709", "r710", "r761" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total long-term assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "LONG-TERM ASSETS:" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedGain": { "auth_ref": [ "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Unrealized Gain", "verboseLabel": "Gross unrealized gains on the marketable securities" } } }, "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedGain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss": { "auth_ref": [ "r80" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Unrealized Loss", "terseLabel": "Gross unrealized Losses on the marketable securities" } } }, "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r78", "r309", "r326", "r575" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Marketable securities" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "auth_ref": [ "r77", "r326" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.", "label": "Debt Securities, Available-for-sale, Current", "terseLabel": "Marketable securities", "verboseLabel": "Government and corporate debentures" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail", "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": { "auth_ref": [ "r77", "r207", "r326" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.", "label": "Debt Securities, Available-for-sale, Noncurrent", "terseLabel": "Marketable securities" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r391", "r392", "r393", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r415", "r416", "r417", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail", "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r153", "r156" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BankTimeDepositsMember": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.", "label": "Bank Time Deposits [Member]", "verboseLabel": "Short term deposits" } } }, "localname": "BankTimeDepositsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r466", "r648", "r649" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r135", "r136", "r466", "r648", "r649" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": { "auth_ref": [ "r131", "r132", "r133" ], "lang": { "en-us": { "role": { "documentation": "Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format.", "label": "Business Acquisition, Effective Date of Acquisition", "terseLabel": "Acquisition date" } } }, "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r139", "r140", "r141" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Business combination, consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r142", "r467" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "ACQUISITION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/Acquisition" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing the disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.", "label": "Business Combination, Separately Recognized Transactions [Table]" } } }, "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business combination" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedContractCostAmortization": { "auth_ref": [ "r332" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Amortization", "verboseLabel": "Amortisation of contracted capitalised costs" } } }, "localname": "CapitalizedContractCostAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNet": { "auth_ref": [ "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Net", "terseLabel": "Deferred commission" } } }, "localname": "CapitalizedContractCostNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r601", "r602", "r656", "r670" ], "calculation": { "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r56", "r206", "r631" ], "calculation": { "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments", "weight": 1.0 }, "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "totalLabel": "Total Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail", "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "auth_ref": [ "r674" ], "calculation": { "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.", "label": "Cash, Cash Equivalents, and Short-term Investments", "totalLabel": "Total Cash and cash equivalents, short-term bank deposits and marketable securities" } } }, "localname": "CashCashEquivalentsAndShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, and Short-term Investments [Abstract]" } } }, "localname": "CashCashEquivalentsAndShortTermInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of the components of cash, cash equivalents, and short-term investments. Short-term investments may include current marketable securities.", "label": "Cash, Cash Equivalents, and Short-term Investments [Text Block]", "terseLabel": "Cash, Cash Equivalents, and Short-term Investments [Text Block]" } } }, "localname": "CashCashEquivalentsAndShortTermInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecurities" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r50", "r56", "r59" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at the end of the year", "periodStartLabel": "Cash and cash equivalents at the beginning of the year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r50", "r171" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CashMember": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.", "label": "Cash [Member]" } } }, "localname": "CashMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ChangeInAccountingPrincipleMember": { "auth_ref": [ "r250", "r251", "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Adjustments for Change in Accounting Principle [Domain]", "terseLabel": "Adjustments for Change in Accounting Principle [Domain]" } } }, "localname": "ChangeInAccountingPrincipleMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]", "terseLabel": "Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r97", "r345", "r346", "r606", "r708" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r21" ], "calculation": { "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail": { "order": 3.0, "parentTag": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Ordinary shares available for issuance under the Equity Incentive Plans" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r681", "r682", "r757" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Ordinary shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Ordinary shares, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Ordinary shares, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Ordinary shares, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r9", "r100" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Ordinary shares, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r9", "r656" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Ordinary shares, NIS 0.01 par value, 500,000,000 shares authorized at December 31, 2022 and 2021; 261,223,970 shares issued at December 31, 2022 and 2021; 120,761,971 and 129,065,690 shares outstanding at December 31, 2022 and 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r29", "r225", "r227", "r234", "r577", "r584" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r42", "r233", "r576", "r583" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive Income" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computers and peripheral equipment" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r67", "r68", "r169", "r170", "r301", "r605" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r67", "r68", "r169", "r170", "r301", "r600", "r605" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r67", "r68", "r169", "r170", "r301", "r605", "r772" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r183", "r281" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentrations of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r67", "r68", "r169", "r170", "r301" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration Risk, Percentage", "verboseLabel": "Percentage of revenue derived from distribution channels" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r67", "r68", "r169", "r170", "r301", "r605" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail": { "order": 6.0, "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.", "label": "Contractual Obligation", "terseLabel": "Total Marketable securities" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r36", "r568" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 9.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Total cost of revenues" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of Revenues" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of Sales, Policy [Policy Text Block]", "terseLabel": "Cost of Revenues" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r34" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r680", "r748" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Foreign taxes, Current" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r680", "r748", "r751" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "Current" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r65", "r301" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationship" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [ "r312", "r328" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "terseLabel": "Continuous Unrealized Loss Position" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Current [Abstract]", "verboseLabel": "Marketable securities:" } } }, "localname": "DebtSecuritiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r129", "r680", "r749" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Foreign taxes, Deferred" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r433", "r434" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax asset, net" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r54", "r129", "r447", "r455", "r456", "r680" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "verboseLabel": "Deferred income tax expense (benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r672" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenuesDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueArrangementByTypeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of deferred revenue disclosure which includes the type of arrangements and the corresponding amount that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date.", "label": "Deferred Revenue Arrangement, by Type [Table]", "terseLabel": "Deferred Revenue Arrangement, by Type [Table]" } } }, "localname": "DeferredRevenueArrangementByTypeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenuesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueArrangementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Revenue Arrangement [Line Items]", "terseLabel": "Deferred Revenue Arrangement [Line Items]" } } }, "localname": "DeferredRevenueArrangementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenuesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueArrangementTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred revenue arrangement.", "label": "Deferred Revenue Arrangement Type [Axis]", "terseLabel": "Deferred Revenue Arrangement Type [Axis]" } } }, "localname": "DeferredRevenueArrangementTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenuesDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueArrangementTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of obligation arising when an entity receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized.", "label": "Deferred Revenue [Domain]", "terseLabel": "Deferred Revenue [Domain]" } } }, "localname": "DeferredRevenueArrangementTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenuesDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r671" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 24.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenues" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Revenue Disclosure [Abstract]" } } }, "localname": "DeferredRevenueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r672" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 27.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred revenues" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r680", "r749", "r751" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "Deferred" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "auth_ref": [ "r127", "r747" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.", "label": "Deferred Tax Assets, Deferred Income", "terseLabel": "Deferred revenues" } } }, "localname": "DeferredTaxAssetsDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r443" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Deferred tax assets before valuation allowance" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r746" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Deferred tax asset, net" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r746" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Deferred tax asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r127", "r747" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Carry forward tax losses" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r127", "r747" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r125", "r127", "r747" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Tax credits" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": { "auth_ref": [ "r127", "r747" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits", "terseLabel": "Accrued employee costs" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": { "auth_ref": [ "r127", "r747" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation", "terseLabel": "Employee stock based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r444" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance - mainly in respect to carryforward losses" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r120", "r746" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 11.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Deferred tax liability" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [ "r127", "r747" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 12.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.", "label": "Deferred Tax Liabilities, Intangible Assets", "negatedLabel": "Intangible assets" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r127", "r747" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 14.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r747" ], "calculation": { "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 13.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "negatedLabel": "Undistributed earnings of subsidiary" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r464" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to undistributed earnings of foreign subsidiaries.", "label": "Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Unrecognized deferred tax liability on undistributed earnings of foreign subsidiaries" } } }, "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r54", "r287" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation of property and equipment" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r756" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Derivative, net gain (loss)" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r154", "r155", "r158", "r160", "r632" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r151", "r154", "r158" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r157", "r159" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Losses (gains) reclassified into earnings, net of tax" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r754", "r755" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r148", "r149", "r151", "r152", "r161", "r246" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivatives and Hedging" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Domestic Tax Authority" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DueFromBanks": { "auth_ref": [ "r177" ], "calculation": { "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail": { "order": 5.0, "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A bank's noninterest bearing demand deposits in other banks (such as correspondents).", "label": "Due from Banks", "verboseLabel": "Short-term bank deposits" } } }, "localname": "DueFromBanks", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "Europe, Middle East and Africa" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/RevenueByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r235", "r254", "r255", "r256", "r257", "r258", "r263", "r265", "r270", "r271", "r272", "r276", "r490", "r491", "r578", "r585", "r635" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic earnings per ordinary share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r235", "r254", "r255", "r256", "r257", "r258", "r265", "r270", "r271", "r272", "r276", "r490", "r491", "r578", "r585", "r635" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted earnings per ordinary share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r62", "r63" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Basic and Diluted Earnings per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r273", "r274", "r275", "r277" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r436" ], "calculation": { "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r244", "r436", "r458" ], "calculation": { "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "verboseLabel": "Statutory tax rate in Israel" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r458", "r743" ], "calculation": { "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "terseLabel": "Effect of \"Preferred Enterprise\" status" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r743", "r752" ], "calculation": { "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Others, net" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 23.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Employees and payroll accruals" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r421" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized compensation expense expected period of recognition (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "verboseLabel": "Employee Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue from External Customer [Line Items]", "terseLabel": "Revenue from External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/RevenuesByProductLinesDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r100", "r200", "r229", "r230", "r231", "r247", "r248", "r249", "r251", "r259", "r261", "r278", "r318", "r365", "r422", "r423", "r424", "r451", "r452", "r489", "r509", "r510", "r511", "r512", "r513", "r514", "r532", "r590", "r591", "r592" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r493", "r494", "r495" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Financial Assets Measured at Fair Value on Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]", "terseLabel": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail", "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r162", "r165" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]", "terseLabel": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail", "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r361", "r380", "r381", "r382", "r383", "r384", "r385", "r494", "r539", "r540", "r541", "r640", "r641", "r645", "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r361", "r380", "r385", "r494", "r539", "r645", "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r361", "r380", "r385", "r494", "r540", "r640", "r641", "r645", "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.", "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueMeasurementInputsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r361", "r380", "r381", "r382", "r383", "r384", "r385", "r539", "r540", "r541", "r640", "r641", "r645", "r646", "r647" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r166", "r168" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r310", "r311", "r321", "r322", "r323", "r324", "r325", "r327", "r329", "r330", "r363", "r364", "r480", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r638", "r687", "r688", "r689", "r773", "r774", "r775", "r776", "r777", "r778", "r779" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail", "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Estimated useful lives of intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r211", "r341" ], "calculation": { "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r89" ], "calculation": { "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r89" ], "calculation": { "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r89" ], "calculation": { "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r89" ], "calculation": { "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r89" ], "calculation": { "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r339", "r340", "r341", "r342", "r569", "r573" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r87", "r573" ], "calculation": { "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Original amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r84", "r86" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r87", "r569" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Intangible assets, net", "totalLabel": "Other intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets", "http://www.checkpoint.com/role/EstimatedFutureAmortizationExpenseOfOtherIntangibleAssetsDetail", "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r505", "r506", "r507", "r508" ], "calculation": { "http://www.checkpoint.com/role/FinancialIncomeNetDetail": { "order": 4.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedLabel": "Foreign currency re-measurement (gain) loss" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign Exchange Forward Contracts" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r242" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.", "label": "Foreign Income Tax Expense (Benefit), Continuing Operations", "terseLabel": "Foreign" } } }, "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfInvestments": { "auth_ref": [ "r54" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.checkpoint.com/role/FinancialIncomeNetDetail": { "order": 3.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.", "label": "Gain (Loss) on Sale of Investments", "negatedLabel": "Realized gain on sale of marketable securities, net", "negatedTerseLabel": "Realized loss (gain) on sale of marketable securities, net" } } }, "localname": "GainLossOnSaleOfInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows", "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r37" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 8.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and Administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r210", "r333", "r574", "r639", "r656", "r691", "r698" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance as of December 31", "periodStartLabel": "Balance as of January 1", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets", "http://www.checkpoint.com/role/ScheduleOfGoodwillDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r335", "r639" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Acquisitions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ScheduleOfGoodwillDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r337", "r338", "r639" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Intangible Assets, Net" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r54", "r334", "r336", "r337", "r639" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill impairment losses" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r151", "r479" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r90", "r95" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of long-lived assets including intangible assets subject to amortization" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r243", "r457" ], "calculation": { "http://www.checkpoint.com/role/IncomeBeforeTaxesDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "Domestic" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/IncomeBeforeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r31", "r173", "r179", "r191", "r289", "r291", "r295", "r297", "r579", "r637" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.checkpoint.com/role/IncomeBeforeTaxesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Income before taxes as reported in the statements of income", "totalLabel": "Income before taxes on income" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/EffectiveIncomeTaxReconciliationDetail", "http://www.checkpoint.com/role/IncomeBeforeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r243", "r457" ], "calculation": { "http://www.checkpoint.com/role/IncomeBeforeTaxesDetail": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/IncomeBeforeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r343", "r344" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]", "terseLabel": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority, Name [Domain]", "terseLabel": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r244", "r437", "r441", "r446", "r453", "r459", "r461", "r462", "r465" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "TAXES ON INCOME" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncome" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear": { "auth_ref": [ "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Additional payment of income tax", "documentation": "The amount the liability recorded for the income tax examination increased or decreased in the current year/accounting period.", "label": "Income Tax Examination, Increase (Decrease) in Liability from Prior Year", "verboseLabel": "Additional payment of income tax" } } }, "localname": "IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": { "auth_ref": [ "r744" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.", "label": "Income Tax Examination, Penalties and Interest Expense", "terseLabel": "payment related to timing differences" } } }, "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExaminationYearUnderExamination": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Year under Income Tax Examination", "documentation": "Tax year being audited in the income tax examination, in YYYY format.", "label": "Income Tax Examination, Year under Examination", "verboseLabel": "Year under Income Tax Examination" } } }, "localname": "IncomeTaxExaminationYearUnderExamination", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "gYearListItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r245", "r260", "r261", "r288", "r435", "r454", "r460", "r586" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 10.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Taxes on income", "verboseLabel": "Taxes on income" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail", "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r228", "r431", "r432", "r441", "r442", "r445", "r448" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid during the year for taxes on income" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r53" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Increase (decrease) in trade payables" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r53" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Increase in trade receivables, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r567", "r678" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Increase in deferred revenues" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r53" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Increase (decrease) in employees and payroll accruals" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r53" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "verboseLabel": "Increase (decrease) in income tax accrual and accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r53" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Decrease in prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r266", "r267", "r268", "r272", "r390" ], "calculation": { "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Employee stock options, RSUs and PSUs" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestReceivableCurrent": { "auth_ref": [ "r673" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Interest Receivable, Current", "verboseLabel": "Interest receivable" } } }, "localname": "InterestReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r39", "r286" ], "calculation": { "http://www.checkpoint.com/role/FinancialIncomeNetDetail": { "order": 2.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInvestmentExpense": { "auth_ref": [ "r41", "r192" ], "calculation": { "http://www.checkpoint.com/role/FinancialIncomeNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the generation of investment income.", "label": "Investment Income, Investment Expense", "totalLabel": "Total financial expense" } } }, "localname": "InvestmentIncomeInvestmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r38", "r40" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "terseLabel": "Financial income, net" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r313", "r770" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments in Marketable Securities" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IsraelTaxAuthorityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government of Israel.", "label": "Israel Tax Authority [Member]" } } }, "localname": "IsraelTaxAuthorityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseholdImprovementsGross": { "auth_ref": [ "r92" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements, Gross", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r16", "r241", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r473", "r477", "r478", "r496", "r636", "r709", "r761", "r762" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 20.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r14", "r176", "r187", "r656", "r679", "r690", "r758" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r18", "r205", "r241", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r473", "r477", "r478", "r496", "r656", "r709", "r761", "r762" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 21.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "CURRENT LIABILITIES:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r1", "r2", "r3", "r5", "r6", "r241", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r473", "r477", "r478", "r496", "r709", "r761", "r762" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 26.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total long-term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "LONG-TERM LIABILITIES:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationReserveCurrent": { "auth_ref": [ "r20", "r703" ], "calculation": { "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.", "label": "Estimated Litigation Liability, Current", "terseLabel": "Legal accrual" } } }, "localname": "LitigationReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r98", "r99", "r347", "r348", "r349", "r704", "r705" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Money Market Funds, at Carrying Value", "verboseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r714" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r239" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r239" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r50", "r52", "r55" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r32", "r55", "r180", "r190", "r203", "r223", "r226", "r231", "r241", "r250", "r254", "r255", "r256", "r257", "r260", "r261", "r269", "r289", "r291", "r295", "r297", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r491", "r496", "r637", "r709" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 8.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash investing activity" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r686" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r686" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of Reportable segment" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "auth_ref": [ "r27", "r30" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "terseLabel": "Other comprehensive income before reclassifications" } } }, "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]", "terseLabel": "Office furniture and equipment" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenseMember": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.", "label": "Operating Expense [Member]", "terseLabel": "Operating Expenses" } } }, "localname": "OperatingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r289", "r291", "r295", "r297", "r637" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r523" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease liability.", "label": "Operating Lease, Liability, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r522" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right of use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r125" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "U.S. loss carry forward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r0", "r147" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "GENERAL" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/General" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r212" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax [Abstract]", "verboseLabel": "Change in unrealized gains (losses) on marketable securities:" } } }, "localname": "OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]", "terseLabel": "Change in unrealized gains (losses) on cash flow hedges:" } } }, "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "auth_ref": [ "r217", "r218", "r220" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 5.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax", "totalLabel": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r216", "r220" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "totalLabel": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "auth_ref": [ "r216", "r220" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "terseLabel": "Unrealized gains (losses) arising during the period, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "verboseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r143", "r144", "r145", "r224", "r227" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Net current period other comprehensive income", "totalLabel": "Other comprehensive income (loss), net of tax", "verboseLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail", "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "auth_ref": [ "r25", "r28", "r81", "r222" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 7.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "negatedLabel": "Gains reclassified into earnings, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r217", "r220" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome": { "order": 6.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax", "terseLabel": "Unrealized gains (losses) arising during the period, net of tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r19" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 29.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "verboseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other Long Term Assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingExpense": { "auth_ref": [ "r41" ], "calculation": { "http://www.checkpoint.com/role/FinancialIncomeNetDetail": { "order": 5.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to nonoperating activities, classified as other.", "label": "Other Nonoperating Expense", "terseLabel": "Others" } } }, "localname": "OtherNonoperatingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Other" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payments for Rent", "verboseLabel": "Rent expenses" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r49" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchase of treasury shares at cost" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r237" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payments Related to Tax Withholding for Share-based Compensation", "negatedLabel": "Payments related to shares withheld for taxes" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r45" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Cash paid in conjunction with acquisitions, net of acquired cash" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r76" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Investment in marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r46" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireShortTermInvestments": { "auth_ref": [ "r47" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Payments to Acquire Short-term Investments", "negatedLabel": "Investment in short-term bank deposits" } } }, "localname": "PaymentsToAcquireShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementPlansPolicy": { "auth_ref": [ "r104", "r105", "r106", "r107", "r108" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.", "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]", "terseLabel": "Employee Benefit Plan" } } }, "localname": "PensionAndOtherPostretirementPlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PhantomShareUnitsPSUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded as phantom share or unit.", "label": "Phantom Share Units (PSUs) [Member]" } } }, "localname": "PhantomShareUnitsPSUsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r674" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.", "label": "Prepaid Expenses and Other Current Assets [Member]" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "auth_ref": [ "r48", "r115" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.", "label": "Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options", "terseLabel": "Proceeds from issuance of treasury shares upon exercise of options" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from maturity of marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r43", "r76", "r236" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale of Debt Securities, Available-for-Sale", "terseLabel": "Proceeds from sale of marketable securities" } } }, "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfShortTermInvestments": { "auth_ref": [ "r44" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Proceeds from Sale of Short-term Investments", "terseLabel": "Proceeds from short-term bank deposits" } } }, "localname": "ProceedsFromSaleOfShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductConcentrationRiskMember": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.", "label": "Product Concentration Risk [Member]", "terseLabel": "Product Concentration Risk" } } }, "localname": "ProductConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r203", "r223", "r226", "r238", "r241", "r250", "r260", "r261", "r289", "r291", "r295", "r297", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r471", "r474", "r475", "r491", "r496", "r579", "r637", "r653", "r654", "r677", "r709" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r96", "r607", "r608", "r609" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Property, Plant and Equipment, Estimated Useful Lives", "terseLabel": "Leasehold improvements" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r92", "r208" ], "calculation": { "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r94", "r188", "r580", "r656" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 }, "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets", "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r94", "r607", "r608" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r27", "r30" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "terseLabel": "Amounts reclassified from accumulated other comprehensive income" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r119", "r194", "r769" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r119" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r11", "r101", "r186", "r594", "r599", "r656" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 19.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r200", "r247", "r248", "r249", "r251", "r259", "r261", "r318", "r422", "r423", "r424", "r451", "r452", "r489", "r590", "r592" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r284", "r285", "r290", "r293", "r294", "r298", "r299", "r301", "r375", "r376", "r568" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/RevenuesByProductLinesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r366", "r367", "r368", "r369", "r370", "r371", "r373", "r374", "r377", "r378" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "DEFERRED REVENUES" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenues" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r633", "r634" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition, Policy [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r372" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue expected to be recognized from remaining performance obligations" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r232", "r241", "r284", "r285", "r290", "r293", "r294", "r298", "r299", "r301", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r496", "r579", "r709" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/RevenueByGeographicAreaDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r526", "r655" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "verboseLabel": "Operating lease liabilities arising from obtaining right of use assets" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r301", "r685" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue, Net [Member]", "terseLabel": "Revenue" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Expenses and Other Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccruedExpensesAndOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r27", "r759", "r760" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r135", "r136", "r466" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AcquisitionAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.", "label": "Cash, Cash Equivalents and Investments [Table Text Block]", "terseLabel": "Summary of Cash, Cash Equivalents and Investments" } } }, "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r753" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]", "terseLabel": "Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Components of Income Tax Expense" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Components of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": { "auth_ref": [ "r61", "r64", "r684" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.", "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]", "terseLabel": "Computation of Basic and Diluted Earnings per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Income Tax Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r113", "r116" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]", "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]", "terseLabel": "Stock-based Compensation Expense Related to Stock Options, RSUs and PSUs" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.", "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]", "terseLabel": "Property and Equipment, Net and Right of Use Assets by Geographic Area" } } }, "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeDataTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table]", "terseLabel": "Revenue from External Customers by Products and Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/RevenuesByProductLinesDetail", "http://www.checkpoint.com/role/RevenuesByProductLinesParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Total Revenues by Product Lines" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeDataTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r84", "r86", "r569" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r84", "r86" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Other Intangible Assets, Net" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GoodwillAndOtherIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r639", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GoodwillAndOtherIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of Income Before Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Summary of Financial Income, Net" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeDataTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/PropertyAndEquipmentNetDetail", "http://www.checkpoint.com/role/SummaryOfAnnualRateOfDepreciationOnPropertyAndEquipmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": { "auth_ref": [ "r35", "r73" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]", "terseLabel": "Summary of Revenue by Geographic Area" } } }, "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeographicInformationAndSelectedStatementsOfIncomeDataTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r387", "r389", "r391", "r392", "r393", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r415", "r416", "r417", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail", "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Units Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r109", "r110", "r111" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Compensation, Stock Options, Activity [Table Text Block]", "terseLabel": "Summary of Stock Option Activity and Related Information" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Weighted Average Assumptions Used to Estimate the Fair Value of Employee Stock Purchase Plans" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt and Equity Securities, FV-NI [Line Items]", "terseLabel": "Schedule of Trading Securities and Other Trading Assets [Line Items]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).", "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]", "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]" } } }, "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Estimated Future Amortization Expense of Other Intangible Assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GoodwillAndOtherIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome": { "order": 7.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Selling and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Selling and Marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r53" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Compensation", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows", "http://www.checkpoint.com/role/ShareholdersEquityStockBasedCompensationExpenseRelatedToStockOptionsRsusAndPsusDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Discount rate from fair value on offering date that participants pay for shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date", "terseLabel": "Price of Ordinary shares purchased under ESPP, percentage of lower of fair market value of Ordinary share on subscription date of each offering period or on purchase date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value of stock units granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r403", "r404" ], "calculation": { "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail": { "order": 2.0, "parentTag": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Unvested the end of the year", "periodStartLabel": "Unvested at beginning of year", "terseLabel": "Stock unit outstanding", "verboseLabel": "Share based compensation arrangement by share based payment award equity instruments other than options non vested number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r410" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Total fair value of restricted stock units vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail", "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Percentage of salary to purchase Ordinary shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "The highest quantity of shares an employee can purchase under the plan per period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee", "terseLabel": "Ordinary shares per employee, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r652" ], "calculation": { "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Options to purchase ordinary shares reserved for issuance", "totalLabel": "Total Reserved and Authorized Shares as of December 31, 2022" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Number of shares available under ESPP" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Options, Exercisable at December 31, 2022" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Exercisable at December 31, 2022" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r410" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Total intrinsic value of options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Options, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r722" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Options, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value granted under options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate intrinsic value, Outstanding", "verboseLabel": "Share based compensation arrangement by share based payment award options outstanding intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r395", "r396" ], "calculation": { "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail": { "order": 1.0, "parentTag": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at December 31, 2022", "periodStartLabel": "Options, Outstanding at beginning of year", "terseLabel": "Stock Options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r395", "r396" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, Outstanding at December 31, 2022", "periodStartLabel": "Weighted average exercise price, Outstanding at beginning of year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased", "terseLabel": "Average price per share purchased by employees" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum", "terseLabel": "Reserved and Authorized Shares, percent of ordinary shares issued and outstanding at year end" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period", "terseLabel": "Ordinary shares issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r741" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award", "terseLabel": "Purchase of Ordinary shares by employees" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r391", "r392", "r393", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r415", "r416", "r417", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Equity Award [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/NumberOfReservedAndAuthorizedSharesUnderTheEquityIncentivePlansDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SummaryOfPerformanceStockUnitsActivityDetail", "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r394", "r413", "r414", "r415", "r416", "r419", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]", "terseLabel": "Accounting for stock-based compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/WeightedAverageAssumptionsOfOptionsGrantedDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "periodEndLabel": "Aggregate intrinsic value, Exercisable as of December 31, 2022" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares", "terseLabel": "Share based compensation arrangement by share based payment award options nonvested number of shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r60", "r240" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareServiceSupportAndMaintenanceArrangementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of deferred revenue by arrangement wherein an entity agrees to debug, revise and maintain software, under which fees are taken into income as performance occurs.", "label": "Software Service, Support and Maintenance Arrangement [Member]", "terseLabel": "Software updates and maintenance" } } }, "localname": "SoftwareServiceSupportAndMaintenanceArrangementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenuesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r680", "r742", "r750" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "State and Local Income Tax Expense (Benefit), Continuing Operations", "terseLabel": "Domestic" } } }, "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ComponentsOfIncomeTaxExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r23", "r100", "r200", "r229", "r230", "r231", "r247", "r248", "r249", "r251", "r259", "r261", "r278", "r318", "r365", "r422", "r423", "r424", "r451", "r452", "r489", "r509", "r510", "r511", "r512", "r513", "r514", "r532", "r590", "r591", "r592" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r247", "r248", "r249", "r278", "r568" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r8", "r9", "r100", "r101", "r400" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Options, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StockOptionActivityAndRelatedInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": { "auth_ref": [ "r9", "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.", "label": "Stock Issued During Period, Shares, Treasury Stock Reissued", "terseLabel": "Treasury stock reissued" } } }, "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquityParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r100", "r101" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Issuance of treasury shares under stock purchase plans, upon exercise of options and vesting of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Authorized amount under share repurchase programs" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r9", "r12", "r13", "r75", "r656", "r679", "r690", "r758" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "SHAREHOLDERS' EQUITY:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubscriptionArrangementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of deferred revenue by arrangement wherein a subscribers pay in advance for media (TV, newspaper, magazine, internet), which will generally be recognized as revenue as the media is delivered.", "label": "Subscription Arrangement [Member]", "terseLabel": "Security subscriptions" } } }, "localname": "SubscriptionArrangementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/DeferredRevenuesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r515", "r534" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r515", "r534" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r515", "r534" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r533", "r535" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events [Text Block]" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TaxYear2020Member": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "Identified as tax year 2020.", "label": "Tax Year 2020 [Member]" } } }, "localname": "TaxYear2020Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CommitmentsAndContingentLiabilitiesAdditionalInformationDetail", "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Text Block [Abstract]" } } }, "localname": "TextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TimeDepositsAtCarryingValue": { "auth_ref": [ "r670" ], "calculation": { "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail": { "order": 4.0, "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Any certificate of deposit or savings account held by a bank or other financial institution for a short-term specified period of time. Because of their short-term, time deposits are considered highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Time Deposits, at Carrying Value", "verboseLabel": "Short term deposits" } } }, "localname": "TimeDepositsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/CashAndCashEquivalentsShortTermBankDepositsAndMarketableSecuritiesScheduleOfCashAndCashEquivalentsAndShortTermInvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r195", "r196", "r197", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Trade Receivables" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trademarks and trade names" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/OtherIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r310", "r311", "r363", "r364", "r480", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r687", "r688", "r689", "r773", "r774", "r775", "r776", "r777", "r778", "r779" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/FinancialAssetsMeasuredAtFairValueOnRecurringBasisDetail", "http://www.checkpoint.com/role/FinancialIncomeNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r22", "r102" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury shares at cost" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r22", "r102" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury shares, shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r9", "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Shares repurchase, shares", "verboseLabel": "Treasury shares" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquityParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r22", "r102", "r103" ], "calculation": { "http://www.checkpoint.com/role/ConsolidatedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury shares at cost, 140,462,677 and 132,181,781 ordinary shares at December 31, 2022 and 2021, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r100", "r101", "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Treasury shares at cost", "terseLabel": "Shares repurchase, value" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r198", "r199", "r200", "r201", "r202", "r250", "r251", "r252", "r253", "r262", "r307", "r308", "r315", "r316", "r317", "r318", "r319", "r320", "r422", "r423", "r424", "r449", "r450", "r451", "r452", "r468", "r469", "r470", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r516", "r517", "r518", "r519", "r520", "r521", "r527", "r528", "r529", "r530", "r531", "r532", "r570", "r571", "r572", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Type of Adoption [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.checkpoint.com/role/StatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r753" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Type of Arrangement and Non-arrangement Transactions [Axis]", "terseLabel": "Type of Arrangement and Non-arrangement Transactions [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/GeneralAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UndistributedEarningsOfForeignSubsidiaries": { "auth_ref": [ "r182", "r193", "r429", "r463" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.", "label": "Undistributed Earnings of Foreign Subsidiaries", "terseLabel": "Undistributed earnings of foreign subsidiaries" } } }, "localname": "UndistributedEarningsOfForeignSubsidiaries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/TaxesOnIncomeAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r430", "r438" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ReconciliationOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r439" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increases related to tax positions taken during the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ReconciliationOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r440" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Decreases related to statute of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ReconciliationOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r69", "r70", "r71", "r279", "r280", "r282", "r283" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r264", "r272" ], "calculation": { "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Number of shares used in computing diluted earnings per share", "totalLabel": "Diluted weighted average ordinary shares outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r263", "r272" ], "calculation": { "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average ordinary shares outstanding", "verboseLabel": "Number of shares used in computing basic earnings per share" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.checkpoint.com/role/ConsolidatedStatementsOfIncome", "http://www.checkpoint.com/role/EarningsPerShareComputationOfBasicAndDilutedEarningsPerShareDetail" ], "xbrltype": "sharesItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e845-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e848-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "https://asc.fasb.org/topic&trid=2155941", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.1)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Subparagraph": "b.", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "https://asc.fasb.org/topic&trid=2134417", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r661": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r662": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r663": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r664": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r665": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r666": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r667": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r668": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r669": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r708": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r713": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "https://asc.fasb.org/topic&trid=2122478", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r773": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r774": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r775": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r776": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r777": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r778": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r779": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 95 0001193125-23-122355-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-122355-xbrl.zip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�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�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�+LT6+M0G6\;8H!?WBPO M1$DS_0NVVO >X=@!*:Q_VO+QB6&0/YLM=6=&08W+*K7I0>8NV3W@QF2I>(-K M&LR!^G[!G;*.N.K'XSOU*9GLK/]DII5XMO7DT6*WL #\C]0HC>L%7K^X[_2X M1^):RONR[SOBQ7*)Y365!:O.,E$QGM]:YB%Q@M5=J[*WM2*VHE^^FHVI5_,) MO==674IX+N]?SDVIOIW#-4SLG7V99V!?TSTG8#T%7KL'#)XJ)V3I) AO,Y]8 MN(0>KM /6Y.'=.OT-!6G:/>JV@Z?[:N61O$?>4'.,B]?3%(DSQ2,'4U3H0/6 M/P,Y=UY>\K#AWX[8Z%),G@4%(M^I5$$=!%&[=Z]SI9]]9RKHVJ"+]WO9-1?3 M4%D>C&QD&;OE8OLY=6$L#*6#]/ MDFJ@KH=8XM(KN&F$?YG&IL+ ][>#;!AH\'2SL\\55\ <6W^ ?Q6;VN($YK3] M(&&,C4L@]*&ZY;2WLM=,9*7-JX7X'R^U^[4VKKPFR721'W:.(":V>4[CRY37 M>MZ1?R;09\(2Q5T^E^D''HI,24SF8SG."27[ M3 2.9L^2AP(AGGBELC^T$OIL%O9*CZ,?T9!^E4[Q,GS3E'AQ=8,<^7'H92KW M=5EEL+L$=))@]B0X6F@(6V8 7O)AG"@JIBY,_V[OP;[JHN9/F,W)K.."GG%6 M?-1]+LMK6B%4AZS)^&^W$NZR@Q/. IB:8@\^"ZWMG)(5YX MQ2V!]YX*]GSBKCJ5Z.YQ>'[_0J42G-&E"9#L;57B!C; MH>U_7#C]R''+EF\%&0=ETFT NV1IX 5VRH[?5+P*98/K2>Q)S-,*>4\_$ML/ M7M?%Z(,;Z.)7;L9J;VD_IS)I5#BZ M]L1BMCQ_->[NW\DIO^ $V!7QQ@' _HG5-8'SYP97DMK_21PL3(][O [@!,D 3)(T) M!!!?V[PW;DQS62.%O! F)K^),@UB4LB&!?7Q.ZQ.$SS*5'%..+I M&*J6S4-!M7R>81'\V-U7Z/H6U=?Q7+OHCL3,A\2U_!960<%\CHT2UBR2"+3_ M*2A9>ILK'BQ9C5CI"2;;FZ_OJT9VGK%LSBZ-YSU#](/"Q'KI\(J_;M#L."X=6OI9YS]EKO34:Q0P_Z_6(PJ3 N=CPL,3 "G[%NH=5\:4N GLKI;WBI(P M2 _[JTH+I"(7YBV)_ ZH-W:T1X"U',/_D0Z6FBVL1F ,NT>5X9\ %A01;TK([W[4V9$X=C'EN%F4NVR^^=*Y82WT:AL/$#]ZT M1 X-U-Y87O25!6A)TL3H^JMR/U*2SV4J=%@]87S?QH]>9,@& 7*:=8ZWK 2IN)WHJ%=N195XPPP/2Q[ MX3X(YS(E$@X)86>IXVVPRP1N[?/48"V-N6,'Y+F(O<4%4X5[0 K!Y+)(5*-X%%_?7&5B6=E,R"E\-;G@C=3X*!$&#QJ3P3;[3/FIH:9<' M^_?&4Y3X&6%_=70:Q(25O^6K8.R-:0=]3=2V1_ZB"4@L=@HQ1%*;*@T]/FIX MSO%J3XEZ/& KA.??%?FG,'0804*? ^F*B'_N.F62?JVN'?QZD6",;KWK>R:S9?QG9C MCW4*_6*<_5G7ZS2?0.\BX]!O,1H<(+-F;_LA!I]4E%S\NQ([IL(=TE3?*]G.^AK&DASS"C=0V%L,26Q[ M["''6'=&ZQ4,?#KGU']:@<;'_L\14=1&*I;^''\U@/Q(><@$"3@P0)?Z?3V! M?1#?7L?=AO-%*7V93&G6[1OS^_+(\<-\O=T;?A"8U++?78'/+6[5FFTYA.Z_ MRO"P#U)?V_=X^#NL;M@Y>+E3K._ DQXI?P,G8:U^'> ''0J=>1<:%=\-M3LK M2Y]EH%.?@H3[:+!Z[H%Z&%/B189%^9]8U91L3SJ^7.RUAWUQ;EJ 'G*+=K.1 M[R@6@HN:E*<)"'=)NL*\IC1:-'2@Y;U6*^DKDBRRY0@L%'G<(I#3^86))/?8 MNZD4<6V_#*,X>)FYJ$T+W-*=XN 0+LUBH)9,3E MU^;OQF8$>6I+(UUJQS^BW2V=\RYTHQ2VXMO"79C.!<=>I\\M*R'=^97#!Z\K MR X#J8@O-#$S@?]S[.'[HGXS:SI#46P4UXVXEA$W.5X&SQXP8&Q-.9_DX MMM-_Z^*B[=Z.\*8]-DD&L;C+%5 -)5UH@C"K'C,G=3F"[6V<1*N(^]J*+K5X MC]-\;/6Z_NY*$S1/HPX^^7^"%B.4XE1=7)YKM=MX6H@*TB>'ATH_AB5\#=$? M&['^D>+IVO^1_,1(B;T(V]-G/400O!D[%(N MAD1-(.?;4.JK"8 UZE$T*;X0#Y5[45R"GR;P+MJ0(8D\%@//$,UT P\KZ QG M/8197Q^4&E9LJR2"X4T? Q@#EXX;0M&G^]R.75?>6>47L:KANBF:UZH^YG,' MVUJ,#']^DA.$^2^_FS5,$6DMPGZ/!L_B!5VI!*H?JUZC9&9D#J7"4]H^!!&^;J^ MM7FBP41U<'F?CV>UQKO#'#UP>W<1/2MC@R@Z_Y"@050O8AE:#0D=^ 2#FIIU MN1 F.__YPPT%Q1BE+>;5*GQ-AN&^4,[+C_O0!EA>DZSGP>(% N9[S)_Y&RPM&/+UF55PS4[*O.7RCUP/.QF.+BHM"]-LG W,6>\= OW4$$:%-,>Y4' MB/B\\%SCWES.L/7PQIA[]VRU2J#8M8Q+PZ_<0&,$0L1T%))5^V+A-8J+H?OQ&S8RT/P-_T5XI<_= M^+7Q?H_.3@MGQ3U@N[)H*N?' X&W..K?]K4E2\!YS"47MBZLCI#_\&J9E31Z022Y;M M"#VF?%I=3]T$%N_%JX*.K#.O>5@BJEG@YXW*,JL#JKA-=%U.W,+A6!\S3GKN MG)(=RV]0A!^D/KR:GF2%]15SX)/7HTNG4R*2/3YS4UB+9^S-;$K"&]X0G;A"V]&]":X3YM/FT*T"D9MN,GAE57.H*] M' 6RP>+,2O4+RZ;Y3*7V:!I1RVCMTT$T%A=H]W(7ZWK)R='I1X\\=J$'ULA3Q*@Y:Y ZIBS040K%L4RP.#)/*4!Y\EU0 M2R/VQY"TY_+T2=V:F&:F2-V8^:Q/6;5 M@U--?^>9VO9FI=66FFTN1(*N2Y*LX= @JN$>P%]0Y9YMS*/2:_HJ:Q.>K*3M MRYT<>)E/."LLO_N=SM/2;4>"'30#.EX9@$KU*BW3S(AS(,(7E^/ENN'*8('U M+U9SJ"U8Y.E'#TN!MG-9S27%C+C5MR'B?LO(@?*U'/5]_;Q>1^O"]QWDAY'0 MVQR!=8ME>V.OH=+R,MEA!EZ)WEUG<_M&8;5K4S1W\#%!AWR.D.+8>I^S!#:[59P9/64]I97CQ*'B]?3 M%*5/=<1;]5C(DWP0O[:O8\ EASW/SV,#'_R$RKH'-!O\HECN&7 M+GS*!.WU19SU6$1AA%B N&,/<8#V+"Q>#%7_?@AQFEYRA--_;*;XK.IP5#+% MMI24IDS_N*%IVS $N"VV50-L>Y>9GM!676%T\*>?MH$J1S>$VIK:B$?7>^N: M",[H?V4Y&'MIQSJ]E?E,_F];L?LD(\+E1J+JXHD&46/]AS*IL#8+7^[3VZ6S M C;Q>0*W+M0&DLPHMJ0$ECOH[%L8B\BC\ $%9\%TJ]!6]'3K MBPGT,W;4]$S*]%$^MC7MSQO>&( =K;;Q!\;0KTIGLY_@CSP3TB)=&';[TL2P M.%N52,]%7M;I4';Z2ES*(F?9GL]^VV7Y("=KXLLW(]^?5@-QI5."E_Z\FY^Q M^'BS3Z0)5>7C52H[_F1M.XGEC)@D+XR! +M\K5UI'*=Y#,ZZL#J"8FS3P9'- MF$89$6=W2:NNU0DL+/@:@93%U/;DGX,7??$C;ZGG$,?^1J6)],I/,QXKU8F_ MH/UE/TS>D\N.KJ,^R>49+XE4F2ZBF*/X'.L#_HX?2U*F&>7MT?][NWI#FJ*C M-U]!O%^+ @WG>^+[:EG&U"Y=O>\(X0VV%&E"BD\5NE:JP5563XCX$Z",&_@: M[O9H&--O$X&UL4$L! A0#% @ \X.; M5B%?V=':D@ J%D( !4 ( !E6X &-H:W M,C R,C$R,S%? M;&%B+GAM;%!+ 0(4 Q0 ( /.#FU9)5KV6Z60 *>%!@ 5 M " :(! 0!C:&MP+3(P,C(Q,C,Q7W!R92YX;6Q02P$"% ,4 " #S@YM6 MXG,Q9?[. @#=11\ #P @ &^9@$ 9#0W,S,P,60R,&8N:'1M M4$L! A0#% @ \X.;5MVQMXU^!P E2D !$ ( !Z34$ M &0T-S,S,#%D97@Q,C$N:'1M4$L! A0#% @ \X.;5J*[RFR?!P ^2L M !$ ( !ECT$ &0T-S,S,#%D97@Q,C(N:'1M4$L! A0#% M @ \X.;5N2.UQAB! M0\ !$ ( !9$4$ &0T-S,S,#%D M97@Q,S$N:'1M4$L! A0#% @ \X.;5E-NS&]E! P@\ !$ M ( !]4D$ &0T-S,S,#%D97@Q,S(N:'1M4$L! A0#% @ \X.;5L_R M7S%R! V!( ! ( !B4X$ &0T-S,S,#%D97@Q-2YH=&U0 M2P$"% ,4 " #S@YM6Z-